Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AGRP,Agouti-related protein,40058,-0.197028332165659,0.0049520001420611,-0.206734252444099,-0.187322411887219,0
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,39913,0.133644736425833,0.00291258755946,0.127936064809291,0.139353408042374,0
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GCG,Pro-glucagon,39477,-0.505819401890177,0.0111976428847983,-0.527766781944382,-0.483872021835973,0
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LDLR,Low-density lipoprotein receptor,39882,-0.208892750078198,0.00481528707458892,-0.218330712744392,-0.199454787412003,0
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MFGE8,Lactadherin,39858,-0.211613398118273,0.003900847738681,-0.219259059686088,-0.203967736550459,0
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRAP1,Proline-rich acidic protein 1,37437,-0.142520597651404,0.00372750715312527,-0.14982651167153,-0.135214683631279,7.05313211022097e-304
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,39858,0.107115011998859,0.00283091328724307,0.101566421955863,0.112663602041856,3.87906764959293e-300
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NPY,Pro-neuropeptide Y,40030,-0.2315581586687,0.00616142979242865,-0.24363456106186,-0.21948175627554,2.03612080753952e-296
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PON3,Serum paraoxonase/lactonase 3,39931,0.0980581171237108,0.00261965096713856,0.0929236012281193,0.103192633019302,4.29543607511462e-294
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGSF9,Protein turtle homolog A,37437,-0.282611502978222,0.00765921475157399,-0.297623563891307,-0.267599442065137,4.12163240792308e-284
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PYY,Peptide YY,37021,-0.291522036539691,0.00863830339474158,-0.308453111193384,-0.274590961885997,1.59554795336177e-239
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRSS8,Prostasin,39805,-0.12292657398997,0.00376262855484463,-0.130301325957466,-0.115551822022475,1.13762640947771e-226
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,39749,-0.0868480161213634,0.00273750032309049,-0.0922135167546208,-0.0814825154881061,3.15575427705579e-214
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TMPRSS15,Enteropeptidase,39788,-0.265934546460368,0.00838694542947871,-0.282372959502146,-0.24949613341859,5.07955908230777e-214
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCN1,CCN family member 1,39758,-0.223258971226557,0.00719506119795158,-0.237361291174542,-0.209156651278572,2.71347305336729e-205
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APOF,Apolipoprotein F,37445,0.0743431728046172,0.00244343647883433,0.0695540373061019,0.0791323083031325,9.28327693748827e-197
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GPR37,Prosaposin receptor GPR37,39585,-0.183013074756403,0.00605215822964996,-0.194875304886517,-0.171150844626289,2.68586504316242e-195
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CES1,Liver carboxylesterase 1,39854,-0.225811627622598,0.00750764244993757,-0.240526606824476,-0.21109664842072,2.21519448333233e-193
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LPL,Lipoprotein lipase,39868,0.12973122927382,0.00447065629337674,0.120968742938801,0.138493715608838,1.75560499665802e-180
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C9,Complement component C9,37445,0.145539401543951,0.00502021525453234,0.135699779645068,0.155379023442835,2.35368518977863e-179
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD4,T-cell surface glycoprotein CD4,39839,-0.0772991197051688,0.00273532363839591,-0.0826603540364248,-0.0719378853739129,1.73939778167116e-171
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL27,C-C motif chemokine 27,39868,-0.163358933177226,0.00592503680651527,-0.174972005317996,-0.151745861036456,1.60033148521643e-163
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,39788,-0.171607099765931,0.00631071610003448,-0.183976103321998,-0.159238096209863,3.32171722952358e-159
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAMDC4,Apical endosomal glycoprotein,37368,-0.143437104211813,0.0052903083926795,-0.153806108661465,-0.133068099762161,1.10049615453149e-157
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,40017,0.314869027481142,0.0116586837302753,0.292018007369803,0.337720047592482,3.6731577629828e-157
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTH,Parathyroid hormone,37039,-0.205412155147204,0.00758676182261768,-0.220282208319534,-0.190542101974873,3.69935577142574e-157
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OXT,Oxytocin-neurophysin 1,40009,-0.349683277185323,0.0131552607866946,-0.375467588327245,-0.323898966043402,2.08699647174137e-152
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,39949,-0.11839690861414,0.00448824085772385,-0.127193860695279,-0.109599956533002,3.6256960867933e-150
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APOM,Apolipoprotein M,39908,0.0665256890078391,0.00253385894163277,0.0615593254822389,0.0714920525334393,8.61289311189155e-149
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FURIN,Furin,39913,-0.0825473210793636,0.00321725039717185,-0.0888531318578204,-0.0762415103009067,2.52404561767508e-142
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",39489,-0.124521056633984,0.00485294192486806,-0.134032822806726,-0.115009290461243,2.9191016504176e-142
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADIPOQ,Adiponectin,37453,0.160711782814562,0.00629415215637158,0.148375244588073,0.17304832104105,1.67225043753633e-140
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACY1,Aminoacylase-1,39868,-0.147786410137268,0.00587322524275541,-0.159297931613068,-0.136274888661467,4.66326210394812e-137
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,39585,-0.342639265835611,0.0137843675707288,-0.36965662627424,-0.315621905396983,8.18797885661125e-134
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,40030,-0.0770422703280065,0.00311166721845928,-0.0831411380761867,-0.0709434025798263,7.27863279879848e-133
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,39749,-0.0743379870966435,0.00301915852252013,-0.080255537800783,-0.0684204363925041,2.10121687667875e-131
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,39820,-0.124776355715692,0.00509087198604425,-0.134754464808339,-0.114798246623046,2.93659989977241e-130
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPY,Pancreatic prohormone,39826,-0.230599044503111,0.00953138130298737,-0.249280551856966,-0.211917537149256,4.96864957245645e-127
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,40030,-0.0780234510358926,0.00322896179684936,-0.0843522161577174,-0.0716946859140679,9.39676217229295e-127
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CXCL13,C-X-C motif chemokine 13,40009,-0.133358364431565,0.00560696513623107,-0.144348016098578,-0.122368712764552,6.2390631747472e-123
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL16,C-C motif chemokine 16,40052,-0.117310983102397,0.00497343191009624,-0.127058909646185,-0.107563056558608,5.63033089698841e-121
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACE2,Angiotensin-converting enzyme 2,39585,-0.111853959746494,0.00474654355396733,-0.12115718511227,-0.102550734380718,1.07002533008427e-120
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTSD,Cathepsin D,38721,-0.0881048437592516,0.00374455089270743,-0.0954441635089582,-0.0807655240095451,3.22616381003006e-120
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MVK,Mevalonate kinase,39587,-0.177296674692521,0.00754931978929789,-0.192093341479545,-0.162500007905498,6.64359316697026e-120
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLTP,Phospholipid transfer protein,39976,0.0803546323812524,0.0034246594885494,0.0736422997836956,0.0870669649788093,9.70286180925136e-120
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLC39A5,Zinc transporter ZIP5,39866,-0.117801770964321,0.00504410576947207,-0.127688218272486,-0.107915323656156,1.19044184762347e-118
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,39585,-0.187873929774038,0.00804441837097093,-0.203640989781141,-0.172106869766935,1.28253067368368e-118
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,39477,-0.138709139288922,0.00595569713839974,-0.150382305680186,-0.127035972897659,5.66601062252702e-118
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NHLRC3,NHL repeat-containing protein 3,36838,-0.0710312498800439,0.003055811574729,-0.0770206405665127,-0.065041859193575,3.91475726263929e-117
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,39683,-0.1029217252586,0.00443628004860454,-0.111616834153865,-0.0942266163633347,4.06836751353738e-117
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PGF,Placenta growth factor,40058,-0.0566778945924901,0.00245642999135243,-0.0614924973755408,-0.0518632918094393,6.31175808028867e-116
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CA14,Carbonic anhydrase 14,40030,0.0767763841535344,0.00335064219856079,0.0702091254443553,0.0833436428627136,2.22373359889548e-114
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GDF15,Growth/differentiation factor 15,40052,-0.0927383524605158,0.00404941438936694,-0.100675204663675,-0.0848015002573566,2.90428323799481e-114
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLUL1,Clusterin-like protein 1,39840,0.0982213533469204,0.0043193674475697,0.0897553931496838,0.106687313544157,1.10569146710828e-112
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GUSB,Beta-glucuronidase,39919,-0.126555225073143,0.00561167510877655,-0.137554108286345,-0.115556341859941,6.709466924629e-111
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GSTA1,Glutathione S-transferase A1,39841,-0.182788691477825,0.00811164283423486,-0.198687511432925,-0.166889871522724,1.01432842997575e-110
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,F7,Coagulation factor VII,39899,-0.0643820092052171,0.00286179103578795,-0.0699911196353614,-0.0587728987750727,2.24693670757689e-110
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL23,C-C motif chemokine 23,39931,-0.0882462216521708,0.00392954204268559,-0.0959481240558346,-0.0805443192485071,5.33780453650912e-110
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UPB1,Beta-ureidopropionase,37437,-0.197964322816976,0.00880957887511667,-0.215231097412204,-0.180697548221747,7.85222409580207e-110
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,37368,-0.180693224879982,0.00808132828470497,-0.196532628318004,-0.16485382144196,9.11047573654513e-109
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RTN4R,Reticulon-4 receptor,40030,-0.0703928811599142,0.00316573099979992,-0.076597713919522,-0.0641880484003064,6.36860086204455e-108
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,40011,-0.0901972904354153,0.00407937887126399,-0.0981928730230927,-0.0822017078477378,9.54463273400426e-107
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,37124,0.0634290719739774,0.00288294691408135,0.057778496022378,0.0690796479255768,2.11673244654464e-105
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,37388,-0.161619488174024,0.0073487233058449,-0.17602298585348,-0.147215990494568,2.34069501338614e-105
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGF21,Fibroblast growth factor 21,40011,-0.249501228463095,0.011392700464092,-0.271830921372715,-0.227171535553474,8.63875206832958e-105
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GIP,Gastric inhibitory polypeptide,37043,-0.0909818377498676,0.00418490680365703,-0.0991842550850354,-0.0827794204146998,5.42282243143665e-103
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LGALS4,Galectin-4,39862,-0.10945490757138,0.00504273982308547,-0.119338677624628,-0.0995711375181329,5.54687949592148e-103
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,39477,-0.122546235142945,0.00565994146751074,-0.133639720419266,-0.111452749866624,1.87916157630566e-102
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CHI3L1,Chitinase-3-like protein 1,39545,-0.155856654458472,0.00720388165852485,-0.169976262509181,-0.141737046407763,2.6160597520376e-102
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AMBP,Protein AMBP,40003,-0.0398605049695159,0.0018476527864921,-0.0434819044310404,-0.0362391055079914,8.67192441410888e-102
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,39913,-0.0717730778830869,0.0033277420897546,-0.0782954523790059,-0.0652507033871678,9.91055290630807e-102
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MUC13,Mucin-13,39489,-0.104118737133425,0.0048442340548789,-0.113613435880987,-0.0946240383858622,5.18694799489372e-101
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,39585,-0.0814642634082892,0.0037949115340227,-0.0889022900149737,-0.0740262368016047,8.87100216364312e-101
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KITLG,Kit ligand,39868,0.0758950816089664,0.0035461069135158,0.0689447120584755,0.0828454511594574,3.20939739127558e-100
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TFF3,Trefoil factor 3,39839,-0.0980619137091145,0.00464044262516033,-0.107157181254429,-0.0889666461638002,8.76074346111411e-98
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,39868,-0.0608503545221329,0.00288981425475019,-0.0665143904614433,-0.0551863185828226,4.09030838381699e-97
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,37124,-0.0752448687473662,0.00357204864204073,-0.082246084085766,-0.0682436534089664,6.40308441965062e-97
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,39948,-0.0623276279975084,0.00297685961770209,-0.0681622728482045,-0.0564929831468123,4.65640652194756e-96
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,39587,-0.109590057840336,0.00524063779164463,-0.119861707911959,-0.0993184077687125,8.4218105974724e-96
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,39749,-0.107939574298715,0.00517373986790322,-0.118080104439805,-0.0977990441576245,2.20086652978882e-95
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RBP5,Retinol-binding protein 5,39788,-0.111393437796806,0.0053596578611086,-0.121898367204578,-0.100888508389033,1.09427903003263e-94
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CPM,Carboxypeptidase M,39955,-0.0683514760504259,0.0032976984814114,-0.0748149650739923,-0.0618879870268596,3.34888650424624e-94
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,INHBC,Inhibin beta C chain,39858,-0.0819506054164084,0.00396805370876113,-0.0897279906855802,-0.0741732201472366,1.53140573595169e-93
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,40030,-0.0734725705577675,0.00356677316832667,-0.0804634459676878,-0.0664816951478472,4.36239834324463e-93
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL17RB,Interleukin-17 receptor B,39644,0.10611653904756,0.00515743276984167,0.09600797081867,0.116225107276449,7.50535617856908e-93
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,39587,-0.082321778215381,0.00400714778454559,-0.0901757878730904,-0.0744677685576717,1.43283844180983e-92
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",39585,-0.17785744344137,0.0087078931960062,-0.194924914105542,-0.160789972777198,1.54486516088454e-91
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HGF,Hepatocyte growth factor,40058,-0.0663009694308321,0.0032555833473739,-0.0726819127916849,-0.0599200260699792,4.67996919490479e-91
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,39788,-0.154975571071758,0.00761051172284964,-0.169892174048543,-0.140058968094973,5.08288139273442e-91
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,39868,-0.0641089551200443,0.00315060480206372,-0.0702841405320892,-0.0579337697079994,6.78970229048914e-91
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",39788,-0.157890531082311,0.00779348831763728,-0.17316576818488,-0.142615293979742,4.00950683195582e-90
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MME,Neprilysin,39788,-0.152733751883088,0.00753932585317919,-0.167510830555319,-0.137956673210857,4.09063394528478e-90
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EPHA1,Ephrin type-A receptor 1,39904,-0.0647579678588578,0.00319756345396613,-0.0710251922286314,-0.0584907434890842,4.52109412695081e-90
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,40009,-0.0655858782266335,0.00324271012466135,-0.0719415900709698,-0.0592301663822973,7.53427999112188e-90
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,39788,-0.167658045470997,0.00832095568098242,-0.183967118605723,-0.151348972336272,3.54698683338802e-89
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,39477,-0.15912960511162,0.00791663597190641,-0.174646211616557,-0.143612998606684,9.62742917682849e-89
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NTRK3,NT-3 growth factor receptor,40009,0.0409086345275237,0.00204213661894765,0.0369060467543863,0.044911222300661,3.38923380435657e-88
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NRP1,Neuropilin-1,39949,0.0532033834712585,0.00265745605953845,0.0479947695945631,0.0584119973479539,4.31374136381083e-88
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,39788,-0.0576258693897529,0.00288620104982754,-0.0632828234474149,-0.0519689153320909,1.28134598868885e-87
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DSG2,Desmoglein-2,39858,0.0509040416951371,0.00255672832441948,0.0458928541792749,0.0559152292109993,3.79063703979482e-87
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AMOT,Angiomotin,37124,-0.0791192844032254,0.00397275817254695,-0.0869058904214174,-0.0713326783850334,5.55311840868361e-87
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GSTA3,Glutathione S-transferase A3,39477,-0.145050915419865,0.00732818144649153,-0.159414151054988,-0.130687679784742,3.83833720294603e-86
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINF1,Pigment epithelium-derived factor,37254,-0.0486508306270369,0.00245881630779354,-0.0534701105903122,-0.0438315506637615,6.56116226162762e-86
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL15,C-C motif chemokine 15,40052,-0.0814778001783859,0.00415727235377387,-0.0896260539917827,-0.0733295463649891,1.50680621246141e-84
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RNASET2,Ribonuclease T2,39974,-0.0477155224236732,0.00244505269147504,-0.0525078256989643,-0.0429232191483821,7.5718064616288e-84
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTSO,Cathepsin O,40058,-0.0558433407864034,0.00287206147308327,-0.0614725812736466,-0.0502141002991602,2.92906105866648e-83
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CPA2,Carboxypeptidase A2,39933,-0.12012355665608,0.0061784340649239,-0.13223328742333,-0.108013825888829,3.05014421141965e-83
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,F9,Coagulation factor IX,39908,-0.0339234144972889,0.00174647921354288,-0.0373465137558329,-0.0305003152387449,4.35313229785085e-83
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NOMO1,Nodal modulator 1,39858,-0.0441348910258615,0.00227447690286219,-0.0485928657554714,-0.0396769162962516,6.34694777907922e-83
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NFASC,Neurofascin,40058,-0.0514647527812053,0.00265761199535201,-0.0566736722920952,-0.0462558332703153,1.30566594113952e-82
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NECTIN2,Nectin-2,39846,-0.0522049546067472,0.00270657842241092,-0.0575098483146726,-0.0469000608988218,5.75585778055223e-82
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRIP2,Cysteine-rich protein 2,39749,-0.0661931231749001,0.00344354415921892,-0.0729424697269692,-0.0594437766228311,2.01733062230754e-81
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,39893,-0.0415010023646004,0.00216303194112222,-0.0457405449692,-0.0372614597600008,3.89024502825503e-81
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,37437,-0.130748928305589,0.00683418195761327,-0.144143924942511,-0.117353931668667,1.57509470865039e-80
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GHR,Growth hormone receptor,37124,-0.0528662518335116,0.0027709833181717,-0.0582973791371281,-0.047435124529895,4.48492529034e-80
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,39788,-0.0988928484862006,0.00521942611277318,-0.109122923667236,-0.0886627733051651,3.46335518711971e-79
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD300LG,CMRF35-like molecule 9,39858,0.0665178323980603,0.0035142420966324,0.0596299178886608,0.0734057469074598,4.88658548704935e-79
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,39931,-0.050857928758601,0.00268951482575617,-0.0561293778170831,-0.0455864797001189,6.8107554498709e-79
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,40058,-0.0657962057627926,0.00348392749342678,-0.0726247036499091,-0.0589677078756761,1.04795266559322e-78
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MENT,Protein MENT,37124,0.0403876122595455,0.00213991733889646,0.0361933742753084,0.0445818502437825,2.00290321398346e-78
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SEMA3F,Semaphorin-3F,39868,-0.0461236464602779,0.00244973498930311,-0.050925127039312,-0.0413221658812438,3.1130919588564e-78
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MEP1A,Meprin A subunit alpha,37382,-0.129247391182656,0.00689455038300513,-0.142760709933346,-0.115734072431966,1.98305310675496e-77
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FETUB,Fetuin-B,39908,-0.0604911919284717,0.00323589660689487,-0.0668335492779856,-0.0541488345789577,3.66647683279337e-77
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MCAM,Cell surface glycoprotein MUC18,39931,0.0587214197453344,0.00314234733527851,0.0525624189681885,0.0648804205224803,4.13322321898288e-77
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GRP,Gastrin-releasing peptide,37043,-0.0937572812126342,0.00502334689689551,-0.103603041130549,-0.083911521294719,9.39535075602411e-77
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ELN,Elastin,37437,-0.0602524532707687,0.00323243860440483,-0.0665880329354021,-0.0539168736061352,1.37321418350805e-76
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APOD,Apolipoprotein D,36780,0.0778199421820247,0.00417784452421009,0.069631366914573,0.0860085174494765,1.9459634325948e-76
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,39788,-0.190132398372133,0.0102289003078397,-0.210181042975499,-0.170083753768768,2.58696998386334e-76
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,39908,0.0512861181318711,0.00276499909883543,0.0458667198981537,0.0567055163655885,5.23663693888417e-76
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCG2,Secretogranin-2,39949,-0.055334568004923,0.00298631295950833,-0.0611877414055593,-0.0494813946042866,7.35818455955592e-76
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCLY,Selenocysteine lyase,39984,-0.0874654544549013,0.00472122475252972,-0.0967190549698596,-0.0782118539399431,7.79509323768929e-76
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,39866,-0.0900406970828098,0.00486690176162437,-0.0995798245355936,-0.080501569630026,1.25308816811403e-75
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTSZ,Cathepsin Z,39865,-0.0547719815955298,0.00298122660928553,-0.0606151857497294,-0.0489287774413302,1.27956298738251e-74
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SELE,E-selectin,40052,-0.0876435011437817,0.00478155765365654,-0.0970153541449486,-0.0782716481426149,2.71358891446197e-74
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GLA,Alpha-galactosidase A,37088,-0.0664874392610977,0.00364280136333683,-0.0736273299332379,-0.0593475485889575,1.59673506889686e-73
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,40052,0.0585837388430654,0.00326330162651451,0.052187667655097,0.0649798100310339,2.26402176275467e-71
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DPY30,Protein dpy-30 homolog,39979,-0.101690564766314,0.00568954062292552,-0.112842064387248,-0.0905390651453796,9.17804195089031e-71
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HAO1,Hydroxyacid oxidase 1,40030,-0.220814488677073,0.0123843286379951,-0.245087772807543,-0.196541204546603,1.94662962479283e-70
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD5,T-cell surface glycoprotein CD5,40003,-0.0562656943970811,0.0031573168538457,-0.0624540354306187,-0.0500773533635435,2.30229461002279e-70
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,37124,-0.0841226534252112,0.00472298022352443,-0.0933796946633191,-0.0748656121871033,3.77775717164002e-70
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,39931,-0.0447606237145092,0.00251698983387598,-0.0496939237889062,-0.0398273236401123,4.45764470682557e-70
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,39713,-0.122488459940206,0.00692167310119868,-0.136054939218556,-0.108921980661857,2.07844072135831e-69
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FAM20A,Pseudokinase FAM20A,37437,-0.0481064844576389,0.00272148474235819,-0.053440594552661,-0.0427723743626169,3.77646614459711e-69
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,39788,-0.0600722037202926,0.00340563751130027,-0.0667472532424412,-0.0533971541981441,5.58927456146492e-69
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CST3,Cystatin-C,39897,-0.0450179197748767,0.00255555053292609,-0.0500267988194119,-0.0400090407303416,8.28973828037321e-69
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL18R1,Interleukin-18 receptor 1,40058,-0.0550514920633684,0.00312895883925818,-0.0611842513883144,-0.0489187327384224,1.18686491075728e-68
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDH2,Cadherin-2,39868,-0.0591177401391166,0.00337311124126659,-0.0657290381719991,-0.0525064421062341,3.9120596999757e-68
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FAM3B,Protein FAM3B,39788,-0.0604366588156521,0.00345160318055965,-0.0672018010495491,-0.0536715165817552,5.23200592420255e-68
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,40058,-0.0606196240302782,0.00347110971589036,-0.0674229990734233,-0.0538162489871331,1.12160778125326e-67
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,39913,-0.036136483797636,0.00207063192804798,-0.04019492237661,-0.0320780452186619,1.39948042953881e-67
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UMOD,Uromodulin,40012,0.088166382084531,0.00506517086411259,0.0782386471908703,0.0980941169781916,3.02997448973548e-67
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PIGR,Polymeric immunoglobulin receptor,39677,-0.0607982833538872,0.00349441975075755,-0.067647346065372,-0.0539492206424024,3.56214823861097e-67
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,37437,-0.107679621113012,0.00622211486589772,-0.119874966250172,-0.0954842759758529,2.18392481279896e-66
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NCS1,Neuronal calcium sensor 1,40030,-0.0466241647490864,0.00270187855059025,-0.0519198467082432,-0.0413284827899295,3.92935513184094e-66
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,39585,-0.090078134816829,0.00523428401805737,-0.100337331492221,-0.0798189381414365,9.05449707455215e-66
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,40040,-0.0636761332321467,0.00370200418607809,-0.0709320614368598,-0.0564202050274337,1.01152918162183e-65
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HJV,Hemojuvelin,37411,-0.0737228630432395,0.00428749791180441,-0.0821263589503762,-0.0653193671361029,1.43813614853276e-65
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MTSS1,Protein MTSS 1,37382,-0.183170227723177,0.0106544021499094,-0.204052855936999,-0.162287599509354,1.51462416937095e-65
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,S100P,Protein S100-P,39585,-0.0864431089853785,0.005051441240211,-0.0963439338161921,-0.0765422841545649,4.64132555791727e-65
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NPPC,C-type natriuretic peptide,39866,-0.0751343009593781,0.00439489735560808,-0.0837482997763699,-0.0665203021423862,6.01322111849409e-65
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLA2G15,Phospholipase A2 group XV,39913,-0.0433849438158233,0.00254138456254318,-0.0483660575584079,-0.0384038300732387,9.03665863937598e-65
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BPIFB1,BPI fold-containing family B member 1,39786,0.103869605474239,0.00608558346630058,0.0919418618802895,0.115797349068188,9.64199408103958e-65
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",39913,-0.0566250111330913,0.00332040270469623,-0.0631330004342959,-0.0501170218318867,1.21741914884488e-64
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OCLN,Occludin,37411,-0.0706135250324058,0.00414854815047319,-0.0787446794073332,-0.0624823706574783,2.65783223892574e-64
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LSP1,Lymphocyte-specific protein 1,39866,-0.0660005666382039,0.00388868607401889,-0.073622391343281,-0.0583787419331269,4.7687499516641e-64
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CPB1,Carboxypeptidase B,40052,-0.0935434215792711,0.0055236646334178,-0.10436980426077,-0.0827170388977722,8.7855822915707e-64
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,37085,-0.0631558510792022,0.00372985563037785,-0.0704663681147427,-0.0558453340436616,1.21143970169802e-63
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTBS,Di-N-acetylchitobiase,37296,-0.0451158829359008,0.00266592983623762,-0.0503411054149266,-0.0398906604568751,1.38270571108144e-63
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,37114,-0.0774312807849171,0.0045781359257363,-0.0864044271993603,-0.068458134370474,1.66251310132666e-63
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AREG,Amphiregulin,39788,-0.075909955882237,0.00449894845649737,-0.0847278948569718,-0.0670920169075021,2.52902407316691e-63
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KYNU,Kynureninase,40058,-0.0737035932411451,0.00437451970356538,-0.0822776518601332,-0.065129534622157,3.71841725792894e-63
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,37437,-0.0515772635358845,0.00306112806310038,-0.0575770745395612,-0.0455774525322078,4.65121890739393e-63
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,39866,-0.0594642147178248,0.00353854899167242,-0.0663997707415028,-0.0525286586941469,7.79115462294277e-63
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,39788,0.0320083732938384,0.00190488426860285,0.0282748001273768,0.0357419464602999,8.01831664143331e-63
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",37043,-0.0929747795967288,0.00554538669652782,-0.103843737521923,-0.0821058216715343,1.91131612435147e-62
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,37021,-0.110197382591983,0.00659327783963793,-0.123120207157673,-0.0972745580262926,4.54798976789722e-62
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AGR3,Anterior gradient protein 3,39464,-0.0944528980232258,0.00567292479331096,-0.105571830618115,-0.0833339654283363,1.03470358625643e-61
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KHK,Ketohexokinase,37043,-0.104262969408594,0.0062590448593409,-0.116530697332902,-0.091995241484286,1.12966171527715e-61
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,37445,0.0410666083943556,0.00246997157170819,0.0362254641138075,0.0459077526749036,1.81688301100189e-61
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,37268,-0.0475667365966301,0.00287224288857616,-0.0531963326582393,-0.0419371405350208,5.38930128138465e-61
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TFPI,Tissue factor pathway inhibitor,39843,0.0500682497294403,0.00302720196215876,0.0441349338836091,0.0560015655752715,6.12038519203105e-61
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL16,Pro-interleukin-16,40058,-0.0655135120593436,0.00396335123878641,-0.073281680487365,-0.0577453436313223,7.05209502623017e-61
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,39858,-0.0434362719157613,0.00264156884779723,-0.0486137468574439,-0.0382587969740788,2.92051013224386e-60
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HEG1,Protein HEG homolog 1,37124,-0.0430497920374576,0.00261803145108185,-0.0481811336815781,-0.0379184503933372,3.66853763161361e-60
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,37382,-0.0410785905792845,0.00250447908523939,-0.0459873695863537,-0.0361698115722153,6.99405438959225e-60
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,39419,-0.0854677089063228,0.0052561431485435,-0.0957697494774681,-0.0751656683351775,5.75956705967903e-59
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,F11R,Junctional adhesion molecule A,39858,-0.0884007975024834,0.00544275586426108,-0.0990685989964351,-0.0777329960085317,7.53273586627192e-59
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",37388,-0.060158161442113,0.00371092850896492,-0.0674315813196842,-0.0528847415645417,1.49889093654395e-58
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,39868,-0.0541243533831051,0.00335107402426807,-0.0606924584706705,-0.0475562482955397,3.20526297570642e-58
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CXCL6,C-X-C motif chemokine 6,40058,-0.118765921638386,0.00739143925171917,-0.133253142571756,-0.104278700705017,1.1922775002814e-57
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,37410,0.0750103501671733,0.00466859129873668,0.0658599112216494,0.0841607891126972,1.47690108811866e-57
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TGFA,Protransforming growth factor alpha,39866,-0.0708451830614611,0.00441821699549296,-0.0795048883726273,-0.0621854777502949,2.04474029705776e-57
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,39885,-0.0452625646193866,0.00282374346890811,-0.0507971018184466,-0.0397280274203267,2.22866356896771e-57
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,39698,-0.0424846806826032,0.00265578623041643,-0.0476900216942195,-0.037279339670987,3.75681699449915e-57
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,40009,-0.0803713478563348,0.00503168262216068,-0.0902334457957698,-0.0705092499168999,5.37944002588584e-57
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,37368,-0.0877865639922609,0.00550771474094225,-0.0985816848845077,-0.0769914431000141,1.1185856375881e-56
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,39826,-0.0759489774756034,0.00478309921444365,-0.085323851935913,-0.0665741030152939,2.40551670941311e-56
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AGR2,Anterior gradient protein 2 homolog,39364,-0.152739491038425,0.00964521828620265,-0.171644118879382,-0.133834863197467,4.84590364432907e-56
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AFM,Afamin,37453,-0.0290293214578705,0.00183307781648916,-0.0326221539781892,-0.0254364889375517,5.52383952136977e-56
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",39477,-0.126486210329692,0.00799246493652905,-0.142151441605289,-0.110820979054095,5.6335707395119e-56
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PXN,Paxillin,39489,-0.0785604612287993,0.00497758723999007,-0.0883165322191798,-0.0688043902384188,1.09909713965987e-55
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SULT2A1,Bile salt sulfotransferase,39866,-0.0848234560148842,0.00537868603175685,-0.0953656806371277,-0.0742812313926408,1.30616317390468e-55
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CREG1,Protein CREG1,39660,-0.0568650798457063,0.00361607688418812,-0.063952590538715,-0.0497775691526976,2.65068528057599e-55
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,39477,-0.102326182718893,0.00650883358809595,-0.115083496551561,-0.0895688688862251,2.87485022331088e-55
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EGLN1,Egl nine homolog 1,39866,-0.0804815316731121,0.00513815956712125,-0.0905523244246697,-0.0704107389215544,6.86730920658896e-55
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,39866,-0.094610929010248,0.00608841561940441,-0.106544223624281,-0.0826776343962154,4.6528508205185e-54
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EFNA4,Ephrin-A4,39720,-0.0413967645246579,0.00266579893293216,-0.046621730433205,-0.0361717986161109,5.52640850106455e-54
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,POSTN,Periostin,37437,0.0555391832600648,0.0035877227110712,0.0485072467463653,0.0625711197737644,1.35105061964554e-53
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PSME1,Proteasome activator complex subunit 1,39738,-0.0549466170494303,0.00355985314864355,-0.0619239292207717,-0.047969304878089,2.32064552930029e-53
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CXCL10,C-X-C motif chemokine 10,39931,-0.0975566728590664,0.00634733006783408,-0.109997439792021,-0.0851159059261116,6.21809818473446e-53
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRSS2,Trypsin-2,39931,-0.076031518526817,0.00495248670802535,-0.0857383924745467,-0.0663246445790873,8.11670501204816e-53
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,39816,-0.0293901504496526,0.0019191595980079,-0.033151703261748,-0.0256285976375571,1.45629754499858e-52
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MET,Hepatocyte growth factor receptor,39879,0.028694533821966,0.00188160812028822,0.0250065819062011,0.0323824857377309,3.82538843265375e-52
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,39868,0.0394180109218334,0.0025850479333056,0.0343513169725544,0.0444847048711123,3.91766787969334e-52
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,39477,-0.161754334622323,0.0106087975542688,-0.18254757782869,-0.140961091415956,4.07820576504858e-52
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCARB2,Lysosome membrane protein 2,39486,-0.0422248560032435,0.00277457377638628,-0.0476630206049606,-0.0367866914015264,6.28137000957149e-52
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",39931,-0.0393003445765801,0.00258872898912065,-0.0443742533952566,-0.0342264357579036,1.07348564040678e-51
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,39788,-0.0572550319941186,0.00377183064555591,-0.0646478200594082,-0.049862243928829,1.10918083830664e-51
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,37368,-0.0767793020174761,0.00505833401172845,-0.0866936366804639,-0.0668649673544884,1.30227302220856e-51
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LGALS9,Galectin-9,39859,-0.0459278750741232,0.00303181738635061,-0.0518702371513704,-0.039985512996876,1.76043959988247e-51
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDHR2,Cadherin-related family member 2,39788,-0.106464167621177,0.00702962044098483,-0.120242223685507,-0.0926861115568463,1.86339381380874e-51
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,39788,-0.0870637566866816,0.00574935800252367,-0.098332498371628,-0.0757950150017352,1.91628906740154e-51
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,39858,-0.0584930204683148,0.00386416840352583,-0.0660667905392254,-0.0509192503974041,2.08690984717258e-51
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,40012,0.0904613497450429,0.00598133934271942,0.0787379246333129,0.102184774856773,2.52963806856689e-51
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,39885,-0.0463038195266248,0.00306335267743889,-0.0523079907744051,-0.0402996482788446,2.8922301078445e-51
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,40002,-0.0308183073066379,0.0020395303940461,-0.0348157868789682,-0.0268208277343075,3.09483447346258e-51
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,39477,-0.0737151874524084,0.00489797404799577,-0.0833152165864801,-0.0641151583183367,7.82711383776162e-51
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NUCB2,Nucleobindin-2,39995,-0.0541564776448475,0.00361062233743534,-0.0612332974262208,-0.0470796578634742,1.62720800905691e-50
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OMD,Osteomodulin,39931,0.0626178210034586,0.00418971670604327,0.0544059762596138,0.0708296657473034,3.61502305276036e-50
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,37043,0.0874077366798711,0.00586311520267757,0.0759160308826231,0.0988994424771191,7.43717270929452e-50
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITGAV,Integrin alpha-V,40030,0.0236889311543327,0.00159300000228548,0.0205666511498531,0.0268112111588122,1.08875601330257e-49
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,39858,-0.0752080605858175,0.00506341963503986,-0.0851323630704956,-0.0652837581011394,1.4186316908573e-49
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VEGFA,Vascular endothelial growth factor A,39993,-0.0812485499400595,0.00549298901712869,-0.0920148084136317,-0.0704822914664872,3.49939419890345e-49
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,39858,-0.0378658004341212,0.00256222660098177,-0.0428877645720455,-0.032843836296197,4.25025993653063e-49
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GAST,Gastrin,37388,-0.165012683136596,0.0112335399260326,-0.18703042139162,-0.142994944881572,1.7830023649387e-48
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITGA11,Integrin alpha-11,39866,0.0480845329414711,0.00327841382613838,0.0416588418422399,0.0545102240407023,2.16093846283677e-48
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AGRN,Agrin,39931,-0.0459324888978019,0.00314375023049568,-0.0520942393495734,-0.0397707384460304,4.87657485595408e-48
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,37382,-0.0842568231234674,0.00577597545301386,-0.0955777350113746,-0.0729359112355603,7.78926799671192e-48
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ELOA,Elongin-A,39788,-0.0716143671745124,0.00492772426379345,-0.0812727067315476,-0.0619560276174772,1.50968097784358e-47
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FUOM,Fucose mutarotase,37124,-0.0893087949540021,0.00614704176091257,-0.101356996805391,-0.0772605931026134,1.84332883757558e-47
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LBR,Delta(14)-sterol reductase LBR,40009,-0.0934095483128898,0.00643417842660924,-0.106020538029044,-0.0807985585967356,1.86245325732138e-47
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SORD,Sorbitol dehydrogenase,39963,-0.0954668316972173,0.00660167380689911,-0.10840611235874,-0.082527551035695,4.21544628801013e-47
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,39749,-0.103155844150281,0.00714261893951945,-0.11715537727174,-0.0891563110288233,5.56164752203663e-47
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RNASE6,Ribonuclease K6,37386,-0.0385993105521303,0.00267507636646347,-0.0438424602303987,-0.0333561608738619,7.54559628665553e-47
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,39429,-0.12073415930186,0.00838781486974837,-0.137174276446566,-0.104294042157153,1.12506435159077e-46
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EGFR,Epidermal growth factor receptor,40052,0.0221848611089797,0.00154615339090704,0.0191544004628019,0.0252153217551575,2.09867307708643e-46
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",39788,-0.0847478836776606,0.00591549893147787,-0.0963422615833572,-0.073153505771964,2.90111948619282e-46
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,39931,0.0530220175836401,0.00371132163277282,0.0457478271834054,0.0602962079838748,5.07831533857251e-46
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,39749,-0.053386946043695,0.0037417028155559,-0.0607206835621846,-0.0460532085252055,6.64586539187379e-46
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SHBG,Sex hormone-binding globulin,37445,0.0711261617423955,0.00499169100119736,0.0613424473800487,0.0809098761047423,9.72166019850004e-46
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,39866,-0.0831511837549446,0.00584338064487434,-0.0946042098188983,-0.0716981576909909,1.13372760476196e-45
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GSN,Gelsolin,37383,0.0256879807128748,0.00180696316135799,0.0221463329166131,0.0292296285091365,1.54877771303633e-45
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,37056,-0.118440847789312,0.00833172598730292,-0.134771030724426,-0.102110664854199,1.58803849445546e-45
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PVR,Poliovirus receptor,40009,-0.0509058492612799,0.00358528743546224,-0.0579330126347858,-0.0438786858877739,1.75662248006478e-45
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AGXT,Serine--pyruvate aminotransferase,39868,-0.10645887360519,0.00751065648962536,-0.121179760324856,-0.0917379868855241,2.48210917551888e-45
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDCP1,CUB domain-containing protein 1,39749,-0.068110368255317,0.00481097387182338,-0.0775398770440909,-0.0586808594665432,3.17071803168357e-45
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,39489,-0.0370377318057502,0.0026241991509273,-0.0421811621415677,-0.0318943014699327,5.88729060381153e-45
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD2AP,CD2-associated protein,39868,-0.0857925179285272,0.00610985669223829,-0.0977678370453143,-0.0738171988117402,1.59221290163838e-44
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FAM3C,Protein FAM3C,39846,-0.0391473557075647,0.0027930385638468,-0.0446217112927044,-0.033673000122425,2.2766014062226e-44
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,39858,-0.0470360311851954,0.00335595722339308,-0.0536137073430458,-0.0404583550273449,2.2871000180606e-44
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MLN,Promotilin,39866,-0.120350784749012,0.00859155662486158,-0.137190235733741,-0.103511333764284,2.54325248832671e-44
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PAXX,Protein PAXX,37124,-0.062394495265638,0.00445204792451944,-0.0711205091976961,-0.0536684813335799,2.61972905798642e-44
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HLA_E,,39866,-0.0369629194256486,0.00264143078918622,-0.0421401237724536,-0.0317857150788436,3.1115721120274e-44
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPIND1,Heparin cofactor 2,37424,-0.0381621248698126,0.00272681350237109,-0.04350667933446,-0.0328175704051653,3.38642210676451e-44
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,37388,-0.0634546379276971,0.0045569940271429,-0.0723863462208972,-0.054522929634497,8.99158106693752e-44
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,THBS2,Thrombospondin-2,39858,-0.04826574556881,0.00347355457473977,-0.0550739125353,-0.0414575786023201,1.21442108171211e-43
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IDUA,Alpha-L-iduronidase,40030,-0.0614599340076474,0.00442379495829953,-0.0701305721259145,-0.0527892958893803,1.24363274375664e-43
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGF23,Fibroblast growth factor 23,40008,-0.0781974923360562,0.00563214027859066,-0.0892364872820939,-0.0671584973900185,1.40683739534555e-43
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,39862,-0.0375162930725473,0.00270392366940927,-0.0428159834645895,-0.0322166026805052,1.60966649553818e-43
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CALCA,Calcitonin,39713,-0.0813092932101494,0.00588012061519853,-0.0928343296159385,-0.0697842568043603,3.08656936140568e-43
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",39788,-0.0587572356197173,0.00424929639433176,-0.0670858565526075,-0.050428614686827,3.0912254331325e-43
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADM,Pro-adrenomedullin,40030,-0.0350674376244497,0.00253791938539321,-0.0400417596198204,-0.030093115629079,3.52210881115411e-43
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,39831,-0.0507151246783729,0.00367307694905644,-0.0579143554985235,-0.0435158938582223,4.07604795819186e-43
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",39763,-0.139107257616567,0.0100762316382565,-0.158856671627549,-0.119357843605584,4.18658254197571e-43
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDH1,Cadherin-1,39315,-0.0537154930504195,0.00389158332087953,-0.0613429963593434,-0.0460879897414957,4.40397393529843e-43
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL18BP,Interleukin-18-binding protein,39931,-0.0393514056185993,0.00285374350696265,-0.0449447428922461,-0.0337580683449525,5.18845488628325e-43
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,XCL1,Lymphotactin,40030,-0.0728877066990165,0.00528801768655363,-0.0832522213646616,-0.0625231920333714,5.60121655931195e-43
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STC1,Stanniocalcin-1,40009,-0.0556743493774054,0.00404140108009812,-0.0635954954943977,-0.0477532032604131,6.21629050181023e-43
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CPA1,Carboxypeptidase A1,40052,-0.0785131052140306,0.00570516425487382,-0.0896952271535832,-0.0673309832744779,7.5423171437805e-43
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,37056,-0.0596525246101945,0.00433680623219598,-0.0681526648252986,-0.0511523843950904,9.37798210905575e-43
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CHMP6,Charged multivesicular body protein 6,37437,-0.0753848156914182,0.00548914533230159,-0.0861435405427293,-0.0646260908401071,1.23368254238838e-42
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APOC1,Apolipoprotein C-I,37424,0.0497770785458671,0.00362548506070653,0.0426711278268823,0.0568830292648519,1.29758077719545e-42
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,37124,-0.100577043343821,0.0073428361230524,-0.114969002145004,-0.0861850845426383,2.04734355959532e-42
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ENO3,Beta-enolase,37043,-0.0800361655774617,0.00585639668290175,-0.0915147030759491,-0.0685576280789742,3.12351241173106e-42
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SIAE,Sialate O-acetylesterase,39875,-0.0620839670632579,0.00454757210662546,-0.0709972083922438,-0.053170725734272,3.37828336953977e-42
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD27,CD27 antigen,39913,-0.0510819096333307,0.0037492305493713,-0.0584304015100985,-0.043733417756563,4.89628589314504e-42
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",37437,-0.0998382853925789,0.00732512011859675,-0.114195520825029,-0.0854810499601293,5.04812166666431e-42
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EZR,Ezrin,40009,-0.0314927454841451,0.00231669441547244,-0.0360334665384711,-0.0269520244298191,7.40432022055333e-42
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,37368,-0.0911522801873284,0.00671179139815634,-0.104307391327715,-0.077997169046942,9.76503234308088e-42
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EPO,Erythropoietin,39866,-0.100946584710628,0.00744855861945038,-0.115545759604751,-0.0863474098165054,1.29918644243571e-41
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,39866,-0.0363512985123344,0.00268403441640328,-0.0416120059684848,-0.031090591056184,1.46599408470125e-41
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RNASE4,Ribonuclease 4,37051,-0.0341263384018596,0.0025184938248095,-0.0390625862984862,-0.029190090505233,1.49646757680868e-41
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EEF1D,Elongation factor 1-delta,37437,-0.119443404996586,0.00883518522022728,-0.136760368028232,-0.102126441964941,2.23550662638701e-41
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LAT2,Linker for activation of T-cells family member 2,39788,-0.161857700652122,0.0120148094327211,-0.185406727140256,-0.138308674163989,3.86518722047878e-41
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD209,CD209 antigen,39885,0.0504361953137912,0.00374759833203857,0.0430909025829956,0.0577814880445868,4.60066987489319e-41
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,37043,-0.110816905395315,0.00823544994995016,-0.126958387297217,-0.0946754234934126,5.28628884416636e-41
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OSM,Oncostatin-M,39785,-0.0924627118462126,0.00689501985426046,-0.105976950760563,-0.0789484729318621,8.78614230472384e-41
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL18,Interleukin-18,39795,-0.0587632622269118,0.00439060642792183,-0.0673688508256385,-0.050157673628185,1.24537152841715e-40
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FSTL3,Follistatin-related protein 3,39803,-0.0387095458996017,0.00289429781212509,-0.0443823696113668,-0.0330367221878365,1.41172209096658e-40
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MYH9,Myosin-9,37437,-0.144152777288446,0.0107776623571901,-0.165276995508539,-0.123028559068353,1.52526124032643e-40
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,39858,-0.05347055769638,0.00400629939673074,-0.0613229045139722,-0.0456182108787877,2.03888753843801e-40
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NPL,N-acetylneuraminate lyase,37437,-0.0566827828388861,0.00425997040321863,-0.0650323248291947,-0.0483332408485776,3.81480039608468e-40
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,39979,-0.0737730216728095,0.00554986155464795,-0.0846507503199195,-0.0628952930256995,4.14598679057268e-40
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GZMA,Granzyme A,40058,-0.043380187558782,0.00326379408665676,-0.0497772239686293,-0.0369831511489348,4.21523334316222e-40
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RBKS,Ribokinase,39504,-0.0635195007406151,0.00478834706034434,-0.0729046609788901,-0.0541343405023402,6.03594758540888e-40
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,39758,-0.0332689072018072,0.00250969551115212,-0.0381879104036654,-0.028349903999949,6.76840173352057e-40
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CNTN1,Contactin-1,40052,0.0340500373765432,0.00257105759561156,0.0290107644891445,0.0390893102639418,7.91729679148545e-40
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SNAP29,Synaptosomal-associated protein 29,39913,-0.116406072187843,0.00880082686507614,-0.133655692843393,-0.0991564515322942,9.92729913027351e-40
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,39788,-0.0871701065520859,0.00659978756640723,-0.100105690182244,-0.0742345229219278,1.27422421538594e-39
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,40003,-0.0763843963202711,0.0057865668777929,-0.0877260674007452,-0.065042725239797,1.40133532996044e-39
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NUMB,Protein numb homolog,37056,-0.108049835427304,0.00819621056532541,-0.124114408135342,-0.0919852627192666,1.95370961390909e-39
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NCAM2,Neural cell adhesion molecule 2,39858,0.0339547331017106,0.0025776117495373,0.0289026140726175,0.0390068521308037,2.01479644438702e-39
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SEL1L,Protein sel-1 homolog 1,37043,-0.040038683837088,0.00303937170075914,-0.0459958523705759,-0.0340815153036001,2.21517420708134e-39
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,37043,-0.0376441189752969,0.00285826145220165,-0.0432463114216122,-0.0320419265289817,2.30550570719212e-39
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD274,Programmed cell death 1 ligand 1,39749,-0.0425690792785315,0.00323845410069833,-0.0489164493159003,-0.0362217092411628,2.91878548384479e-39
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,37021,-0.0713681399204365,0.00543658921138592,-0.0820238547747529,-0.0607124250661201,4.04042814423503e-39
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,39788,-0.0552547470340202,0.00421230862996195,-0.0635108719487456,-0.0469986221192948,4.1718148639861e-39
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,39477,-0.0897997680819532,0.00684930309970521,-0.103224402157375,-0.0763751340065309,4.59272555447096e-39
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DTYMK,Thymidylate kinase,37437,-0.0870276501763892,0.00664948049618345,-0.100060631948909,-0.0739946684038696,6.64067865120397e-39
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,YTHDF3,YTH domain-containing family protein 3,39587,-0.107384645709722,0.00823246176917412,-0.123520270777303,-0.0912490206421406,1.09085528973239e-38
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,40058,-0.0527082263553568,0.00404135609422868,-0.060629284300045,-0.0447871684106686,1.10237698693615e-38
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,40052,-0.0269974199205999,0.00207332573517816,-0.0310611383615491,-0.0229337014796507,1.44593891211116e-38
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APLP1,Amyloid-like protein 1,39868,0.0643528054269116,0.00494324152523529,0.0546640520374505,0.0740415588163728,1.51034261731168e-38
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,39866,-0.0687790673066774,0.00528514359247222,-0.0791379487479229,-0.0584201858654318,1.60484081418645e-38
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL21,C-C motif chemokine 21,39931,-0.049127825315811,0.00377722499428758,-0.0565311863046147,-0.0417244643270073,1.76153078251158e-38
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",39842,-0.0820252028782354,0.00631236818114642,-0.0943974445132824,-0.0696529612431884,2.06158079241365e-38
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DCTN1,Dynactin subunit 1,40030,-0.081495735031005,0.00627358845748613,-0.0937919684076778,-0.0691995016543322,2.16186630464993e-38
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GFRA1,GDNF family receptor alpha-1,40011,-0.0335958888792926,0.00259495679677438,-0.0386820042009704,-0.0285097735576149,3.80164644503327e-38
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HEPH,Hephaestin,37437,-0.0329635808662594,0.00255016887986853,-0.0379619118708017,-0.0279652498617171,5.37644042443408e-38
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINA5,Plasma serine protease inhibitor,37283,-0.0398004943612775,0.00308317994959331,-0.0458435270624803,-0.0337574616600746,6.73772978930122e-38
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BECN1,Beclin-1,37043,-0.0758097578205227,0.00587585998209518,-0.0873264433854292,-0.0642930722556161,7.44074573477946e-38
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,39757,-0.0331921490989787,0.00258402991264399,-0.0382568477277609,-0.0281274504701965,1.40893282755361e-37
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,39866,-0.0700904227547749,0.00546210715498132,-0.0807961527785383,-0.0593846927310115,1.65859164518391e-37
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CFI,Complement factor I,37453,-0.0248255339678873,0.00193470936549322,-0.028617564324254,-0.0210335036115205,1.79825614882205e-37
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,40052,-0.0395170568771308,0.00309043369352863,-0.045574306916447,-0.0334598068378147,2.93896897292617e-37
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BCAN,Brevican core protein,39749,0.0410870545056846,0.00321405858210915,0.0347874996847506,0.0473866093266185,3.09140389177414e-37
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ERMAP,Erythroid membrane-associated protein,37056,-0.0551737044636944,0.00431766560602423,-0.0636363290515019,-0.0467110798758869,3.58571626106911e-37
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BMPER,BMP-binding endothelial regulator protein,37124,-0.0277790217051201,0.00217931973676024,-0.0320504883891702,-0.0235075550210701,5.36349276912342e-37
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IMMT,MICOS complex subunit MIC60,37368,-0.0541368576517826,0.00425114081262411,-0.0624690936445258,-0.0458046216590393,6.18686858860622e-37
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CKB,Creatine kinase B-type,37437,0.0715390834278649,0.00563068035385865,0.0605029499343019,0.0825752169214279,8.95532777302214e-37
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,39931,-0.0521022599081908,0.00411113697277468,-0.0601600883748291,-0.0440444314415524,1.2425461249951e-36
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARSA,Arylsulfatase A,39858,-0.0550008302042412,0.00434072149665753,-0.0635086443376899,-0.0464930160707924,1.28549604483001e-36
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FUS,RNA-binding protein FUS,39455,-0.0480391924614767,0.00379214047821035,-0.055471787798769,-0.0406065971241844,1.34567304518733e-36
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",37411,-0.0772016785746505,0.00609299168616733,-0.0891439422795385,-0.0652594148697625,1.38795729653311e-36
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTSF,Cathepsin F,39913,-0.0493567575285896,0.00390044348079574,-0.0570016267509492,-0.0417118883062299,1.58587246895955e-36
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,39489,-0.0628710070090207,0.004979334975132,-0.0726305035602794,-0.0531115104577619,2.2736041041515e-36
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ULBP2,UL16-binding protein 2,39749,-0.0444906401744529,0.0035259842860593,-0.0514015693751292,-0.0375797109737767,2.51177790159227e-36
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTSE,Cathepsin E,37124,-0.0646464128202621,0.00512316073056121,-0.0746878078521621,-0.0546050177883621,2.69968011069639e-36
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CES3,Carboxylesterase 3,39788,-0.0831729747521996,0.00664865960154286,-0.0962043475712236,-0.0701416019331756,9.72298801052623e-36
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PALM2,Paralemmin-2,37388,-0.045907030817481,0.00366841001215525,-0.0530971144413053,-0.0387169471936567,9.85176549273408e-36
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,39866,0.041978697189668,0.00335629399889642,0.035400360951831,0.048557033427505,9.9846381016325e-36
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SNAPIN,SNARE-associated protein Snapin,37411,-0.0704333329605021,0.00563061752719922,-0.0814693433138126,-0.0593973226071916,1.04972409168514e-35
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,39900,0.0376828371425842,0.00301450494773384,0.0317744074450259,0.0435912668401425,1.08790244702048e-35
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,YES1,Tyrosine-protein kinase Yes,39788,-0.137554608161232,0.011010787935033,-0.159135752513896,-0.115973463808567,1.20199560971861e-35
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CPE,Carboxypeptidase E,39906,0.0464909264230391,0.00372415103077151,0.0391915904027269,0.0537902624433513,1.34206054083213e-35
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL3,C-C motif chemokine 3,39866,-0.0756655101928504,0.00606388723021777,-0.0875507291640773,-0.0637802912216236,1.43982982761363e-35
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,39477,-0.0593973391413395,0.00476234573886059,-0.0687315367895063,-0.0500631414931727,1.56149797192253e-35
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,39821,0.0305394071205424,0.00245114684811137,0.0257351592982442,0.0353436549428407,1.82118193901282e-35
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEP20,Centrosomal protein 20,39477,-0.0888794659808374,0.00713445313260363,-0.102862994120741,-0.0748959378409343,1.86972343703803e-35
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NCAN,Neurocan core protein,40009,0.0441271757327204,0.00354260070700482,0.0371836783469909,0.0510706731184498,1.88386874562803e-35
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,39908,-0.0590744378491244,0.00474596089965201,-0.0683765212124423,-0.0497723544858064,2.1073788167714e-35
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,THOP1,Thimet oligopeptidase,39798,-0.0365715901874363,0.0029387668023773,-0.0423315731200958,-0.0308116072547768,2.18673536477532e-35
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,37021,-0.0736490862869543,0.00594543885626351,-0.0853021464452308,-0.0619960261286778,4.78843032963967e-35
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,39931,-0.0496333983086271,0.00401097730816913,-0.0574949138326386,-0.0417718827846156,5.19157910396994e-35
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,37056,-0.084708752877361,0.00684223034777789,-0.0981195243590057,-0.0712979813957164,5.22706147794559e-35
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARF6,ADP-ribosylation factor 6,37382,-0.12715822436797,0.0103197412732643,-0.147384917263568,-0.106931531472372,1.06070998027727e-34
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,39868,-0.0497460529398593,0.00404359516211753,-0.0576714994576096,-0.0418206064221089,1.25996296397658e-34
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BST2,Bone marrow stromal antigen 2,40009,-0.0631918729490187,0.00513766705322059,-0.073261700373331,-0.0531220455247063,1.29849047850427e-34
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,39788,-0.0332731718787767,0.00270594009388372,-0.0385768144627888,-0.0279695292947646,1.36005626093362e-34
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ASAH2,Neutral ceramidase,39749,-0.0621869190384254,0.00505901034022836,-0.072102579305273,-0.0522712587715778,1.43028546859098e-34
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TTR,Transthyretin,37309,-0.0300132737286645,0.00244179402768159,-0.0347991900229204,-0.0252273574344085,1.54202494799937e-34
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TOP2B,DNA topoisomerase 2-beta,37056,-0.094705500653385,0.00771475638153843,-0.1098264231612,-0.0795845781455697,1.88108490314607e-34
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLXNB2,Plexin-B2,39984,-0.0279290142535606,0.002278055159051,-0.0323940023653006,-0.0234640261418206,2.11246746162502e-34
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLAT,Tissue-type plasminogen activator,40002,-0.058660572416449,0.00478654222721814,-0.0680421951817965,-0.0492789496511015,2.23686364757288e-34
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",39885,0.0393178173419634,0.00321203821160224,0.033022222447223,0.0456134122367037,2.67853972831613e-34
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL12A_IL12B,Interleukin-12,39788,-0.087021770396923,0.00711556884059811,-0.100968285324495,-0.0730752554693507,3.0697815261693e-34
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TGFBR2,TGF-beta receptor type-2,39913,-0.0350990898421624,0.00287456687960751,-0.0407332409261931,-0.0294649387581317,3.88510942525413e-34
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DKK1,Dickkopf-related protein 1,40009,-0.0702221467812023,0.00576369044911539,-0.0815189800614684,-0.0589253135009361,5.36377723884241e-34
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",37043,-0.082698841589755,0.00679976032851955,-0.0960263718336533,-0.0693713113458567,7.51664755481263e-34
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GLB1,Beta-galactosidase,39749,-0.0494247852231649,0.00407254413360035,-0.0574069717250216,-0.0414425987213082,9.58934544523519e-34
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PSME2,Proteasome activator complex subunit 2,39666,-0.0424124868578644,0.0034975294258108,-0.0492676445324536,-0.0355573291832752,1.08006325708415e-33
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SHISA5,Protein shisa-5,37437,-0.0269141599149684,0.00221940898588241,-0.0312642015272979,-0.0225641183026389,1.13817498341191e-33
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,39866,-0.0418574238006597,0.00345396339807564,-0.048627192060888,-0.0350876555404315,1.18109728180105e-33
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FYB1,FYN-binding protein 1,39836,-0.107275107733741,0.00885883666191509,-0.124638427591094,-0.089911787876387,1.32201346732162e-33
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,39720,-0.104740225533937,0.00864953368769174,-0.121693311561812,-0.0877871395060608,1.32592479208378e-33
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ASPN,Asporin,37437,0.0316303726788953,0.00261476823582015,0.0265054269366878,0.0367553184211028,1.63262692182085e-33
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,39383,-0.0224744769965384,0.00186018010672537,-0.0261204300057201,-0.0188285239873567,1.86046506911534e-33
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,37368,-0.0932660036529149,0.00774976919494084,-0.108455551274999,-0.0780764560308308,3.45197480037694e-33
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,39762,-0.0329302433542558,0.0027427356703512,-0.0383060052681442,-0.0275544814403675,4.57345230339848e-33
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD72,B-cell differentiation antigen CD72,37124,-0.0483930518338313,0.00402902793009238,-0.0562899465768124,-0.0404961570908503,4.61113925258153e-33
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITGBL1,Integrin beta-like protein 1,37437,-0.0415433893138599,0.00345922917713601,-0.0483234785010465,-0.0347633001266733,4.66149839686721e-33
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CXCL17,C-X-C motif chemokine 17,40058,-0.0497608194420905,0.00414674682625034,-0.0578884432215411,-0.0416331956626398,4.90747592255766e-33
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DCXR,L-xylulose reductase,39913,-0.0623286894434817,0.00519888398201579,-0.0725185020482326,-0.0521388768387307,5.62145299359573e-33
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TXLNA,Alpha-taxilin,39749,-0.103240385821892,0.00861674863711016,-0.120129213150628,-0.086351558493156,6.16926692689963e-33
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SARG,Specifically androgen-regulated gene protein,37390,-0.127257295052464,0.0106215455911726,-0.148075524411162,-0.106439065693766,6.55254827887222e-33
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CXCL9,C-X-C motif chemokine 9,39931,-0.0753823673362339,0.00629452469286205,-0.0877196357342436,-0.0630450989382243,6.56423010670222e-33
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCN4,CCN family member 4,40030,-0.0462547055387196,0.00386831072607717,-0.0538365945618308,-0.0386728165156083,8.1735566187697e-33
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,37366,-0.0951638831784251,0.00795558664150336,-0.110756832995772,-0.0795709333610785,8.24033245449371e-33
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDCD5,Programmed cell death protein 5,40009,-0.0668627528392731,0.00559768934262925,-0.0778342239508264,-0.0558912817277198,9.50685654261825e-33
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,39835,-0.0510294498566105,0.00427517727571296,-0.0594087973170079,-0.0426501023962131,1.05549546302802e-32
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STAB2,Stabilin-2,37437,-0.0323936031069494,0.00271548001764692,-0.0377159439415373,-0.0270712622723614,1.21312156403422e-32
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,39868,-0.0323408416628032,0.00271283546123609,-0.0376579991668259,-0.0270236841587805,1.25807162610454e-32
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,39477,-0.0393453209487986,0.00330368266185298,-0.0458205389660305,-0.0328701029315668,1.46050110945851e-32
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FEN1,Flap endonuclease 1,39477,-0.0717378992139958,0.00602622378952401,-0.0835492978414629,-0.0599265005865287,1.55444771111172e-32
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,39585,-0.0552782501077412,0.0046470715282336,-0.0643865103030791,-0.0461699899124033,1.72597366881035e-32
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NCAM1,Neural cell adhesion molecule 1,39931,0.0344451204206422,0.00289858994367461,0.02876388413104,0.0401263567102445,1.97373981233846e-32
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,39017,-0.0410864179152457,0.00346144623910822,-0.0478708525438978,-0.0343019832865936,2.36498700452727e-32
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL15,Interleukin-15,39866,-0.0371773638912647,0.00313651905999715,-0.0433249412488591,-0.0310297865336702,2.83103821304287e-32
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,39858,-0.0384872976767471,0.00324776544594323,-0.0448529179507958,-0.0321216774026983,2.9224032897273e-32
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,40052,-0.0771762717833172,0.00653755564807323,-0.0899898808535408,-0.0643626627130937,4.97280727294278e-32
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",39788,-0.11130921673485,0.00943468420720868,-0.129801197780979,-0.0928172356887212,5.4395438350996e-32
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLK14,Kallikrein-14,40030,0.0513986346331966,0.00435859546172419,0.0428557875282172,0.059941481738176,5.77017165980708e-32
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,INSL5,Insulin-like peptide INSL5,37382,-0.110838952830209,0.00940447404592132,-0.129271721960215,-0.092406183700203,6.62061100395768e-32
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SBSN,Suprabasin,37420,0.0387730269207082,0.00329001364749924,0.0323246001716097,0.0452214536698067,6.66882143395718e-32
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,37388,-0.0883478683198921,0.00750571970955652,-0.103059078950623,-0.0736366576891613,7.8971082867314e-32
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,39788,-0.0958978527405737,0.00816875409072395,-0.111908610758393,-0.0798870947227548,1.07888326267249e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINH1,Serpin H1,37169,-0.14654456719494,0.0124870130401198,-0.171019112753575,-0.122070021636305,1.19670360601687e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RETN,Resistin,39790,-0.0461659088488903,0.00394007342983462,-0.0538884527713661,-0.0384433649264144,1.40534626175397e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FMNL1,Formin-like protein 1,39489,-0.0689919879182289,0.00588828807348451,-0.0805330325422585,-0.0574509432941992,1.41673196732361e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,39908,-0.0589017210385263,0.00502928848831647,-0.0687591264756266,-0.049044315601426,1.49157877623175e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,39585,-0.0457538432694724,0.00390789678273622,-0.0534133209636354,-0.0380943655753094,1.56681472189066e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,39858,-0.0265354766907885,0.00226792209747429,-0.0309806040018381,-0.0220903493797389,1.70563567139056e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD248,Endosialin,37437,0.0449563636744187,0.00384233428784438,0.0374253884702438,0.0524873388785937,1.79881910351268e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C19orf12,Protein C19orf12,39489,-0.0733134351275024,0.00627387009795163,-0.0856102205194875,-0.0610166497355172,2.04211256467659e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL12B,Interleukin-12 subunit beta,40058,-0.0590575179412969,0.0050585701274516,-0.068972315391102,-0.0491427204914918,2.2914299386046e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CXCL11,C-X-C motif chemokine 11,40009,-0.0874825223873692,0.0075157053083601,-0.102213304791755,-0.0727517399829834,3.4386059979436e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LAT,Linker for activation of T-cells family member 1,40058,-0.0851518440110949,0.00733215998530307,-0.0995228775822889,-0.0707808104399008,4.67325372928775e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ISM1,Isthmin-1,39866,-0.0447485042416892,0.00385323843484918,-0.0523008515739936,-0.0371961569093848,4.702892602226e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,39862,-0.0423015184912228,0.00364352599230869,-0.0494428294361478,-0.0351602075462978,4.87936148318127e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MFAP5,Microfibrillar-associated protein 5,40052,-0.0451262649294921,0.00388726364920431,-0.0527453016819325,-0.0375072281770516,4.93704963995255e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",39489,-0.0566523578220374,0.00488060244437743,-0.0662183386130172,-0.0470863770310577,5.05085494683699e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,37388,-0.0345045789281529,0.00297265895224251,-0.0403309904745482,-0.0286781673817576,5.30558899933178e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTSS,Cathepsin S,36543,-0.0274995193443943,0.00236911872528024,-0.0321429920459435,-0.022856046642845,5.41451686485147e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,39858,0.0439193788285829,0.00378949798572399,0.0364919627765639,0.0513467948806019,6.1729217681512e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL7,C-C motif chemokine 7,39866,-0.0652744526375727,0.00563294697430665,-0.0763150287072137,-0.0542338765679316,6.30099550242755e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,39859,-0.0563586090373562,0.00486518731823129,-0.0658943761810895,-0.0468228418936228,6.59414298608061e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,39866,-0.0366777857055563,0.0031706690071349,-0.0428922969595407,-0.0304632744515719,7.95358234526135e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,40052,0.0272974741920826,0.00236011269573462,0.0226716533084428,0.0319232950757225,8.08191154798357e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,37411,-0.0415964864324452,0.00359629349125513,-0.0486452216753053,-0.0345477511895852,8.4994793517923e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,39617,-0.0326517941016517,0.00282951819400279,-0.0381976497618972,-0.0271059384414062,1.10540367394625e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,39868,-0.0631186185625636,0.005487470231234,-0.0738740602157822,-0.0523631769093449,1.69235528512618e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PSMG3,Proteasome assembly chaperone 3,39866,-0.0552402983342098,0.00480323664788079,-0.0646546421640562,-0.0458259545043635,1.725321972369e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,37056,-0.0575217242003881,0.00501597390379666,-0.0673530330518296,-0.0476904153489467,2.66718379660566e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,40002,-0.0353072259283448,0.00308124498106957,-0.0413464660912412,-0.0292679857654484,2.78327455590139e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MDK,Midkine,39843,-0.0559770476256937,0.00488545862092802,-0.0655525465227126,-0.0464015487286748,2.81842924342339e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",37358,-0.121492717934976,0.0106002737666025,-0.142269254517517,-0.100716181352435,2.84964685116695e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IFNGR2,Interferon gamma receptor 2,39749,-0.0575054830836423,0.00503135152227444,-0.0673669320673002,-0.0476440340999844,3.908794077968e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MTSS2,Protein MTSS 2,37368,-0.110353638654478,0.00967129336527933,-0.129309373650426,-0.0913979036585309,5.08970570896083e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SIGLEC1,Sialoadhesin,39931,-0.0459865036549053,0.00403645552628104,-0.0538979564864162,-0.0380750508233945,5.91815149548108e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,39841,-0.0675132211990087,0.00593524347561698,-0.079146298411218,-0.0558801439867994,7.25937850033806e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,B2M,Beta-2-microglobulin,37453,-0.033950218281736,0.00298703560275042,-0.0398048080631268,-0.0280956285003452,8.43095483504346e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CNTN3,Contactin-3,39858,-0.0357921951787759,0.00315450152685488,-0.0419750181714115,-0.0296093721861403,1.00402824093872e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,37382,-0.155267124510112,0.01368361611775,-0.182087012100902,-0.128447236919322,1.04644558482697e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",39587,-0.0654787452432087,0.00577658526895425,-0.076800852370359,-0.0541566381160584,1.1448986257621e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDC27,Cell division cycle protein 27 homolog,39477,-0.0671388993147568,0.00592815533192476,-0.0787580837653293,-0.0555197148641842,1.28122789945101e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SNCA,Alpha-synuclein,37124,-0.127457910187661,0.0112706997354594,-0.149548481669162,-0.105367338706161,1.62045450065073e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HNMT,Histamine N-methyltransferase,39669,-0.050528633233465,0.00447039511925037,-0.0592906076671957,-0.0417666587997342,1.64687291712327e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPOCK1,Testican-1,39749,0.0277281483996206,0.00245330365148874,0.0229196732427026,0.0325366235565385,1.65543562221708e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEP85,Centrosomal protein of 85 kDa,39477,-0.0697462282046253,0.00617416731728919,-0.0818475961465121,-0.0576448602627385,1.77771719655489e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,39866,-0.047418397048924,0.00419867697245974,-0.0556478039149451,-0.039188990182903,1.82332281093287e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,39477,-0.070696322387358,0.00626655872329422,-0.0829787774850147,-0.0584138672897013,2.10407848524554e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,36995,-0.0557713519656356,0.00495033647206028,-0.0654740114508738,-0.0460686924803975,2.62679508174884e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,40052,-0.0340154042938452,0.00302139252577589,-0.039937333644366,-0.0280934749433245,2.71170553308784e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NAA80,N-alpha-acetyltransferase 80,37039,-0.131945677335297,0.0117465024823935,-0.154968822200788,-0.108922532469805,3.81872470603574e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACAN,Aggrecan core protein,39730,0.0305480673271046,0.00272508053398705,0.02520690948049,0.0358892251737192,4.68446873042989e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TPP1,Tripeptidyl-peptidase 1,39767,-0.0503516480753302,0.00449980598651572,-0.059171267808901,-0.0415320283417594,5.87230749860878e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TFF2,Trefoil factor 2,39908,-0.0614690163635726,0.00551492679573386,-0.072278272883211,-0.0506597598439342,9.55732939743089e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD80,T-lymphocyte activation antigen CD80,37437,-0.0362683065596986,0.00325475710270446,-0.0426476304809993,-0.0298889826383978,1.02992418658293e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,39749,-0.0478290828827457,0.00429484835140405,-0.0562469856514976,-0.0394111801139937,1.06562314341436e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TDRKH,Tudor and KH domain-containing protein,39489,-0.0917919437544226,0.00824463468357529,-0.10795142773423,-0.075632459774615,1.10441713480915e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,37382,-0.054618703146906,0.00490678252697044,-0.0642359968997681,-0.0450014093940439,1.17708138754257e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,39931,-0.0441888125082491,0.00397128153067866,-0.0519725243083793,-0.0364051007081189,1.17854039092257e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LEP,Leptin,39868,-0.0728822395604176,0.00655028497596685,-0.0857207981133126,-0.0600436810075226,1.18644723395179e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD83,CD83 antigen,39866,-0.0352376979867153,0.00317218067304698,-0.0414551721058874,-0.0290202238675432,1.45302154035722e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL5,C-C motif chemokine 5,39931,-0.108322176751485,0.00977241945707189,-0.127476118887346,-0.0891682346156244,1.89205967494097e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,39913,-0.036347923107136,0.00328394252909443,-0.0427844504641611,-0.0299113957501109,2.26215558099425e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,37043,-0.0781816894088384,0.00706984604936315,-0.0920385876655902,-0.0643247911520866,2.65632018486963e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,37021,-0.0803134946006494,0.0072635057252612,-0.0945499658221613,-0.0660770233791374,2.69737819832e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AMN,Protein amnionless,39587,-0.050839191502178,0.00460890493602296,-0.059872645176783,-0.041805737827573,3.44964867696828e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GAL,Galanin peptides,39931,0.0685527171145072,0.00622064881513574,0.0563602454368411,0.0807451887921732,3.85185666367924e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD300E,CMRF35-like molecule 2,39991,-0.0409319067549617,0.00371543926389234,-0.0482141677121907,-0.0336496457977328,3.99908943533026e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,40009,-0.0874699418935317,0.00795498834518098,-0.103061719050086,-0.071878164736977,5.04382288024291e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,37437,-0.0312002968730555,0.00284053486800222,-0.0367677452143399,-0.0256328485317712,5.98519889445313e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,39477,-0.0492210546009488,0.00449222518484263,-0.0580258159632404,-0.0404162932386573,7.77196482647898e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,39537,-0.0531760781439859,0.00485460362846929,-0.0626911012557857,-0.043661055032186,8.04229082333938e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COCH,Cochlin,37437,-0.048562079561006,0.00443657808443061,-0.05725777260649,-0.039866386515522,9.08735993584237e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTGR1,Prostaglandin reductase 1,37437,-0.0845009710028017,0.00772687167000941,-0.0996456394760202,-0.0693563025295833,1.01211911236214e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,39585,-0.0393557575732251,0.00360215927618424,-0.0464159897545462,-0.032295525391904,1.09358480843324e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,39749,-0.060610079928593,0.00555669321699629,-0.0715011986339057,-0.0497189612232803,1.32840971358768e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,37056,-0.128045353118626,0.0117357636235351,-0.151047449820755,-0.105043256416498,1.34410803505613e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SNCG,Gamma-synuclein,39749,-0.0685058141142416,0.00628123201436444,-0.0808170288623959,-0.0561945993660873,1.34520837330213e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,39489,-0.0648229764993102,0.00594953812271904,-0.0764840712198396,-0.0531618817787809,1.52180171882203e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCN2,CCN family member 2,39880,-0.0615974874480007,0.00565532186175838,-0.0726819182970471,-0.0505130565989543,1.57248609813452e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD300A,CMRF35-like molecule 8,37124,-0.0305900513395791,0.00280915728213685,-0.0360959996125673,-0.0250841030665909,1.69260448949309e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,A1BG,Alpha-1B-glycoprotein,37453,-0.0180431605483022,0.00165820180431683,-0.0212932360847632,-0.0147930850118412,1.83955718088215e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,REN,Renin,39868,-0.0692166277151315,0.00637363888104246,-0.0817089599219747,-0.0567242955082882,2.23111004715039e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,37411,-0.103252028402236,0.00950607588161604,-0.121883937130203,-0.0846201196742685,2.27491819768002e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,40009,-0.100721540738275,0.00930587453239494,-0.118961054821769,-0.0824820266547812,3.30544294461391e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NFX1,Transcriptional repressor NF-X1,37021,-0.0707426938309813,0.00653420693092216,-0.0835497394155888,-0.0579356482463739,3.35612073654368e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,37124,-0.0291543102709196,0.00269414290036915,-0.0344348303556431,-0.0238737901861961,3.5411403807077e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNF,Tumor necrosis factor,39555,-0.0396097334469655,0.00366444969850524,-0.0467920548560357,-0.0324274120378952,3.88062908748646e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,37382,-0.0310911188305177,0.00287695045451223,-0.0367299417213617,-0.0254522959396738,4.11708218303225e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANGPT2,Angiopoietin-2,40030,-0.0397400979981626,0.00368128512321095,-0.046955416839656,-0.0325247791566691,4.48705088614109e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APOA1,Apolipoprotein A-I,37453,0.0286136070066324,0.00265118824022229,0.0234172780557967,0.0338099359574681,4.79415383942741e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,39858,-0.0264535366386589,0.00245242366593867,-0.0312602870238987,-0.0216467862534191,4.92866586695791e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD300C,CMRF35-like molecule 6,40009,-0.0345655396480742,0.00321341357407915,-0.0408638302532693,-0.0282672490428791,6.80167349912895e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MTDH,Protein LYRIC,37056,-0.0966824529855161,0.00898550319375565,-0.114294039245277,-0.079070866725755,6.88678970731379e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,39587,-0.073665590416364,0.00685072105365048,-0.087093003681519,-0.0602381771512091,7.11582206158602e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DTNB,Dystrobrevin beta,37348,-0.0458198168463509,0.00426489194769125,-0.0541790050638258,-0.0374606286288761,8.1639266588673e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL6,Interleukin-6,39788,-0.0735436528050157,0.00684858183266766,-0.0869668731970443,-0.0601204324129871,8.28997583330934e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EREG,Proepiregulin,39713,-0.0828616551014198,0.00772012583745807,-0.0979931017428376,-0.067730208460002,8.78687078728365e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PQBP1,Polyglutamine-binding protein 1,39477,-0.0567292388598215,0.0052896930184555,-0.0670970371759942,-0.0463614405436487,9.67983834377101e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,39788,-0.0465689163815635,0.00434529622984491,-0.0550856969920596,-0.0380521357710675,1.04365220546285e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BSG,Basigin,40040,-0.0201419401623206,0.00188103894583853,-0.0238287764961641,-0.0164551038284771,1.14825397555175e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",39908,-0.0899419840010697,0.0084060149949592,-0.10641777339119,-0.0734661946109497,1.25536748412074e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,F10,Coagulation factor X,37445,-0.0275361433758435,0.00257520596970968,-0.0325835470764745,-0.0224887396752125,1.40324217992848e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,39866,0.0401219538224304,0.00375374869531023,0.0327646063796224,0.0474793012652385,1.41633003742763e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,37165,-0.0453385870604344,0.00424948785475776,-0.0536675832557596,-0.0370095908651092,1.81485290282051e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OGFR,Opioid growth factor receptor,39788,-0.0336939742142836,0.00316130518814253,-0.0398901323830429,-0.0274978160455242,1.95907474872137e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINA4,Kallistatin,37241,-0.0242127598409618,0.00227269506099934,-0.0286672421605206,-0.0197582775214031,2.1362933050163e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL25,C-C motif chemokine 25,40058,-0.0513116015914114,0.0048212388559597,-0.0607612297490924,-0.0418619734337304,2.30159274471782e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,REG4,Regenerating islet-derived protein 4,39885,-0.0483474223698572,0.00454356385736627,-0.0572528075302951,-0.0394420372094193,2.35540402935584e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,39866,-0.063755438691228,0.0060037201043099,-0.0755227300956754,-0.0519881472867806,2.96317523921245e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,39984,-0.0743189363555286,0.00700100028423322,-0.0880408969126257,-0.0605969757984315,3.08245035945021e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,39877,-0.0403241311833204,0.00380281816090428,-0.0477776547786928,-0.032870607587948,3.49611955772132e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGR,Tyrosine-protein kinase Fgr,39489,-0.0576080840698132,0.00545345814252243,-0.0682968620291572,-0.0469193061104692,5.37806426757923e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,37437,-0.0782191973462229,0.00740921813782446,-0.0927412648963589,-0.063697129796087,5.9426484707925e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGF19,Fibroblast growth factor 19,39931,-0.0780173658339172,0.00739833997419227,-0.092518112183334,-0.0635166194845004,6.49272579306519e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PENK,Proenkephalin-A,37124,-0.0298475934194783,0.00283072663715475,-0.0353958176283016,-0.024299369210655,6.84409340124219e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPARCL1,SPARC-like protein 1,39871,0.0277588238664943,0.00263560608655237,0.0225930359368517,0.032924611796137,7.45479185883785e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TSPAN8,Tetraspanin-8,37382,-0.100230904910063,0.00951898068844159,-0.118888107059409,-0.0815737027607175,7.9441999868601e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,39962,-0.0426233504424492,0.00405365447221202,-0.0505685132079847,-0.0346781876769136,8.94995171627227e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,S100A4,Protein S100-A4,39913,-0.0576979543184624,0.00549159589315437,-0.068461482269045,-0.0469344263678799,9.76341485475236e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL14,C-C motif chemokine 14,39843,-0.0395464671771113,0.00376448469729347,-0.0469248571838065,-0.0321680771704161,9.92126020652355e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,37124,-0.0396941651367552,0.00377927982493982,-0.0471015535936373,-0.0322867766798732,1.05436702194579e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,39469,-0.0598410266725078,0.00569977656909398,-0.071012588747932,-0.0486694645970836,1.06512333757993e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SRPK2,SRSF protein kinase 2,39866,-0.0851928139570214,0.0081332287740897,-0.101133942354237,-0.0692516855598056,1.36652678872177e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,39985,-0.0283342720482492,0.00271147256604187,-0.0336487582776913,-0.0230197858188071,1.77149549272277e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",37043,-0.0988134546666017,0.00945966979607522,-0.117354407466909,-0.0802725018662943,1.92582640390089e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ERBIN,Erbin,39788,-0.103738273484152,0.00993860463467369,-0.123217938568113,-0.0842586084001916,2.0102837391864e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEP43,Centrosomal protein 43,39476,-0.0704506927713854,0.0067506982845129,-0.0836820614090307,-0.0572193241337401,2.05729526362749e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ICAM4,Intercellular adhesion molecule 4,39866,0.0528666130406371,0.00507136405166714,0.0429267394993695,0.0628064865819047,2.30988478903375e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MMP1,Interstitial collagenase,39314,-0.0926091101993413,0.00888332109045801,-0.110020419536639,-0.0751978008620436,2.31270299515446e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CA6,Carbonic anhydrase 6,39817,0.0640427471172299,0.00614841040815993,0.0519918627172365,0.0760936315172234,2.52280372555371e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,39587,-0.0371155306804052,0.00356676333038801,-0.0441063868079657,-0.0301246745528447,2.81390187678154e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EPHA2,Ephrin type-A receptor 2,39248,-0.0295788131377513,0.00284270927765183,-0.0351505233219489,-0.0240071029535538,2.84903554933965e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NCF2,Neutrophil cytosol factor 2,39843,-0.0835132606744637,0.00803023565500805,-0.0992525225582795,-0.0677739987906479,2.98934748768009e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HSPB6,Heat shock protein beta-6,40030,-0.037627264787606,0.00362324962819732,-0.0447288340588728,-0.0305256955163393,3.48392758485818e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RASSF2,Ras association domain-containing protein 2,39477,-0.0553201703732948,0.00532828217002164,-0.0657636034265372,-0.0448767373200524,3.60198014306827e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",40052,-0.0487284488979956,0.0046936957870071,-0.0579280926405296,-0.0395288051554617,3.60363442714691e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,40040,-0.0503856568696845,0.00485439393601533,-0.0599002689842745,-0.0408710447550944,3.69097261123337e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DDT,D-dopachrome decarboxylase,37437,-0.0404253162614465,0.00389427401196185,-0.0480580933248918,-0.0327925391980013,3.76936384833875e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CHAD,Chondroadherin,37124,0.050795978556868,0.00489771020148994,0.0411964665619477,0.0603954905517883,4.17425418870371e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BACH1,Transcription regulator protein BACH1,39866,-0.0743005586167226,0.00717093589799072,-0.0883555929767844,-0.0602455242566608,4.4612691825651e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,37056,0.0321221083130596,0.00310047283175601,0.0260451815628178,0.0381990350633014,4.68340509675691e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,37169,-0.114151131508116,0.0110288428179286,-0.135767663431256,-0.0925345995849764,5.19354934861458e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GH1,Somatotropin,39846,0.180538423029535,0.0174617249307012,0.14631344216536,0.214763403893709,5.62122023034977e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FCN1,Ficolin-1,37430,-0.0565349169668937,0.00546780191822622,-0.0672518087266171,-0.0458180252071703,5.77392318519021e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPP1R9B,Neurabin-2,40058,-0.0945262778780041,0.00916160028641425,-0.112483014439376,-0.0765695413166322,7.00164406026209e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,40058,-0.0994111974697468,0.00963705305464481,-0.118299821456851,-0.080522573482643,7.15849069548734e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,39868,-0.0633627908151556,0.006147191140072,-0.0754112854496967,-0.0513142961806145,7.78538857066906e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,37388,-0.0869704298161569,0.00845430038627954,-0.103540858573265,-0.070400001059049,9.93455176677334e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,39913,-0.0253074840393633,0.00246606339677962,-0.0301409682970513,-0.0204739997816752,1.24149686053586e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",39788,-0.0323350410351423,0.0031525452430092,-0.0385140297114403,-0.0261560523588443,1.31551056691139e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,39858,0.0515836175589249,0.00503276332677133,0.041719401438453,0.0614478336793967,1.41612886821929e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CBS,Cystathionine beta-synthase,37043,-0.0508436472522547,0.00496069421045921,-0.0605666079047548,-0.0411206865997546,1.47368861409979e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CNTN5,Contactin-5,39897,0.0356329268551488,0.00347874411740588,0.0288145883850333,0.0424512653252643,1.5135786618857e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ICAM1,Intercellular adhesion molecule 1,39822,-0.028176842730487,0.00275206976661372,-0.0335708994730499,-0.0227827859879241,1.58848696782222e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EPPK1,Epiplakin,37043,-0.0743227156951869,0.00725838493312968,-0.0885491501641211,-0.0600962812262527,1.62844934762486e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,39788,-0.0756292054809023,0.00742573237033051,-0.0901836409267501,-0.0610747700350545,2.75326491158969e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,39489,-0.0783347700548471,0.00770094960586692,-0.0934286312823462,-0.0632409088273479,3.14313538687106e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NBN,Nibrin,39587,-0.0506912299024168,0.00498465442357404,-0.060461152572622,-0.0409213072322117,3.22528309694561e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,39749,-0.0525569168740776,0.00516864522518393,-0.0626874615154381,-0.0424263722327171,3.25412686165276e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GOLM2,Protein GOLM2,40009,-0.0217577340546028,0.00213990098559377,-0.0259519399863666,-0.017563528122839,3.27104101457056e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,37388,-0.0406591034329938,0.0040027538302824,-0.0485045009403473,-0.0328137059256403,3.73519694425977e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SELP,P-selectin,39931,-0.05642284723946,0.00555656341550239,-0.0673137115338447,-0.0455319829450753,3.75144846095168e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DAG1,Dystroglycan,39931,-0.0476334382122331,0.00469391268019005,-0.0568335070654056,-0.0384333693590606,4.00214666983306e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,39991,-0.0248744244670432,0.00245658876261591,-0.0296893384417703,-0.020059510492316,5.0188259281246e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,36764,-0.0488562320750165,0.00482684380965827,-0.0583168459419467,-0.0393956182080863,5.43613592338776e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",39858,-0.0367458917504314,0.00363634793923553,-0.043873133711333,-0.0296186497895297,6.18357334691541e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD63,CD63 antigen,39720,-0.0502569171126129,0.00497910148734906,-0.060015956027817,-0.0404978781974087,6.96414900903515e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TFF1,Trefoil factor 1,39789,-0.0733788252709499,0.00727308591311262,-0.0876340736606507,-0.0591235768812492,7.28210366931482e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,37124,-0.0211893677724745,0.00210094467445443,-0.0253072193344051,-0.0170715162105438,7.79373814342986e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL1R2,Interleukin-1 receptor type 2,39830,-0.0191092551228193,0.00189536729530914,-0.0228241750216252,-0.0153943352240134,7.81372515365884e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,37039,-0.0670648591262831,0.00667429896928727,-0.0801464851060862,-0.0539832331464801,1.13812545821266e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,39998,-0.0292552443992896,0.00291742938278388,-0.034973405989546,-0.0235370828090332,1.34962665816879e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,39749,-0.0572535586727187,0.00571012532418746,-0.0684454043081261,-0.0460617130373113,1.36768580979011e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,37124,-0.0804295509323694,0.00803528049566139,-0.0961787007038657,-0.0646804011608731,1.67669533303446e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",39788,0.0414486136656663,0.00414248815091925,0.0333293368898646,0.0495678904414681,1.68746914504939e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FABP1,"Fatty acid-binding protein, liver",39862,-0.0905865827602578,0.00905582319668517,-0.108335996225761,-0.0728371692947549,1.73079359706834e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,39788,-0.0529048277738186,0.00529378082311143,-0.0632806381871169,-0.0425290173605202,1.90262869743518e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,39835,-0.0343025264552315,0.00343363640012578,-0.0410324537994781,-0.027572599110985,1.97213533218662e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TCTN3,Tectonic-3,37437,-0.0286104721250995,0.00286366379509263,-0.0342232531634811,-0.022997691086718,2.01326953289277e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,37437,-0.057111701386657,0.00572083613795123,-0.0683245402170414,-0.0458988625562726,2.17589437254182e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,37388,-0.105151631557321,0.0105429493854988,-0.125815812352899,-0.0844874507617435,2.39343377754917e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",39858,-0.0448693816401421,0.00450219600341665,-0.0536936858068388,-0.0360450774734455,2.50823517635691e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,37388,0.0354375936694793,0.00356002746531279,0.0284599398374662,0.0424152475014923,2.90354028002088e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COL3A1,Collagen alpha-1(III) chain,37437,-0.0223924453146853,0.00225560070207349,-0.0268134226907493,-0.0179714679386212,3.79071383070655e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATP6AP2,Renin receptor,39477,-0.0390165113089675,0.00394185873550191,-0.0467425544305512,-0.0312904681873837,4.96449085403311e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,39749,-0.0905168424299406,0.00915204694679944,-0.108454854445667,-0.0725788304142137,5.34267836399946e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,39788,-0.131646191973696,0.0133188778541175,-0.157751192567766,-0.105541191379625,5.67730131050797e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,39858,-0.0493157243942384,0.00499044299793815,-0.0590969926701972,-0.0395344561182797,5.79569192434194e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NADK,NAD kinase,39868,-0.0510047135903552,0.0051653185024721,-0.0611287378552006,-0.0408806893255099,6.2473643345388e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,39931,-0.0238036470062857,0.00241508546061909,-0.0285372145090991,-0.0190700795034723,7.47872726091391e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANG,Angiogenin,39843,-0.0321998837067667,0.00327037402274374,-0.0386098167913444,-0.0257899506221889,8.28760485797807e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,37388,-0.0297826683581964,0.00302630981821594,-0.0357142356018996,-0.0238511011144931,8.91728471436009e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,39749,-0.0671438380405605,0.00682915281299792,-0.0805289775540364,-0.0537586985270846,9.52428704291841e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TJAP1,Tight junction-associated protein 1,39913,-0.0788789022376633,0.00802522928858337,-0.0946083516432867,-0.0631494528320399,9.80304613675605e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLIN1,Perilipin-1,39489,-0.0329207488809866,0.00334933696603557,-0.0394854493344163,-0.0263560484275568,9.82588522650393e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,37411,-0.0456250646893981,0.00464342779477009,-0.0547261831671475,-0.0365239462116487,1.0389138250925e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,40009,-0.0650202045860607,0.00662622355271855,-0.0780076027493891,-0.0520328064227324,1.15033448754032e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,40040,-0.0341080012949988,0.00347903962451206,-0.0409269189590424,-0.0272890836309552,1.25294145858357e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,39858,0.0406268509873004,0.00414431899263066,0.0325039857617443,0.0487497162128565,1.26533964469695e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD6,T-cell differentiation antigen CD6,40040,-0.0496169682439253,0.00507362142975697,-0.059561266246249,-0.0396726702416017,1.59358234884873e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,39372,-0.0344483129126892,0.00352436005933129,-0.0413560586289786,-0.0275405671963999,1.68498318438859e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTSC,Dipeptidyl peptidase 1,39856,-0.0403905329369588,0.00413538607357595,-0.0484958896411677,-0.03228517623275,1.80184331428516e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,39885,-0.0312778852842222,0.00320291296913289,-0.0375555947037226,-0.0250001758647217,1.8299174777366e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLSCR3,Phospholipid scramblase 3,37373,-0.0563949106813361,0.00578460797672456,-0.0677327423157162,-0.045057079046956,2.2049116532351e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NRP2,Neuropilin-2,39858,0.0268605653362026,0.00275801660851599,0.0214548527835113,0.032266277888894,2.3695898616223e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,39866,-0.0439762274030436,0.00452760525336451,-0.052850333699638,-0.0351021211064491,3.05984350972188e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTRB1,Chymotrypsinogen B,39858,-0.0502024914914442,0.00516867765338187,-0.0603330996920727,-0.0400718832908158,3.06245791001157e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TAX1BP1,Tax1-binding protein 1,37388,-0.059564225858504,0.00613142454763697,-0.0715818179718724,-0.0475466337451355,3.08903900213841e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,39908,0.0725025008726897,0.0074654069896157,0.0578703031730429,0.0871346985723365,3.09220896462849e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDH15,Cadherin-15,39973,-0.0503123841707326,0.00518394238769551,-0.0604729112506158,-0.0401518570908494,3.28840564966539e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD48,CD48 antigen,39908,-0.027165166609279,0.00280058547863446,-0.0326543141474026,-0.0216760190711555,3.47524042793559e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,37437,0.0243395855463549,0.00250902426910411,0.0194218979789108,0.0292572731137989,3.53015533924444e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL11,Eotaxin,40058,-0.0357681832897523,0.00369398057988267,-0.0430083852263223,-0.0285279813531822,4.0949778532007e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BOC,Brother of CDO,39585,0.0218762535773603,0.00226028237001376,0.0174461001321333,0.0263064070225873,4.28670364585722e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,39587,0.0366101324422404,0.00378308368533164,0.0291952884189904,0.0440249764654904,4.33791169808103e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SH3GLB2,Endophilin-B2,37388,-0.0621145073938039,0.00643099314919413,-0.0747192539662244,-0.0495097608213834,5.32197521427175e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CSTB,Cystatin-B,39619,-0.0396004986766579,0.00410605893204398,-0.0476483741834641,-0.0315526231698517,5.96903331247376e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,39585,-0.0902782283668075,0.00936243098921197,-0.108628593105663,-0.0719278636279521,6.07588138458276e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,37368,-0.0499688383064231,0.00518184509797155,-0.0601252546984474,-0.0398124219143989,6.18906590559057e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,37388,-0.0649563098824911,0.00674460003792411,-0.0781757259568224,-0.0517368938081599,6.96237250369066e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,39913,-0.0880308970855501,0.00914827947885278,-0.105961524864102,-0.0701002693069986,7.34779216832787e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLA2,Src-like-adapter 2,37411,-0.0987435074966303,0.0102593343987908,-0.11885180291826,-0.0786352120750002,7.38408259503508e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANXA2,Annexin A2,36879,-0.0652582225886234,0.00678369565973597,-0.0785542660817059,-0.0519621790955409,7.79155736884802e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RNASE1,Ribonuclease pancreatic,37445,-0.0208961691226701,0.00217687272337387,-0.0251628396604829,-0.0166294985848574,9.44718706439284e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AXIN1,Axin-1,39866,-0.0881553864523437,0.00923533729649148,-0.106256647553467,-0.0700541253512204,1.54651704459402e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATG16L1,Autophagy-related protein 16-1,37382,-0.0798110447376412,0.00836157206982295,-0.0961997259944942,-0.0634223634807882,1.59134107994484e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINA9,Serpin A9,39715,-0.0670259103067709,0.00703242235206215,-0.0808094581168127,-0.0532423624967291,1.77864698932054e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,37368,-0.0673000922482849,0.00706766684780812,-0.0811527192699888,-0.053447465226581,1.97844809637912e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,37365,-0.0387775893122981,0.00407410686232126,-0.0467628387624477,-0.0307923398621484,2.0593916631618e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,39868,-0.027159557782115,0.00285467311551293,-0.0327547170885204,-0.0215643984757097,2.08859536036112e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,39477,-0.0417309916880992,0.0043861047017926,-0.0503277569036127,-0.0331342264725857,2.08951915591768e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",37382,-0.0947130346498995,0.00996323539658986,-0.114240976027216,-0.0751850932725834,2.30476640332974e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,WDR46,WD repeat-containing protein 46,37368,-0.0332765736286171,0.00350390353569314,-0.0401442245585756,-0.0264089226986585,2.51786968564569e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EHBP1,EH domain-binding protein 1,37437,-0.0692146424928911,0.00729194674267713,-0.0835068581085383,-0.054922426877244,2.64055392254285e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,37043,-0.068846562290502,0.00725761692706443,-0.0830714914675483,-0.0546216331134557,2.80370490078002e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,39913,0.0218083195032551,0.00230081208304394,0.017298727820489,0.0263179111860213,2.93105952101926e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,37169,-0.0399260753643025,0.00421198613617141,-0.0481815681911984,-0.0316705825374065,2.99124796542659e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL4,C-C motif chemokine 4,39882,-0.0570869035673156,0.00602555716130455,-0.0688969956034725,-0.0452768115311586,3.05736146409774e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TRIM5,Tripartite motif-containing protein 5,39866,-0.0791004990098784,0.0083535069771755,-0.0954733726851424,-0.0627276253346145,3.20660072292656e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LYN,Tyrosine-protein kinase Lyn,39788,-0.0775284562092704,0.00819373495781439,-0.0935881767265866,-0.0614687356919542,3.43670930282963e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TALDO1,Transaldolase,37415,-0.0410809990676283,0.00434163962086475,-0.0495906127245232,-0.0325713854107333,3.50850528994281e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL19,C-C motif chemokine 19,40009,-0.105743791322626,0.011185833588039,-0.127668025155183,-0.0838195574900699,3.72133488892785e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTSL,Cathepsin L1,39868,-0.0218441493001491,0.00231167729090606,-0.026375036790325,-0.0173132618099733,3.86560659947966e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,39749,-0.0530327795807667,0.00561679694044777,-0.0640417015840444,-0.0420238575774891,4.16126085938145e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,REG1B,Lithostathine-1-beta,40052,-0.0496224880871539,0.0052569042379951,-0.0599260203936243,-0.0393189557806835,4.24423718137183e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NSFL1C,NSFL1 cofactor p47,40009,-0.0592493992085251,0.00628434817469677,-0.0715667216309308,-0.0469320767861194,4.73042108868206e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,40009,-0.0416312496921979,0.00441767398547103,-0.0502898907037211,-0.0329726086806747,4.92699059943861e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AP3B1,AP-3 complex subunit beta-1,37382,-0.0703081754946806,0.0074629663715501,-0.0849355895829188,-0.0556807614064424,5.18503295573303e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,39489,-0.0613194131512857,0.00651508982615199,-0.0740889892105436,-0.0485498370920278,5.53674550809257e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLRD1,Natural killer cells antigen CD94,40058,-0.041606967718981,0.00442201919193947,-0.0502741253351823,-0.0329398101027796,5.66340733857425e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',37388,-0.0369887867770266,0.0039320198434501,-0.0446955456701888,-0.0292820278838644,5.91141343668101e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,39931,-0.0779028726427023,0.00828935797584558,-0.0941500142753596,-0.0616557310100449,6.29651958497904e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,39931,-0.114839265219142,0.0122203768778884,-0.138791203899803,-0.0908873265384804,6.33108419885707e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,39587,-0.0640297561851471,0.00681508126893486,-0.0773873154722594,-0.0506721968980348,6.47263005659872e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,39477,-0.0513474530818925,0.00546749137597494,-0.0620637361788034,-0.0406311699849817,6.72100712211313e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,39477,-0.0611025065207378,0.00650750740033845,-0.0738572210254011,-0.0483477920160744,6.84066680369168e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",36991,-0.0595841938178338,0.00634413284044251,-0.0720186941851011,-0.0471496934505664,6.84445040897068e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,39477,-0.03076760978161,0.00327838118364719,-0.0371932369015585,-0.0243419826616615,7.14016536401931e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SFRP4,Secreted frizzled-related protein 4,37124,-0.037877548508501,0.00403647363797532,-0.0457890368389326,-0.0299660601780694,7.3831218850004e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,40058,-0.0508755911593751,0.00542349669805984,-0.0615056446875724,-0.0402455376311779,7.41011673902724e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LGALS8,Galectin-8,40009,-0.0554884721390911,0.00591556781751394,-0.0670829850614184,-0.0438939592167638,7.44881739678812e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HPSE,Heparanase,37306,-0.0856500628789368,0.00914016054959731,-0.103564777556148,-0.0677353482017261,8.33468172428215e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,37388,-0.0802861484570158,0.0085726737061493,-0.0970885889210685,-0.0634837079929632,8.76005294734472e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD302,CD302 antigen,39788,-0.0263234584599382,0.0028117654854022,-0.0318345188113265,-0.0208123981085499,8.85557861646087e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AGT,Angiotensinogen,37445,-0.0203914478878451,0.0021802717209044,-0.0246647804608177,-0.0161181153148724,9.86033284718443e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,40030,-0.0298987546122038,0.00319974937710766,-0.0361702633913348,-0.0236272458330728,1.04509650656219e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CFH,Complement factor H,36763,-0.0214143494674956,0.00229096868240073,-0.025904648085001,-0.0169240508499902,1.0453700991641e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,37135,-0.0593169426267606,0.00634828214368742,-0.0717595756283879,-0.0468743096251332,1.07588036862087e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AP2B1,AP-2 complex subunit beta,37039,-0.0446320015020582,0.00477768453153392,-0.0539962631838647,-0.0352677398202517,1.09757862067169e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VEGFC,Vascular endothelial growth factor C,39913,-0.0501448681812636,0.00537152258183622,-0.0606730524416626,-0.0396166839208646,1.13588371282768e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GBP1,Guanylate-binding protein 1,37376,-0.057681671988509,0.00617826751084056,-0.0697910763097565,-0.0455722676672615,1.1519585410806e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STK11,Serine/threonine-protein kinase STK11,39585,-0.0660240537692028,0.00707654196786617,-0.0798940760262205,-0.0521540315121851,1.19713615976699e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,39477,-0.035563050522012,0.00381544122487087,-0.0430413153227589,-0.0280847857212651,1.30569482912723e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SNAP23,Synaptosomal-associated protein 23,39868,-0.0784357764464133,0.00841825510285406,-0.0949355564480073,-0.0619359964448194,1.34493513093285e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RFC4,Replication factor C subunit 4,37368,-0.019332359176507,0.00207618933236288,-0.0234016902679383,-0.0152630280850758,1.45280784377906e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,37437,-0.0578747948325353,0.006215523086792,-0.0700572200826476,-0.0456923695824229,1.45354959534022e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,37382,-0.075824330038617,0.00814638482879515,-0.0917912443030555,-0.0598574157741785,1.50424656447755e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DSC2,Desmocollin-2,39673,-0.0299488811141446,0.00322108396095062,-0.0362622056776078,-0.0236355565506814,1.61786094268706e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,39866,-0.0955091861236818,0.0102893510844849,-0.115676314249272,-0.0753420579980914,1.86612545474135e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARSB,Arylsulfatase B,39788,-0.0496509088927089,0.00534956324128688,-0.0601360528456311,-0.0391657649397866,1.88527824585061e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SORT1,Sortilin,39846,-0.0333779932328133,0.00361024179389767,-0.0404540671488527,-0.0263019193167738,2.63414451098751e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,S100A14,Protein S100-A14,37411,-0.0459655863690929,0.00497365232148494,-0.0557139449192034,-0.0362172278189824,2.77969596459948e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,37388,-0.0562609934631085,0.00608964364233556,-0.0681966950020862,-0.0443252919241308,2.85938616429904e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,40058,0.0231874132953386,0.00251483329456481,0.0182583400379916,0.0281164865526856,3.32093821705073e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COL5A1,Collagen alpha-1(V) chain,37124,-0.0354775196687525,0.00384694224239158,-0.04301752646384,-0.027937512873665,3.34247740255843e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL32,Interleukin-32,39866,0.0382115742203249,0.00414473959811246,0.0300878846080245,0.0463352638326253,3.35533736114919e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FOXO1,Forkhead box protein O1,39866,-0.0766966661093056,0.0083224281344,-0.0930086252527296,-0.0603847069658816,3.47036671966437e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",39866,-0.0873467248730769,0.00949635338638821,-0.105959577510398,-0.068733872235756,4.09012028646044e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,37169,-0.0479625849144518,0.00522468980833272,-0.0582029769387839,-0.0377221928901196,4.93943314339001e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,39841,-0.0865324120460198,0.00943132164919624,-0.105017802478444,-0.0680470216135951,5.05620419922374e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCN5,CCN family member 5,39858,-0.0341504050794932,0.00372247918624983,-0.0414464642845429,-0.0268543458744435,5.09785033438911e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,37021,-0.0327345745566673,0.00357093926576644,-0.0397336155175695,-0.0257355335957651,5.57956326155181e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NIT2,Omega-amidase NIT2,37377,-0.0671714895312832,0.00732818113610064,-0.0815347245580405,-0.0528082545045259,5.59806205324636e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NCK2,Cytoplasmic protein NCK2,39931,-0.0941723390356422,0.0102781940809035,-0.114317599434213,-0.0740270786370713,5.67918004208442e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PCDH17,Protocadherin-17,39868,-0.0309533623169319,0.00338468137573941,-0.0375873378133812,-0.0243193868204827,6.65777793085377e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",37411,-0.0689306371328445,0.00754417604171035,-0.0837172221745968,-0.0541440520910922,7.32486143050334e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SEPTIN8,Septin-8,37357,-0.0282741907570142,0.0030962572915572,-0.0343428550484663,-0.0222055264655621,7.68734842658289e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,40052,0.0252499483384628,0.00276852439353639,0.0198236405271315,0.0306762561497942,8.34964537981163e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,QDPR,Dihydropteridine reductase,39790,-0.038322364771818,0.00420575225462599,-0.046565639190885,-0.0300790903527511,9.04058886327848e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FOLR1,Folate receptor alpha,39809,-0.0241378268109401,0.00264987462051702,-0.0293315810671535,-0.0189440725547268,9.27860451034682e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CFHR4,Complement factor H-related protein 4,37409,0.0636800376894389,0.00699845718071899,0.0499630616152297,0.0773970137636482,1.03573575407109e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,39826,-0.0568997072784453,0.00626322620238233,-0.0691756306351147,-0.044623783921776,1.15913432949355e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL22,C-C motif chemokine 22,39686,-0.0442052920450088,0.00486977623481646,-0.053750053465249,-0.0346605306247685,1.2397339568702e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,39866,-0.0324301973607464,0.00357803487707251,-0.0394431457198085,-0.0254172490016843,1.40436765421884e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,39858,-0.0263231838817184,0.00290474884383007,-0.0320164916156254,-0.0206298761478115,1.42469412326474e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",37026,-0.0704086059188393,0.00777463212868258,-0.0856468848910571,-0.0551703269466214,1.53873146337439e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VASN,Vasorin,39642,0.023923750643422,0.00265178113493672,0.018726259618946,0.029121241667898,2.06010606855239e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IKBKG,NF-kappa-B essential modulator,39866,-0.0802768962703201,0.00891961491268943,-0.0977593414991914,-0.0627944510414488,2.50525230716433e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RAB6A,Ras-related protein Rab-6A,39866,0.0401934648324649,0.00447953590820792,0.0314135744523774,0.0489733552125524,3.20893802637932e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",37043,-0.0553973580915356,0.00618457502196631,-0.0675191251345896,-0.0432755910484817,3.7673176776906e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANGPT1,Angiopoietin-1,39794,-0.0732096012334373,0.0081778719650503,-0.0892382302849359,-0.0571809721819387,3.86391447572622e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",39788,-0.029398325144915,0.00328945569503834,-0.0358456583071901,-0.0229509919826398,4.42385544660506e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,POF1B,Protein POF1B,37056,-0.039248416398325,0.00439611602934525,-0.0478648038158417,-0.0306320289808084,4.90603702369409e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,39477,-0.0676135754055259,0.00757512138066191,-0.0824608133116232,-0.0527663374994285,4.91143516951749e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,37169,-0.0485708637562173,0.00544299349279626,-0.059239131002098,-0.0379025965103367,5.09933492899233e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,39862,-0.022847000705469,0.00256175630883844,-0.0278680430707924,-0.0178259583401457,5.22908300597654e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITGA5,Integrin alpha-5,39858,-0.0213910266786517,0.00239905909509823,-0.0260931825050442,-0.0166888708522592,5.3272394753468e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATXN3,Ataxin-3,37388,-0.0530636827429303,0.0059611964766509,-0.064747627837166,-0.0413797376486945,6.20186468355728e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD207,C-type lectin domain family 4 member K,39496,-0.0324074462507194,0.00364355588643471,-0.0395488157881314,-0.0252660767133074,6.50260336049856e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BCR,Breakpoint cluster region protein,39866,-0.0791365944488759,0.00889904862927522,-0.0965787297622554,-0.0616944591354965,6.58998475479557e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BID,BH3-interacting domain death agonist,39866,-0.0568864726924348,0.00640265488044443,-0.0694356762581059,-0.0443372691267637,7.07158889254225e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IDS,Iduronate 2-sulfatase,40058,0.00773861983988768,0.000871944682906949,0.00602960826139007,0.0094476314183853,7.70352133575251e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,37445,-0.0528008447388572,0.00595732231682497,-0.0644771964798342,-0.0411244929978803,8.7324738391657e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HEXIM1,Protein HEXIM1,39866,-0.0700209558676013,0.00790334690009923,-0.0855115157917958,-0.0545303959434068,8.85547037851722e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DAB2,Disabled homolog 2,40030,-0.0955703760623308,0.0107910477270599,-0.116720829607368,-0.0744199225172934,9.10366421247002e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PCBP2,Poly(rC)-binding protein 2,37411,-0.0624171861290131,0.00706436452594146,-0.0762633405998583,-0.0485710316581678,1.11781508901807e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,METAP2,Methionine aminopeptidase 2,40011,-0.0493519256766057,0.00558705360404663,-0.0603025507405371,-0.0384013006126744,1.11944291916189e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,37368,-0.0982685489705214,0.0111234548747305,-0.120070520524993,-0.0764665774160496,1.12965877533813e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DPP4,Dipeptidyl peptidase 4,39575,0.025652388789077,0.0029069546480329,0.0199547576789325,0.0313500198992215,1.2135652807749e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,37411,-0.0450333183873394,0.00510406885953187,-0.0550372933520219,-0.035029343422657,1.24890679624135e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,37388,-0.0777582030222908,0.00882078326920675,-0.095046938229936,-0.0604694678146456,1.33733748411988e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APP,Amyloid-beta precursor protein,39829,-0.0567345119206878,0.00644217571801401,-0.0693611763279952,-0.0441078475133803,1.41869615602458e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OTUD7B,OTU domain-containing protein 7B,37411,-0.0550361654405822,0.00624838678290747,-0.0672830035350809,-0.0427893273460836,1.42628450969958e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TCOF1,Treacle protein,37437,-0.0260525677224638,0.00295952089570401,-0.0318532286780437,-0.020251906766884,1.49182483224308e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SEZ6L2,Seizure 6-like protein 2,39788,0.0204401305503357,0.00232526704104585,0.0158826071498858,0.0249976539507856,1.63950318027851e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BGN,Biglycan,39448,0.101486046025441,0.0115475716711997,0.0788528055498893,0.124119286500992,1.67118663035276e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CASP10,Caspase-10,39489,-0.0607479868438864,0.00691801957853453,-0.0743073052178141,-0.0471886684699587,1.78378164259805e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLF4,Krueppel-like factor 4,36991,-0.0337409056609875,0.00384332234396977,-0.0412738174551683,-0.0262079938668068,1.84977707371526e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PZP,Pregnancy zone protein,37453,-0.0469303213420343,0.00534964112873204,-0.057415617954349,-0.0364450247297195,1.95127111814199e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CFC1,Cryptic protein,39477,-0.0395776566138663,0.00451905702103031,-0.0484350083750857,-0.0307203048526469,2.18942744143993e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,40052,-0.0608824628190354,0.00695303423719463,-0.0745104099239369,-0.0472545157141339,2.21500403994684e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,JAM3,Junctional adhesion molecule C,37124,-0.0430747611294548,0.00492350618067664,-0.052724833243581,-0.0334246890153286,2.41400490690363e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",37043,-0.0316525419537346,0.00362362706061034,-0.0387548509925308,-0.0245502329149383,2.72657636636288e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BTD,Biotinidase,37453,-0.017424017145817,0.00199564449181169,-0.0213354803497679,-0.013512553941866,2.81517823866524e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KAZN,Kazrin,37382,-0.0884608675160411,0.0101333459265868,-0.108322225532151,-0.0685995094999309,2.85023559457019e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MMP8,Neutrophil collagenase,39985,-0.0604891686482559,0.00693379524318219,-0.074079407324893,-0.0468989299716189,2.94852466134109e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EPHB4,Ephrin type-B receptor 4,40052,-0.0198326681945077,0.00227390171007309,-0.0242895155462509,-0.0153758208427644,2.99841338357602e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GOLGA3,Golgin subfamily A member 3,37411,-0.0655937429731042,0.00756664075285313,-0.0804243588486963,-0.050763127097512,4.85770960459671e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,39904,-0.0599079844027389,0.00691348205047861,-0.073458409221677,-0.0463575595838009,4.92319888523821e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HYAL1,Hyaluronidase-1,39747,-0.0191418105561136,0.00221017753733687,-0.0234737585292938,-0.0148098625829333,5.13083159334096e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NT5E,5'-nucleotidase,39913,-0.0462950615705146,0.00534715133968344,-0.0567754781962941,-0.035814644944735,5.25586095348237e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,37039,-0.0612855345041344,0.00708020301009581,-0.0751627324039222,-0.0474083366043467,5.45300560259863e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADD1,Alpha-adducin,37124,-0.0580433602294949,0.00671257448716163,-0.0712000062243317,-0.0448867142346581,5.89080854939996e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COLEC12,Collectin-12,39862,-0.0207553596658101,0.00240393128776471,-0.0254670649898289,-0.0160436543417912,6.47912489577715e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APOA2,Apolipoprotein A-II,37445,0.0399992968089006,0.00463247199776078,0.0309196516932895,0.0490789419245118,6.54641136727996e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,37124,-0.0654499781350497,0.00758342419732459,-0.0803134895618059,-0.0505864667082935,6.78841586860928e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SEMA7A,Semaphorin-7A,40002,-0.0224506864687969,0.00260521015987624,-0.0275568983821543,-0.0173444745554395,7.46123786293043e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,39866,-0.0866768264654465,0.0100597733423456,-0.106393982216444,-0.0669596707144491,7.56010656837416e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,37411,-0.0506669355885065,0.00588020793951901,-0.0621921431499638,-0.0391417280270493,7.658666507047e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,39732,-0.0327164340385227,0.00379948640383776,-0.0401634273900447,-0.0252694406870007,7.93104297366875e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPBP,Platelet basic protein,37371,-0.0710504944538568,0.00826083077462975,-0.0872417227721311,-0.0548592661355824,8.77350394495899e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,39862,-0.0428768965255798,0.00499854290193733,-0.052674040613377,-0.0330797524377827,1.05380931808539e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATG4A,Cysteine protease ATG4A,39477,-0.0488674833380207,0.00569958761784793,-0.0600386750690026,-0.0376962916070387,1.09338020124446e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ING1,Inhibitor of growth protein 1,39453,-0.0373678853265273,0.00435850297010008,-0.0459105511479235,-0.0288252195051312,1.09640046245879e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RILP,Rab-interacting lysosomal protein,39984,-0.0491622501982958,0.00574399665539544,-0.0604204836428709,-0.0379040167537208,1.24092097253982e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CNST,Consortin,39868,-0.0893821300832065,0.0104593370262632,-0.109882430654682,-0.0688818295117307,1.3916156168657e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,39713,-0.0926609407331152,0.0108451680101883,-0.113917470033084,-0.0714044114331462,1.41326375266575e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CXCL5,C-X-C motif chemokine 5,39805,-0.0942321295103878,0.0110292305054929,-0.115849421301154,-0.0726148377196217,1.41415267349161e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,37382,-0.0393641390045563,0.00461422902618391,-0.0484080278958767,-0.0303202501132358,1.60340939398992e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DLK1,Protein delta homolog 1,40052,-0.0460308235174059,0.00539813222098319,-0.0566111626705329,-0.0354504843642788,1.63041954747685e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,37411,-0.0544624362077204,0.00640691446181776,-0.0670199885528832,-0.0419048838625576,2.08215406727307e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLAMF6,SLAM family member 6,39477,-0.0310562571511128,0.00365502058906581,-0.0382200975056818,-0.0238924167965438,2.1214079291608e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINA12,Serpin A12,39405,-0.0974299308552142,0.0114699909894188,-0.119911113194475,-0.0749487485159533,2.16899612125236e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL2,C-C motif chemokine 2,39720,-0.0424725258585889,0.00500265717104281,-0.0522777339138328,-0.032667317803345,2.24735509661777e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,37124,-0.0482021531039915,0.00567733840041812,-0.059329736368811,-0.0370745698391719,2.27896714604892e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,37437,-0.0197953421777895,0.00233227941554499,-0.0243666098322577,-0.0152240745233213,2.32729849473364e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FCRLB,Fc receptor-like B,39477,-0.0475281672137133,0.00560330200369483,-0.0585106391409552,-0.0365456952864714,2.40613778106519e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,40030,-0.0244071769043439,0.00287770784044608,-0.0300474842716182,-0.0187668695370696,2.41373868111571e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",39758,-0.0614564715925637,0.00724603737365875,-0.0756587048449349,-0.0472542383401926,2.41865013293112e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STAT2,Signal transducer and activator of transcription 2,37056,-0.0648588561950243,0.00766085066292903,-0.0798741234943652,-0.0498435888956834,2.79925098270966e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,39489,-0.0414128504577185,0.00489610185710105,-0.0510092100976366,-0.0318164908178005,2.94967734210138e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SYTL4,Synaptotagmin-like protein 4,37437,-0.0593274852834424,0.00702435684773434,-0.0730952247050018,-0.0455597458618831,3.31913829250568e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,39585,-0.0462073633279717,0.00547245798098016,-0.0569333809706929,-0.0354813456852506,3.34217319759253e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,WASHC3,WASH complex subunit 3,37388,-0.0621892937778855,0.00737283271814012,-0.0766400459054401,-0.0477385416503309,3.64744005711953e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MMP9,Matrix metalloproteinase-9,39843,-0.0493810529117643,0.00586274368531493,-0.0608720305349815,-0.037890075288547,3.98289337267609e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",39868,0.0633525023149528,0.00753670790831547,0.0485805548146545,0.0781244498152511,4.60085347362043e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NGRN,Neugrin,37388,-0.0174386396931184,0.00207421683051426,-0.0215041046809264,-0.0133731747053105,4.61039144022178e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PF4,Platelet factor 4,37385,-0.0788922588667108,0.0093844925919119,-0.0972858643468581,-0.0604986533865634,4.6369384404333e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,39749,-0.0313445312308625,0.00373116444819273,-0.0386576135493203,-0.0240314489124048,4.80798813412239e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FABP5,Fatty acid-binding protein 5,39972,-0.0553146821591978,0.00659843716042278,-0.0682476189936265,-0.0423817453247692,5.58139283580551e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,USO1,General vesicular transport factor p115,39788,-0.0728487430473819,0.00869108223043748,-0.0898832642190393,-0.0558142218757244,5.63329213967781e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IFNG,Interferon gamma,39587,-0.0927615383923455,0.0110735998978282,-0.114465794192089,-0.0710572825926022,5.89213395948989e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,39866,-0.0493841182230996,0.00589690808466893,-0.0609420580690507,-0.0378261783771485,5.9964387978723e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,39913,-0.0206453214750405,0.00246910065779845,-0.0254847587643255,-0.0158058841857556,6.69681388869949e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CMIP,C-Maf-inducing protein,37368,-0.067353168506397,0.00806201956483168,-0.0831547268534671,-0.0515516101593269,7.21459002264e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,37411,-0.062283091550604,0.00746533033873601,-0.0769151390145266,-0.0476510440866814,7.93931953156444e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRTAC1,Cartilage acidic protein 1,40052,0.024296087653152,0.00291425559300288,0.0185841466908664,0.0300080286154377,8.22719940723862e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLXNA4,Plexin-A4,39866,-0.0655576068669488,0.00786346260731203,-0.0809699935772804,-0.0501452201566172,8.23375274630244e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,39585,-0.0276828067916452,0.00332360223282966,-0.0341970671679914,-0.0211685464152991,8.80667456678127e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,39585,-0.0424780976572029,0.00510161261875064,-0.0524772583899541,-0.0324789369244516,9.01278827247585e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINB8,Serpin B8,40058,-0.0443995460840091,0.00533308156563222,-0.0548523859526483,-0.03394670621537,9.07563434609004e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,37368,-0.0391554073821702,0.00470311204186895,-0.0483735069842333,-0.0299373077801071,9.20459404722949e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,37043,-0.0835838126602354,0.0100396007216238,-0.103261430074618,-0.0639061952458527,9.22624823521338e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RPL14,60S ribosomal protein L14,37043,-0.0328137118703809,0.00394191833529654,-0.0405398718075621,-0.0250875519331996,9.31278878285591e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",37411,-0.0650803063273865,0.00783005360631705,-0.0804272113957679,-0.0497334012590051,1.03336811045137e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL1R1,Interleukin-1 receptor type 1,39826,-0.0180571330746806,0.00217477169519024,-0.0223196855972535,-0.0137945805521077,1.0956707420533e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,37039,-0.0645851948809387,0.0077799467483262,-0.079833890507658,-0.0493364992542193,1.12757501594283e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,39866,-0.0588301193548485,0.00709203526848305,-0.0727305084810752,-0.0449297302286217,1.16910635117046e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STAMBP,STAM-binding protein,39713,-0.0517088871932353,0.00623643823758847,-0.0639323061389087,-0.0394854682475619,1.20803773189188e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,39587,-0.0478143987915084,0.00577029455743143,-0.059124176124074,-0.0365046214589428,1.2616178009454e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,39585,-0.0607162406309531,0.00733309847822577,-0.0750891136482756,-0.0463433676136306,1.3326608866046e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TREH,Trehalase,37437,-0.0606171156442434,0.00731987823357146,-0.0749640769820435,-0.0462701543064433,1.3330476392508e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,37388,-0.0230942371074173,0.00279121755664539,-0.0285650235184423,-0.0176234506963923,1.41696882453909e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,36874,-0.0429908626934756,0.0052123817956476,-0.0532071310129449,-0.0327745943740063,1.76687954901643e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRSS22,Brain-specific serine protease 4,37056,-0.0269735836436187,0.00327113756064502,-0.0333850132624829,-0.0205621540247544,1.79280244846506e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,39477,-0.0508810387790136,0.0061756731901771,-0.0629853582317607,-0.0387767193262665,1.87396879478949e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LAYN,Layilin,39713,-0.0257141215726636,0.0031234527836609,-0.031836089028639,-0.0195921541166882,1.97341511349015e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,39477,-0.0280550756251931,0.00341006575583824,-0.034738804506636,-0.0213713467437501,2.06733081109303e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,39931,-0.020931802979011,0.00254437611158693,-0.0259187801577214,-0.0159448258003007,2.07055199757746e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GLO1,Lactoylglutathione lyase,39585,-0.0459599340417674,0.00558869386706197,-0.0569137740212089,-0.0350060940623259,2.12549563969469e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,39585,0.0170408565864764,0.00207338345287616,0.0129770250188391,0.0211046881541136,2.2132197795557e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DOK2,Docking protein 2,39868,-0.0976230173317463,0.0118812740714995,-0.120910314511885,-0.0743357201516074,2.25328573998456e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDA,Cytidine deaminase,37422,-0.0370647680019728,0.00451115844888839,-0.0459066385617941,-0.0282228974421516,2.28882089759452e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SNX15,Sorting nexin-15,37124,-0.0430900103455213,0.00524519455761978,-0.0533705916784561,-0.0328094290125866,2.31427695922653e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TPR,Nucleoprotein TPR,37021,-0.037595174323261,0.00457666843536097,-0.0465654444565685,-0.0286249041899535,2.32764374656304e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OGA,Protein O-GlcNAcase,37382,-0.0568836014811923,0.00692883172812485,-0.070464111668317,-0.0433030912940676,2.41706787117619e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,39825,-0.0219496942858742,0.00267446191233269,-0.0271916396340463,-0.0167077489377022,2.43650374834792e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,37043,-0.03678847141998,0.00448222026207975,-0.0455736231336563,-0.0280033197063037,2.46392951715374e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DNMBP,Dynamin-binding protein,39749,-0.0492460445940373,0.00600561011006235,-0.0610170404097595,-0.0374750487783151,2.585858213209e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,39931,-0.0301131974834055,0.00367463296506684,-0.0373154780949365,-0.0229109168718745,2.69565965633817e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLC16A1,Monocarboxylate transporter 1,39489,-0.0459982948745596,0.00561658878839316,-0.0570068088998102,-0.034989780849309,2.8190940938153e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AZI2,5-azacytidine-induced protein 2,37411,-0.0440414532487453,0.00540275068347374,-0.0546308445883538,-0.0334520619091368,3.90232081642468e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DNM3,Dynamin-3,37411,-0.0435803085628353,0.00534892161243145,-0.054064194923201,-0.0330964222024697,4.03880977547301e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LTA,Lymphotoxin-alpha,39866,-0.0310605790438584,0.00382433578920181,-0.038556277190694,-0.0235648808970229,4.92441077420234e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,37123,-0.0415475770052786,0.00511670171280002,-0.0515763123623666,-0.0315188416481906,5.07137595827577e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CIT,Citron Rho-interacting kinase,37039,-0.0357675627459227,0.00441375153288579,-0.0444185157503788,-0.0271166097414665,5.80011825244856e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,39477,-0.0447918268772083,0.0055324845517199,-0.0556354965985793,-0.0339481571558373,6.08793795073675e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GASK1A,Golgi-associated kinase 1A,37021,-0.0336928976282515,0.00416146849425291,-0.0418493758769872,-0.0255364193795157,6.15610256898881e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GMPR,GMP reductase 1,40058,-0.0388819960158753,0.00480677032087256,-0.0483032658447856,-0.0294607261869651,6.43798588669365e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SEC31A,Protein transport protein Sec31A,37043,-0.0607446870972726,0.0075078365573431,-0.0754600467496651,-0.0460293274448801,6.44132363901742e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CST7,Cystatin-F,39882,-0.0721930299977172,0.00892611236678359,-0.089688210236613,-0.0546978497588213,6.50414165474116e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL8,C-C motif chemokine 8,40003,-0.0472171433868275,0.00584174791222955,-0.0586669692947974,-0.0357673174788576,6.77962444852852e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TADA3,Transcriptional adapter 3,37368,-0.0310929887597708,0.00385196968875026,-0.0386428493497213,-0.0235431281698203,7.49864818612656e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDH3,Cadherin-3,40009,-0.027038059499893,0.00335219221513291,-0.0336083562415535,-0.0204677627582325,7.78362134884183e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SH2B3,SH2B adapter protein 3,39477,-0.0767910876814235,0.00954489337094935,-0.0954990786884842,-0.0580830966743628,9.22093069246135e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPARC,SPARC,39913,-0.0548201340824463,0.0068220765768504,-0.0681914041730731,-0.0414488639918195,9.94725850000024e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SH3BP1,SH3 domain-binding protein 1,37382,-0.0375178847984657,0.00466828016118575,-0.0466677139143897,-0.0283680556825416,9.98466230907843e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,37043,0.0163972110882109,0.00204033253561134,0.0123981593184127,0.0203962628580091,1.00236209533383e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PCDH9,Protocadherin-9,37382,-0.0259666963241755,0.00323568302554537,-0.0323086350542444,-0.0196247575941066,1.09755862921301e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ASAH1,Acid ceramidase,37340,-0.0368825425774632,0.00459747479926528,-0.0458935931840232,-0.0278714919709033,1.12263927742465e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C1RL,Complement C1r subcomponent-like protein,37432,-0.0150000536317413,0.00187056484008508,-0.0186663607183081,-0.0113337465451746,1.15292684596578e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RAB27B,Ras-related protein Rab-27B,37437,-0.0636055657142725,0.00797500858525921,-0.0792365825413806,-0.0479745488871644,1.6369926371946e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL13,C-C motif chemokine 13,40024,-0.0530460891998098,0.00666545782105374,-0.0661103865290751,-0.0399817918705444,1.85828921061913e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,37026,-0.0446021765435072,0.00560834082668483,-0.0555945245638094,-0.0336098285232049,1.97106955378181e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,39836,-0.0656442971239993,0.00825640666989921,-0.0818268541970017,-0.0494617400509968,1.97766439737383e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,37056,-0.0280218288035865,0.0035244524560633,-0.0349297556174706,-0.0211139019897024,2.00488852438287e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,39749,-0.0603940916121951,0.00761612252812971,-0.0753216917673293,-0.0454664914570609,2.34067460268317e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,37056,-0.0702992180619255,0.00886386050324562,-0.0876723846482869,-0.0529260514755641,2.34819871976185e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FCRL5,Fc receptor-like protein 5,39858,-0.0427834826751566,0.00540847174901791,-0.0533840873032317,-0.0321828780470815,2.73113344093393e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,37124,-0.0524206662732182,0.00662576001286955,-0.0654071558984426,-0.0394341766479939,2.74052461806196e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,37056,-0.0384061056513015,0.00485615234381676,-0.0479241642451823,-0.0288880470574206,2.80575698666832e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,37382,-0.0787432461809811,0.00996921569051343,-0.0982829089343874,-0.0592035834275748,3.03627896002382e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IMPACT,Protein IMPACT,37388,-0.0425369083468027,0.00538760513693167,-0.0530966144151888,-0.0319772022784167,3.11753327708945e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MMP12,Macrophage metalloelastase,39900,-0.0383666464759548,0.00486242209005219,-0.0478969937724571,-0.0288362991794525,3.20443442087952e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,THY1,Thy-1 membrane glycoprotein,40009,-0.0206149129960384,0.00261364136274602,-0.0257376500670206,-0.0154921759250562,3.28095891896943e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FOXO3,Forkhead box protein O3,39477,-0.0745669338246938,0.00945937513515325,-0.0931073090895942,-0.0560265585597934,3.40988648076497e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,37382,-0.0307891143100369,0.00390774164492933,-0.0384482879340983,-0.0231299406859754,3.55099246714142e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,37043,-0.0589678802554961,0.00749732326772928,-0.0736626338602455,-0.0442731266507467,3.97105821809022e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",37437,-0.0321839991694461,0.00409434256039116,-0.0402089105878128,-0.0241590877510794,4.10970898240791e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COL1A1,Collagen alpha-1(I) chain,40052,0.0188266626279373,0.0023972069518681,0.0141281370022758,0.0235251882535988,4.29524385374218e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LARP1,La-related protein 1,37368,-0.0489383952439894,0.00623358977995193,-0.0611562312126952,-0.0367205592752837,4.44564878413359e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,37411,0.0196168777883896,0.00250098139566034,0.0147149542528953,0.0245188013238838,4.70163401184106e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,37411,-0.0645197239842212,0.00823844011295953,-0.0806670666056219,-0.0483723813628205,5.17589603646621e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEMIP2,Cell surface hyaluronidase,37056,-0.0243852365392319,0.00311418397425421,-0.0304890371287701,-0.0182814359496936,5.23402513719926e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TREML2,Trem-like transcript 2 protein,39858,-0.025091422951713,0.00320807269227741,-0.0313792454285767,-0.0188036004748493,5.55088551190385e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,S100A12,Protein S100-A12,39615,-0.0566482864508372,0.00724408978327753,-0.0708467024260612,-0.0424498704756133,5.61824542837051e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD160,CD160 antigen,40058,-0.033963203766006,0.00434460987731239,-0.0424786391255383,-0.0254477684064737,5.72601969473392e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,38022,0.0233472828030241,0.00298714576436868,0.0174924771048615,0.0292020885011867,5.83936185851457e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ESYT2,Extended synaptotagmin-2,37388,-0.0625442325425885,0.0080129061136428,-0.0782495285253284,-0.0468389365598486,6.36347063835124e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,40009,-0.0175556515669936,0.00225425530174325,-0.0219739919584103,-0.0131373111755768,7.23152382365137e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DLL1,Delta-like protein 1,39913,-0.0214056107749672,0.00274884775706754,-0.0267933523788196,-0.0160178691711148,7.27189796835153e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LGALS3BP,Galectin-3-binding protein,37453,-0.0228202063774227,0.00293094140027084,-0.0285648515219536,-0.0170755612328919,7.41697131958154e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD46,Membrane cofactor protein,39777,-0.0213803821500704,0.00274776247577961,-0.0267659966025985,-0.0159947676975424,7.63410437081292e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,40034,-0.019990178752252,0.00257208892395935,-0.0250314730432123,-0.0149488844612916,8.19027061666559e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,39850,-0.0425642796674583,0.00548604676271856,-0.0533169313223867,-0.0318116280125299,9.10032161868879e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FKBPL,FK506-binding protein-like,37382,-0.0448871150008927,0.00579690426430715,-0.0562490473589347,-0.0335251826428507,1.03741272428063e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SOST,Sclerostin,39846,-0.0286913611749036,0.00370657194182034,-0.0359562421808715,-0.0214264801689357,1.04782893041488e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNXB,Tenascin-X,39858,0.0192637175425557,0.00248935902576215,0.0143845738520619,0.0241428612330495,1.06640426013916e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BRAP,BRCA1-associated protein,37249,-0.0828796636713153,0.0107314727923383,-0.103913350344298,-0.0618459769983322,1.21626999163833e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,37382,-0.0489263353858173,0.00633743378074561,-0.0613477055960787,-0.0365049651755559,1.24266591869889e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MYDGF,Myeloid-derived growth factor,37437,-0.0760250987830542,0.00985058770061764,-0.0953322506762648,-0.0567179468898437,1.26572239435894e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,37382,-0.0221516453657181,0.00287020789704913,-0.0277772528439344,-0.0165260378875018,1.2664574132847e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AAMDC,Mth938 domain-containing protein,37043,-0.0402031298916754,0.00521122721248041,-0.050417135228137,-0.0299891245552138,1.29942387561904e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",39913,-0.0458179430756404,0.00595065114823113,-0.0574812193261734,-0.0341546668251074,1.44357868329808e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,39809,-0.0143624438857571,0.00186594172625855,-0.0180196896692238,-0.0107051981022903,1.47248603229738e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",39842,-0.0472191545076811,0.00613560563294152,-0.0592449415482465,-0.0351933674671157,1.48651476914947e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTSB,Cathepsin B,39847,0.0381431347853865,0.00496810455709059,0.028405649853489,0.0478806197172841,1.71433742201025e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD36,Platelet glycoprotein 4,37056,-0.0341470037329537,0.00444783222835201,-0.0428647549005236,-0.0254292525653837,1.73983068755934e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,39931,-0.0315091302358539,0.00412313775983408,-0.0395904802451287,-0.0234277802265791,2.2585667044032e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,39913,0.0301490804836727,0.00395163702503989,0.0224038719145945,0.0378942890527509,2.48818351599695e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LY96,Lymphocyte antigen 96,39749,-0.0260991028045062,0.00342133849588814,-0.032804926256447,-0.0193932793525655,2.51249162007252e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LEPR,Leptin receptor,39868,0.022832181194845,0.002993833015592,0.0169642684842847,0.0287000939054054,2.54913364236366e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINE2,Glia-derived nexin,37437,-0.0478101443327815,0.00627998733222884,-0.06011891950395,-0.0355013691616129,2.85235679427818e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BAP18,Chromatin complexes subunit BAP18,37388,-0.0482157430710198,0.00633452691922753,-0.0606314158327057,-0.0358000703093338,2.88658783740095e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,40058,-0.0499360742075509,0.00656781047471465,-0.0628089827379916,-0.0370631656771102,3.04797126639447e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,39846,-0.0505360623905795,0.00664727560035004,-0.0635647225672656,-0.0375074022138935,3.06498885206122e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAP2,Microtubule-associated protein 2,37388,-0.0340172285931214,0.00448037494231323,-0.0427987634800553,-0.0252356937061874,3.34322716655031e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VNN1,Pantetheinase,37445,-0.053544672909419,0.00705309814610588,-0.0673687452757866,-0.0397206005430515,3.36407171587312e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LMNB2,Lamin-B2,37388,-0.0201857040943798,0.00266081099313789,-0.0254008936409301,-0.0149705145478296,3.50631557541757e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,40009,0.0327230541896273,0.00431507033552715,0.0242655163319941,0.0411805920472605,3.5478549424072e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CHRDL2,Chordin-like protein 2,39868,-0.041350748560726,0.00545591092431842,-0.0520443339723901,-0.0306571631490619,3.6704319246585e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SUSD2,Sushi domain-containing protein 2,39858,0.0206477856222981,0.00272795906647012,0.0153009858520167,0.0259945853925796,3.96708453009566e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GET3,ATPase GET3,37437,-0.0411127188231832,0.00544639555060834,-0.0517876541023756,-0.0304377835439909,4.67923558693221e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RBP2,Retinol-binding protein 2,39788,0.0558614914417687,0.0074037094699814,0.0413502208806052,0.0703727620029323,4.76425750613838e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,37043,-0.0440281934410924,0.0058371991364516,-0.0554691037485375,-0.0325872831336473,4.90472261262262e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BMP10,Bone morphogenetic protein 10,37124,0.0207281978473642,0.00275232484600811,0.0153336411491883,0.0261227545455401,5.35393692416087e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SYAP1,Synapse-associated protein 1,37124,-0.0421754991127116,0.00560107381572986,-0.0531536037915421,-0.0311973944338811,5.40581395880091e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FAM3D,Protein FAM3D,37382,-0.0610221554021415,0.00812391967911108,-0.0769450379731992,-0.0450992728310838,6.21543028184058e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLAMF8,SLAM family member 8,39477,-0.0377673081222126,0.00503971389760981,-0.0476451473615278,-0.0278894688828973,7.04146858553779e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NIT1,Deaminated glutathione amidase,37043,-0.0344272254558616,0.00459433196025814,-0.0434321160979676,-0.0254223348137557,7.13785300307867e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PCDH7,Protocadherin-7,37382,-0.0244580817049713,0.00327041352941155,-0.0308680922226179,-0.0180480711873247,7.97475336591277e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CXCL16,C-X-C motif chemokine 16,40034,-0.0168169888151667,0.00224999196155767,-0.0212269730598197,-0.0124070045705136,8.16168973031792e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MITD1,MIT domain-containing protein 1,39749,-0.0702488793309033,0.0094144451778573,-0.0887011918795036,-0.051796566782303,8.97476522083569e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DGKA,Diacylglycerol kinase alpha,37056,-0.03975722162691,0.00533095925415961,-0.0502059017650628,-0.0293085414887571,9.34695803154832e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UROD,Uroporphyrinogen decarboxylase,37124,-0.0503190692827641,0.00675636997077304,-0.0635615544254792,-0.0370765841400489,1.00883777434266e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDH17,Cadherin-17,39868,-0.0478618643048577,0.00643531378386288,-0.060475079321229,-0.0352486492884865,1.07902325423775e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,37021,-0.0452178086905417,0.00607968485348964,-0.0571339910033814,-0.033301626377702,1.0893758528922e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ESM1,Endothelial cell-specific molecule 1,39862,0.0245135349849314,0.0033001550282129,0.0180452311296342,0.0309818388402287,1.1581171235454e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,P4HB,Protein disulfide-isomerase,39776,-0.0279531075025352,0.00376784109151637,-0.0353380760419073,-0.0205681389631631,1.240830424973e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NUB1,NEDD8 ultimate buster 1,39866,-0.0605259886842513,0.00816399712046759,-0.0765274230403678,-0.0445245543281349,1.28896183462093e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLIN3,Perilipin-3,39868,-0.0308300763281516,0.00416043331511395,-0.0389845256257749,-0.0226756270305282,1.32296418386944e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL19,Interleukin-19,39419,-0.0492414122741064,0.00664819497919552,-0.0622718744333296,-0.0362109501148831,1.36083247241015e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,39931,-0.0929551872957797,0.0125507006280304,-0.117554560526719,-0.0683558140648402,1.36234782602905e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NXPH3,Neurexophilin-3,37056,0.021404477117423,0.00289046754590375,0.0157391607274517,0.0270697935073944,1.38898264422277e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL10,Interleukin-10,39587,-0.0566056346219897,0.00766838523952717,-0.071635669691463,-0.0415755995525165,1.64110975604887e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MMP7,Matrilysin,39563,-0.0352448758622378,0.00477839741224267,-0.0446105347902335,-0.0258792169342422,1.71418151940937e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ALPP,"Alkaline phosphatase, placental type",39788,-0.0753898786778111,0.010230889074031,-0.0954424212629117,-0.0553373360927104,1.80544810740337e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,39489,-0.0482078389133059,0.0065553275306471,-0.0610562808733742,-0.0353593969532376,2.01908191280513e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,39585,-0.0374953983551416,0.0051001791998824,-0.0474917495869111,-0.0274990471233721,2.05208588950022e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,37056,-0.0323947227688138,0.00440594396348662,-0.0410303729372476,-0.02375907260038,2.05987054543006e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD7,T-cell antigen CD7,37037,-0.0305665425945162,0.0041616307567364,-0.0387233388777196,-0.0224097463113129,2.18096618380703e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",39868,-0.0517255921909887,0.00704562149354191,-0.0655350103183309,-0.0379161740636466,2.21324349260121e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APOE,Apolipoprotein E,37453,-0.0517808924347008,0.00705412593275746,-0.0656069792629054,-0.0379548056064961,2.24859237971309e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,40009,-0.0397469400877967,0.00541788161428726,-0.0503659880517998,-0.0291278921237937,2.30090542280466e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FOXJ3,Forkhead box protein J3,37056,-0.0320316908051821,0.00436624376818135,-0.0405895285908175,-0.0234738530195466,2.32552593710253e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BCL2L15,Bcl-2-like protein 15,37056,-0.0403522837741434,0.00550095660346456,-0.0511341587169339,-0.0295704088313529,2.33782388299604e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,39587,-0.0397048405290034,0.00541388392582251,-0.0503160530236155,-0.0290936280343913,2.34456283820058e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,40009,-0.0464994170584746,0.00634899981329807,-0.0589434566925388,-0.0340553774244104,2.52233622143861e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APOBR,Apolipoprotein B receptor,37043,0.0303411796964414,0.00414606601874832,0.0222148902996947,0.0384674690931881,2.66129655442046e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCARF1,Scavenger receptor class F member 1,40052,-0.0303062699362041,0.004143964382534,-0.0384284401259707,-0.0221840997464375,2.727449248881e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FAM13A,Protein FAM13A,37382,-0.0482368725294012,0.00659900484250951,-0.0611709220207198,-0.0353028230380825,2.827243614811e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FCN2,Ficolin-2,39810,-0.0287206985385501,0.00393311567517301,-0.0364296052618892,-0.021011791815211,2.96294480133371e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,39868,-0.0230970179995494,0.00316422772932351,-0.0292989043490235,-0.0168951316500753,3.0258777677793e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",37382,-0.104818279410512,0.0143644219803187,-0.132972546491937,-0.0766640123290877,3.10477867236504e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MPO,Myeloperoxidase,39858,-0.0320104163048664,0.00438848601112114,-0.0406118488866639,-0.023408983723069,3.14555988193898e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDGFC,Platelet-derived growth factor C,39477,-0.0206035298781022,0.00282571788471098,-0.0261419369321357,-0.0150651228240687,3.21381024702136e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,39788,-0.024285428985932,0.00333313341163401,-0.0308183704727346,-0.0177524874991293,3.34088952681679e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,37056,-0.0258507077329977,0.00354974310744898,-0.0328082042235977,-0.0188932112423977,3.46477577577778e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CPXM1,Probable carboxypeptidase X1,39913,-0.0478198170657596,0.00657046346124781,-0.0606979254498053,-0.0349417086817138,3.54488686610678e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLB,Beta-klotho,39489,0.0518884528015624,0.00713230075853148,0.0379091433148407,0.0658677622882841,3.62504386079313e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ICAM2,Intercellular adhesion molecule 2,40052,-0.0220643457060452,0.00303325180618854,-0.0280095192461747,-0.0161191721659156,3.64548675978238e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,37411,0.0318177951880299,0.00438036877580762,0.0232322723874469,0.0404033179886128,3.97129594647311e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,37124,-0.0510129660202446,0.00702699630643654,-0.0647858787808602,-0.037240053259629,4.09943740381845e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,S100G,Protein S100-G,37411,0.0317887840954556,0.00437923618970055,0.0232054811636425,0.0403720870272687,4.1125791850834e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITGB1,Integrin beta-1,39862,0.0152855802760322,0.00210624538592393,0.0111573393196213,0.0194138212324431,4.13124001749111e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,37265,-0.0389823198523769,0.00537226699498949,-0.0495119631625563,-0.0284526765421975,4.19956515351399e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,REEP4,Receptor expression-enhancing protein 4,37411,-0.0441087340524869,0.00608051548914699,-0.056026544411215,-0.0321909236937588,4.26262269770245e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CASC3,Protein CASC3,37039,-0.0296544868145103,0.00408910982872015,-0.0376691420788018,-0.0216398315502188,4.33374085977834e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BPIFA2,BPI fold-containing family A member 2,36593,0.076734624801244,0.0105993215745555,0.0559599545151151,0.0975092950873728,4.75919448980034e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,39866,-0.0793075848286914,0.0109705628507247,-0.100809888016112,-0.0578052816412709,5.08069788174313e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,39805,-0.0187293705371392,0.00259748213345502,-0.0238204355187111,-0.0136383055555674,5.82117877070613e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HMOX2,Heme oxygenase 2,39489,-0.0330054823612591,0.00458085987765057,-0.0419839677214543,-0.024026997001064,6.0657090114961e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,39919,-0.0231636350518155,0.00321649465995421,-0.0294679645853257,-0.0168593055183052,6.21871107594283e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,37411,-0.0657103658130529,0.0091326624362033,-0.0836103841880113,-0.0478103474380944,6.56973029250758e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL17,C-C motif chemokine 17,39836,-0.0627957261378273,0.00873069004076769,-0.079907878617732,-0.0456835736579226,6.64234631625197e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,39788,0.045232024735027,0.00629090120670153,0.032901858369892,0.057562191100162,6.76344597150377e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,37437,-0.0435430103625962,0.00606240370827621,-0.0554253216308175,-0.0316606990943748,7.20299622877418e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CNTN4,Contactin-4,39858,0.0165902645177945,0.00231054375716399,0.0120615987537531,0.0211189302818359,7.26485217661475e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,37382,-0.0189513976119256,0.00263924096674974,-0.024124309906755,-0.0137784853170961,7.30185335378432e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,37437,0.0229071700875933,0.00319272166699103,0.0166494356202909,0.0291649045548957,7.61620803546676e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD164,Sialomucin core protein 24,39858,-0.0181992325977956,0.00253838112832205,-0.0231744596093069,-0.0132240055862844,7.84934084783655e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LEFTY2,Left-right determination factor 2,40011,-0.0370387243455484,0.00516634811625365,-0.0471647666534055,-0.0269126820376912,7.8687287016387e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,37124,-0.0371906119562238,0.00519065332394361,-0.0473642924711533,-0.0270169314412943,8.19424532377696e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RRAS,Ras-related protein R-Ras,37039,-0.0919079731129023,0.012842951572938,-0.117080158195861,-0.0667357880299439,8.72700749499285e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,37382,-0.0754047603386996,0.0105423278335684,-0.0960677228924937,-0.0547417977849055,8.95458408631992e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FSHB,Follitropin subunit beta,37043,0.0456206647197881,0.00637897869070897,0.0331178664859986,0.0581234629535777,9.02178798379954e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLEC3B,Tetranectin,37138,0.0147475907406809,0.00206261640218996,0.0107048625923885,0.0187903188889732,9.13546047313979e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RGCC,Regulator of cell cycle RGCC,37411,-0.0527493343913599,0.00738575015421681,-0.0672254046936249,-0.038273264089095,9.66447150111486e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,39788,-0.0613994212781301,0.00859853668452067,-0.0782525531797906,-0.0445462893764696,9.68816564123232e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COMMD1,COMM domain-containing protein 1,37043,-0.0431542636064807,0.00604494130265455,-0.0550023485596836,-0.0313061786532778,9.90035979439572e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,37021,-0.0248256840180984,0.00348140830142607,-0.0316492442888935,-0.0180021237473033,1.04897950818175e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,39585,-0.0647749844391856,0.00910012047583863,-0.0826112205718293,-0.0469387483065419,1.14208230912205e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,39788,-0.0309290927042568,0.0043467673214656,-0.0394487566543294,-0.0224094287541842,1.16322542710456e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,39945,0.016553539368598,0.0023265551114449,0.011993491350166,0.02111358738703,1.16596067391079e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPRY2,Protein sprouty homolog 2,39587,-0.0638664463493488,0.00897849055814971,-0.0814642878433223,-0.0462686048553754,1.1820851450172e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCRIB,Protein scribble homolog,37043,-0.0625609848513204,0.00879878821737947,-0.0798066097573842,-0.0453153599452567,1.2186129163194e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RAB33A,Ras-related protein Rab-33A,37021,-0.0464434851487522,0.0065354117072592,-0.0592528920949803,-0.0336340782025242,1.25210745135508e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FABP3,"Fatty acid-binding protein, heart",37437,-0.0338869084390933,0.0047714646119406,-0.0432389790784969,-0.0245348377996897,1.29090116305619e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,37056,-0.061141657668274,0.0086104190639623,-0.0780180790336401,-0.0442652363029079,1.30300839834334e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,39858,-0.0396089833678354,0.00558286017160993,-0.0505513893041909,-0.02866657743148,1.35020511546197e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,37437,-0.0196924788303758,0.00277762170685183,-0.0251366173758054,-0.0142483402849463,1.41054727851986e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VSNL1,Visinin-like protein 1,37388,-0.0260551407885505,0.00367623440539818,-0.033260560223131,-0.0188497213539701,1.4336939186451e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TSNAX,Translin-associated protein X,37021,-0.027019828761252,0.00381629294228323,-0.0344997629281271,-0.0195398945943768,1.51333172275926e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OPHN1,Oligophrenin-1,37388,-0.0743864428899416,0.0105104774686492,-0.0949869787284941,-0.0537859070513891,1.54162700502883e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,37043,-0.030009526619717,0.00424198537473148,-0.0383238179541907,-0.0216952352852433,1.57668487844579e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DCTN2,Dynactin subunit 2,39788,-0.0650091747664376,0.00919095249397551,-0.0830234416546295,-0.0469949078782456,1.57732801681525e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CETN2,Centrin-2,39489,-0.0464118947700757,0.0065636707573119,-0.059276689454407,-0.0335471000857443,1.6030545924714e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HGFAC,Hepatocyte growth factor activator,37318,0.0194996333660087,0.0027597619767334,0.0140904998916112,0.0249087668404062,1.67677093506283e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CAPG,Macrophage-capping protein,39739,-0.0397594859831281,0.00562889752787814,-0.0507921251377693,-0.028726846828487,1.69148633742515e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GMPR2,GMP reductase 2,37124,-0.0458822573339602,0.00652881685301772,-0.0586787383658749,-0.0330857763020454,2.20298825740274e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,F12,Coagulation factor XII,37453,-0.0283277470400591,0.00403450807961424,-0.036235382876103,-0.0204201112040152,2.30145593530406e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SOD3,Extracellular superoxide dismutase,37445,0.0415710768654131,0.0059297037548127,0.0299488575059802,0.053193296224846,2.48414463878985e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AZU1,Azurocidin,39344,-0.0520097866935461,0.0074199824866477,-0.0665529523673756,-0.0374666210197166,2.49186604279399e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TP53,Cellular tumor antigen p53,39477,-0.02991453907115,0.00427983500752718,-0.0383030156859033,-0.0215260624563967,2.86731267459367e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,37056,-0.0664115927684257,0.00950488804834957,-0.0850411733431909,-0.0477820121936606,2.94095172173327e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TSC22D1,TSC22 domain family protein 1,37411,-0.0461442762590171,0.00660930871765019,-0.0590985213456114,-0.0331900311724227,3.05186226296257e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,37043,-0.0212794043705026,0.00305024033617183,-0.0272578754293994,-0.0153009333116058,3.17513440319556e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ZNRD2,Protein ZNRD2,37382,-0.0461160022086392,0.00661503300493528,-0.0590814668983123,-0.033150537518966,3.28372346009074e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,39931,-0.070262798430419,0.0100825925316726,-0.0900246797924974,-0.0505009170683406,3.32253218591501e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDCD1,Programmed cell death protein 1,39998,-0.0276273409139103,0.00396555905104643,-0.0353998366539613,-0.0198548451738593,3.36707847558425e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRTN3,Myeloblastin,39421,-0.0311185806233421,0.00447975277337848,-0.0398988960591639,-0.0223382651875203,3.89313470201665e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,37437,-0.0611221575903268,0.00881630230920128,-0.0784021101163613,-0.0438422050642923,4.31060658721009e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNR,Tenascin-R,39749,0.0281728663266408,0.00406509922854865,0.0202052718386855,0.0361404608145962,4.35706488340343e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C8B,Complement component C8 beta chain,37453,0.0204451311262559,0.00295018869343186,0.0146627612871294,0.0262275009653823,4.39460823860903e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,37382,-0.051752002158407,0.00747594839057337,-0.0664048610039308,-0.0370991433128832,4.63862797989258e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,39587,-0.0392792306968978,0.00567510464276928,-0.0504024357967256,-0.02815602559707,4.64735452200311e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,37039,-0.0293646063479167,0.00424689198289187,-0.0376885146343848,-0.0210406980614487,4.91581812016175e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OGN,Mimecan,39858,-0.0264117679210693,0.00382345930354232,-0.0339057481560122,-0.0189177876861263,5.107032704682e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,37368,-0.0240790462909315,0.00348639766833548,-0.030912385720869,-0.017245706860994,5.18724704736518e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LGALS3,Galectin-3,39901,-0.0196981285056045,0.00285323687639565,-0.02529047278334,-0.014105784227869,5.2533935990027e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,39477,-0.0438985013788295,0.00636041972786149,-0.056364924045438,-0.031432078712221,5.33144050966068e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPING1,Plasma protease C1 inhibitor,37424,0.0126357143116426,0.00183073556333922,0.00904747260749774,0.0162239560157875,5.35579514503263e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APCS,Serum amyloid P-component,37333,-0.0233866722924582,0.00338908803382453,-0.0300292848387543,-0.0167440597461621,5.41054505524329e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,39477,-0.0350908725941447,0.00508726400810618,-0.0450619100500328,-0.0251198351382566,5.48459947823832e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NEXN,Nexilin,37445,-0.0461661719698314,0.00670237687794494,-0.0593028306506035,-0.0330295132890593,5.90592370892438e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RWDD1,RWD domain-containing protein 1,40009,-0.0425509000648154,0.00618133125977135,-0.0546663093339673,-0.0304354907956636,6.04318258286765e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ST13,Hsc70-interacting protein,37124,-0.0370516753848919,0.00538457025689786,-0.0476054330884117,-0.0264979176813721,6.20662433393473e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,39506,-0.0524715339784374,0.00762684372229524,-0.067420147674136,-0.0375229202827387,6.21882161138485e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRKL,Crk-like protein,39881,-0.0712272552716702,0.010371625529727,-0.0915556413099351,-0.0508988692334053,6.7733006158902e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD226,CD226 antigen,37056,-0.028018563474796,0.0040804610078869,-0.0360162670502543,-0.0200208598993377,6.87317084645384e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD300LF,CMRF35-like molecule 1,40030,-0.03968479653291,0.00578181195852273,-0.0510171479716145,-0.0283524450942054,6.95227812157306e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,39477,-0.0297832931581252,0.00433983503213425,-0.0382893698211083,-0.021277216495142,7.00783205063903e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,40009,-0.0313036931543667,0.00457235562733325,-0.0402655101839399,-0.0223418761247936,7.8516822036595e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DKK4,Dickkopf-related protein 4,39718,-0.0300204890272881,0.00438992654080121,-0.0386247450472585,-0.0214162330073177,8.29523215365298e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VEGFD,Vascular endothelial growth factor D,40024,0.0235231872009043,0.00344306877080096,0.0167747724101344,0.0302716019916742,8.67020686233251e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,39868,-0.0534307394847166,0.00782512943269715,-0.068767993172803,-0.0380934857966302,8.91423859543397e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,37437,-0.0309436400486712,0.00454392057726763,-0.0398497243801158,-0.0220375557172267,1.01775209439646e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LGMN,Legumain,39931,-0.0236883415295106,0.00347916271512648,-0.0305075004511585,-0.0168691826078627,1.02019073546389e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PKD2,Polycystin-2,37021,-0.0394509663938431,0.00579906676880726,-0.0508171372607053,-0.0280847955269808,1.06903885315301e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",37411,-0.0311806512792689,0.00458649665383003,-0.0401701847207758,-0.0221911178377621,1.10246706495877e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TRAF2,TNF receptor-associated factor 2,39866,-0.0467583216791353,0.00688522468769811,-0.0602533620670236,-0.033263281291247,1.15189168477946e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,37368,-0.0249003623516194,0.00366640896854357,-0.0320865239299648,-0.017714200773274,1.15626791370767e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BLVRB,Flavin reductase,39858,-0.0423707172559717,0.00624432376091659,-0.0546095918273682,-0.0301318426845751,1.19763344792862e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STK24,Serine/threonine-protein kinase 24,39489,-0.0408295659034017,0.00603060951359841,-0.0526495605500546,-0.0290095712567488,1.33011737539338e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,37056,-0.0315845832747788,0.00466773122424871,-0.0407333364743062,-0.0224358300752513,1.37426374879045e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,36846,-0.0217244194055163,0.00321087143238388,-0.0280177274129888,-0.0154311113980439,1.38169261261132e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,39788,0.0173684624165998,0.00256810599111117,0.0123349746740219,0.0224019501591777,1.39729210324171e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGL1,Fibrinogen-like protein 1,37445,-0.0407972007671169,0.00603191737723695,-0.0526197588265013,-0.0289746427077324,1.40154463730225e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,39477,-0.0395472534327352,0.00585116735143589,-0.0510155414415495,-0.0280789654239208,1.43999827199273e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,39866,-0.0664509154454021,0.00983381911964989,-0.0857252009199159,-0.0471766299708884,1.45350155763397e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BAG6,Large proline-rich protein BAG6,39585,-0.0241180418704889,0.00357273322314432,-0.0311205989878518,-0.017115484753126,1.52400726350813e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",39788,-0.0456692605008964,0.00678045450546601,-0.0589589513316098,-0.0323795696701831,1.6904219757761e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,39374,-0.0800610495264807,0.0118926157681599,-0.103370576432074,-0.0567515226208874,1.73220977331506e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",40052,-0.0188851320204349,0.00280542471200311,-0.024383764455961,-0.0133864995849088,1.73385299426585e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,39977,-0.0672151354720226,0.00998546058128402,-0.0867866382113393,-0.0476436327327059,1.73825665961946e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,WIF1,Wnt inhibitory factor 1,40030,0.0218492910000033,0.00324596894211806,0.0154871918734519,0.0282113901265547,1.73917406231358e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD244,Natural killer cell receptor 2B4,40058,-0.0174138201837621,0.00258874257766189,-0.0224877556359794,-0.0123398847315448,1.79303504238361e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,37388,-0.0405135774358066,0.00602376695621481,-0.0523201606699876,-0.0287069942016255,1.81867429081905e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,40052,0.0200750809448542,0.00298692043158974,0.0142207168989383,0.0259294449907701,1.86509222278188e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDHR5,Cadherin-related family member 5,39868,-0.025250350113235,0.00375839487497104,-0.0326168040681783,-0.0178838961582918,1.89941270315996e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TSPAN1,Tetraspanin-1,39585,-0.026208140515815,0.00390104747000566,-0.0338541935570261,-0.0185620874746039,1.90256140249358e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,37056,-0.0374901369615111,0.00558728567563599,-0.0484412168857577,-0.0265390570372646,2.0270438539291e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,37422,-0.0159193135741062,0.00237446380593822,-0.0205732626337451,-0.0112653645144673,2.10261806324787e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,37027,-0.0237776303305516,0.00354710326135737,-0.030729952722812,-0.0168253079382911,2.11931009820762e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,37021,-0.0402850862126855,0.00602284808128574,-0.0520898684520055,-0.0284803039733654,2.34244165662512e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AMPD3,AMP deaminase 3,37388,-0.0460925239305551,0.00689250312216869,-0.0596018300500058,-0.0325832178111045,2.36183785268941e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,37013,-0.0556692118651217,0.00834075755912238,-0.0720170966810016,-0.0393213270492419,2.58269879058017e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,39788,-0.0353035874759764,0.00529045644818102,-0.0456728821144112,-0.0249342928375416,2.58768094231781e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TMSB10,Thymosin beta-10,39858,-0.0498714613862989,0.00748482541461012,-0.0645417191989347,-0.035201203573663,2.77032462098923e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,37437,-0.0174073400878863,0.00261299115634721,-0.0225288027543268,-0.0122858774214457,2.80831038642312e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CETN3,Centrin-3,37382,-0.05125467870655,0.00769450653016001,-0.0663359115056636,-0.0361734459074364,2.82096341437325e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADA,Adenosine deaminase,40058,-0.022433370065049,0.00337005316959893,-0.0290386742774629,-0.0158280658526351,2.89072035335071e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PGA4,Pepsin A-4,37445,-0.0403182098041695,0.00605732302902947,-0.0521905629410672,-0.0284458566672717,2.91958778061546e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MINK1,Misshapen-like kinase 1,37388,-0.060207833754088,0.0090459831729018,-0.0779379607729755,-0.0424777067352005,2.92711982497132e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,39477,-0.0329285452426972,0.00494815042811711,-0.0426269200818067,-0.0232301704035877,2.93290235002548e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,39489,-0.0247138191972854,0.00371401921540009,-0.0319932968594695,-0.0174343415351012,2.94318432443276e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CA2,Carbonic anhydrase 2,39821,-0.0437470649357695,0.00657599713868131,-0.0566360193275849,-0.0308581105439542,2.97448763901468e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GUCA2A,Guanylin,39796,-0.0207699532166496,0.00312332497768137,-0.0268916701729051,-0.0146482362603942,3.0272585540146e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STX8,Syntaxin-8,39866,-0.0314322047544334,0.00472768534495347,-0.0406984680305422,-0.0221659414783246,3.05587814823597e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINA7,Thyroxine-binding globulin,37453,-0.0120011426927846,0.00180498072821407,-0.0155389049200841,-0.008463380465485,3.06559951298921e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NID2,Nidogen-2,39858,-0.0467437442887618,0.00703936867021599,-0.0605409068823851,-0.0329465816951385,3.23054851578336e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C3,Complement C3,36816,-0.0298062514480368,0.00449202087293169,-0.0386106123589829,-0.0210018905370907,3.36547325226158e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,39749,-0.0511700062445457,0.00771866941091164,-0.0662985982899325,-0.0360414141991589,3.47953594615519e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RALY,RNA-binding protein Raly,37368,-0.0313667983440912,0.00473574020240619,-0.0406488491408073,-0.022084747547375,3.6426413101475e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,37388,-0.0346587090542321,0.00523321788028585,-0.0449158160995923,-0.0244016020088718,3.65699395297565e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NID1,Nidogen-1,39892,-0.0241370256836521,0.00364708001095523,-0.0312853025051244,-0.0169887488621799,3.7518193111078e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FIS1,Mitochondrial fission 1 protein,39855,-0.0500495726995787,0.00757266441767714,-0.0648919949582259,-0.0352071504409315,3.98502900026568e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TBCC,Tubulin-specific chaperone C,39749,-0.0520674025145492,0.00787887124860467,-0.0675099901618143,-0.036624814867284,4.00623279313714e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CXCL8,Interleukin-8,39750,-0.0422881198415254,0.00640211824627017,-0.0548362716042149,-0.0297399680788359,4.09217516717075e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",39866,-0.0616804195413216,0.00934701809341588,-0.0800005750044167,-0.0433602640782265,4.27105158974036e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,37389,-0.0127291577140669,0.00193279808296923,-0.0165174419566866,-0.00894087347144722,4.68933633335937e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,37388,-0.0229136685181729,0.0034797086963636,-0.0297338975630456,-0.0160934394733003,4.71875454875814e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRLF1,Cytokine receptor-like factor 1,39931,-0.0166205941344212,0.00252781898601598,-0.0215751193470125,-0.0116660689218299,5.01279441977735e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UBXN1,UBX domain-containing protein 1,37124,-0.0444353020322063,0.00676254053344293,-0.0576898814777545,-0.0311807225866582,5.19147317123283e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,37437,-0.0688331928775162,0.0104775455110162,-0.0893691820791079,-0.0482972036759245,5.2292397355509e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,39749,-0.0602163589017352,0.0091981916823607,-0.0782448145991622,-0.0421879032043082,6.06884257653141e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COMT,Catechol O-methyltransferase,39403,-0.0539001900746226,0.00823926931671099,-0.0700491579353761,-0.0377512222138691,6.26544821065019e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,37411,-0.0432174349199987,0.00661145179300477,-0.056175880434288,-0.0302589894057093,6.51187794450068e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,37382,-0.0320343170443667,0.00490134874201692,-0.0416409605787199,-0.0224276735100136,6.55316469684858e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TMPRSS5,Transmembrane protease serine 5,39667,0.0240785805213843,0.00368649840572865,0.0168530436461561,0.0313041173966124,6.70754732348275e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ZBP1,Z-DNA-binding protein 1,37056,-0.0261939596808444,0.004011580648759,-0.0340566577524121,-0.0183312616092768,6.83667243782863e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,39489,-0.030544050296167,0.00467843097178002,-0.0397137750008558,-0.0213743255914781,6.83899700495932e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GLRX,Glutaredoxin-1,39771,-0.0354946356703689,0.00543691833128095,-0.0461509955996795,-0.0248382757410582,6.84661230905974e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPRR3,Small proline-rich protein 3,37388,-0.0415527416731621,0.00637729405872607,-0.0540522380282652,-0.029053245318059,7.48967066962429e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TTF2,Transcription termination factor 2,37039,-0.031221980679964,0.00479857323628047,-0.0406271842230738,-0.0218167771368543,7.96956360645749e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GPI,Glucose-6-phosphate isomerase,37445,-0.0300747974446487,0.00462418695634822,-0.0391382038790913,-0.0210113910102062,8.10555508467523e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,39866,-0.066037799139055,0.0101577839015789,-0.0859470555861498,-0.0461285426919603,8.20386169142592e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HS1BP3,HCLS1-binding protein 3,37043,-0.0580414044350419,0.00893438638032192,-0.0755528017404729,-0.040530007129611,8.52158637846304e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",37368,-0.0321944175084857,0.00496099615227363,-0.0419179699669421,-0.0224708650500294,8.9122738425076e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,39832,-0.0224771230926225,0.00346631739533598,-0.0292711051874811,-0.015683140997764,9.16765792979089e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,YJU2,Splicing factor YJU2,37368,-0.020490205099782,0.00316033734574522,-0.0266844662974426,-0.0142959439021214,9.27037519404459e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADA2,Adenosine deaminase 2,39782,-0.0259227759584524,0.00400134748435043,-0.0337654170277792,-0.0180801348891256,9.53492895411137e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,37124,-0.0266012683289186,0.00410649426661503,-0.034649997091484,-0.0185525395663531,9.63199434567652e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,37169,-0.0424062362824495,0.00655178512787155,-0.0552477351330778,-0.0295647374318213,9.97929570980348e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,39788,-0.0192323705927513,0.00298206501279345,-0.0250772180178265,-0.0133875231676762,1.15569249462738e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DPEP1,Dipeptidase 1,39713,0.029571493110232,0.00459079315370758,0.0205735385289652,0.0385694476914989,1.217235091227e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CHCHD6,MICOS complex subunit MIC25,37368,-0.0182113975830945,0.00282722842865725,-0.0237527653032627,-0.0126700298629263,1.2236139629141e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,37043,-0.0344690675356533,0.00535328802273973,-0.0449615120602232,-0.0239766230110835,1.24548135195982e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",37397,-0.0252109016722484,0.00392233000273886,-0.0328986684776165,-0.0175231348668802,1.34038811260964e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,37021,-0.0417353003306005,0.00649436094515794,-0.0544642477831101,-0.0290063528780909,1.35172433622878e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,39477,-0.0270223164838248,0.00421455498714804,-0.035282844258635,-0.0187617887090147,1.48071188438337e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",39585,-0.0577339502853292,0.00902167877746944,-0.0754164406891694,-0.0400514598814891,1.60330792327614e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,37411,-0.066586578594426,0.0104047895190717,-0.0869799660518066,-0.0461931911370454,1.60901812994369e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,39868,0.0158143373189773,0.00247627423446676,0.0109608398194224,0.0206678348185321,1.74582943461173e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,37437,0.0201239890229127,0.00315230504622381,0.013945471132314,0.0263025069135113,1.78252506457749e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,39699,-0.0175384068104987,0.00274836941205724,-0.0229252108581309,-0.0121516027628665,1.80367008192563e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OPLAH,5-oxoprolinase,37043,-0.0431562746519817,0.00676553686259762,-0.056416726902673,-0.0298958224012904,1.84395145512152e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,37324,-0.0380450527930153,0.00596497781724393,-0.0497364093148134,-0.0263536962712172,1.85192993947884e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PSAP,Prosaposin,37347,-0.0173542272734935,0.00272232756371072,-0.0226899892983665,-0.0120184652486205,1.89196646106219e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DLG4,Disks large homolog 4,37388,-0.0444751757463018,0.00698085768340475,-0.0581576568057751,-0.0307926946868285,1.93857137484197e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GIMAP8,GTPase IMAP family member 8,36962,-0.0307439466565017,0.00482638730876916,-0.0402036657816893,-0.0212842275313142,1.95384140340503e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FCRL6,Fc receptor-like protein 6,39866,-0.0407034262461997,0.00639292171497247,-0.0532335528075457,-0.0281732996848536,1.98073901685367e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OPTC,Opticin,39788,0.0272189933345943,0.00427614218204839,0.0188377546577795,0.0356002320114092,2.00218671468568e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITGAM,Integrin alpha-M,39858,0.0194336002375252,0.00305485197905279,0.0134460903585817,0.0254211101164687,2.0515013855669e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,37437,0.0134485716417243,0.0021149018284162,0.00930336405802851,0.01759377922542,2.09631592085917e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLSTN2,Calsyntenin-2,40058,0.0242776143295672,0.00381900367166208,0.0167923671331095,0.0317628615260249,2.11160181213291e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTGES2,Prostaglandin E synthase 2,36961,-0.0344009212268476,0.00541417636316169,-0.0450127068986445,-0.0237891355550507,2.16926813295859e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,39477,-0.0569454698301504,0.00897402077667555,-0.0745345505524345,-0.0393563891078663,2.27678602415523e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,37411,-0.0708193766653838,0.0111759706001645,-0.0927242790417062,-0.0489144742890614,2.42081203951634e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,37056,-0.0361263989195123,0.00570403785781194,-0.0473063131208237,-0.0249464847182009,2.47470764591965e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,39477,-0.0363667568827281,0.00574371024329297,-0.0476244289595823,-0.0251090848058739,2.49293537842402e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RTBDN,Retbindin,39788,-0.0179417759549445,0.00284192479667667,-0.0235119485564307,-0.0123716033534582,2.80472684047093e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AIF1,Allograft inflammatory factor 1,39477,-0.0322747717610169,0.00511385845645958,-0.0422979343356776,-0.0222516091863561,2.8428063549357e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,JAM2,Junctional adhesion molecule B,40009,-0.0153225926136783,0.00242843749411144,-0.0200823301021367,-0.0105628551252199,2.86950497596868e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,39866,-0.0459441016593569,0.00728340616818179,-0.0602195777489932,-0.0316686255697206,2.89989578625559e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,39809,-0.0211664301795281,0.00335576140544479,-0.0277437225341999,-0.0145891378248564,2.91068377558171e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EBI3_IL27,Interleukin-27,40011,-0.0187421158140887,0.00298197454365527,-0.0245867859196531,-0.0128974457085244,3.35967790321061e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,37382,-0.0545126947269852,0.00868256523662404,-0.0715305225907683,-0.037494866863202,3.52511954355999e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PARK7,Parkinson disease protein 7,39858,-0.0318821103268355,0.00508300962224025,-0.0418448091864264,-0.0219194114672446,3.64914892212767e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STX4,Syntaxin-4,39788,-0.0360215489471137,0.00574587741651323,-0.0472834686834796,-0.0247596292107478,3.72462815782681e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SDC1,Syndecan-1,39868,-0.0241102079717671,0.00385081046011759,-0.0316577964735976,-0.0165626194699366,3.92081423042994e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDCD6,Programmed cell death protein 6,39868,0.0422746663385108,0.00675383731219686,0.0290371452066049,0.0555121874704166,3.96415505985702e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],39487,-0.0294174506220263,0.00470126105353973,-0.0386319222869642,-0.0202029789570884,4.01769033360898e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GRN,Progranulin,39787,-0.0149639290279695,0.00239205349180064,-0.0196523538718987,-0.0102755041840402,4.05884910741719e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CXCL1,Growth-regulated alpha protein,39839,-0.0573881107341896,0.00918873240405912,-0.0753980262461455,-0.0393781952222337,4.33164015052577e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TBC1D23,TBC1 domain family member 23,39788,-0.0545011578071493,0.00872870328498352,-0.071609416245717,-0.0373928993685817,4.37606571878755e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,39931,0.0260396200297621,0.00417862389847508,0.0178495171887509,0.0342297228707732,4.7312304478601e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL18,C-C motif chemokine 18,39715,-0.0426307684083942,0.00684563642953321,-0.0560482158102792,-0.0292133210065091,4.86074119647013e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,37382,-0.0551248516757506,0.00885733193610533,-0.072485222270517,-0.0377644810809841,5.0009179513527e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BCL2,Apoptosis regulator Bcl-2,37382,-0.0306456946148973,0.0049275269306265,-0.0403036473989252,-0.0209877418308693,5.14131346496403e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DDHD2,Phospholipase DDHD2,37411,-0.0404658955005535,0.00650939496375988,-0.0532243096295228,-0.0277074813715841,5.23153464135703e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",37169,-0.0301193615632089,0.0048603512945383,-0.039645650100504,-0.0205930730259139,5.92654641837539e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,40009,-0.0266784126543622,0.00431229235593975,-0.0351305056720041,-0.0182263196367203,6.29585865883741e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,YWHAQ,14-3-3 protein theta,37124,-0.0447441809463366,0.00723508061183807,-0.0589249389455392,-0.030563422947134,6.41950435858979e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ASS1,Argininosuccinate synthase,37021,-0.0480818344550619,0.0077816766240586,-0.0633339206382168,-0.0328297482719071,6.64734074796888e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EFNA1,Ephrin-A1,39826,-0.0157536875364985,0.00255258640371745,-0.0207567568877847,-0.0107506181852123,6.92097766803656e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,37124,-0.0517320751323158,0.00838820894794639,-0.0681729646702907,-0.0352911855943409,7.15118204671978e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINI2,Serpin I2,37382,-0.0343088892901161,0.00557753810148214,-0.0452408639690212,-0.0233769146112111,7.90367579711033e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,37368,-0.0501458677729278,0.00815535267133713,-0.0661303590087486,-0.034161376537107,8.02566742848998e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DBNL,Drebrin-like protein,39931,-0.0553689862179474,0.00901766667025608,-0.0730436128916493,-0.0376943595442455,8.44310077018338e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANXA10,Annexin A10,39489,-0.0466130130387853,0.00759404256704505,-0.0614973364701936,-0.031728689607377,8.55295040876506e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LIF,Leukemia inhibitory factor,39489,-0.0305414121589293,0.0049768615009536,-0.0402960607007983,-0.0207867636170602,8.62961553684469e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CENPF,Centromere protein F,37169,-0.0322345427646066,0.00526658898171725,-0.0425570571687724,-0.0219120283604408,9.58583976913899e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EGF,Pro-epidermal growth factor,39808,-0.0614972243819097,0.0100530286109636,-0.0812011604593983,-0.0417932883044211,9.74060862817508e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,39932,-0.0665423615663523,0.0108867259029391,-0.087880344336113,-0.0452043787965917,1.0050584444468e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,37021,-0.0403120188393774,0.00659875515140404,-0.0532455789361293,-0.0273784587426255,1.03062458591688e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,37411,-0.0292663680314402,0.00481042967261269,-0.038694810189761,-0.0198379258731193,1.20422647471712e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,37368,-0.0505743052070439,0.00831477866247433,-0.0668712713854936,-0.0342773390285942,1.21547777136524e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LGALS7_LGALS7B,Galectin-7,39822,-0.0239574955891695,0.00394038306641782,-0.0316806463993484,-0.0162343447789906,1.22925445340132e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,37382,-0.0288945064490419,0.00475227660165024,-0.0382089685882764,-0.0195800443098075,1.23311099448148e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATXN2L,Ataxin-2-like protein,37411,-0.0284859639206075,0.00468668977968718,-0.0376718758887943,-0.0193000519524206,1.24912236750221e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",39931,-0.0648154909985879,0.0106673631100382,-0.0857235226942629,-0.043907459302913,1.25952956949453e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HMBS,Porphobilinogen deaminase,40030,-0.0252912022711907,0.00416318369104281,-0.0334510423056346,-0.0171313622367468,1.26791336008166e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DHPS,Deoxyhypusine synthase,37368,-0.0242262246791666,0.00398749324390065,-0.0320417114372119,-0.0164107379211213,1.26882251875817e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",37088,-0.0510468388108818,0.00842065647269104,-0.0675513254973562,-0.0345423521244074,1.38013967079041e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,37411,-0.020852827597729,0.00343997735409858,-0.0275951832117623,-0.0141104719836958,1.38087518507272e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LAP3,Cytosol aminopeptidase,39587,-0.028558475242702,0.00471637065840393,-0.0378025617331737,-0.0193143887522303,1.43450287467057e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MIF,Macrophage migration inhibitory factor,39826,-0.0399888986356615,0.00660594280582977,-0.0529365465350878,-0.0270412507362351,1.4492721587792e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IFNLR1,Interferon lambda receptor 1,39866,-0.0219410008413744,0.00362590601728634,-0.0290477766352556,-0.0148342250474932,1.46995225068634e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,39858,-0.0279928132643538,0.00462847152829716,-0.0370646174598163,-0.0189210090688914,1.499545854944e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COMP,Cartilage oligomeric matrix protein,39729,0.019641263809975,0.00324796290694371,0.0132752565123654,0.0260072711075847,1.50636793547838e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DNPEP,Aspartyl aminopeptidase,37388,-0.0347385558342448,0.00575273764342777,-0.0460139216153633,-0.0234631900531264,1.59516791436766e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TWF2,Twinfilin-2,37437,-0.04963877773093,0.00822317715989279,-0.0657562049643198,-0.0335213504975401,1.61650189391829e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,39587,-0.0251738276111221,0.00417513068387344,-0.033357083751514,-0.0169905714707302,1.6817662247052e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,37021,-0.0380919946740817,0.00632156345778207,-0.0504822590513345,-0.0257017302968288,1.7285127566187e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MRC1,Macrophage mannose receptor 1,37445,-0.0161593182400288,0.00268243173541635,-0.0214168844414448,-0.0109017520386127,1.74414693835802e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",39587,-0.0422470052480638,0.00701406737671812,-0.0559945773064313,-0.0284994331896962,1.74829979852263e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,37043,-0.0276955891599276,0.00460303273677722,-0.0367175333240109,-0.0186736449958442,1.82599481401755e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAX,Protein max,39489,-0.0613850070274903,0.0102213940997891,-0.0814189394630769,-0.0413510745919037,1.94919480686277e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,39866,-0.0192751939503972,0.00321759295851771,-0.025581676149092,-0.0129687117517025,2.13594548069557e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ICA1,Islet cell autoantigen 1,39587,-0.0465749002510956,0.00777852258189806,-0.0618208045116158,-0.0313289959905754,2.17556472108107e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CGA,Glycoprotein hormones alpha chain,39858,0.0512908557145651,0.00857054791136819,0.0344925818082835,0.0680891296208468,2.21623179731466e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OLFM4,Olfactomedin-4,36654,-0.071739787876447,0.011989450432915,-0.0952391107249603,-0.0482404650279336,2.24126906645957e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,F11,Coagulation factor XI,37249,0.0182199722400228,0.00304805195783167,0.0122457904026728,0.0241941540773729,2.32237567907692e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,39477,-0.0298672751254272,0.00499707299565244,-0.039661538196906,-0.0200730120539485,2.32295863131038e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,37382,-0.030968763550584,0.00518888157682615,-0.0411389714411632,-0.0207985556600047,2.45749020351859e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,37411,-0.0696685605097658,0.0116807275624829,-0.0925627865322323,-0.0467743344872993,2.51646401943301e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DBI,Acyl-CoA-binding protein,39793,-0.0461942668863141,0.00774960697535085,-0.0613834965580018,-0.0310050372146264,2.56219544262781e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TF,Serotransferrin,37453,-0.0126540107740132,0.0021258178245701,-0.0168206137101706,-0.00848740783785578,2.70520489830397e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",39858,-0.0446908791625889,0.00752497957815772,-0.0594398391357781,-0.0299419191893998,2.92699600959613e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,40030,-0.0310662924926529,0.00523695939086209,-0.0413307328987426,-0.0208018520865632,3.05140334595429e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,40058,-0.0190944691234712,0.00322988055941906,-0.0254250350199326,-0.0127639032270099,3.45147575546174e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,37411,-0.021838364437498,0.00369524455958122,-0.0290810437742772,-0.0145956851007188,3.5063163627584e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PADI4,Protein-arginine deiminase type-4,39456,-0.0402480243452846,0.00681434142895248,-0.0536041335460315,-0.0268919151445377,3.57000244504517e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,37056,-0.0180099284959491,0.00304916932480758,-0.0239863003725719,-0.0120335566193262,3.58048865222588e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GFAP,Glial fibrillary acidic protein,39453,0.0249897712461966,0.00423625484454179,0.0166867117508947,0.0332928307414986,3.73225524982886e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACYP1,Acylphosphatase-1,37073,-0.0377277591207103,0.00640201911469665,-0.0502757165855158,-0.0251798016559049,3.88245826599023e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MYOC,Myocilin,39858,0.0262152073524899,0.00445081452182125,0.0174916108897203,0.0349388038152596,3.93986768299379e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SMS,Spermine synthase,36991,-0.0367515780205111,0.00625955533610105,-0.0490203064792692,-0.0244828495617531,4.42904515847345e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GIMAP7,GTPase IMAP family member 7,37124,0.0186571068379593,0.00317807518540495,0.0124280794745656,0.024886134201353,4.44689120107672e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPME1,Protein phosphatase methylesterase 1,39788,-0.0340596084559383,0.00580766245995446,-0.045442626877449,-0.0226765900344275,4.59134793745917e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,39868,-0.0386714652175149,0.0066009439245875,-0.0516093153097064,-0.0257336151253234,4.76301424873524e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,37043,0.0200138531972655,0.00341604886016687,0.0133183974313384,0.0267093089631926,4.77431563602358e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,37056,-0.0520051350037531,0.0088774642350139,-0.0694049649043803,-0.0346053051031259,4.79332339453174e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,37056,-0.0242014056735066,0.0041326544546671,-0.0323014084046541,-0.0161014029423591,4.85024285754623e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,37368,-0.0290197940166609,0.00496674377358816,-0.0387546118128937,-0.0192849762204281,5.25068062861384e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,37411,-0.0383148021304165,0.00656226135927636,-0.0511768343945982,-0.0254527698662349,5.38281046779137e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VCAM1,Vascular cell adhesion protein 1,39908,-0.0151147089307854,0.00258951306764715,-0.0201901545433738,-0.010039263318197,5.42092367811983e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTF1,Cardiotrophin-1,39585,-0.0478303666622531,0.0082041330058285,-0.0639104673536769,-0.0317502659708292,5.65023707968372e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,37382,-0.0368890882090825,0.00633086343407034,-0.0492975805398604,-0.0244805958783046,5.77642649105021e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,39786,-0.0150939708780039,0.0025913145635549,-0.0201729474225715,-0.0100149943334363,5.82724474969573e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,39866,0.0246838990670607,0.00423823731547718,0.0163769539287255,0.032990844205396,5.85236834326237e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRDX1,Peroxiredoxin-1,39434,0.0512854083754386,0.00880594097916043,0.0340257640562842,0.0685450526945931,5.86034856287206e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,39720,-0.0130803046208624,0.00225045287085282,-0.0174911922477339,-0.00866941699399086,6.28036721124618e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CES2,Cocaine esterase,39788,-0.0304867328072898,0.00524875389180339,-0.0407742904352245,-0.0201991751793552,6.42845758942608e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITGAL,Integrin alpha-L,37056,-0.0241604906112946,0.00416270946342049,-0.0323194011595988,-0.0160015800629904,6.62275318585093e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BAX,Apoptosis regulator BAX,39456,-0.0514417545746846,0.00887458710664074,-0.0688359453037004,-0.0340475638456687,6.90115151002189e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPAG1,Sperm-associated antigen 1,37411,-0.0328679107311989,0.00568992535048006,-0.0440201644181398,-0.021715657044258,7.7940789156831e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,REG1A,Lithostathine-1-alpha,39804,-0.0260165534315174,0.0045064255531534,-0.0348491475156981,-0.0171839593473368,7.92204824535499e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD58,Lymphocyte function-associated antigen 3,39835,0.00973824501199116,0.00168690176690345,0.0064319175488604,0.0130445724751219,7.93841447499905e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLTA,Clathrin light chain A,39585,-0.0259718554047645,0.00450046802012936,-0.034792772724218,-0.0171509380853109,8.03227934939903e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD99L2,CD99 antigen-like protein 2,39858,-0.0134278967118178,0.00233447884525149,-0.0180034752485107,-0.00885231817512483,8.98107208226356e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,39788,-0.0257440462015718,0.00448312154392977,-0.0345309644276742,-0.0169571279754695,9.50244382897863e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ERI1,3'-5' exoribonuclease 1,37169,-0.0187673053138037,0.00326821953388396,-0.0251730156002163,-0.0123615950273912,9.54038749659895e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TPD52L2,Tumor protein D54,37124,-0.0610138425405855,0.0106400117414316,-0.0818682655537915,-0.0401594195273795,1.00005177859006e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLC51B,Organic solute transporter subunit beta,37021,-0.0422905909173816,0.00737751981263257,-0.0567505297501414,-0.0278306520846217,1.01217036326071e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,40030,-0.0214184608306495,0.0037398386875953,-0.0287485446583363,-0.0140883770029627,1.039720751847e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,37043,-0.013517503428563,0.00236105278237215,-0.0181451668820124,-0.00888983997511354,1.05563257764154e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD69,Early activation antigen CD69,39785,-0.0486969295947405,0.00851321542677533,-0.0653828318312201,-0.0320110273582608,1.08336705150984e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD99,CD99 antigen,39858,0.010596763605074,0.00185464518111205,0.00696165905009436,0.0142318681600536,1.12556676831187e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",39713,-0.0534680005228777,0.00936406944372551,-0.0718215766325797,-0.0351144244131757,1.15060253608935e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PKN3,Serine/threonine-protein kinase N3,37169,-0.0423271866050877,0.00742179992765299,-0.0568739144632875,-0.0277804587468878,1.20157680186992e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,37056,-0.0499544204000238,0.00878108966549853,-0.067165356144401,-0.0327434846556467,1.3060428046081e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,37043,-0.0279927040755631,0.00492364559119399,-0.0376430494343033,-0.0183423587168229,1.3330535258623e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,37388,-0.0245694135163186,0.0043240937595655,-0.0330446372850669,-0.0160941897475702,1.35889580928903e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,40030,-0.0350156256228353,0.00616743146109269,-0.047103791286577,-0.0229274599590936,1.39020149606851e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MICALL2,MICAL-like protein 2,37039,-0.037677785021704,0.00663759852543532,-0.0506874781315572,-0.0246680919118508,1.40444820990847e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,37124,0.0135266434570684,0.00238509839945338,0.00885185059413972,0.018201436319997,1.44664390066035e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,37437,-0.0542751382262502,0.00961283888335929,-0.0731163024376345,-0.035433974014866,1.67408464264741e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FCRL2,Fc receptor-like protein 2,39990,-0.0253397689295642,0.00449004240530437,-0.0341402520439607,-0.0165392858151676,1.6938237087201e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DPP7,Dipeptidyl peptidase 2,39754,-0.0329163557380379,0.00583504916799448,-0.0443530521073071,-0.0214796593687687,1.71801661253942e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C4BPB,C4b-binding protein beta chain,39913,0.0216606261219737,0.0038400296989463,0.014134167912039,0.0291870843319085,1.72171831946005e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SEZ6L,Seizure 6-like protein,39913,0.0147030306212642,0.00260726934116457,0.00959278271258166,0.0198132785299468,1.736746543276e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPART,Spartin,37124,-0.042902010890005,0.00760735806640634,-0.0578124327001614,-0.0279915890798486,1.73985823849686e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,39477,-0.0466131497866201,0.00827130094726849,-0.0628248996432663,-0.0304013999299739,1.77537501629326e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,39846,-0.0265639516064098,0.00471462635798336,-0.0358046192680572,-0.0173232839447624,1.78661250201594e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTRC,Chymotrypsin-C,39856,0.0337383980045788,0.00598855696912237,0.022000826345099,0.0454759696640587,1.79239132152267e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UNC79,Protein unc-79 homolog,36962,-0.0309672907458751,0.00550381826313353,-0.0417547745416168,-0.0201798069501334,1.87659812896927e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LPP,Lipoma-preferred partner,37021,-0.0367656476481933,0.00653722435238992,-0.0495786073788775,-0.023952687917509,1.90334908488997e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,39904,-0.0276278894323101,0.00491906923954231,-0.0372692651418131,-0.0179865137228072,1.98111921347478e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,THTPA,Thiamine-triphosphatase,37345,-0.0482699182627259,0.00859734387921427,-0.0651207122659859,-0.031419124259466,2.01004762208708e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,37411,-0.0324085152865405,0.00578752509702076,-0.0437520644767012,-0.0210649660963798,2.18872954002818e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,39749,-0.0124649533600748,0.00222654152608652,-0.0168289747512044,-0.00810093196894524,2.19984599823513e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,39755,-0.0130750671285328,0.00233645038412319,-0.0176545098814143,-0.00849562437565133,2.22815614294621e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",39749,-0.0312926923807337,0.00559524794911424,-0.0422593783609976,-0.0203260064004698,2.27214500067096e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DMD,Dystrophin,37043,-0.0282490149976983,0.0050540771885947,-0.0381550062873439,-0.0183430237080527,2.324412758304e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IST1,IST1 homolog,37287,-0.0543072594782822,0.00972684531502014,-0.0733718762957217,-0.0352426426608428,2.40664840790185e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,37411,-0.0424408736184892,0.00761671772223463,-0.0573696403540691,-0.0275121068829093,2.56531843579609e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RBM17,Splicing factor 45,37411,-0.0416445056423577,0.00747433095320027,-0.0562941943106302,-0.0269948169740852,2.57118210231866e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TBCA,Tubulin-specific chaperone A,37124,-0.0469327438736355,0.00842634034262037,-0.0634483709451714,-0.0304171168020996,2.60043190893915e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,39931,0.0229978584626146,0.0041340832850906,0.014895055223837,0.0311006617013921,2.69424131968076e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,39846,-0.0611642216089052,0.0109951200422214,-0.0827146568916591,-0.0396137863261513,2.69658101364246e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GPA33,Cell surface A33 antigen,39788,-0.0707528182215016,0.0127319886604897,-0.0957075159960615,-0.0457981204469418,2.78705653470949e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRSS27,Serine protease 27,39818,-0.0216095603763192,0.00389162960402537,-0.0292371544002089,-0.0139819663524295,2.85564557466483e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTN,Pleiotrophin,39585,-0.0270170386588091,0.00487048485179181,-0.0365631889683211,-0.0174708883492972,2.95140178472679e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APOA4,Apolipoprotein A-IV,37453,-0.0191078368830861,0.00344632917811207,-0.0258626420721858,-0.0123530316939865,3.00457327921326e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",37437,-0.036845828723643,0.00664624077593625,-0.049872460644478,-0.0238191968028079,3.01394930610743e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,37031,-0.0150909477907945,0.00272459898247828,-0.0204311617964519,-0.00975073378513703,3.10427881262664e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GRAP2,GRB2-related adapter protein 2,39868,-0.0689519023853438,0.0124544316205441,-0.0933625883616103,-0.0445412164090774,3.13722324363439e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GFRAL,GDNF family receptor alpha-like,36942,0.0335620518950419,0.00606978832086937,0.021665266786138,0.0454588370039459,3.27559973130419e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,40030,0.0300291651073528,0.00543154936128956,0.0193833283592252,0.0406750018554803,3.27688736740464e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,37169,-0.0573575429420072,0.0103736746519177,-0.0776899452597659,-0.0370251406242486,3.27858378289711e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,39749,0.0592317947568797,0.0107144994372404,0.0382313758598886,0.0802322136538709,3.28645568108417e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LPA,Apolipoprotein(a),37186,0.094651556508571,0.0171306218898369,0.0610755376044907,0.128227575412651,3.35124004534217e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LACRT,Extracellular glycoprotein lacritin,37339,-0.0259189245958061,0.00469442573163072,-0.0351199990298023,-0.0167178501618099,3.42893326979172e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",39858,0.0130346713208797,0.00236179053190179,0.00840556187835222,0.0176637807634072,3.46273808980962e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,XRCC4,DNA repair protein XRCC4,39489,-0.019884846151635,0.0036029587385363,-0.0269466452791661,-0.0128230470241038,3.46293764312708e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LGALS1,Galectin-1,39868,-0.0179317957512425,0.00325028265687802,-0.0243023497587235,-0.0115612417437616,3.50190930739699e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BMP6,Bone morphogenetic protein 6,39568,-0.0222936141593391,0.00404119060927521,-0.0302143477535185,-0.0143728805651597,3.51090514295504e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,39868,-0.0446300257555016,0.00809063057317349,-0.0604876616789216,-0.0287723898320815,3.51655740653133e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANXA3,Annexin A3,39985,-0.0373155523485047,0.00676665794811241,-0.0505782019268051,-0.0240529027702044,3.54904193247945e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GTPBP2,GTP-binding protein 2,37039,-0.0434883152678032,0.00789500478993005,-0.0589625246560661,-0.0280141058795403,3.69038183642649e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,37437,-0.021418203775003,0.00388980538437683,-0.0290422223283816,-0.0137941852216244,3.73236531166793e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPL,Periplakin,37056,-0.0171788885090956,0.00312545608469657,-0.0233047824351009,-0.0110529945830903,3.94724084115904e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BOLA1,BolA-like protein 1,36991,-0.0294755924004479,0.00536303111417587,-0.0399871333842326,-0.0189640514166632,3.95592385435409e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DKK3,Dickkopf-related protein 3,40052,0.0152910909487042,0.00278439571297631,0.00983367535127067,0.0207485065461378,4.04056312823497e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,37445,-0.0116985113932687,0.00213061299253473,-0.0158745128586368,-0.00752250992790064,4.07580824110998e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DGCR6,Protein DGCR6,36991,-0.0232132256301853,0.00422906563903526,-0.0315021942826944,-0.0149242569776762,4.11780442629425e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NME3,Nucleoside diphosphate kinase 3,39885,0.0126624751876585,0.00230988591316517,0.00813509879785476,0.0171898515774622,4.27231683952935e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PI3,Elafin,39594,-0.0280903064405351,0.00513293652927136,-0.038150862037907,-0.0180297508431633,4.50360107871756e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANXA11,Annexin A11,39829,-0.0354185057214214,0.00648229630586836,-0.0481238064809234,-0.0227132049619194,4.72804411214716e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,37430,-0.0255741100822486,0.00468972089059921,-0.0347659630278231,-0.0163822571366742,5.03296102165339e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,39730,-0.0500077622357852,0.00920271561544282,-0.0680450848420531,-0.0319704396295172,5.59100027773275e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TMED8,Protein TMED8,37382,-0.0548046566316172,0.0100893606275977,-0.0745798034617087,-0.0350295098015257,5.67133765429615e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,37056,-0.0172981522176731,0.00318655769606731,-0.023543805301965,-0.0110524991333812,5.78422686948979e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CSNK1D,Casein kinase I isoform delta,37056,-0.0341451576245054,0.0062971016680678,-0.0464874768939183,-0.0218028383550925,5.9852435385058e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,37445,-0.0140693532276279,0.00259755462602365,-0.0191605602946342,-0.00897814616062149,6.18517252197394e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TBCB,Tubulin-folding cofactor B,39749,-0.0531715190837455,0.00982588060894532,-0.0724302450772784,-0.0339127930902127,6.34489406641316e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AK1,Adenylate kinase isoenzyme 1,39868,-0.0328502338146151,0.00607282833819512,-0.0447529773574775,-0.0209474902717527,6.41515351131921e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,THBD,Thrombomodulin,39868,-0.0142540873402704,0.00263670956154723,-0.019422038080903,-0.00908613659963781,6.53660295451361e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,39811,-0.046854445203543,0.00867456708390849,-0.0638565966880036,-0.0298522937190823,6.70857266244866e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAGED1,Melanoma-associated antigen D1,39477,-0.0253390783070151,0.00469471911548638,-0.0345407277733684,-0.0161374288406618,6.86164025564247e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BDNF,Brain-derived neurotrophic factor,37437,-0.0433102649288576,0.00802756515955898,-0.0590442926415932,-0.027576237216122,6.95980875740585e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,37097,-0.0148704583759801,0.0027575575699655,-0.0202752712131124,-0.00946564553884767,7.06306473034047e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLIT2,Slit homolog 2 protein,39489,-0.0269272502413656,0.00500281732379812,-0.0367327721960099,-0.0171217282867213,7.45522962349959e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",37043,-0.0458375818657035,0.00852554523069628,-0.0625476505178682,-0.0291275132135388,7.72429904441964e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,39672,-0.0614968487349045,0.0114416228275419,-0.0839224294768867,-0.0390712679929224,7.7739180181525e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MYL4,Myosin light chain 4,37043,-0.0272169702772096,0.00506354663854135,-0.0371415216887507,-0.0172924188656686,7.78521016757934e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,37382,-0.061946152574815,0.01155654412767,-0.0845969790650481,-0.0392953260845818,8.44640673585226e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,37437,-0.0464115783103967,0.00867444777795375,-0.0634134959551861,-0.0294096606656074,8.9195668911243e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MGLL,Monoglyceride lipase,39908,-0.045299829101164,0.00846971432835676,-0.0619004691847432,-0.0286991890175847,8.99272085800115e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CSDE1,Cold shock domain-containing protein E1,37021,-0.0623260450517134,0.0116651522170425,-0.0851897433971167,-0.03946234670631,9.29821113554463e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLGN,Calmegin,37039,-0.022741427478302,0.00425768500118793,-0.0310864900806303,-0.0143963648759737,9.38338344194792e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SELENOP,Selenoprotein P,37453,0.0115556119352276,0.00216374501064794,0.00731467171435766,0.0157965521560976,9.41515056841235e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GRK5,G protein-coupled receptor kinase 5,39585,-0.0273367994451225,0.00512405873900419,-0.0373799545735708,-0.0172936443166743,9.68735032394103e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ELOB,Elongin-B,37021,-0.020366166456262,0.003823227229071,-0.0278596918252412,-0.0128726410872828,1.01516767405299e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,39721,-0.0302471744988299,0.00568713706575796,-0.0413939631477155,-0.0191003858499443,1.06031706133747e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,39788,-0.0602163004957449,0.0113454646359249,-0.0824534111821577,-0.0379791898093322,1.12614903250757e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ROBO2,Roundabout homolog 2,40009,0.011682606005578,0.00220282316520175,0.00736507260178262,0.0160001394093735,1.15119250811285e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,37169,-0.0196882012087395,0.00371234961866841,-0.0269644064613295,-0.0124119959561494,1.15463402283639e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BCL2L1,Bcl-2-like protein 1,37388,-0.0516750476665496,0.00975033713745251,-0.0707857084559565,-0.0325643868771427,1.17736259478784e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BLNK,B-cell linker protein,37056,-0.0201876628224315,0.00380980594301981,-0.0276548824707503,-0.0127204431741127,1.18397099175263e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCN3,CCN family member 3,40042,-0.0166181817304386,0.00313752763903581,-0.0227677359029488,-0.0104686275579284,1.19532178264138e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLA2G1B,Phospholipase A2,40031,0.0209638264672239,0.00395902519696352,0.0132041370811754,0.0287235158532724,1.2044179978818e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDIA4,Protein disulfide-isomerase A4,37437,-0.0316674518947795,0.00598040724650588,-0.043389050097931,-0.019945853691628,1.20740224630085e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,37411,-0.0441620196069163,0.00834203681603784,-0.0605124117663505,-0.0278116274474822,1.21595091740915e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL20,C-C motif chemokine 20,40058,-0.0432382721931657,0.00816888667847662,-0.0592492900829798,-0.0272272543033515,1.21865604118777e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,39846,-0.0162170113644509,0.00306557762064947,-0.0222255435009239,-0.010208479227978,1.23905284358405e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRYM,Ketimine reductase mu-crystallin,36991,-0.0395992083107224,0.00748656738141705,-0.0542728803782998,-0.024925536243145,1.24710862423211e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,39749,-0.0149572125480736,0.00282835436832305,-0.0205007871099868,-0.00941363798616046,1.25087318853569e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GM2A,Ganglioside GM2 activator,37178,-0.0185998718102013,0.00352126665685779,-0.0255015544576426,-0.01169818916276,1.29684522608585e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",37124,-0.0537899134810807,0.0102001008505245,-0.0737821111481087,-0.0337977158140527,1.35972223600189e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,39928,-0.0412423531521583,0.00782469547151717,-0.056578756276332,-0.0259059500279846,1.3759153234191e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PEPD,Xaa-Pro dipeptidase,37445,0.0131544217310669,0.00250389028729719,0.00824679676796439,0.0180620466941694,1.51414205233092e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGF2,Fibroblast growth factor 2,39866,-0.0339566893001915,0.00646441883612005,-0.0466269502189868,-0.0212864283813962,1.51673222139599e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,37039,-0.0311774192144548,0.00593566942720069,-0.0428113312917681,-0.0195435071371414,1.52340710758074e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLG,Plasminogen,37162,-0.0115854584067599,0.00220614805299351,-0.0159095085906271,-0.00726140822289259,1.5323902416069e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,39453,-0.0336425104330372,0.00641741891024208,-0.0462206514971117,-0.0210643693689628,1.60591949972533e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,39489,-0.0327018124551711,0.00624414132374973,-0.0449403294497205,-0.0204632954606216,1.65145749225604e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CACYBP,Calcyclin-binding protein,37088,-0.0529887755507273,0.0101186520518665,-0.0728213335723857,-0.0331562175290689,1.65941028295892e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,37021,-0.0178893424053501,0.00341688743575983,-0.0245864417794394,-0.0111922430312608,1.67011626085487e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SEMA4D,Semaphorin-4D,40009,-0.0151795942611596,0.00290141250419509,-0.020866362769382,-0.00949282575293725,1.69970221841336e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EHD3,EH domain-containing protein 3,37043,-0.0600071160875908,0.0114729593921561,-0.0824941164962167,-0.0375201156789649,1.71818341542045e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,37368,-0.0171918802323368,0.00329203849047266,-0.0236442756736632,-0.0107394847910104,1.79377555172845e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,39597,-0.0114305789608999,0.00219032759850667,-0.0157236210539729,-0.00713753686782678,1.82509609189985e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FSTL1,Follistatin-related protein 1,37043,-0.0116725622361769,0.00223670114974192,-0.016056496489671,-0.00728862798268274,1.82966675571236e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,39477,-0.0496874377594155,0.00953921071899214,-0.0683842907686401,-0.0309905847501909,1.92524577641335e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATOX1,Copper transport protein ATOX1,39913,-0.0367238661662368,0.00705073900737134,-0.0505433146206847,-0.022904417711789,1.92712147346703e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLAU,Urokinase-type plasminogen activator,39858,0.0144209045527403,0.00277183798248418,0.00898810210707136,0.0198537069984093,1.98891413590056e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DXO,Decapping and exoribonuclease protein,37388,-0.0230302504210887,0.00443035080899453,-0.031713738006718,-0.0143467628354594,2.04059091570158e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,37382,-0.0295432502807343,0.00568583560384041,-0.0406874880642615,-0.0183990124972071,2.06652773323487e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,39845,-0.0122313609030499,0.00235447268068335,-0.0168461273571893,-0.00761659444891056,2.07293650899219e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DENR,Density-regulated protein,37056,-0.0292375908258985,0.00563139651952424,-0.040275128004166,-0.0182000536476309,2.11263929834985e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SDHB,Succinate dehydrogenase,37382,-0.0354844703506883,0.00683910200947251,-0.0488891102892545,-0.0220798304121222,2.15096707328549e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NOS1,"Nitric oxide synthase, brain",39489,-0.0271462499267044,0.00523281797915424,-0.0374025731658467,-0.0168899266875621,2.15576822059063e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,39913,0.0227887410803269,0.00439587653466163,0.0141728230723901,0.0314046590882637,2.19673281244212e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLXNB3,Plexin-B3,39812,-0.0238930607468767,0.00461893731393522,-0.0329461778821898,-0.0148399436115637,2.33343943735861e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD200,OX-2 membrane glycoprotein,39866,0.0129035352158069,0.00249456051827085,0.00801419659999608,0.0177928738316178,2.33558173363928e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,39956,-0.013899618406064,0.00269259450446376,-0.0191771036348129,-0.00862213317731499,2.47014895114665e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SMTN,Smoothelin,37342,-0.0484379996989166,0.00938426709253179,-0.0668311632002789,-0.0300448361975543,2.48305699101279e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SWAP70,Switch-associated protein 70,37382,-0.0180502184268508,0.00349887100215574,-0.0249080055910761,-0.0111924312626255,2.51960157282908e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,39788,-0.0282831346638709,0.00548722735576819,-0.0390381002811765,-0.0175281690465652,2.57544619176219e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RSPO3,R-spondin-3,40030,-0.0134513974233452,0.00261123243276448,-0.0185694129915636,-0.00833338185512685,2.61643795305465e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MYO9B,Unconventional myosin-IXb,39587,-0.0330218190154512,0.00641092119289146,-0.0455872245535185,-0.020456413477384,2.62413577806452e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPP3R1,Calcineurin subunit B type 1,39749,-0.0207322980156626,0.00402650604139608,-0.0286242498567989,-0.0128403461745263,2.65069187670429e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SIL1,Nucleotide exchange factor SIL1,37043,-0.0167590102339062,0.00325604207558699,-0.0231408527020567,-0.0103771677657557,2.68421354202807e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,37043,-0.0464550026259797,0.0090270616109154,-0.0641480433833739,-0.0287619618685855,2.69646709474171e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MILR1,Allergin-1,39587,-0.0246941260221973,0.00479995073267002,-0.0341020294582305,-0.0152862225861641,2.71224698019998e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,37382,-0.0165697475206457,0.00322054840408783,-0.0228820223926578,-0.0102574726486335,2.71254200780939e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,39818,-0.0141258445986459,0.00274877032124438,-0.0195134344282849,-0.0087382547690069,2.79509606007917e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STC2,Stanniocalcin-2,39831,-0.0131800729353576,0.00256507560869464,-0.0182076211283991,-0.00815252474231607,2.80533495334478e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RCOR1,REST corepressor 1,39585,-0.0223295534666775,0.00434624926485775,-0.0308482020257987,-0.0138109049075563,2.81507266312505e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C1QA,Complement C1q subcomponent subunit A,39971,-0.0114194594076392,0.00222516005121319,-0.0157807731080171,-0.00705814570726139,2.90054700775361e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EDF1,Endothelial differentiation-related factor 1,37411,-0.0344801102433367,0.00672156114037732,-0.0476543700784762,-0.0213058504081971,2.94091271095993e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CNPY4,Protein canopy homolog 4,39788,-0.0376101514947983,0.00733726302719979,-0.0519911870281099,-0.0232291159614867,2.99569310144828e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,S100A11,Protein S100-A11,39703,-0.022569151157827,0.00440340138564207,-0.0311998178736854,-0.0139384844419685,3.00414405201637e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATRN,"Attractin, Isoform 2",37453,-0.00811756058400551,0.00158635300797263,-0.0112268124796319,-0.00500830868837915,3.14464202012938e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STX7,Syntaxin-7,37056,-0.0245931871400852,0.00480885512544555,-0.0340185431859585,-0.0151678310942119,3.19580673118943e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,37368,-0.0296994012948083,0.00581090449001174,-0.0410887740952313,-0.0183100284943853,3.24873379634212e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TMEM106A,Transmembrane protein 106A,37368,-0.0354084175798992,0.00693660379667767,-0.0490041610213875,-0.021812674138411,3.36043733214811e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,39587,-0.0208789730856748,0.00409054409075802,-0.0288964395035605,-0.0128615066677891,3.36062648951089e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SDK2,Protein sidekick-2,37124,-0.0184635963190354,0.00362116406128591,-0.0255610778791558,-0.011366114758915,3.46521554008715e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,39913,-0.0123647563034011,0.00242838219509347,-0.0171243854057843,-0.00760512720101795,3.58755848659311e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLAMF7,SLAM family member 7,39866,-0.0284444714405803,0.00559610599394345,-0.0394128391887094,-0.0174761036924511,3.75896839878528e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,39477,-0.0336082217717746,0.00661716597465251,-0.0465778670820935,-0.0206385764614556,3.83908628352038e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDH5,Cadherin-5,40052,0.0150043153264742,0.00295608270710429,0.00921039322054975,0.0207982374323986,3.90262446683027e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GBP4,Guanylate-binding protein 4,39489,-0.0240535382011778,0.00473925961763827,-0.0333424870517488,-0.0147645893506068,3.91163863169015e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ENAH,Protein enabled homolog,39587,-0.0235782968924726,0.00465413420750737,-0.0327003999391871,-0.0144561938457582,4.10653533765368e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MBL2,Mannose-binding protein C,37257,0.0530485082850843,0.0104733914623239,0.0325206610189294,0.0735763555512391,4.13668805391831e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ROBO1,Roundabout homolog 1,39885,-0.0115853708983831,0.00228840079249548,-0.0160706364516743,-0.007100105345092,4.18053391588438e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,37021,-0.0136219320934592,0.00269120016913344,-0.0188966844249607,-0.00834717976195764,4.21239680843013e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LACTB2,Endoribonuclease LACTB2,39868,-0.0326871660212011,0.00646010061751855,-0.0453489632315375,-0.0200253688108647,4.2422388327577e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NUDC,Nuclear migration protein nudC,40058,-0.0314937243056004,0.00624269759795249,-0.0437294115975873,-0.0192580370136135,4.58690888312224e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CASP7,Caspase-7,37388,-0.0414517814210277,0.00821924930433776,-0.0575615100575297,-0.0253420527845256,4.63601531016262e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CST5,Cystatin-D,39559,-0.0265083739660315,0.00526079586058698,-0.0368195338527819,-0.016197214079281,4.73535517522072e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CAT,Catalase,37252,-0.0259325017851637,0.0051482713744604,-0.036023113679106,-0.0158418898912213,4.78721194037215e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,39913,-0.0354533880085454,0.007039693782424,-0.0492511878220965,-0.0216555881949944,4.79984497473882e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,37388,0.0322784182800558,0.00641232651184998,0.0197102583168298,0.0448465782432817,4.87012989937551e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DOK1,Docking protein 1,37388,-0.0672890829736208,0.0133707742907349,-0.0934958005834613,-0.0410823653637804,4.90215210214597e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,37382,-0.0371413199777046,0.0073976843701207,-0.0516407813431412,-0.022641858612268,5.21475101272351e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ALCAM,CD166 antigen,40052,-0.00942952569696253,0.00188157602155289,-0.0131174146992062,-0.00574163669471887,5.45758955176226e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,F2R,Proteinase-activated receptor 1,39908,-0.0283259698186586,0.00566501175791498,-0.039429392864172,-0.0172225467731453,5.78868133928837e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",37437,-0.042747356644977,0.00855461105584418,-0.0595143943144315,-0.0259803189755224,5.89551718351792e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GRSF1,G-rich sequence factor 1,36874,-0.0392128066908407,0.00787748531792532,-0.0546526779139743,-0.0237729354677071,6.51229751318691e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,39585,-0.0540914042953466,0.0108684629179462,-0.0753935916145212,-0.0327892169761719,6.52892110641418e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCGN,Secretagogin,39587,-0.0207641854535089,0.00417915255652914,-0.028955324464306,-0.0125730464427118,6.81759971048685e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPP1,Osteopontin,40012,0.0216642018344811,0.00436118413663097,0.0131162809266844,0.0302121227422778,6.85130096236789e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UROS,Uroporphyrinogen-III synthase,37039,-0.0332000721899544,0.00668619446966626,-0.0463050133505003,-0.0200951310294085,6.93940125673286e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EDN1,Endothelin-1,37043,-0.0135954551210778,0.00274053190316692,-0.0189668976512849,-0.00822401259087061,7.10486980070928e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PI16,Peptidase inhibitor 16,37445,0.0115361175635263,0.00232639185492279,0.00697638952787766,0.016095845599175,7.17856366766753e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL17A,Interleukin-17A,39558,-0.0203436039134976,0.00410749740505398,-0.0283942988274034,-0.0122929089995918,7.39144592516824e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",39866,-0.0211104981401957,0.00426525710347671,-0.02947040206301,-0.0127505942173813,7.51963746446193e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GAS2,Growth arrest-specific protein 2,37169,-0.0255856448100096,0.00517185120543138,-0.0357224731726551,-0.015448816447364,7.62490078014241e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COL2A1,Collagen alpha-1(II) chain,37043,-0.0387793241207455,0.00785198281118106,-0.0541692104306604,-0.0233894378108307,7.95704648845097e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SAA4,Serum amyloid A-4 protein,37453,-0.0158699150224651,0.00321373141966962,-0.0221688286050176,-0.00957100143991268,7.98003299189576e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,37169,-0.0322614385512206,0.00653560537986066,-0.0450712250957475,-0.0194516520066937,8.06000690103572e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,L1CAM,Neural cell adhesion molecule L1,39913,0.0136609337694168,0.00276850004407667,0.00823467368302655,0.0190871938558071,8.11959684686685e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BIN2,Bridging integrator 2,39858,-0.0428252580934637,0.00869467737394222,-0.0598668257463905,-0.025783690440537,8.50037328424666e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",37388,-0.0470100946038513,0.00954900742845789,-0.0657261491636287,-0.0282940400440738,8.62172074283097e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MMP10,Stromelysin-2,39857,0.0280236196351361,0.00569380430966443,0.0168637631881938,0.0391834760820784,8.66168882910111e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CASP1,Caspase-1,39489,-0.031894435993899,0.00648310475059205,-0.0446013213050594,-0.0191875506827386,8.75928817194805e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LAMB1,Laminin subunit beta-1,37043,-0.0145866872007348,0.00296752995683784,-0.020403045916137,-0.00877032848533262,8.96533153825833e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,37368,-0.0453049598658464,0.00922080160187515,-0.0633777310055217,-0.0272321887261711,9.05858753200211e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,37407,0.00691905320843188,0.00140938606562857,0.00415665651979989,0.00968144989706388,9.24821109565541e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CERT,Ceramide transfer protein,39489,-0.029329278288366,0.00597568636205454,-0.0410416235579929,-0.0176169330187391,9.28891358569447e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",37388,0.0285984452643548,0.00583023048508399,0.0171711935135902,0.0400256970151194,9.4417553143183e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINB6,Serpin B6,39970,-0.028595124180884,0.00583018898304678,-0.0400222945876557,-0.0171679537741123,9.44996399660312e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,39858,-0.0562649265886599,0.0114957396031929,-0.078796576210918,-0.0337332769664018,9.9558883460225e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLK10,Kallikrein-10,39856,-0.0186632106278361,0.00381553779778009,-0.0261416647114851,-0.0111847565441872,1.01109388822944e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,37388,-0.0171807370394088,0.00351719525555548,-0.0240744397402976,-0.0102870343385201,1.04727313569336e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,40009,-0.0222530156047714,0.00456463110459154,-0.0311996925697708,-0.013306338639772,1.09789120496714e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD59,CD59 glycoprotein,39173,-0.00997287554197896,0.00204941826123292,-0.0139897353339955,-0.00595601574996243,1.14897922749028e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,39908,0.021304993800472,0.00438456635635254,0.012711243742021,0.0298987438589229,1.19041378954617e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,37093,0.0232188446634113,0.00478215026711877,0.0138458301398585,0.0325918591869641,1.21569197603958e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RLN2,Prorelaxin H2,37095,-0.0670341114876229,0.0138331749145009,-0.0941471343200447,-0.0399210886552012,1.27471577560649e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CIAPIN1,Anamorsin,39913,-0.0296170094208175,0.00611619558379997,-0.0416047527650655,-0.0176292660765696,1.29481233968705e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,39908,-0.0360292376413377,0.00744376667984727,-0.0506190203338384,-0.0214394549488371,1.30922389808928e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,37382,-0.0253033256018556,0.00523129537036057,-0.0355566645277623,-0.0150499866759488,1.3332356446427e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,YAP1,Transcriptional coactivator YAP1,37388,-0.0120136003136876,0.00248443718067267,-0.016883097187806,-0.00714410343956914,1.34244232194896e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",37411,-0.0196099631703787,0.00406889788363989,-0.0275850030223129,-0.0116349233184445,1.45495119930973e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HSPB1,Heat shock protein beta-1,39617,-0.0325144504745511,0.00674896828319088,-0.0457424283096052,-0.0192864726394969,1.46579823589758e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APRT,Adenine phosphoribosyltransferase,39738,-0.0224559924335374,0.00466614347165114,-0.0316016336379736,-0.0133103512291011,1.50396134462734e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VWC2,Brorin,39684,-0.0179662198550424,0.00373534249069774,-0.0252874911368099,-0.0106449485732748,1.524787586679e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,37368,-0.0204734229549278,0.00425975715843233,-0.0288225469854551,-0.0121242989244004,1.55449106233435e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,37368,-0.0227730880198329,0.00473829315185891,-0.0320601425974764,-0.0134860334421895,1.55497354148811e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,37411,-0.0466421528420487,0.00971656542981861,-0.0656866210844932,-0.0275976845996043,1.60142388771e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",37437,-0.0345410209940541,0.00721550141187909,-0.0486834037613371,-0.0203986382267711,1.71028704121585e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD40LG,CD40 ligand,40058,-0.0361031590929255,0.00754591212757554,-0.0508931468629736,-0.0213131713228775,1.72953574101391e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",37021,-0.0295339578611836,0.00618215876844477,-0.0416509890473353,-0.0174169266750318,1.79592113461714e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STXBP3,Syntaxin-binding protein 3,39477,-0.0204187665890288,0.00428611567070513,-0.0288195533036108,-0.0120179798744467,1.91562995097238e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,37169,-0.0344422495131144,0.00722944760395551,-0.0486119668168672,-0.0202725322093616,1.91643934084855e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCRG1,Scrapie-responsive protein 1,37437,-0.01224262684122,0.00257499879861224,-0.0172896244865,-0.00719562919594005,2.01060184810091e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,37056,-0.0371470111191475,0.00782609434471072,-0.0524861560347805,-0.0218078662035144,2.0907972999641e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACRBP,Acrosin-binding protein,37368,-0.0177438842595332,0.00373873997779852,-0.0250718146160183,-0.0104159539030481,2.09654186314123e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,39489,-0.0297590775787778,0.00627348930674684,-0.0420551166200016,-0.0174630385375539,2.11783171048281e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,37021,0.00930996162582924,0.00196375244637633,0.00546100683093165,0.0131589164207268,2.14996420091394e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,37362,-0.0187530068933754,0.00395624158719353,-0.0265072404042747,-0.0109987733824761,2.15785993262509e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,39585,-0.0167859603969262,0.00354217759133365,-0.0237286284759402,-0.0098432923179123,2.16781363148341e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,37445,-0.0182285914571634,0.00384740088279309,-0.0257694971874378,-0.0106876857268889,2.18133497576188e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,36962,-0.031319034547469,0.00661427055478514,-0.0442830048348479,-0.0183550642600902,2.21273557663674e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,39962,-0.013631083158832,0.00288198333456607,-0.0192797704945815,-0.00798239582308247,2.26694333146911e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GNAS,Neuroendocrine secretory protein 55,37411,-0.0417148182017257,0.00882292368153901,-0.0590077486175421,-0.0244218877859092,2.29020949527477e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NEFL,Neurofilament light polypeptide,39438,-0.0199222308590251,0.00421594485008606,-0.0281854827651938,-0.0116589789528565,2.31613898574604e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FCRL1,Fc receptor-like protein 1,39868,-0.0200572109100812,0.00425729449121312,-0.0284015081128589,-0.0117129137073035,2.48261684849405e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CXCL3,C-X-C motif chemokine 3,39859,-0.0432048554985767,0.0091796841496425,-0.061197036431876,-0.0252126745652774,2.54025568358961e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",39866,-0.0379591548515486,0.00806589894841596,-0.0537683167904439,-0.0221499929126533,2.54578669902403e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CASP3,Caspase-3,40052,-0.0405969898461383,0.00862647345799406,-0.0575048778238067,-0.02368910186847,2.54597743351083e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,39837,-0.0438101354299864,0.00932322559867791,-0.0620836576033951,-0.0255366132565777,2.63576466233803e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",37437,-0.0136869503959313,0.0029147614822765,-0.0193998829011932,-0.00797401789066936,2.68248768349273e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,37124,-0.0546713753540437,0.0116450956661745,-0.0774957628597457,-0.0318469878483416,2.69541990954553e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,39477,-0.0387398650494068,0.00825384876390373,-0.0549174086266581,-0.0225623214721555,2.70781913325446e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SNX9,Sorting nexin-9,39868,-0.0314825427525261,0.00672522692018101,-0.0446639875160809,-0.0183010979889713,2.87453303546859e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MERTK,Tyrosine-protein kinase Mer,40058,-0.0115056889593464,0.0024588670925189,-0.0163250684606835,-0.00668630945800939,2.90235109582592e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STX16,Syntaxin-16,39477,-0.0264373459317326,0.00565168043514464,-0.0375146395846161,-0.0153600522788491,2.92420796390711e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,37043,-0.0194675489764733,0.00416288126705059,-0.0276267962598924,-0.0113083016930541,2.94765462914e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLK13,Kallikrein-13,39490,-0.019146313994083,0.00409794052023541,-0.0271782774137444,-0.0111143505744216,3.00504363131665e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UNC5D,Netrin receptor UNC5D,37056,0.0120617428520569,0.00259139176573033,0.00698261499122549,0.0171408707128884,3.27862288242777e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD22,B-cell receptor CD22,40058,-0.018098537260921,0.00389062574420185,-0.0257241637195566,-0.0104729108022854,3.31600912168527e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SEZ6,Seizure protein 6 homolog,37039,0.0141011466570281,0.00303288529029046,0.00815669148805882,0.0200456018259974,3.36106857581275e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MESD,LRP chaperone MESD,39858,-0.0549441987879683,0.0118366164354394,-0.0781439670014295,-0.0317444305745072,3.47988774108615e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",37043,-0.0207662000777185,0.00447670436000672,-0.0295405406233317,-0.0119918595321053,3.53937244910938e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,39713,-0.0105767637669823,0.002283745131704,-0.0150529042251221,-0.00610062330884248,3.66221256872779e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,37169,-0.0321600341753831,0.00694995916258953,-0.0457819541340586,-0.0185381142167076,3.73833291678099e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,39585,-0.0136740410305594,0.00295958331294271,-0.0194748243239271,-0.00787325773719169,3.86303186741704e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,37021,-0.0169951620591518,0.00368588924297931,-0.0242195049753912,-0.00977081914291236,4.04759003507373e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,39788,0.018161606098815,0.00394079720402403,0.0104376435789279,0.0258855686187021,4.08510838060566e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,39587,-0.0153231941520379,0.00332619314275699,-0.0218425327118416,-0.00880385559223416,4.12069450518554e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,37021,-0.0310981391328803,0.00676400846370683,-0.0443555957217457,-0.017840682544015,4.31384746624157e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SELL,L-selectin,37453,0.0101131576041989,0.00220406120913636,0.00579319763429159,0.0144331175741061,4.50608897046592e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EPHB6,Ephrin type-B receptor 6,39713,-0.0134197735877071,0.0029323262163972,-0.0191671329718456,-0.00767241420356859,4.76421419808156e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,37368,-0.0307660077732721,0.00672550660727262,-0.0439480007235264,-0.0175840148230177,4.81544529445081e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C7orf50,Uncharacterized protein C7orf50,37388,-0.00975291493542628,0.00213547563715355,-0.0139384471842472,-0.00556738268660533,4.98901254484566e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD86,T-lymphocyte activation antigen CD86,37382,0.0130433553308936,0.00285686425269557,0.00744390139561026,0.0186428092661769,5.02414135829893e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,39866,-0.036292001377256,0.00795198428175541,-0.0518778905694966,-0.0207061121850154,5.0587242741722e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,39749,-0.0153165328478767,0.00335942216188735,-0.0219010002851759,-0.0087320654105775,5.17133473368317e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KIFBP,KIF-binding protein,39788,-0.036664742327989,0.00805299959198652,-0.0524486215282826,-0.0208808631276955,5.32956609820426e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL17C,Interleukin-17C,39587,-0.0293083195673045,0.00644239016113832,-0.0419354042831356,-0.0166812348514734,5.42289378485047e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL22,Interleukin-22,37368,-0.0289787537450898,0.00637289734770421,-0.0414696325465901,-0.0164878749435896,5.48404327067023e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,39788,-0.0168729349895335,0.00371442631178148,-0.0241532105606252,-0.00959265941844183,5.59880664558628e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,39913,-0.0367968990119524,0.00811011217650198,-0.0526927188778963,-0.0209010791460086,5.74294562987308e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,37368,-0.0242633168260125,0.00535812080377539,-0.0347652336014123,-0.0137614000506128,5.99615298674101e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,37124,-0.0160935383677743,0.00355491622642712,-0.0230611741715714,-0.00912590256397712,6.03129992916045e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,39453,-0.0183314104120307,0.0040576827010556,-0.0262844685060997,-0.0103783523179617,6.29726972882071e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,37388,-0.0212766055721807,0.00471152019336127,-0.0305111851511687,-0.0120420259931926,6.35908367638841e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,37368,-0.0474462027372717,0.0105198435286331,-0.0680650960533925,-0.0268273094211509,6.53237598047668e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RNASE3,Eosinophil cationic protein,39791,-0.046848837487101,0.0104214104925278,-0.0672748020524554,-0.0264228729217466,6.99153802904236e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,39749,-0.0262275406677349,0.00584112508484504,-0.0376761458340312,-0.0147789355014387,7.16731947293249e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,39912,-0.0213236366460206,0.00475323570590116,-0.0306399786295868,-0.0120072946624543,7.30317669908583e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,37382,-0.0386056183792163,0.00860882431194789,-0.0554789140306341,-0.0217323227277984,7.37130951258385e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRYBB1,Beta-crystallin B1,37437,-0.0290416530075499,0.00648291554999702,-0.0417481674855441,-0.0163351385295557,7.53510559496544e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STX6,Syntaxin-6,39477,-0.0296315974411825,0.00661510484575628,-0.0425972029388648,-0.0166659919435002,7.53897444929258e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",39477,-0.0351560003498993,0.00784939693211007,-0.050540818336835,-0.0197711823629635,7.55906690180299e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,37437,-0.00969091695712146,0.00216914121769269,-0.0139424337437991,-0.0054394001704438,7.97307899471453e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD14,Monocyte differentiation antigen CD14,39564,-0.0177970134939051,0.00398499384229209,-0.0256076014247976,-0.00998642556301261,8.02485848967246e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDZD2,PDZ domain-containing protein 2,37021,-0.0260604435699634,0.00584271817439906,-0.0375121711917855,-0.0146087159481413,8.25121749358514e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,37169,-0.025641106844724,0.00575516078198518,-0.0369212219774149,-0.014360991712033,8.44499825255927e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,39477,-0.0331978860858634,0.00745777579257177,-0.0478151266393041,-0.0185806455324228,8.58848099030793e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SUSD1,Sushi domain-containing protein 1,39585,-0.0208739655460642,0.00470458846150416,-0.0300949589306124,-0.0116529721615161,9.18676238362284e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,37021,0.0111761579146627,0.00252386668642682,0.00622937920926609,0.0161229366200592,9.579367459869e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,39477,-0.0224409901306936,0.00506912976900279,-0.032376484477939,-0.0125054957834481,9.62049505388752e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,39489,-0.031945025583787,0.00721776612008767,-0.0460918471791588,-0.0177982039884151,9.6696559352412e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RP2,Protein XRP2,39788,-0.017886034878475,0.00405097277586308,-0.0258259415191667,-0.0099461282377834,1.01560034417679e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,39489,-0.0315586169227278,0.00714863577661248,-0.0455699430448883,-0.0175472908005674,1.01859001740142e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,39587,-0.0131258361939109,0.00297394078017777,-0.0189547601230594,-0.00729691226476252,1.02334375719737e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL7,Interleukin-7,39866,-0.0278858660787242,0.00632547809677937,-0.0402838031484118,-0.0154879290090366,1.04767128105504e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GZMH,Granzyme H,39585,-0.0321048390242683,0.00728400927781693,-0.0463814972087895,-0.0178281808397471,1.05225286195365e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PARD3,Partitioning defective 3 homolog,37169,-0.0317583987433952,0.00722442840770923,-0.0459182784225053,-0.0175985190642851,1.1113185153802e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PROCR,Endothelial protein C receptor,37021,0.0156036985297261,0.00355882026949688,0.00862841080151224,0.02257898625794,1.17146837318199e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,37411,-0.0283053222552347,0.00646216908626863,-0.0409711736643212,-0.0156394708461482,1.19483517150316e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RAB44,Ras-related protein Rab-44,37368,-0.0179547542112103,0.00411239150769938,-0.0260150415663011,-0.00989446685611955,1.27476239462609e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLK11,Kallikrein-11,39779,-0.0122826092533663,0.00281930095211031,-0.0178084391195025,-0.00675677938723005,1.32915734133009e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,40058,0.0121844748408826,0.00279782995663529,0.00670072812587746,0.0176682215558878,1.33900304438655e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DCLRE1C,Protein artemis,36962,0.0131704508164951,0.00302451138428378,0.0072424085032989,0.0190984931296913,1.34339843104755e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",37437,-0.0228947588051262,0.00525992830447764,-0.0332042182819023,-0.01258529932835,1.35470067317368e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,39868,-0.0206011560095849,0.00473737093118725,-0.0298864030347119,-0.0113159089844579,1.37826107254632e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AKAP12,A-kinase anchor protein 12,37124,0.00893794557767581,0.00205545729996234,0.00490924926974963,0.012966641885602,1.38158751187354e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLC12A2,Solute carrier family 12 member 2,37021,0.0117920706100089,0.00271243118472177,0.00647570548795425,0.0171084357320636,1.3878457945928e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FOLR2,Folate receptor beta,40009,-0.0121423378743271,0.00279327776991658,-0.0176171623033636,-0.00666751344529055,1.38865496007014e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,37445,-0.0107237471647445,0.00246933241846066,-0.0155636387049274,-0.00588385562456159,1.41715818550028e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,37382,0.0297850211593937,0.00686233678917621,0.0163348410526083,0.043235201266179,1.43282043768386e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,37039,-0.0259335360535935,0.00597979702483106,-0.0376539382222624,-0.0142131338849246,1.4560743147503e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,37388,-0.016248458056547,0.00374688931604316,-0.0235923611159916,-0.00890455499710243,1.45804303767766e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",37056,-0.0151553391479567,0.00349721831412833,-0.0220098870436483,-0.00830079125226522,1.47815735236791e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",39858,-0.0156690991290155,0.00361688071324161,-0.022758185326969,-0.00858001293106193,1.48517332330198e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,37382,-0.0407091712341197,0.00939990874751554,-0.0591329923792501,-0.0222853500889892,1.49635497342211e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,37169,-0.0148057119721275,0.00342117761671129,-0.0215112201008816,-0.00810020384337338,1.51798158759009e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINA11,Serpin A11,40052,-0.0171483998759613,0.00396663573411779,-0.0249230059148321,-0.0093737938370904,1.54728977022382e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,39962,-0.0144076719675511,0.00333417157416154,-0.0209426482529077,-0.0078726956821945,1.56102851474651e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CA12,Carbonic anhydrase 12,39788,-0.0133297807579031,0.00309060855345852,-0.0193873735226818,-0.00727218799312444,1.62026600376387e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CALB2,Calretinin,39489,-0.0122019422342181,0.00282923804362597,-0.017747248799725,-0.00665663566871119,1.62187273495496e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,37169,-0.0309194106734898,0.00717146895459589,-0.0449754898244978,-0.0168633315224819,1.63356395033991e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LPO,Lactoperoxidase,39344,-0.025019795886679,0.00580826758797132,-0.0364040003591028,-0.0136355914142552,1.66039074949425e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,37021,-0.0184963811872417,0.00430652453669918,-0.026937169279172,-0.0100555930953113,1.75972085099299e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,39788,-0.0223977238649961,0.00522099013569696,-0.0326308645309622,-0.0121645831990301,1.79776725262575e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EGFLAM,Pikachurin,37382,-0.0128091913123626,0.00298733447425157,-0.0186643668818957,-0.00695401574282953,1.81675809281088e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IFNL1,Interferon lambda-1,39489,-0.0186647491468611,0.00435337035889181,-0.027197355050289,-0.0101321432434331,1.81839907419499e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",39809,-0.0272029376278333,0.0063511191686134,-0.0396511311983155,-0.014754744057351,1.85325709844832e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,39489,-0.0168415097682367,0.0039341515432457,-0.0245524467929982,-0.0091305727434751,1.87291128263963e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,36991,-0.0415245792585833,0.0097181873457305,-0.0605722264562151,-0.0224769320609515,1.94330286052506e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",39453,-0.0194282226695947,0.00455531045694011,-0.0283566311651973,-0.0104998141739921,2.01114483392613e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,40030,-0.0146689971887109,0.00344342391488813,-0.0214181080618916,-0.00791988631553014,2.05579732453438e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MMP3,Stromelysin-1,39858,0.019631083042383,0.00462100686184975,0.0105739095931575,0.0286882564916086,2.16688120452438e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GUK1,Guanylate kinase,37021,0.0171337221746684,0.00403474273828206,0.0092256264076356,0.0250418179417013,2.18581546220311e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RAB37,Ras-related protein Rab-37,39587,-0.0343069029543186,0.0080839103735541,-0.0501513672864847,-0.0184624386221526,2.20976244875709e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,37124,-0.0250857024181371,0.00591553836173132,-0.0366801576071305,-0.0134912472291437,2.24388161199095e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TST,Thiosulfate sulfurtransferase,39455,-0.031453872496137,0.00741840999632238,-0.0459939560889289,-0.0169137889033451,2.24832027796356e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD70,CD70 antigen,39866,0.0173544194925497,0.00409773236773204,0.00932286405179493,0.0253859749333045,2.29697898571059e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,37000,-0.016586789280159,0.00391646742426404,-0.0242630654317165,-0.0089105131286015,2.29963860414183e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,37039,-0.0253176236973372,0.00599268978480226,-0.0370632956755496,-0.0135719517191248,2.40813231603277e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,40003,-0.0123911836418144,0.00293352981079284,-0.0181409020709683,-0.0066414652126604,2.41336905111786e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,39788,-0.012928620727928,0.00306189020991615,-0.0189299255393636,-0.00692731591649229,2.43022383857141e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DNLZ,DNL-type zinc finger protein,36991,0.0370194494990365,0.00876813365706245,0.0198339075311941,0.0542049914668789,2.43726226094701e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KIF1C,Kinesin-like protein KIF1C,37021,-0.0150373844377927,0.00356354135237003,-0.022021925488438,-0.00805284338714745,2.46172663868778e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,F3,Tissue factor,39931,0.0111082559444051,0.00263413333412791,0.00594535460951437,0.0162711572792958,2.48880553324904e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD33,Myeloid cell surface antigen CD33,39913,-0.0320124693303306,0.00760259973261971,-0.0469135648062652,-0.0171113738543959,2.55937425793885e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,39489,-0.0156194751139883,0.00373019609255961,-0.0229306594554051,-0.00830829077257141,2.83830758192268e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,39868,-0.0267663254716039,0.00639261828033483,-0.0392958573010602,-0.0142367936421477,2.84092651465918e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C2,Complement C2,39908,-0.00959132346128985,0.00229595243933931,-0.0140913902423949,-0.00509125668018481,2.96299253176147e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,39913,-0.0109592314723001,0.00262906583667734,-0.0161122005121877,-0.00580626243241253,3.08233426624241e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PADI2,Protein-arginine deiminase type-2,39587,-0.0230417243052559,0.00552775746859257,-0.0338761289436974,-0.0122073196668145,3.08430752599095e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,37382,-0.0194501137177026,0.00466919726141736,-0.0286017403500806,-0.0102984870853246,3.12432241281584e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,36962,0.0123545737934949,0.00296842740385506,0.00653645608193902,0.0181726915050508,3.17497579893859e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,37306,-0.0123345816657825,0.00296454855442851,-0.0181450968324624,-0.00652406649910264,3.19253493600818e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",37411,-0.0191074255565118,0.00459490628503995,-0.0281134418751901,-0.0101014092378335,3.22467407164462e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,37124,-0.0335438029347635,0.00807327308154084,-0.0493674181745835,-0.0177201876949434,3.27441610935064e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CFB,Complement factor B,37220,-0.0133695401892304,0.00321847968503654,-0.019677760371902,-0.00706132000655875,3.28755909483745e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CA7,Carbonic anhydrase 7,37169,0.0136073866322817,0.00328908034323027,0.00716078915955039,0.020053984105013,3.5382285855052e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PKLR,Pyruvate kinase PKLR,39881,-0.0256298166310293,0.00619909610684537,-0.0377800450004462,-0.0134795882616124,3.57626528320322e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRADD,Death domain-containing protein CRADD,39713,-0.0306197305542162,0.00740605951167739,-0.0451356071971039,-0.0161038539113285,3.57689634026883e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCGB2A2,Mammaglobin-A,37021,0.0126420997431888,0.00305905785447368,0.00664634634842039,0.0186378531379572,3.60781353820026e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TEK,Angiopoietin-1 receptor,39913,-0.00865604370754387,0.00209849128537525,-0.0127690866268794,-0.00454300078820838,3.72781880599928e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTSV,Cathepsin L2,39967,0.0163682978552172,0.00396922771841121,0.00858861152713121,0.0241479841833031,3.74542942881995e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GMFG,Glia maturation factor gamma,37437,-0.0289104691882633,0.00701679183223953,-0.0426633811794527,-0.0151575571970738,3.80816603724711e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ABHD14B,Protein ABHD14B,39687,-0.0229203491786439,0.0055794716126441,-0.0338561135394263,-0.0119845848178615,4.01144989136543e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DBH,Dopamine beta-hydroxylase,37430,0.043602942624956,0.010621083787548,0.022785618401362,0.06442026684855,4.06119975146844e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,39477,-0.0187418787723911,0.00456885863078639,-0.0276968416887325,-0.00978691585604981,4.11507111528844e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,39749,-0.0406318889961505,0.00991867778314403,-0.0600724974511128,-0.0211912805411881,4.21518138859625e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LXN,Latexin,39682,0.0265600146597028,0.00648620942832105,0.0138470441801935,0.039272985139212,4.24552938887354e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TBC1D5,TBC1 domain family member 5,39866,-0.0309270069721099,0.00755926106150637,-0.0457431586526624,-0.0161108552915574,4.31111154802987e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RAB10,Ras-related protein Rab-10,37437,-0.0213212235738655,0.00521464852380953,-0.0315419346805321,-0.0111005124671988,4.36264230518019e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,37366,-0.0351389099283638,0.00861050106564949,-0.0520154920170368,-0.0182623278396908,4.51124818491542e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NRCAM,Neuronal cell adhesion molecule,39868,-0.0109542829791915,0.00268514924211553,-0.0162171754937379,-0.00569139046464507,4.53355382799569e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,39477,-0.0158382840757468,0.00388623326939259,-0.0234553012837563,-0.00822126686773735,4.61457311359402e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CSF3,Granulocyte colony-stimulating factor,39587,-0.01889854721122,0.00465171891482037,-0.0280159162842679,-0.0097811781381721,4.87433846189709e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,40058,-0.0225314435088473,0.00555350599336312,-0.0334163152558391,-0.0116465717618556,4.99066229317683e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CA1,Carbonic anhydrase 1,39531,-0.0233376630493017,0.00576540976794486,-0.0346378661944736,-0.0120374599041298,5.19328089020519e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DCTN6,Dynactin subunit 6,39489,-0.0278702023936458,0.00688797334083996,-0.0413706301416921,-0.0143697746455995,5.23033482271182e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,37043,-0.0206366700102715,0.00510679879991698,-0.0306459956581088,-0.0106273443624342,5.35215208955351e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CILP,Cartilage intermediate layer protein 1,37437,-0.0210764081572536,0.00523150146319267,-0.0313301510251113,-0.010822665289396,5.63797967420855e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CX3CL1,Fractalkine,39749,0.0129614736686785,0.00321761957626969,0.0066549392991899,0.0192680080381671,5.64476454561967e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DCN,Decorin,39585,0.00845124824582934,0.00210179939518522,0.0043317214312663,0.0125707750603924,5.82323267787196e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,37437,-0.0279634840969238,0.00695428674396861,-0.0415938861151023,-0.0143330820787453,5.82544110316367e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NRGN,Neurogranin,37445,-0.0358974143831185,0.00894105647775928,-0.0534218850795267,-0.0183729436867103,5.97914868159118e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",37388,-0.0417270609605868,0.0103932128454712,-0.0620977581377104,-0.0213563637834633,5.98077139063906e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,37362,-0.0277745833678944,0.00693072785554434,-0.0413588099647614,-0.0141903567710276,6.17059056616823e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AMIGO2,Amphoterin-induced protein 2,39788,-0.00873426709839372,0.00217977847345974,-0.0130066329063748,-0.00446190129041263,6.17871095183801e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,37056,0.0116230574575907,0.00290083620015118,0.00593741850529438,0.017308696409887,6.1885974487117e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PER3,Period circadian protein homolog 3,37056,-0.0458588272919905,0.011448285001423,-0.0682974658947796,-0.0234201886892014,6.21632591672048e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",39984,-0.0274075234468425,0.00685147677312322,-0.040836417922164,-0.013978628971521,6.35617994235482e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ABO,Histo-blood group ABO system transferase,37445,0.0558902249974518,0.0139834487263315,0.0284826654938421,0.0832977845010614,6.45206998301412e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,39788,-0.00840355888650265,0.00210606147167896,-0.0125314393709934,-0.0042756784020119,6.63193725560503e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PMS1,PMS1 protein homolog 1,37039,-0.0193666901956852,0.00485420607130467,-0.0288809340954423,-0.00985244629592799,6.65225369810238e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CFHR2,Complement factor H-related protein 2,37364,-0.0218552468033839,0.00548862661124553,-0.0326129549614251,-0.0110975386453427,6.87202523017731e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,39788,-0.0366625058855656,0.0092099745013612,-0.0547140559082335,-0.0186109558628976,6.90060256006814e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,37043,-0.0206446674572133,0.0051874111129734,-0.0308119932386412,-0.0104773416757854,6.93534223340753e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PAEP,Glycodelin,39749,-0.0558735837216174,0.0140455035362795,-0.0834027706527253,-0.0283443967905096,6.97936560318068e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MPI,Mannose-6-phosphate isomerase,39788,-0.0332319644621725,0.00837626969096147,-0.049649453056457,-0.016814475867888,7.29809352756986e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCN4B,Sodium channel subunit beta-4,37043,-0.0160431968862159,0.00404543096298394,-0.0239722415736644,-0.00811415219876742,7.35499506305403e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",37382,-0.033829089167762,0.00854024572251122,-0.050567970783884,-0.01709020755164,7.49761006747849e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,37382,0.0191710890741084,0.00484811528282538,0.0096687831197706,0.0286733950284461,7.71377679969732e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TXNL1,Thioredoxin-like protein 1,36971,-0.0377462925355568,0.00954684617797461,-0.0564581110443871,-0.0190344740267266,7.73247271524305e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PROC,Vitamin K-dependent protein C,39908,-0.00989432206824267,0.00250284461969278,-0.0147998975228405,-0.00498874661364483,7.7433662926909e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TPSAB1,Tryptase alpha/beta-1,40038,-0.0200275388165143,0.00507183895892517,-0.0299683431760076,-0.010086734457021,7.88856182947153e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,37056,-0.0332265695518121,0.00841621896007702,-0.0497223587135631,-0.0167307803900611,7.92418656510291e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRNN,Cornulin,39397,0.0247521464976779,0.00627400435753921,0.012455097956901,0.0370491950384547,8.00868011074537e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,37124,-0.0122491185240757,0.00310514228937729,-0.0183351974112552,-0.00616303963689622,8.02827887943415e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EPHA4,Ephrin type-A receptor 4,37124,-0.0108208771333212,0.00274472284770615,-0.0162005339148253,-0.00544122035181718,8.1074545101083e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,37220,-0.0214073149501714,0.00543394223107706,-0.0320578417230824,-0.0107567881772604,8.20479538171824e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AHCY,Adenosylhomocysteinase,39868,-0.0258767064052786,0.00657448952580253,-0.0387627058758515,-0.0129907069347056,8.3226788985939e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,37021,0.0159024647422274,0.00404354289449919,0.00797712066900899,0.0238278088154458,8.43910367680113e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,36991,0.0110560279305129,0.0028115381405452,0.00554541317504434,0.0165666426859815,8.45422005931527e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AMOTL2,Angiomotin-like protein 2,37333,-0.0184582651751042,0.00471500269695264,-0.0276996704611314,-0.00921685988907707,9.09268312241486e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCG3,Secretogranin-3,39885,0.0122995023558537,0.00314343957202503,0.0061383607946846,0.0184606439170227,9.16267558292158e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MATN2,Matrilin-2,39885,-0.0112506745089194,0.00288593825432737,-0.0169071134874011,-0.00559423553043777,9.72063135715007e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,36962,0.00996052679913065,0.00255925557129553,0.00494438587939141,0.0149766677188699,9.99290395525259e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SF3B4,Splicing factor 3B subunit 4,39788,-0.0274984573967234,0.00707713823390686,-0.0413696483351809,-0.013627266458266,0.000102518649711337
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NPPB,Natriuretic peptides B,39585,-0.0475288627885342,0.0122475678696569,-0.0715340958130616,-0.0235236297640067,0.000104590825859155
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ELAVL4,ELAV-like protein 4,36991,-0.031912899636071,0.00825014266237716,-0.0480831792543302,-0.0157426200178117,0.000110187624094751
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,39587,-0.0245390347366794,0.00634705324330527,-0.0369792590935577,-0.0120988103798011,0.000110984817663565
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,37437,-0.0120318102341235,0.00311729500213913,-0.0181417084383162,-0.00592191202993077,0.000114054003749747
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,37039,-0.0253804282111419,0.00658009312159603,-0.0382774107294701,-0.0124834456928136,0.000115261116915025
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MSTN,Growth/differentiation factor 8,39585,-0.0193095359989062,0.00501695367633885,-0.0291427652045303,-0.00947630679328203,0.000119139723904077
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SUGT1,Protein SGT1 homolog,39477,-0.0302525664484099,0.00786498651973504,-0.0456679400270906,-0.0148371928697293,0.000120299687026474
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCARA5,Scavenger receptor class A member 5,40009,-0.0108791304972216,0.00282907256132571,-0.01642411271742,-0.00533414827702322,0.000120780484966204
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,39587,-0.0217913697502368,0.00566693699087704,-0.0328985662523558,-0.0106841732481178,0.000120853719256521
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NPTX2,Neuronal pentraxin-2,37437,0.0125921586111752,0.0032796219023259,0.00616409968261639,0.0190202175397339,0.00012383709254718
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,39868,-0.0117797544246621,0.00307502425973636,-0.0178068019737454,-0.00575270687557889,0.000128223003570929
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,37445,-0.0092314945121918,0.00241732201464536,-0.0139694456608967,-0.0044935433634869,0.000134647783265589
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,37388,-0.0257742795654685,0.00678932184106281,-0.0390813503739516,-0.0124672087569854,0.000147514975890614
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,37043,-0.0225718837744644,0.0059548816999584,-0.0342434519063829,-0.0109003156425459,0.000151023765296841
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDIA3,Protein disulfide-isomerase A3,37124,-0.0093623326760681,0.00247050396432808,-0.0142045204461511,-0.00452014490598507,0.00015153015105904
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD101,Immunoglobulin superfamily member 2,37382,-0.0155676820461743,0.00410832697982532,-0.0236200029266319,-0.00751536116571666,0.000151727863660949
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDIA5,Protein disulfide-isomerase A5,36962,-0.0226597792708754,0.00598696157624196,-0.0343942239603096,-0.0109253345814411,0.000154483926356308
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRDX6,Peroxiredoxin-6,40030,0.0216827408372887,0.00573134439620114,0.0104493058207344,0.0329161758538429,0.000155391801887293
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITGA6,Integrin alpha-6,39866,-0.0194686208564196,0.00514719146867585,-0.0295571161350243,-0.00938012557781496,0.000155902758944622
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DBN1,Drebrin,37056,-0.019280221827001,0.00510765478969127,-0.0292912252147959,-0.00926921843920613,0.000160857017112487
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DAPK2,Death-associated protein kinase 2,37056,-0.0195844863597415,0.00518871734973802,-0.029754372365228,-0.00941460035425498,0.000161071806212764
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,37382,-0.00785325709894184,0.00208385957200377,-0.0119376218600692,-0.00376889233781445,0.000164855663103287
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,39585,-0.0223218720325527,0.0059371815731686,-0.0339587479159632,-0.0106849961491423,0.000170750313338037
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EPCAM,Epithelial cell adhesion molecule,39867,-0.0346507225239663,0.00922171404029717,-0.0527252820429487,-0.0165761630049838,0.000172218569213259
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NAA10,N-alpha-acetyltransferase 10,37021,-0.0184796928525487,0.00492667010891462,-0.0281359662660214,-0.00882341943907605,0.00017692147211043
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,37124,-0.0462573281668964,0.012344542015856,-0.0704526305179742,-0.0220620258158185,0.00017958573705102
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,39866,-0.0541316318216475,0.0144813106306695,-0.0825150006577598,-0.0257482629855351,0.000186110328530606
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GP6,Platelet glycoprotein VI,39836,-0.0321165387232359,0.0085993650705231,-0.0489712942614612,-0.0152617831850106,0.000188549549006343
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,37388,-0.0118869561136134,0.00318478855132347,-0.0181291416742074,-0.00564477055301943,0.000190428573408467
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,39489,-0.040797771298508,0.0109367157223926,-0.0622337341143976,-0.0193618084826185,0.000191890686626768
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MSLN,Mesothelin,39766,-0.0189870576806957,0.00509398072905342,-0.0289712599096404,-0.00900285545175098,0.00019417278618049
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,39844,-0.00803362405151056,0.00215844175527077,-0.0122641698918413,-0.00380307821117985,0.000198363780331554
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",39477,-0.0184677436378599,0.00497018634588312,-0.0282093088757908,-0.00872617839992899,0.000203345037982701
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,37056,-0.0147242799087854,0.00396275306315244,-0.0224912759125642,-0.00695728390500661,0.000203503153766366
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,39914,0.0108194320087366,0.00291859257826279,0.00509899055534154,0.0165398734621317,0.000210374701208351
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HDGF,Hepatoma-derived growth factor,40014,-0.0336620192384805,0.00909959522288578,-0.0514972258753366,-0.0158268126016244,0.000216922451051626
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGF5,Fibroblast growth factor 5,39587,0.0118815805617935,0.00321221074347488,0.00558564750458272,0.0181775136190042,0.000217290625125257
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,37368,-0.0140930254022909,0.00381012024115456,-0.0215608610749538,-0.00662518972962794,0.000217445667096116
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,37411,-0.0138990751756368,0.00376453521515469,-0.02127756419734,-0.00652058615393358,0.000223274813458759
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KIF22,Kinesin-like protein KIF22,37021,-0.0436170305804659,0.0118144618508484,-0.0667733758081288,-0.020460685352803,0.000223542396036485
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,39788,-0.0193184919810266,0.00523608729334125,-0.0295812230759755,-0.00905576088607778,0.000225452192659557
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,37021,0.0131190522983896,0.00357223593638752,0.00611746986307007,0.0201206347337092,0.000241136432565092
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,37021,0.0109935693970915,0.00299531558727285,0.00512275084603668,0.0168643879481463,0.000243267101498004
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,37382,-0.0151256099013302,0.00412691814478494,-0.0232143694651087,-0.00703685033755175,0.000248178070982857
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,37039,-0.0130377863246917,0.00355774881813543,-0.0200109740082371,-0.00606459864114623,0.000248681141866187
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CASP2,Caspase-2,39866,-0.0242831383013807,0.00662987778809121,-0.0372776987660395,-0.0112885778367219,0.000250392311619974
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,37411,-0.0453610535027005,0.0124116071330453,-0.0696878034834694,-0.0210343035219317,0.000258426928133642
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DAND5,DAN domain family member 5,37056,0.0191136653264585,0.00523057852591266,0.00886173141566966,0.0293655992372473,0.000258968973907974
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,37021,0.0204865784474563,0.00561259031677672,0.00948590142657392,0.0314872554683387,0.000263141652348738
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PMVK,Phosphomevalonate kinase,39480,-0.0392878524311818,0.0107773407556507,-0.0604114403122572,-0.0181642645501063,0.000267829702450519
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL26,C-C motif chemokine 26,39866,-0.0302557910322285,0.00830121851426674,-0.0465261793201913,-0.0139854027442657,0.000268508415603501
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,39585,-0.011287179001854,0.00309887020819487,-0.0173609646099159,-0.00521339339379203,0.000271025526281544
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEP170,Centrosomal protein of 170 kDa,37043,-0.0274100931949261,0.00753397550969062,-0.0421766851939197,-0.0126435011959325,0.000275600702169671
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BTC,Probetacellulin,39477,-0.0260407279710407,0.00718141528750027,-0.0401163019345413,-0.0119651540075402,0.000288618793112202
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,37437,-0.0258934208777321,0.00714589551843467,-0.0398993760938641,-0.0118874656616002,0.000291661990190474
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,36962,-0.0261183008988229,0.00721493886850128,-0.0402595810810854,-0.0119770207165604,0.000295678457864261
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,36962,0.0105743442774656,0.00292193696306709,0.00484734782985411,0.0163013407250771,0.000296914483468616
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,39866,-0.0292771589810058,0.00810195891253091,-0.0451569984495664,-0.0133973195124453,0.000302911789621431
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NECTIN4,Nectin-4,39913,-0.0102706259252218,0.0028490705813476,-0.0158548042646631,-0.00468644758578048,0.000313213988670613
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,39881,-0.0170222358479307,0.00472971720706196,-0.0262924815737721,-0.00775199012208925,0.00032041082843386
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DCTD,Deoxycytidylate deaminase,37124,-0.033519013689838,0.00933946257630496,-0.0518243603393957,-0.0152136670402803,0.000333189117174249
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SNU13,NHP2-like protein 1,37021,-0.0216323182661305,0.00602967035188894,-0.0334504721558328,-0.0098141643764282,0.000334888667843508
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,39858,-0.0105090019573299,0.00292942541850044,-0.0162506757775908,-0.00476732813706909,0.0003349965680044
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,37124,-0.030800931406493,0.00860470433924447,-0.0476661519114122,-0.0139357109015739,0.000345421033230793
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,39931,-0.00960001717487296,0.00268839421534823,-0.0148692698369555,-0.00433076451279044,0.000356779997313484
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,37043,-0.0256187544933986,0.00718044118174278,-0.0396924192096144,-0.0115450897771827,0.000361196241413405
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,37043,-0.0356234289856667,0.00999868291116269,-0.0552208474915455,-0.0160260104797878,0.000368198277664119
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNC,Tenascin,39931,0.0162793905938871,0.00457165890518704,0.00731893913972046,0.0252398420480537,0.000370600978942928
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,F13B,Coagulation factor XIII B chain,37380,-0.00884655626905397,0.00248565175533681,-0.0137184337095141,-0.00397467882859383,0.000373476069139058
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BCHE,Cholinesterase,37208,-0.00956555690759994,0.00269134854338031,-0.0148406000526253,-0.00429051376257453,0.000380458815245752
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,37437,-0.0123022210105744,0.00346487731680814,-0.0190933805515183,-0.00551106146963043,0.00038572734075346
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PSPN,Persephin,39866,-0.0323615444613561,0.00914177424943148,-0.0502794219902418,-0.0144436669324704,0.000401318322658107
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RGMB,RGM domain family member B,40009,-0.00874494176049711,0.002470565561444,-0.0135872502609273,-0.00390263326006688,0.000401781715731264
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RBP7,Retinoid-binding protein 7,37382,-0.0207825665641731,0.00587697735611232,-0.0323014421821532,-0.00926369094619291,0.000407180826632461
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CPQ,Carboxypeptidase Q,37430,-0.0129845755601489,0.00367399795729029,-0.0201856115564378,-0.00578353956385991,0.000410400971930193
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PREB,Prolactin regulatory element-binding protein,39587,-0.00980472568448105,0.00277595760991206,-0.0152456025999087,-0.00436384876905341,0.000413585962428591
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NFIC,Nuclear factor 1 C-type,37411,-0.0144153335503101,0.0040952279359898,-0.0224419803048501,-0.00638868679577003,0.000432910858858979
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,39720,-0.0134570213101206,0.00383559466324296,-0.0209747868500768,-0.00593925577016443,0.000451961304891289
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLC39A14,Zinc transporter ZIP14,39489,-0.0111074576387957,0.00316719603595592,-0.0173151618692693,-0.00489975340832208,0.000454406368088972
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,39788,-0.0131588344387458,0.00376542846933312,-0.0205390742386387,-0.00577859463885287,0.000475983233049739
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,39862,-0.0100464480501928,0.00287768649913157,-0.0156867135884907,-0.00440618251189496,0.000482234126439459
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,37021,-0.0335251298004646,0.00960691290533563,-0.0523546790949224,-0.0146955805060068,0.000485166807080562
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TBC1D17,TBC1 domain family member 17,39489,-0.0148823440278424,0.00426578560689659,-0.0232432838173598,-0.00652140423832513,0.000486584273359829
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",37043,-0.0311487078566886,0.00894059473679378,-0.0486722735408044,-0.0136251421725728,0.000495650333139255
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD5L,CD5 antigen-like,37380,-0.0158405516680331,0.00455435267207964,-0.0247670829053092,-0.00691402043075705,0.000506546094165429
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANXA1,Annexin A1,37072,-0.0147635547023663,0.00426370220459342,-0.0231204110233694,-0.0064066983813632,0.000536648980510514
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EVPL,Envoplakin,37169,0.0111287572692248,0.00321558083205849,0.00482621883839021,0.0174312957000595,0.000540090590157657
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FN1,Fibronectin,37453,-0.0089803700331858,0.00259525590328893,-0.0140670716036321,-0.0038936684627395,0.000541225408667926
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPM1F,Protein phosphatase 1F,37437,-0.017944591312823,0.00518848357994336,-0.028114019129512,-0.00777516349613403,0.000544772286007657
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,39931,-0.0403603665595612,0.0117011183396321,-0.0632945585052402,-0.0174261746138822,0.00056353726179121
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TLR3,Toll-like receptor 3,40058,-0.0203939258701846,0.00591287966120981,-0.0319831700061558,-0.00880468173421338,0.000563955656088115
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GDF2,Growth/differentiation factor 2,39868,0.0118072989726294,0.00342334883216833,0.00509753526157942,0.0185170626836793,0.000564012288884305
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,39477,-0.0135774581713489,0.00393705396433766,-0.0212940839414507,-0.00586083240124706,0.000564916091367727
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL1B,Interleukin-1 beta,39478,-0.0186406922177756,0.00541549576166968,-0.0292550639106482,-0.00802632052490303,0.000578723014871371
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FRMD4B,FERM domain-containing protein 4B,37021,-0.0235256232307441,0.00685452389623565,-0.036960490067366,-0.0100907563941222,0.000600700044333319
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FOSB,Protein fosB,39489,-0.0129840374760975,0.00378905194603641,-0.0204105792903288,-0.00555749566186612,0.000612480831817788
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,39477,-0.0156744724627962,0.00457463627975702,-0.02464075957112,-0.00670818535447246,0.000613244191139456
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CASP9,Caspase-9,37056,-0.0211248681705769,0.00617209910950509,-0.0332221824252069,-0.00902755391594696,0.000622045958119492
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCS,Copper chaperone for superoxide dismutase,39749,-0.0156711603640009,0.00458044833574814,-0.0246488391020673,-0.0066934816259346,0.000624757772615779
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,37037,-0.0200729934204676,0.00587734805916555,-0.0315925956164321,-0.00855339122450313,0.000639004828903176
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TUBB3,Tubulin beta-3 chain,36991,0.00938269551572349,0.00274858131499671,0.00399547613832994,0.014769914893117,0.000642924194527497
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",37043,-0.0167483645200552,0.00490837420333031,-0.0263687779585826,-0.0071279510815278,0.000646339217369471
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,39699,-0.00985149900955352,0.00288727413502351,-0.0155105563141996,-0.00419244170490743,0.000646394798704744
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINB9,Serpin B9,39749,-0.0110624051110899,0.0032434958083108,-0.017419656895379,-0.00470515332680072,0.000649712172235862
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,39984,-0.0112355792396406,0.0032944636368316,-0.0176927279678305,-0.00477843051145064,0.000650164999684873
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GAD1,Glutamate decarboxylase 1,36962,0.00861664267097972,0.00252817133373775,0.00366142685685374,0.0135718584851057,0.000655774886054587
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TK1,"Thymidine kinase, cytosolic",37169,-0.0152810547539842,0.00450128563620897,-0.0241035746009538,-0.0064585349070146,0.000688742293485128
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DDI2,Protein DDI1 homolog 2,37124,-0.0248720524525699,0.0073277649118359,-0.0392344716797682,-0.0105096332253715,0.00069025663744434
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SEPTIN9,Septin-9,39788,-0.00930253276638316,0.00274839062490661,-0.0146893783912001,-0.0039156871415662,0.000714227779044266
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,39788,0.0108559273034667,0.00321057660534335,0.00456319715699375,0.0171486574499397,0.00072316739477852
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,39931,-0.0288947105844812,0.0085557412003565,-0.0456639633371799,-0.0121254578317824,0.000733932789612257
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RPS10,40S ribosomal protein S10,37021,0.0141180066221766,0.00418129034169197,0.0059226775524603,0.0223133356918928,0.000736345070365879
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,39477,-0.0153382564937298,0.00455161912687719,-0.0242594299824091,-0.00641708300505049,0.000753921953004136
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACHE,Acetylcholinesterase,37124,-0.0107088788044808,0.00318815298868439,-0.0169576586623022,-0.00446009894665943,0.000784566879028935
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TPMT,Thiopurine S-methyltransferase,39477,-0.0236776741292102,0.00705996521072145,-0.0375152059422242,-0.00984014231619613,0.000799010277612573
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,37411,-0.0104194584852464,0.00311132078568842,-0.0165176472251957,-0.00432126974529709,0.000813583672399905
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,39931,0.00654050843245426,0.0019544475723837,0.0027097911905822,0.0103712256743263,0.000820338899790326
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,39391,-0.0189427476758901,0.00566544995974954,-0.0300470295969992,-0.00783846575478098,0.000829076287167999
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,37169,-0.0234194431823808,0.00701144894331897,-0.037161883111286,-0.00967700325347566,0.000839567724808818
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,39817,-0.0105363381069851,0.00316431522489197,-0.0167383959477733,-0.00433428026619681,0.000871249655919206
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,36931,-0.0284967930475145,0.00856220704339307,-0.0452787188525649,-0.0117148672424641,0.000876484726330792
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LYZL2,Lysozyme-like protein 2,36962,-0.0116903698904559,0.00351455686008526,-0.018578901336223,-0.00480183844468874,0.000882581926231735
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD84,SLAM family member 5,39866,-0.0100464058597987,0.00302244828068448,-0.0159704044899402,-0.00412240722965708,0.000889577560652313
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",37021,0.0154673957033719,0.00465319145006452,0.00634714046124541,0.0245876509454983,0.000889656364403044
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEP350,Centrosome-associated protein 350,36962,0.0117276331796822,0.0035288539037623,0.00481107952830807,0.0186441868310563,0.000891854993495419
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,36991,0.0122950720559254,0.00370102668189549,0.0050410597594102,0.0195490843524405,0.000895960582188529
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PROK1,Prokineticin-1,39866,-0.0208527113400315,0.0062825236628827,-0.0331664577192816,-0.00853896496078139,0.000904897336576664
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLU,Clusterin,37453,0.0102932339460936,0.00310391777875753,0.00420955509972887,0.0163769127924584,0.000914873232147319
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SAFB2,Scaffold attachment factor B2,37411,-0.00884705296494527,0.0026752099577144,-0.0140904644820655,-0.00360364144782504,0.000945293900603503
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MARCO,Macrophage receptor MARCO,39868,-0.00840860813268015,0.00254381377871007,-0.0133944831389519,-0.00342273312640841,0.000950113090021109
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,39931,-0.0089838052230468,0.0027205622878378,-0.0143161073072089,-0.00365150313888472,0.000961434113164907
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NGF,Beta-nerve growth factor,39749,0.00393743253901884,0.00119238205111755,0.00160036371882845,0.00627450135920924,0.000961561194473171
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,37388,-0.0148132202157248,0.00448757513203132,-0.0236088674745062,-0.00601757295694339,0.000966106134273396
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PSMG4,Proteasome assembly chaperone 4,37056,-0.0178205118454532,0.00540102855928484,-0.0284065278216515,-0.00723449586925493,0.000971254808376929
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,37056,-0.0100703957840216,0.00305252851765454,-0.0160533516786245,-0.00408743988941871,0.000972750147239612
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,39585,-0.00857608829938032,0.00260211763370291,-0.013676238861438,-0.00347593773732261,0.000983552210841056
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,40052,-0.0125319428872817,0.00380314470992826,-0.0199861065187411,-0.00507777925582235,0.000985795081899218
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,37043,-0.0150605856946348,0.00457599149643582,-0.0240295290276491,-0.00609164236162064,0.00100016663719706
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SNX5,Sorting nexin-5,37043,-0.00976990442512764,0.00297423877973383,-0.015599412433406,-0.00394039641684933,0.00102305762040164
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,37368,-0.0141948260147073,0.00432190815912377,-0.0226657660065899,-0.00572388602282475,0.00102463941395306
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,37388,0.00969541765146285,0.00295220362508737,0.00390909854629161,0.0154817367566341,0.0010255790943097
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LIFR,Leukemia inhibitory factor receptor,39866,-0.00776652383602757,0.00236670092821872,-0.0124052576553363,-0.00312779001671888,0.00103447342819628
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RCC1,Regulator of chromosome condensation,37368,-0.0161824940448739,0.00493252507362753,-0.0258502431891838,-0.00651474490056391,0.00103785445784478
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VCAN,Versican core protein,40009,0.00939307398996512,0.00286582655115546,0.00377605394970042,0.0150100940302298,0.00104909441527396
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,39489,-0.0148988228942192,0.0045460809467707,-0.0238091415498898,-0.00598850423854867,0.0010503751790407
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,THBS4,Thrombospondin-4,39892,-0.0141999969347826,0.00434351930159199,-0.0227132947659029,-0.00568669910366233,0.00108064924377797
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,39868,-0.029363686791995,0.00899407757644041,-0.0469920788418182,-0.0117352947421718,0.0010977906763497
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,39866,-0.0319031436510545,0.00977277176266055,-0.0510577763058692,-0.0127485109962399,0.00109890448436545
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",39713,-0.0231804833988718,0.00712002807737268,-0.0371357384305222,-0.00922522836722135,0.00113361343461244
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,37437,-0.0187968475422795,0.00577487712526467,-0.0301156067077983,-0.00747808837676077,0.00113696183355912
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CASP8,Caspase-8,39984,-0.0194301046200107,0.0059796790885558,-0.03115027563358,-0.00770993360644129,0.00115903673333417
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,36962,0.0081121410372287,0.00249848819630123,0.00321510417247828,0.0130091779019791,0.00116995642806597
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LUZP2,Leucine zipper protein 2,37368,-0.0138205566632859,0.00425718066318082,-0.0221646307631203,-0.00547648256345149,0.00117154980321652
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CST1,Cystatin-SN,35640,-0.0319542455900975,0.00984416881941089,-0.0512488164761428,-0.0126596747040521,0.00117362753194204
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,37357,-0.011435152032114,0.00352377610231239,-0.0183417531926463,-0.00452855087158175,0.00117678226669
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,39477,-0.0181716737567422,0.0056021576036507,-0.0291519026598976,-0.00719144485358687,0.00118239219156179
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AOC3,Membrane primary amine oxidase,39931,0.00945086164668828,0.00291858940037936,0.00373042642194473,0.0151712968714318,0.0012054712848302
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,40030,0.00997604934559305,0.00308190814539252,0.00393550938062372,0.0160165893105624,0.001210487183225
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,39862,-0.0920002363686016,0.0285139903826559,-0.147887657518607,-0.0361128152185961,0.00125568605923776
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,REST,RE1-silencing transcription factor,36962,0.0112080016387832,0.00347945139566188,0.00438827690328595,0.0180277263742805,0.00127967638317125
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GSTP1,Glutathione S-transferase P,39393,0.0216595910513356,0.00672995551556102,0.008468878240836,0.0348503038618352,0.00129179055316023
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,37437,-0.00863145692433085,0.00268738586002408,-0.013898733209978,-0.00336418063868365,0.00132194628975207
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SNX18,Sorting nexin-18,37382,-0.0141578050552193,0.00440908855456258,-0.0227996186221619,-0.0055159914882766,0.00132560037306225
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,37056,-0.0118250353934158,0.00368485159787904,-0.0190473445252587,-0.00460272626157288,0.00133472260595834
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,39453,-0.0147951338603581,0.0046116511172581,-0.023833970050184,-0.00575629767053227,0.00133835009397722
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,39749,0.0112067212499782,0.00349425913196056,0.00435797335133548,0.0180554691486209,0.00134308195746975
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,37021,-0.0211568079916157,0.00660064981168374,-0.0340940816225159,-0.00821953436071561,0.00135261920406179
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RILPL2,RILP-like protein 2,37437,-0.0308239755854296,0.00962012180460563,-0.0496794143224567,-0.0119685368484026,0.00135791401419962
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,37382,-0.0356759579072161,0.0111385201259587,-0.0575074573540952,-0.013844458460337,0.00136349736920537
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FADD,FAS-associated death domain protein,39868,-0.0238616872655875,0.00746017735993425,-0.0384836348910587,-0.00923973964011641,0.00138393522080567
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,39931,0.010255076286467,0.00320679406933996,0.0039697599105607,0.0165403926623733,0.00138690093137361
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,37411,0.014801534661289,0.0046468362773911,0.00569373555760246,0.0239093337649756,0.00144935102036186
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TXN,Thioredoxin,37289,-0.0134231254937995,0.00421416344141465,-0.0216828858389722,-0.00516336514862677,0.00144964144992797
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,39477,-0.0169555622052464,0.00533568279304068,-0.0274135004796061,-0.00649762393088668,0.00148702575568579
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,39862,0.0123576124098083,0.00389011699171243,0.00473298310605192,0.0199822417135646,0.00149260064658134
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MYH4,Myosin-4,37021,0.014754022757479,0.00465460754752381,0.00563099196433236,0.0238770535506257,0.0015291052405537
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GSR,"Glutathione reductase, mitochondrial",37403,-0.00695354774663917,0.00219688407368663,-0.011259440531065,-0.00264765496221337,0.00155326745159031
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TLR1,Toll-like receptor 1,37056,-0.00804489377904882,0.00254228415358045,-0.0130277707200665,-0.00306201683803113,0.00155736977202546
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,36991,0.0104281847085836,0.00329758931212463,0.00396490965681937,0.0168914597603479,0.00156848879448539
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,39477,-0.0235756650290952,0.00746050507035451,-0.0381982549669901,-0.00895307509120039,0.00158036139294283
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,37169,-0.0199119376570999,0.00631261625519207,-0.0322846655172764,-0.00753920979692348,0.00161236958674662
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GBP2,Guanylate-binding protein 2,39587,-0.0181284012253089,0.00575179110973135,-0.0294019118003824,-0.00685489065023546,0.00162581041115528
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,37382,-0.0153534151548824,0.00488083908235942,-0.0249198597563069,-0.00578697055345794,0.00166076973906533
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,39788,-0.0103853415605486,0.00330267664847115,-0.016858587791552,-0.00391209532954511,0.00166663724137099
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,39812,-0.0178872252437915,0.00569053283430354,-0.0290406695990265,-0.00673378088855661,0.00167343197807676
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,INSR,Insulin receptor,37056,-0.00508293435503235,0.00162165204664311,-0.00826137236645284,-0.00190449634361185,0.0017257321916055
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINC1,Antithrombin-III,37424,0.00443611023206123,0.00141895205837817,0.00165496419764001,0.00721725626648245,0.0017737764091614
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPON2,Spondin-2,39775,-0.0101702454153102,0.00325417258513702,-0.0165484236821788,-0.00379206714844165,0.00177946940072018
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MYL3,Myosin light chain 3,37043,-0.022214657536716,0.00710977187928373,-0.0361498104201121,-0.00827950465331991,0.0017847887362966
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRSS53,Serine protease 53,37388,0.0113390328420292,0.00363469938558514,0.00421502204628234,0.0184630436377761,0.00181439295762547
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FST,Follistatin,39908,-0.015559283715258,0.00499009207049872,-0.0253398641734355,-0.00577870325708051,0.00182382820027924
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STK4,Serine/threonine-protein kinase 4,39868,-0.0263849162067492,0.00846414019000663,-0.0429746309791622,-0.00979520143433623,0.00182864441858567
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,37043,-0.01733146792896,0.0055679717745829,-0.0282446926071425,-0.00641824325077752,0.00185776122585878
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATXN10,Ataxin-10,39489,-0.0220031762961737,0.00709687233790386,-0.0359130460784653,-0.00809330651388213,0.00193600010549445
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,39864,-0.0120335457276454,0.00388272342026994,-0.0196436836313745,-0.00442340782391631,0.00194345082914318
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCND2,G1/S-specific cyclin-D2,37169,0.011123857255245,0.00359425467112599,0.00407911809983803,0.0181685964106519,0.00197287984366001
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SYT1,Synaptotagmin-1,37388,0.0111637978884301,0.00360850059546799,0.0040911367213128,0.0182364590555473,0.00198046942285427
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,37124,0.00853143436781859,0.00276605238477773,0.00310997169365424,0.0139528970419829,0.00204426563683153
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,39931,0.00841679379661005,0.00273099759792473,0.00306403850467757,0.0137695490885425,0.00205998337630865
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,37056,0.0129336103241958,0.00420912695371604,0.00468372149491234,0.0211834991534792,0.00212525714511154
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,39456,-0.0152412467154459,0.00496677749496371,-0.0249761306055748,-0.00550636282531707,0.00215405272428575
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PODXL,Podocalyxin,39788,0.00447756941720188,0.00145917443515072,0.00161758752430647,0.0073375513100973,0.00215451920352665
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,39869,-0.0171244908423648,0.00558721590178002,-0.0280754340098536,-0.00617354767487593,0.00218074746145005
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BEX3,Protein BEX3,36962,0.0139709263511046,0.0045630035097108,0.00502743947207142,0.0229144132301377,0.00220468664936354
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,39858,-0.0107027516698082,0.00350088301579493,-0.0175644823807663,-0.00384102095885015,0.00223815284506308
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRDX2,Peroxiredoxin-2,37249,-0.0181305867880749,0.0059337882242096,-0.0297608117075257,-0.00650036186862405,0.00225140720069934
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,37169,-0.0212250201321249,0.00695391933165221,-0.0348547020221632,-0.00759533824208659,0.00227589408813867
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VEGFB,Vascular endothelial growth factor B,37056,-0.00842715382616653,0.00276310331564224,-0.0138428363248253,-0.00301147132750774,0.00229381169476445
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCT,Secretin,37039,-0.0131484400080831,0.00431158625567212,-0.0215991490692005,-0.00469773094696578,0.00229631873835505
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCRN1,Secernin-1,39866,-0.0166370387226522,0.00545834570831046,-0.0273353963109407,-0.00593868113436368,0.00230745510313041
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NXPE4,NXPE family member 4,37021,0.0103677526550371,0.00340424259841508,0.00369543716214356,0.0170400681479307,0.00232723252068852
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RLN1,Prorelaxin H1,37411,-0.0239415934681985,0.00787421657197403,-0.0393750579492676,-0.00850812898712936,0.00236632852269309
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,39788,-0.0130436740477839,0.00429935172217271,-0.0214704034232424,-0.00461694467232542,0.00241827509086162
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,37039,-0.0142852322717395,0.00471286759531414,-0.0235224527585552,-0.00504801178492375,0.0024412734395562
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,39866,-0.0159590947798782,0.00526576504265935,-0.0262799942634905,-0.00563819529626587,0.00244355664584839
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,37388,-0.0705523304075963,0.0232953963295584,-0.116211307213531,-0.0248933536016619,0.00246156684927412
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,39887,-0.0351129504138689,0.0116287791987744,-0.0579053576434667,-0.0123205431842711,0.00253601443090787
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,37021,-0.0129452154564975,0.00429486948947206,-0.0213631596558628,-0.00452727125713229,0.00258223859467711
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GBP6,Guanylate-binding protein 6,37021,0.0135394949285069,0.00449870022118084,0.00472204249499245,0.0223569473620214,0.00262047738981152
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,39477,-0.00875568503997682,0.0029107427375436,-0.0144607408055623,-0.00305062927439136,0.00263341145968014
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,37169,0.00812382007577318,0.00270117946231551,0.00282950832963478,0.0134181318219116,0.00263890826975031
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDH22,Cadherin-22,37169,0.00851268973374125,0.00283177063186061,0.00296241929529445,0.014062960172188,0.0026508341798189
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CNTN2,Contactin-2,40030,0.0129095275118214,0.0042961336572189,0.00448910554367236,0.0213299494799704,0.00266059953315039
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,39477,-0.0175204977041972,0.00583143688608371,-0.0289501140009213,-0.00609088140747313,0.00266447835602554
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BPIFB2,BPI fold-containing family B member 2,37405,-0.0179738893579794,0.00598699256637222,-0.0297083947880689,-0.00623938392788983,0.00268563061721281
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GC,Vitamin D-binding protein,37453,-0.00756238769402206,0.00251928859980726,-0.0125001933496443,-0.00262458203839983,0.00268880411948125
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,37056,-0.00588053021415187,0.00196269636388821,-0.00972741508737277,-0.00203364534093097,0.00273921088138695
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GPR15L,Protein GPR15L,37382,-0.0179178004167095,0.00598628546405588,-0.029650919926259,-0.00618468090715993,0.00276620419034598
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",37043,-0.00758886096373824,0.00253755574834941,-0.0125624702305031,-0.00261525169697339,0.00278927518234485
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLHL41,Kelch-like protein 41,37411,-0.0148958413072655,0.00498968596567683,-0.0246756257999921,-0.0051160568145389,0.0028378171372831
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FXN,"Frataxin, mitochondrial",40030,-0.0212361263506564,0.00711779410217808,-0.0351870027909254,-0.00728524991038735,0.00285372936357577
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCP2,Non-specific lipid-transfer protein,39477,-0.0225216783589059,0.00756389487111465,-0.0373469123062906,-0.00769644441152116,0.0029103286331248
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,37382,-0.0287437950788817,0.0096583292291638,-0.0476741203680427,-0.00981346978972061,0.00292491602036197
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HEPACAM2,HEPACAM family member 2,37388,0.0121473105732668,0.00408229773142122,0.00414600701968123,0.0201486141268524,0.00292926915295827
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACTA2,"Actin, aortic smooth muscle",39585,-0.0124286281647695,0.00417867503021111,-0.0206188312239833,-0.00423842510555575,0.00294104762317791
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,37039,-0.0152800161582994,0.0051381138559028,-0.0253507193158689,-0.00520931300072991,0.00294614481162695
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,37043,-0.00812388888007449,0.00273223841882632,-0.0134790761809741,-0.0027687015791749,0.00295105476950551
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HSBP1,Heat shock factor-binding protein 1,37043,-0.0280078373962389,0.00943228233240919,-0.0464951107677609,-0.00952056402471688,0.00298958385365845
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IFNW1,Interferon omega-1,37021,0.0102208448173258,0.00344972144766449,0.00345939077990337,0.0169822988547482,0.00305396921618337
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTSH,Pro-cathepsin H,39546,-0.0206166573020637,0.00700186487824444,-0.0343403124634228,-0.00689300214070459,0.00324001393416134
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PCDH12,Protocadherin-12,37411,-0.00723355990308104,0.00247067027258293,-0.0120760736373436,-0.0023910461688185,0.00341967906667449
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD177,CD177 antigen,39844,-0.0353908769403882,0.0121003660038477,-0.0591075943079297,-0.0116741595728467,0.00345186986866938
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CA4,Carbonic anhydrase 4,40052,0.00663680037084486,0.00227169030361673,0.00218428737575606,0.0110893133659337,0.00348803269707273
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,37021,0.0106169963581517,0.00363511842329657,0.00349216424849042,0.017741828467813,0.00349867912676059
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TYMP,Thymidine phosphorylase,39764,-0.0191608997128614,0.00657297501666908,-0.0320439307455328,-0.00627786868018999,0.00356067131955097
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,37453,0.00721907902881027,0.00247666347831049,0.00236481861132171,0.0120733394462988,0.00356451080043648
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FMR1,Synaptic functional regulator FMR1,39477,-0.010024689915739,0.00345397599788352,-0.0167944828715907,-0.00325489695988732,0.00370877748866865
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CYTL1,Cytokine-like protein 1,37437,0.00645479313776516,0.00222714846841254,0.00208958213967659,0.0108200041358537,0.00375873292238996
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,37325,0.0075832451622627,0.00262056521663667,0.00244693733765482,0.0127195529868706,0.00381289036968641
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",37411,-0.0257420571975247,0.00891245194088115,-0.0432104630016518,-0.00827365139339768,0.00387912822011464
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GHRL,Appetite-regulating hormone,39868,-0.0214807930392166,0.00744407577626147,-0.0360711815606891,-0.0068904045177441,0.00391162137638584
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,QSOX1,Sulfhydryl oxidase 1,37186,-0.0118114498141852,0.00409378633791352,-0.0198352710364957,-0.00378762859187469,0.00391774999570671
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TPSD1,Tryptase delta,37411,-0.010293360670156,0.00357107170758906,-0.0172926612170306,-0.00329406012328147,0.0039524230262384
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HPCAL1,Hippocalcin-like protein 1,40058,-0.020686127004437,0.00719777746927863,-0.0347937708442231,-0.00657848316465086,0.00405887179133234
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,39866,-0.0336095284062589,0.0117254703248216,-0.0565914502429093,-0.0106276065696085,0.00415750942989093
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,37043,-0.0172951729633344,0.006040628142332,-0.0291348041223051,-0.00545554180436364,0.0042012463588044
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ECM1,Extracellular matrix protein 1,37106,0.0100966540726986,0.00353013122227032,0.00317759687704882,0.0170157112683485,0.00424121875316279
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLIC5,Chloride intracellular channel protein 5,37039,0.00894522880672172,0.00312926119496694,0.00281187686458651,0.0150785807488569,0.00426215413613253
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL17RA,Interleukin-17 receptor A,39858,-0.0121839371034899,0.00427234281539484,-0.0205577290216638,-0.00381014518531604,0.00435258810113655
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,40011,-0.0180473899124981,0.00633440399542569,-0.0304628217435324,-0.00563195808146374,0.00438976658268423
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRL,Prolactin,40009,-0.0209205387060257,0.00734984353504086,-0.0353262320347058,-0.00651484537734558,0.00442733875524932
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,37169,-0.00996079909332566,0.00350163152028502,-0.0168239968730843,-0.00309760131356702,0.00445327451658607
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LAMA4,Laminin subunit alpha-4,39931,-0.00927160195114642,0.00326183839908021,-0.0156648052133436,-0.00287839868894921,0.00448251099458703
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C1QL2,Complement C1q-like protein 2,37056,0.0116215181987125,0.00408962479649942,0.00360585359757368,0.0196371827998514,0.00449414025767249
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MKI67,Proliferation marker protein Ki-67,37056,-0.0108748952863528,0.00382851117287274,-0.0183787771851834,-0.00337101338752225,0.00451114723314183
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",37437,-0.0170624053972508,0.00600885259809567,-0.0288397564895183,-0.00528505430498325,0.00452450950556428
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,37043,-0.0114147430604404,0.00402430486299777,-0.0193023805919161,-0.0035271055289648,0.00456875272592382
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,37445,-0.020151825361935,0.00711729104774721,-0.0341017158155195,-0.00620193490835043,0.00464143087062648
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGF9,Fibroblast growth factor 9,36931,0.0111774008983588,0.00394978376809037,0.00343582471290168,0.0189189770838159,0.00466369388557409
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HCG22,Protein PBMUCL2,37021,0.0149198481072195,0.00527864327110578,0.0045737072958522,0.0252659889185868,0.00471372923098679
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CA9,Carbonic anhydrase 9,40030,-0.0118283989963491,0.00419643818259501,-0.0200534178342354,-0.00360338015846291,0.00482807608065817
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,37411,-0.0132801040993107,0.00471189021106093,-0.0225154089129902,-0.00404479928563133,0.0048329975779144
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",39585,-0.0241694386081233,0.00858011064291886,-0.0409864554682443,-0.00735242174800234,0.0048547848320323
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLASP1,CLIP-associating protein 1,36962,-0.0201151548480711,0.0071410259174182,-0.0341115656462108,-0.00611874404993147,0.00485706371485405
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,39858,0.0090780497488132,0.00322499796583712,0.00275705373577244,0.015399045761854,0.0048851887799798
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRH,Corticoliberin,39455,-0.0236293937032309,0.00843935603069869,-0.0401705315234003,-0.0070882558830615,0.00511805204015069
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DSG4,Desmoglein-4,39725,0.0133136886907334,0.00476454735898719,0.00397517586711852,0.0226522015143483,0.00520707546601919
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MYH7B,Myosin-7B,36962,0.0119765729228508,0.00428961127583828,0.00356893482220776,0.0203842110234938,0.00524600596038163
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",39818,-0.0296655718776079,0.0106537787666375,-0.0505469782602175,-0.00878416549499842,0.00536715226068138
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,39477,0.00817305865114589,0.00295567424625968,0.00237993712847692,0.0139661801738149,0.00569530083097141
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NPHS1,Nephrin,37056,0.00923032760449358,0.003338330146433,0.0026872005174849,0.0157734546915023,0.00570099697301759
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,39477,0.00996766678414399,0.00360559516475428,0.00290070026122561,0.0170346333070624,0.00570770103493589
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",39699,0.0107770930961567,0.00390710137081801,0.00311917440935337,0.01843501178296,0.00581633218277719
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,37124,-0.0141781795442452,0.00514541444463625,-0.0242631918557323,-0.00409316723275817,0.00586828213328598
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NPTN,Neuroplastin,39477,0.022157719401573,0.00814499274424784,0.00619353362284723,0.0381219051802988,0.00652731879699558
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SUSD4,Sushi domain-containing protein 4,37368,-0.0110512676871713,0.0040662728037654,-0.0190211623825515,-0.00308137299179116,0.00658037254648826
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SNX2,Sorting nexin-2,37368,-0.0213390615695954,0.00785333304995992,-0.0367315943475168,-0.00594652879167391,0.00659210803106408
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,40052,-0.00772449595147339,0.0028441383819927,-0.0132990071801791,-0.00214998472276771,0.00661589548122867
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CR2,Complement receptor type 2,39931,-0.0119358545370831,0.00440468686682768,-0.0205690407960654,-0.00330266827810088,0.00673936177592427
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C9orf40,Uncharacterized protein C9orf40,37382,-0.0209570828293543,0.00773384353779323,-0.036115416163429,-0.00579874949527952,0.00674109201186842
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,39794,-0.00681984854614701,0.00251923443823937,-0.0117575480450962,-0.00188214904719785,0.00679437952846453
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARG1,Arginase-1,39754,-0.013550954897535,0.00501597390196057,-0.0233822637453777,-0.00371964604969229,0.00690882112213519
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,37021,-0.0148138814115,0.00549123152640999,-0.0255766952032636,-0.00405106761973639,0.00699021997294034
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,39587,-0.017595460603101,0.0065429747468099,-0.0304196911068484,-0.00477123009935358,0.00716959689704932
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,37021,-0.0119689014299651,0.00445502755769752,-0.0207007554430523,-0.003237047416878,0.00722727982383461
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APOB,Apolipoprotein B-100,37445,0.00592635148884308,0.00220954588941221,0.00159564154559515,0.010257061432091,0.00732373359641163
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,37370,-0.00959881201015019,0.00358192636980552,-0.016619387694969,-0.00257823632533136,0.00737575690063091
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,36991,0.00842428438667695,0.00314623099207242,0.00225767164221501,0.0145908971311389,0.007424841438064
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NPTXR,Neuronal pentraxin receptor,39868,0.00878283863230978,0.00329910448428234,0.0023165938431164,0.0152490834215032,0.00777119173398426
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NUP50,Nuclear pore complex protein Nup50,37021,0.00857266738264629,0.00322111222085751,0.00225928742976558,0.014886047335527,0.00779109779919338
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,37056,-0.0168191137530674,0.00632574690524662,-0.0292175776873508,-0.00442064981878406,0.00785061034455511
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KEL,Kell blood group glycoprotein,39489,-0.00914189289663872,0.00344222031836173,-0.0158886447206277,-0.00239514107264972,0.00791977920826
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,JUN,Transcription factor AP-1,39587,-0.0133722592409196,0.00503611903115737,-0.0232430525419881,-0.00350146593985119,0.00793246403636602
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CFP,Properdin,37453,-0.00598021802069771,0.00225613844130307,-0.0104022493656517,-0.00155818667574369,0.0080431743251615
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",39489,-0.0140613342743666,0.00530689320546984,-0.0244628449570874,-0.00365982359164567,0.00806596636805086
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CALB1,Calbindin,39788,-0.0107653214190629,0.00406691359484496,-0.0187364720649591,-0.00279417077316681,0.00812773709791592
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HBQ1,Hemoglobin subunit theta-1,40030,0.0153471083360268,0.00581480533728426,0.00395008987494968,0.026744126797104,0.00831532029402676
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APOL1,Apolipoprotein L1,37445,0.0157945751038232,0.00598467499474521,0.0040646121141226,0.0275245380935238,0.00832041435683381
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FAP,Prolyl endopeptidase FAP,40052,0.00697692801088143,0.00264673458787892,0.00178932821863875,0.0121645278031241,0.0083957049265133
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,37368,-0.0173381587806353,0.00657976039347892,-0.0302344891518539,-0.00444182840941657,0.00842148525287434
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,37368,-0.0134777896762047,0.005124390232696,-0.0235215945322889,-0.00343398482012058,0.00854501306070905
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DLL4,Delta-like protein 4,37043,-0.0221044397899456,0.00840557818692382,-0.0385793730363163,-0.00562950654357492,0.00855507886577404
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LCN15,Lipocalin-15,37411,-0.0159165393585733,0.00605281969979382,-0.0277800659701692,-0.00405301274697738,0.00855800927015396
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD55,Complement decay-accelerating factor,39315,-0.0064788713439634,0.00246746663636904,-0.0113151059512467,-0.00164263673668009,0.00865516288700076
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PCDH1,Protocadherin-1,40018,-0.00528884960175769,0.0020181899059606,-0.00924450181744047,-0.00133319738607491,0.00878597298521109
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,INSL4,Early placenta insulin-like peptide,37368,-0.0136412490159448,0.0052068385776569,-0.0238466526281523,-0.00343584540373726,0.00880612242617114
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",37388,-0.0141063844180979,0.00538944425215871,-0.024669695152329,-0.00354307368386686,0.00886984952075419
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C2orf69,UPF0565 protein C2orf69,37039,-0.0149130970818791,0.00570671509768229,-0.0260982586733363,-0.00372793549042178,0.00897864513569006
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",37056,-0.0116007818487725,0.0044421440273332,-0.0203073841423456,-0.00289417955519948,0.0090240724805687
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL28,C-C motif chemokine 28,39815,-0.0151015498864247,0.0057831789657432,-0.0264365806592813,-0.00376651911356799,0.00902861165589625
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,37411,-0.00711644377146097,0.00273153221254577,-0.0124702469080507,-0.00176264063487125,0.00918958399532557
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,37021,0.00954970857675753,0.00369014551652762,0.0023170233643634,0.0167823937891517,0.00966705468295103
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SATB1,DNA-binding protein SATB1,37411,-0.00757782379939243,0.00292906889690178,-0.0133187988373199,-0.00183684876146493,0.00968878177702959
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APPL2,DCC-interacting protein 13-beta,37124,-0.0285045066072303,0.0110286592162368,-0.0501206786710544,-0.00688833454340622,0.00976020871585535
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IFNGR1,Interferon gamma receptor 1,39931,-0.00505312832858319,0.00195810391429368,-0.0088910120005988,-0.00121524465656758,0.00987100161794402
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,36991,0.00865392250712325,0.00337375823720966,0.00204135636219231,0.0152664886520542,0.0103265376779258
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDK1,Cyclin-dependent kinase 1,36962,-0.00905125852283318,0.00352965962990574,-0.0159693913974484,-0.00213312564821793,0.0103481723865929
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CORO1A,Coronin-1A,39520,-0.0222070256346442,0.00866841322286617,-0.0391971155514618,-0.00521693571782646,0.0104214162237565
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,37043,0.00901827547464771,0.00352470523694334,0.00210985321023877,0.0159266977390567,0.0105208325361363
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CBX2,Chromobox protein homolog 2,37021,0.0100453830897341,0.00394100856520598,0.00232100630193038,0.0177697598775378,0.0108164264072467
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SUSD5,Sushi domain-containing protein 5,37064,0.00840635213242648,0.00330291047563564,0.00193264760018063,0.0148800566646723,0.010934833725181
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,37021,0.0128502807475004,0.00504965239054905,0.00295296206202424,0.0227475994329765,0.0109458152029847
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UPK3A,Uroplakin-3a,36991,0.0118233787912053,0.00466179235354603,0.00268626577825506,0.0209604918041555,0.011216790072219
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD2,T-cell surface antigen CD2,37021,-0.00946292176093203,0.00373929649939562,-0.0167919428997474,-0.00213390062211661,0.0113960761208795
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",37411,-0.0172779153608258,0.00686508914163722,-0.0307334900784347,-0.00382234064321681,0.0118547416997755
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",37368,-0.00895800634625798,0.00356473418540695,-0.0159448853496556,-0.00197112734286035,0.0119841058033289
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GFRA3,GDNF family receptor alpha-3,39709,0.00672224402991641,0.00268256053562725,0.00146442538008701,0.0119800626797458,0.0122237560644601
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARTN,Artemin,39587,-0.0108901694659495,0.00434759719517784,-0.0194114599684981,-0.00236887896340094,0.0122596441926134
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLK8,Kallikrein-8,39315,-0.00839185097176427,0.00336670939671274,-0.0149906013893212,-0.0017931005542073,0.0126916430128998
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,37043,0.00632210218236522,0.0025379875459178,0.00134764659236634,0.0112965577723641,0.0127509674987982
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,40052,-0.0141617592204757,0.00569253109494236,-0.0253191201665627,-0.0030043982743887,0.0128643403961761
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,36962,0.0135981768926313,0.00547711638373152,0.00286302878051753,0.0243333250047451,0.0130505718486194
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,37453,0.00630716344533835,0.00254509126443971,0.00131878456703652,0.0112955423236402,0.013217948687394
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C5,Complement C5,37453,-0.00366866946335447,0.00148289316396514,-0.00657514006472614,-0.000762198861982801,0.0133732963075453
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CADPS,Calcium-dependent secretion activator 1,37039,0.0104436352278701,0.00422985166648196,0.0021531259615655,0.0187341444941748,0.0135605304450934
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STXBP1,Syntaxin-binding protein 1,37411,-0.018759135166017,0.00763686010058609,-0.0337273809631657,-0.00379088936886824,0.0140463826411868
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PAMR1,Inactive serine protease PAMR1,39858,-0.00659563078574585,0.00268729388245594,-0.0118627267953595,-0.0013285347761322,0.0141234914166703
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITGB2,Integrin beta-2,39731,0.00684255885751083,0.00278897304556033,0.00137617168821258,0.0123089460268091,0.0141606586108634
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,39682,-0.00757549109756756,0.00309218154099749,-0.0136361669179226,-0.00151481527721247,0.0143009181745626
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,39489,-0.0335997070205269,0.0137222516433164,-0.0604953202414269,-0.00670409379962678,0.0143539078923371
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RGS10,Regulator of G-protein signaling 10,37411,-0.0143140417476956,0.00585203662930978,-0.0257840335411427,-0.0028440499542484,0.0144579998834808
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,37124,-0.0159162411110899,0.00652162374431548,-0.0286986236499482,-0.00313385857223158,0.0146785808313647
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANPEP,Aminopeptidase N,39891,0.00660549538579224,0.00271341391840804,0.00128720410571247,0.011923786665872,0.0149279394394719
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,37056,-0.0102886689398261,0.00423026717010843,-0.0185799925932386,-0.0019973452864136,0.0150224555365108
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CHRDL1,Chordin-like protein 1,39908,-0.00723068227467423,0.00297418354976845,-0.0130600820322204,-0.00140128251712807,0.0150619127897886
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PROS1,Vitamin K-dependent protein S,37453,-0.00576473052903784,0.00238751685974307,-0.0104442635741342,-0.00108519748394142,0.0157686550578946
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C1S,Complement C1s subcomponent,37453,-0.00490423583191517,0.00204042960280874,-0.00890347785342031,-0.000904993810410037,0.0162508959869467
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RAB2B,Ras-related protein Rab-2B,37368,-0.0146729082074474,0.00611174446276713,-0.026651927354471,-0.00269388906042379,0.0163739404096211
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARFIP1,Arfaptin-1,37411,-0.0162179169661251,0.00676514785999073,-0.029477606771707,-0.00295822716054329,0.0165309953799293
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDHR1,Cadherin-related family member 1,39489,-0.00989774577357163,0.00414265571653195,-0.0180173509779742,-0.00177814056916901,0.0168956414491285
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NRTN,Neurturin,39587,-0.0114792065661997,0.00481671444976865,-0.0209199668877463,-0.00203844624465315,0.0171745441157087
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MUCL3,Mucin-like protein 3,36962,0.010408237403689,0.00438542225589447,0.00181280978213587,0.0190036650252422,0.0176408505052096
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL4,Interleukin-4,39587,-0.0207351785222884,0.00875849933618369,-0.0379018372212084,-0.0035685198233684,0.0179238951479215
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,36991,0.00940906227226412,0.00397648093405514,0.00161515964151603,0.0172029649030122,0.017987228065163
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",37124,-0.0205964337077979,0.00873717074625831,-0.0377212883704642,-0.00347157904513165,0.0184211042192538
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,36991,-0.0141931390078922,0.00602682493009795,-0.0260057158708841,-0.00238056214490019,0.0185376165119354
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRELP,Prolargin,39862,0.00506381834923617,0.00215119379680572,0.000847478507496964,0.00928015819097538,0.0185867661380609
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,37021,0.00767235235656428,0.00325950823873306,0.00128371620864747,0.0140609885044811,0.0185953566037704
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,37368,-0.00863277282366491,0.00367088633659101,-0.0158277100433833,-0.00143783560394652,0.0187028129202014
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLC4A1,Band 3 anion transport protein,37437,-0.010632042377518,0.00454023477334752,-0.0195309025332791,-0.00173318222175684,0.0192085386932457
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,39489,-0.0156656942604605,0.00669148590104108,-0.028781006626501,-0.00255038189441995,0.0192375409472073
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RTKN2,Rhotekin-2,37021,0.011850775256639,0.00506314858354896,0.00192700403288305,0.021774546480395,0.0192679437595034
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,37056,-0.0137477677163434,0.005891341731786,-0.025294797510644,-0.00220073792204288,0.0196339931589849
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,37039,0.0142381425538361,0.00612419993822648,0.00223471067491217,0.02624157443276,0.0200925044290655
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CGN,Cingulin,37039,-0.00879684554858588,0.00379370910290473,-0.0162325153902791,-0.00136117570689261,0.020421202837725
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,39835,-0.0163393621180938,0.00706103454287535,-0.0301789898221295,-0.00249973441405812,0.02067935005179
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL36A,Interleukin-36 alpha,37056,0.013217641957288,0.00573409318365246,0.00197881931732915,0.0244564645972468,0.0211765717469129
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLINT1,Clathrin interactor 1,36962,0.0109716436988466,0.00477012369428121,0.00162220125805541,0.0203210861396378,0.0214595937270804
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DKKL1,Dickkopf-like protein 1,39788,-0.0187585435162922,0.00816733211127499,-0.0347665144543912,-0.00275057257819325,0.0216443860319378
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STX3,Syntaxin-3,37388,-0.00850094549989369,0.00370488705056074,-0.0157625241189927,-0.00123936688079463,0.0217757650055694
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ENO2,Gamma-enolase,40009,-0.0146948956866034,0.00641761782158737,-0.0272734266169147,-0.00211636475629216,0.0220472462156901
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL3,Interleukin-3,36962,0.0132970958743082,0.00581389613763526,0.00190185944454311,0.0246923323040733,0.0222045107362237
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLKB1,Plasma kallikrein,37187,-0.00555395893785102,0.00243856473571823,-0.0103335458198588,-0.000774372055843285,0.0227690274130714
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD93,Complement component C1q receptor,39238,0.00681078545541499,0.00299290040740638,0.000944700656898489,0.0126768702539315,0.0228808264453786
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,36962,-0.019065366469768,0.00843049248644237,-0.0355891317431951,-0.00254160119634098,0.0237460454502725
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AMBN,Ameloblastin,39587,0.00625316480959917,0.00276875136618129,0.000826412131883851,0.0116799174873145,0.0239294989092531
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,40052,-0.00599515972281901,0.00265685863158654,-0.0112026026407286,-0.000787716804909394,0.0240535970318459
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,36991,0.0134749391855533,0.00598106183413185,0.00175205799065485,0.0251978203804517,0.0242797294588847
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DPEP2,Dipeptidase 2,39788,0.0063520415063695,0.00282212874831177,0.000820669159678438,0.0118834138530606,0.0244119199206687
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PKD1,Polycystin-1,37437,-0.00569316883156093,0.002552723173606,-0.0106965062518287,-0.000689831411293164,0.0257482226560149
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,37368,0.0110942547261392,0.00501524836828193,0.00126436792430661,0.0209241415279718,0.0269760970589373
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRTG,Protogenin,40030,-0.00533908750005275,0.00241399541557174,-0.0100705185145734,-0.000607656485532133,0.026999788432803
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,37437,0.00549014185623192,0.00248406201415761,0.000621380308482997,0.0103589034039808,0.0271115886359166
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,36991,0.0129896506329569,0.0058831149834768,0.00145874526534237,0.0245205560005714,0.0272646592413485
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,37021,0.0108908768066592,0.00494644448345744,0.00119584561908264,0.0205859079942358,0.0276996497541839
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,39866,-0.0261816478692904,0.0118931692877527,-0.0494922596732857,-0.00287103606529504,0.0277217891824302
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,37169,-0.0180066274950482,0.00819049953800973,-0.0340600065895472,-0.00195324840054909,0.0279322589844126
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,36991,0.0148419240202083,0.00677167532130019,0.00156944039045989,0.0281144076499566,0.0284139448224074
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTX3,Pentraxin-related protein PTX3,39866,0.0105484603989395,0.00482348694863914,0.00109442597960676,0.0200024948182722,0.0287645994332545
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,37039,0.00781540691187106,0.00358445640969906,0.000789872348860914,0.0148409414748812,0.0292483834870714
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SAT1,Diamine acetyltransferase 1,37021,0.0105519051287272,0.00483966918448665,0.00106615352713332,0.020037656730321,0.0292532765284226
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SEMA3G,Semaphorin-3G,37124,-0.00931302743418264,0.00427336218919184,-0.0176888173249986,-0.000937237543366646,0.0293253724064413
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HLA_A,,37411,-0.00683255623940532,0.00315259978806498,-0.0130116518240127,-0.000653460654797959,0.0302311176944414
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NPTX1,Neuronal pentraxin-1,39858,0.00857579314938215,0.00396130312533975,0.000811639023716249,0.0163399472750481,0.0304107002583802
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RAB6B,Ras-related protein Rab-6B,39489,-0.00986800745854566,0.00456256701251674,-0.0188106388030785,-0.000925376114012838,0.0305702044878833
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,40030,0.00525270725499915,0.00244336716452264,0.000463707612534781,0.0100417068974635,0.0315872334721884
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL34,Interleukin-34,39456,-0.00741758067874166,0.00347084600955155,-0.0142204388574627,-0.000614722500020628,0.0326045325861454
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RYR1,Ryanodine receptor 1,37021,0.00703083885677805,0.00329790221549545,0.000566950514406969,0.0134947271991491,0.0330325078855017
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNNI3,"Troponin I, cardiac muscle",39585,-0.0173127237131339,0.00814097312127756,-0.033269031030838,-0.00135641639542993,0.0334675288624448
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD82,CD82 antigen,37169,0.0087469772878391,0.00411792966695432,0.000675835140608632,0.0168181194350696,0.033678486293984
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TERF1,Telomeric repeat-binding factor 1,37056,0.00604811610378285,0.00284736766833329,0.000467275473849606,0.0116289567337161,0.0336796677386361
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CENPJ,Centromere protein J,37169,-0.0150678236528632,0.00709635952860592,-0.0289766883289308,-0.00115895897679558,0.0337456631425044
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,39877,-0.0117373855814856,0.00553748188087973,-0.0225908500680099,-0.000883921094961319,0.0340530122140749
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,37056,-0.00793135970589293,0.00374296042406522,-0.0152675621370608,-0.000595157274725097,0.0341084944577129
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,37124,-0.01319802343969,0.00626827784676939,-0.025483848019358,-0.000912198860022003,0.0352642755589135
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,39477,-0.015241761822816,0.00724104523042985,-0.0294342104744585,-0.00104931317117353,0.0353149156104101
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,37382,-0.00793604236172125,0.00377031372495064,-0.0153258572626245,-0.000546227460818001,0.0353205168437501
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FZD8,Frizzled-8,36991,-0.00871120844680956,0.00415771967737527,-0.0168603390144651,-0.000562077879154041,0.0361733024433371
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MYL6B,Myosin light chain 6B,37039,-0.018895205520722,0.00902504747364932,-0.0365842985690746,-0.0012061124723693,0.0363110718729365
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EFHD1,EF-hand domain-containing protein D1,37411,-0.00705436719245098,0.00337002695815365,-0.0136596200304321,-0.000449114354469824,0.0363438445573005
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,36962,0.0088719750290553,0.00424312271624631,0.000555454505212546,0.0171884955528981,0.0365556175730232
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTNNA1,Catenin alpha-1,36991,0.0071710182800864,0.00343072488101812,0.000446797513290877,0.0138952390468819,0.0366159571629454
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",39489,-0.00549451339451428,0.0026448720919619,-0.0106784626947596,-0.000310564094268953,0.0377789895302026
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,YY1,Transcriptional repressor protein YY1,37056,0.00561821818409149,0.00270553944790161,0.000315360866204334,0.0109210755019787,0.0378613858670051
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ICAM3,Intercellular adhesion molecule 3,40052,-0.00509774712974919,0.00245668457617767,-0.00991284889905742,-0.000282645360440959,0.0379975112632099
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MATN3,Matrilin-3,39720,0.00629770643825978,0.00303933666326383,0.000340606578262683,0.0122548062982569,0.0382754003598733
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SULT1A1,Sulfotransferase 1A1,40009,0.0258073871325835,0.0125087892672698,0.00129016016873475,0.0503246140964322,0.0391152482264479
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANK2,Ankyrin-2,37021,0.0142218718209653,0.00692084194326128,0.000657021612173165,0.0277867220297574,0.0399050969330366
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LY6D,Lymphocyte antigen 6D,39761,-0.00717612291712674,0.00350440539814553,-0.014044757497492,-0.000307488336761492,0.0406015439719294
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,39477,-0.00940929979477805,0.00459535510723576,-0.0184161958049601,-0.000402403784595967,0.0406190884466512
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PITHD1,PITH domain-containing protein 1,36931,0.0157878476410532,0.00771126946647997,0.000673759486752514,0.030901935795354,0.0406413873912363
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCN2B,Sodium channel subunit beta-2,37039,0.00575743271035006,0.00281384923000871,0.000242288219532982,0.0112725772011671,0.040765783424449
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NME1,Nucleoside diphosphate kinase A,37056,0.00433956512169378,0.00212748448652802,0.000169695528098861,0.0085094347152887,0.0413937639020292
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGA,Fibrinogen alpha chain,37149,0.00612634284990637,0.00300515583870438,0.000236237406045779,0.012016448293767,0.0415086478494925
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,37437,0.00586889553629027,0.00288198576362762,0.000220203439580132,0.0115175876330004,0.0417288833200342
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,39587,-0.00899001378376831,0.00442254564612003,-0.0176582032501636,-0.00032182431737306,0.0420926273345492
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CNTF,Ciliary neurotrophic factor,36991,0.00673674611165344,0.00331453224863021,0.000240262904338231,0.0132332293189686,0.0421243865584037
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRUNE2,Protein prune homolog 2,37169,-0.00565023518225754,0.00278526928529452,-0.0111093629814348,-0.000191107383080289,0.0425175312497866
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CA13,Carbonic anhydrase 13,39657,-0.0207841716560654,0.0102516473797353,-0.0408774005203466,-0.000690942791784145,0.0426384593675365
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,37411,-0.0228878892552101,0.0112931875951996,-0.0450225369418013,-0.000753241568618855,0.0427127726991075
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TSHB,Thyrotropin subunit beta,39868,-0.014713942158669,0.00726601629166329,-0.028955334090329,-0.000472550227008912,0.0428802654076387
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLMP,CXADR-like membrane protein,40030,-0.00400715048741337,0.00198584173008785,-0.00789940027838556,-0.000114900696441181,0.0436223335008226
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PALM3,Paralemmin-3,37021,-0.0148606855650457,0.00737185010463585,-0.0293095117701319,-0.000411859359959393,0.0438339373016827
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TTN,Titin,37021,-0.0134321555799548,0.00666431825880809,-0.0264942193672187,-0.000370091792690957,0.0438690843502626
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATP1B4,Protein ATP1B4,36962,0.00818896919202804,0.00408387268299082,0.000184578733366039,0.01619335965069,0.0449625218844095
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,37368,-0.0104359334860141,0.00521142547070457,-0.020650327408595,-0.000221539563433109,0.045249820544411
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINB5,Serpin B5,39585,-0.00940342177918154,0.00470682503047292,-0.0186287988389085,-0.000178044719454623,0.0457526209868464
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,39868,0.00595724101455454,0.00298218335853601,0.000112161631823961,0.0118023203972851,0.0457757882339304
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GZMB,Granzyme B,39866,-0.012408499910012,0.00621837618223233,-0.0245965172271874,-0.000220482592836671,0.0460100208704198
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,37021,0.00709304357875881,0.00356081562867557,0.000113844946554684,0.0140722422109629,0.046394801882801
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",37043,-0.0165380977207075,0.00831382637581618,-0.0328331974173072,-0.0002429980241078,0.0466966540833455
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GGH,Gamma-glutamyl hydrolase,39573,-0.00655394930600102,0.00329542405514937,-0.0130129804540938,-9.4918157908264e-05,0.046740263971993
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,39817,-0.00761845466080294,0.00384110372497368,-0.0151470179617514,-8.9891359854535e-05,0.0473396024359126
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CFHR5,Complement factor H-related protein 5,37267,0.00796265671461455,0.00402932329162544,6.51830630286915e-05,0.0158601303662004,0.0481551801459501
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRND,Prion-like protein doppel,37388,-0.00976502575096937,0.00495053700545155,-0.0194680782816544,-6.19732202843393e-05,0.0485707803249627
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDAN1,Codanin-1,37388,0.0043258278409295,0.00219675049167995,2.01968772367955e-05,0.0086314588046222,0.0489511965022335
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CABP2,Calcium-binding protein 2,37039,-0.012647810393273,0.00642289701944126,-0.0252366885513778,-5.89322351680893e-05,0.0489538764564332
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATXN2,Ataxin-2,36991,-0.0213505526799874,0.0108734209240774,-0.0426624576911791,-3.86476687957577e-05,0.0496028682301987
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",37388,0.00484792356786237,0.00247071519145237,5.32179261572303e-06,0.00969052534310902,0.0497650332984279
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,39489,-0.0151308643852424,0.00771289383296366,-0.0302481362978512,-1.3592472633675e-05,0.049807886510013
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,37169,-0.00835116447278929,0.0042774724980017,-0.0167350105688726,3.26816232940445e-05,0.0509164631064433
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TP73,Tumor protein p73,37039,0.0065919514551669,0.00337906860957957,-3.10230196090572e-05,0.0132149259299428,0.0510997369197398
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,37445,0.00888218684033771,0.00455963938699913,-5.47063581805857e-05,0.017819080038856,0.0514352857964735
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PMM2,Phosphomannomutase 2,37021,-0.0113898289044413,0.00586549451277171,-0.0228861981494738,0.000106540340591283,0.0521782575001533
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,36962,0.00622411016060528,0.00320726880385542,-6.21366949513464e-05,0.0125103570161619,0.0523250453063198
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,36991,0.0116591003188118,0.00601664759302347,-0.000133528963514184,0.0234517296011378,0.0526682158028766
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,39788,-0.00437504413676797,0.00226361873871433,-0.00881173686464806,6.16485911121168e-05,0.0532828013113929
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,39585,0.00594348951987464,0.00307898982996117,-9.13305468492618e-05,0.0119783095865985,0.0535829940469786
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ENOPH1,Enolase-phosphatase E1,37368,0.0104672067734089,0.00543582914200279,-0.000187018344916577,0.0211214318917343,0.0541758989841316
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SOX2,Transcription factor SOX-2,37391,0.00446469090722425,0.00231902498058334,-8.05980547191054e-05,0.0090099798691676,0.0542196685338059
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,37021,-0.00893133586400535,0.00464545072451643,-0.0180364192840575,0.000173747556046849,0.0545520695839358
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,INHBB,Inhibin beta B chain,37124,-0.00926705121938099,0.00482661126641662,-0.0187272093015576,0.000193106862795576,0.0548804316726908
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITGB7,Integrin beta-7,40030,0.00846078021413747,0.00441182433773494,-0.000186395487823012,0.0171079559160979,0.055160195936595
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TAGLN3,Transgelin-3,36962,0.0111694993143598,0.00583156203905294,-0.000260362282184005,0.0225993609109035,0.055469257600352
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PSMA1,Proteasome subunit alpha type-1,39477,-0.0086198567211042,0.00450900170649645,-0.0174575000658372,0.00021778662362883,0.0559330180264372
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,36962,0.00860998946184964,0.0045037965286024,-0.000217451734211069,0.0174374306579104,0.0559341483834894
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",37411,0.00808596477501717,0.00423068408339106,-0.000206176028429306,0.0163781055784636,0.0559914150720675
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,37021,0.00685644521098831,0.00358926485929092,-0.000178513913221895,0.0138914043351985,0.0561208777271158
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,37056,-0.0203475479866126,0.010680258563894,-0.0412808547718448,0.000585758798619548,0.0567816410199386
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,S100A16,Protein S100-A16,39456,-0.0114763653374587,0.00602779985666004,-0.0232908530565123,0.00033812238159503,0.0569407915649637
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRR5,Proline-rich protein 5,37056,0.00882515905026413,0.00463924115752721,-0.000267753618489214,0.0179180717190175,0.0571556500635598
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,39788,-0.00381371686942396,0.00200988172470767,-0.007753085049851,0.000125651311003075,0.0577822565140896
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCIN,Adseverin,36991,-0.0136740408358451,0.00722094768279388,-0.0278270982941211,0.000479016622430876,0.0582917272812887
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,39587,-0.00729323880025495,0.00385656337009575,-0.0148521030056426,0.000265625405132723,0.0586261798419918
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PODXL2,Podocalyxin-like protein 2,39913,0.0050264686985162,0.00266263878845849,-0.000192303326862447,0.0102452407238948,0.0590738920463209
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NPHS2,Podocin,37056,0.0187692359993563,0.00994386073782835,-0.000720731046787298,0.0382592030454998,0.0591123434168367
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GLI2,Zinc finger protein GLI2,37056,0.00632510069272733,0.00335230421436065,-0.000245415567419535,0.0128956169528742,0.0592102435017971
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PCNA,Proliferating cell nuclear antigen,36962,0.0117218888186053,0.0062340244219784,-0.00049679904847235,0.023940576685683,0.0600882171566929
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TSPAN15,Tetraspanin-15,37021,0.00902521128923409,0.0048109110612867,-0.000404174390887833,0.018454596969356,0.0606790465560356
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COPB2,Coatomer subunit beta',37021,-0.00781305875963454,0.00416666044291915,-0.0159797132277561,0.000353595708486995,0.0607960165933849
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,36962,0.00614055732058264,0.00327576801729472,-0.000279947993315009,0.0125610626344803,0.0608783014704658
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANXA5,Annexin A5,39415,-0.00548782650593942,0.00293513590711452,-0.0112406928838839,0.000265039872005038,0.0615441235085002
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GPC1,Glypican-1,40030,0.00524711667173057,0.00281163213830303,-0.000263682319343377,0.0107579156628045,0.0620290517910543
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,36991,0.0102776222963041,0.00550990880656723,-0.000521798964567676,0.0210770435571759,0.0621619201839194
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,36962,0.00742372924258292,0.00398141997882735,-0.000379853915918688,0.0152273124010845,0.0622607673938734
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL36G,Interleukin-36 gamma,37021,-0.0122313960943906,0.00656923137688308,-0.0251070895930814,0.000644297404300239,0.0626363643860618
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD276,CD276 antigen,39862,-0.00635470397300128,0.00341311370853788,-0.0130444068417355,0.000334998895732968,0.0626426284586013
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ESPL1,Separin,36962,0.00973793909446807,0.00524666296104707,-0.000545520309184191,0.0200213984981203,0.0634723910916404
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RGMA,Repulsive guidance molecule A,40009,0.00554009359625036,0.00300199562606793,-0.000343817830842785,0.0114240050233435,0.0649874576328582
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DHODH,Dihydroorotate dehydrogenase,37021,-0.00830395046198439,0.00452270310084088,-0.0171684485396325,0.000560547615663737,0.066371452179477
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,37056,0.00856278625124915,0.00466810718275709,-0.000586703826954738,0.017712276329453,0.0666295218861108
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL11,Interleukin-11,39587,-0.0110744110134001,0.00603791724500966,-0.022908728813619,0.000759906786818875,0.066651471570552
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRKCQ,Protein kinase C theta type,39587,-0.00771609649848802,0.0042083950065459,-0.015964550711318,0.000532357714341945,0.0667469864748783
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,39585,-0.00868880304625861,0.00474571673366081,-0.0179904078442338,0.000612801751716572,0.0671384637258908
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NEDD9,Enhancer of filamentation 1,37056,-0.00595859672407623,0.00325495021447379,-0.0123382991444449,0.000421105696292405,0.0671789141025958
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,39931,-0.00809989462359775,0.0044253428584443,-0.0167735666261486,0.000573777378953077,0.067217198691659
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,36675,-0.0087294929946495,0.00477041546565654,-0.0180795073073363,0.000620521318037314,0.0672846702502917
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SH3GL3,Endophilin-A3,37083,-0.0147031590417235,0.00806794079634003,-0.0305163230025499,0.00111000491910301,0.0684141878122531
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",39489,-0.00532886742538273,0.00293953477333066,-0.0110903555811108,0.000432620730345354,0.0698777153658811
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACTN4,Alpha-actinin-4,39587,-0.00549054379365486,0.00304661870902549,-0.0114619164633448,0.000480828876035112,0.071536824605292
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LIPF,Gastric triacylglycerol lipase,37043,0.0105188496806584,0.00584719360936821,-0.000941649793703285,0.0219793491550201,0.0720483509155419
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL17D,Interleukin-17D,39587,-0.00590689500489927,0.00328749724310246,-0.0123503896013801,0.000536599591581545,0.0723904239493195
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DRAXIN,Draxin,39749,-0.00729459630657201,0.00407963615433326,-0.0152906831690652,0.00070149055592118,0.0737868763694129
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AFAP1,Actin filament-associated protein 1,37124,-0.0147754646621362,0.00827666628684586,-0.0309977305843541,0.00144680126008169,0.0742525086876533
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",37021,0.0107306422518991,0.00602791006499055,-0.0010840614754824,0.0225453459792806,0.0750729020474293
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ERVV_1,,37021,0.00834295688858877,0.00468750560260541,-0.000844554092517841,0.0175304678696954,0.0751270706541147
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CBLN1,Cerebellin-1,36991,0.0167086872094609,0.00939201901579736,-0.00169967006150191,0.0351170444804238,0.0752579073972352
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,METAP1,Methionine aminopeptidase 1,39489,-0.00525859564766611,0.00295724885680502,-0.011054803407004,0.000537612111671733,0.07538957592141
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GP5,Platelet glycoprotein V,37124,-0.00626829279220858,0.00352995440896127,-0.0131870034337727,0.000650417849355519,0.0757981637376798
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TPSG1,Tryptase gamma,37056,0.0046361614237166,0.00262145555947957,-0.000501891472863355,0.00977421432029657,0.0769929793469685
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",37021,0.0111201040933194,0.00629531122648174,-0.00121870591058479,0.0234589140972236,0.0773501754489618
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TJP3,Tight junction protein ZO-3,36991,0.00745139924378592,0.00424452538294913,-0.000867870506794368,0.0157706689943662,0.0791917025648234
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CHGA,Chromogranin-A,37437,-0.013387584861324,0.00762882451625152,-0.028340080913177,0.00156491119052896,0.0793043339683054
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANXA4,Annexin A4,39783,-0.0123286988008836,0.00703612059942389,-0.0261194951757544,0.00146209757398722,0.0797584684927356
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CYB5A,Cytochrome b5,36962,-0.0122357048540452,0.00698854727185583,-0.0259332575068826,0.00146184779879226,0.0799999148365622
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNN,Tenascin-N,37437,-0.00730465154040705,0.00418335151926671,-0.0155040205181698,0.0008947174373557,0.0808119799620694
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NDRG1,Protein NDRG1,39489,-0.0117070389035965,0.00672040230209124,-0.0248790274156953,0.00146494960850235,0.0815255620319207
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LMNB1,Lamin-B1,37348,-0.00983832758354608,0.00565387301259277,-0.0209199186882279,0.00124326352113575,0.0818635489068002
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SSB,Lupus La protein,39489,-0.010200569077788,0.00588947621567497,-0.021743942460511,0.0013428043049349,0.0832934054603015
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,37382,-0.00421194480631529,0.00243298643767744,-0.00898059822416307,0.000556708611532498,0.0834419371079307
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,F2,Prothrombin,37453,0.00247765528623427,0.00143139857938504,-0.000327885929360403,0.00528319650182895,0.0834863765505628
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,39587,-0.00698211382740832,0.00404217169174294,-0.0149047703432245,0.000940542688407839,0.0841302947922122
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,39477,-0.00893191486875995,0.00517921875764809,-0.0190831836337502,0.0012193538962303,0.0846251437617783
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,39887,-0.00394587819707676,0.00229106235391842,-0.00843636041075687,0.00054460401660335,0.0850359422225486
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRG3,Proteoglycan 3,37437,0.008368947548864,0.00486302054506576,-0.00116257271946488,0.0179004678171929,0.085285204962362
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEP112,Centrosomal protein of 112 kDa,37021,-0.00781010639390564,0.00454625626132876,-0.01672076866611,0.00110055587829872,0.0858346564418104
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,40052,0.00579431290226873,0.00338250903570893,-0.000835404807720769,0.0124240306122582,0.0867276080119446
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,39913,0.0038941028602634,0.00227358490258296,-0.000562123548799196,0.008350329269326,0.0867762079212442
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MMP13,Collagenase 3,39489,0.00525073777538959,0.00311318034234746,-0.000851095695611437,0.0113525712463906,0.0916972947253803
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,39931,-0.00446473143763119,0.00264827542731703,-0.00965535127517256,0.000725888399910183,0.091834190423584
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NOP56,Nucleolar protein 56,37021,-0.0180950457850035,0.0107525610346499,-0.0391700654129173,0.00297997384291025,0.0924260792637604
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,39214,0.00617042670973812,0.00366781079727606,-0.00101848245292295,0.0133593358723992,0.0925273896812638
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MIA,Melanoma-derived growth regulatory protein,39913,-0.00589435337928659,0.00350417825812641,-0.0127625427652143,0.000973836006641169,0.0925702755851218
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,40052,-0.00439039551949192,0.00261480044737046,-0.00951540439633803,0.000734613357354193,0.0931604888625316
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LMOD1,Leiomodin-1,37411,0.00577005096394948,0.00343950579563487,-0.000971380395494873,0.0125114823233938,0.0934519070989115
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MST1,Hepatocyte growth factor-like protein,37271,-0.0103246923847225,0.00615490552813689,-0.0223883072198708,0.00173892245042582,0.0934731835449141
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCN3B,Sodium channel subunit beta-3,36991,0.00727668296770215,0.00434484265621746,-0.00123920863848406,0.0157925745738884,0.0939999798283463
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,37124,-0.0060449929387593,0.00360958837999383,-0.0131197861635472,0.00102980028602859,0.0940158506763548
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CA3,Carbonic anhydrase 3,40017,-0.00978636157341299,0.00584439441891924,-0.0212413746344947,0.00166865148766871,0.0940543114916254
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRYGD,Gamma-crystallin D,37388,-0.0157040836627548,0.00938978142208308,-0.0341080552500376,0.00269988792452807,0.0944557278171309
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,39247,-0.00998211356650278,0.0059735899864115,-0.0216903499398693,0.00172612280686375,0.0947339229558442
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGF20,Fibroblast growth factor 20,37056,0.00696595941207517,0.00418774791104511,-0.00124202649357324,0.0151739453177236,0.0962532952082772
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,39489,-0.00627132612759367,0.00377146373792618,-0.013663395053929,0.00112074279874164,0.0963652957780351
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,37021,0.00559035797750553,0.00336741348025101,-0.00100977244378645,0.0121904883987975,0.0969112993881915
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,37021,-0.00754382664728186,0.00455004709179147,-0.0164619189471931,0.00137426565262941,0.0973480158711387
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,39489,-0.0135264001650253,0.0081594254123173,-0.0295188739731672,0.00246607364311659,0.0973852176544094
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",40058,-0.0110727198629663,0.00671682710702769,-0.0242377009927406,0.00209226126680797,0.0992685767757346
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,36931,0.00846650041464304,0.00513796737005498,-0.00160391563066472,0.0185369164599508,0.0994114507930062
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TEX33,Testis-expressed protein 33,37169,0.00638978693287592,0.00388047558032803,-0.00121594520456702,0.0139955190703188,0.0996535203241747
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ENO1,Alpha-enolase,39830,0.0125849667952676,0.00765491778644407,-0.00241867206616283,0.0275886056566979,0.100188277859121
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LAMA1,Laminin subunit alpha-1,37021,0.00865636100504076,0.00528325665935789,-0.0016988220473007,0.0190115440573822,0.101351399639511
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,36709,-0.017436604180344,0.0106874105945572,-0.0383839289456761,0.00351072058498803,0.102807516341582
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,36991,-0.00942559219976151,0.00579198685087368,-0.0207778864274739,0.00192670202795091,0.103686689285115
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CFD,Complement factor D,37453,-0.00289290053462784,0.00177955245302169,-0.00638082334255035,0.000595022273294677,0.104050772397389
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PALLD,Palladin,37056,0.00644274950824234,0.003969481253793,-0.00133743374919193,0.0142229327656766,0.104598136286983
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RASA1,Ras GTPase-activating protein 1,39489,-0.00513891312093895,0.00316765752128158,-0.0113475218626508,0.00106969562077295,0.104757790398343
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FRZB,Secreted frizzled-related protein 3,39695,0.00414750837303955,0.0025577242991418,-0.000865631253278379,0.00916064799935748,0.104917086996158
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",36991,-0.00505311629481287,0.00311699107756878,-0.0111624188068477,0.00105618621722193,0.105009055899105
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,37021,0.0065027279190897,0.00401120714140727,-0.00135923807806855,0.0143646939162479,0.105011595252869
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,39749,0.0110220660289272,0.00680102768736245,-0.00230794823830325,0.0243520802961576,0.105113181098674
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GAS6,Growth arrest-specific protein 6,39947,0.00399830481604163,0.00247387004508567,-0.000850480472326275,0.00884709010440955,0.106067537840434
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OBP2B,Odorant-binding protein 2b,39701,0.0098658742509392,0.0061132483764958,-0.00211609256699257,0.021847841068871,0.106579587332219
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RBP1,Retinol-binding protein 1,37039,-0.0110649699357219,0.00685644790103351,-0.0245036078217476,0.00237366795030381,0.106593669734356
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",37169,-0.0110518614193382,0.00686546005529505,-0.0245081631277164,0.00240444028904014,0.107470209370161
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDH23,Cadherin-23,37388,0.00421220719964714,0.00261763927194019,-0.000918365773355632,0.00934278017264991,0.107604127045733
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",37056,0.00718867053429955,0.00447237931856254,-0.00157719293008303,0.0159545339986821,0.108001946338221
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SEMA4C,Semaphorin-4C,39788,0.00439889425278265,0.00274963725215069,-0.000990394761432698,0.00978818326699801,0.109660808628161
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,37388,-0.00893582749810773,0.00560107131214073,-0.0199139272699036,0.0020422722736881,0.110651030099654
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRTAP,Cartilage-associated protein,37039,-0.00769356597782144,0.00482387179572861,-0.0171483546974495,0.00176122274180663,0.110759837107032
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DGKZ,Diacylglycerol kinase zeta,39587,-0.00556567065472837,0.0034926960823762,-0.0124113549761857,0.00128001366672898,0.111064348811588
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,37021,0.0050713387548479,0.00318988777106171,-0.00118084127643305,0.0113235187861289,0.111900012992965
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,36962,0.00752016904841407,0.00473440601162921,-0.00175926673437919,0.0167996048312073,0.112218207315902
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DUSP29,Dual specificity phosphatase 29,37039,-0.010297859913772,0.00648723580559412,-0.0230128420927365,0.00241712226519246,0.112445308608522
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,39788,-0.00588045681244401,0.00370718817832488,-0.0131465456419608,0.00138563201707275,0.112706768640048
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ICAM5,Intercellular adhesion molecule 5,39868,-0.00678982698950597,0.00428168622719979,-0.0151819319948176,0.00160227801580562,0.112808202076269
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,37445,-0.0053792226874888,0.00339456326356421,-0.0120325666840746,0.00127412130909704,0.113067278270262
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",37039,-0.00604687593588345,0.00382342245792447,-0.0135407839534154,0.00144703208164851,0.113779789642537
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,37382,0.00716820266805647,0.00453765088349006,-0.00172559306358405,0.016061998399697,0.114195160157611
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,37437,-0.00603261795377138,0.00382069373575341,-0.0135211776758481,0.00145594176830529,0.114374810017761
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LTB,Lymphotoxin-beta,37368,-0.00525375068328285,0.00332868599640034,-0.0117779752362275,0.00127047386966182,0.114514218420025
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LTO1,Protein LTO1 homolog,39587,0.00614932239018906,0.00391533916150369,-0.00152474236635817,0.0138233871467363,0.116302195486878
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GAD2,Glutamate decarboxylase 2,37056,0.00709242648448042,0.00453972698970644,-0.00180543841534419,0.015990291384305,0.118240740809024
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,37169,0.00672492520038609,0.00432588017765842,-0.00175379994782441,0.0152036503485966,0.120069996136734
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EVI2B,Protein EVI2B,36962,0.00623989858900433,0.00402122620788174,-0.00164170477844387,0.0141215019564525,0.120748539228985
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GPC5,Glypican-5,39749,0.00841647363492535,0.00542577092239995,-0.00221803737297854,0.0190509846428292,0.120872893699077
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VIM,Vimentin,39585,-0.0175690696999405,0.0113441949832352,-0.0398036918670816,0.00466555246720057,0.121467301392451
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,37021,-0.0146805857204241,0.00949004050632741,-0.0332810651128258,0.0039198936719776,0.12190017130135
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SHPK,Sedoheptulokinase,37169,-0.00631647613249306,0.00409261655756675,-0.0143380045853239,0.00170505232033776,0.122761573635574
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",37021,-0.00847016745438218,0.00549125004998365,-0.0192330175523501,0.00229268264358578,0.122979972087597
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,36991,-0.0112419622917567,0.00729998306415087,-0.0255499290974924,0.00306600451397899,0.123584837767677
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCARF2,Scavenger receptor class F member 2,40009,0.00418478073646728,0.00272824784083895,-0.00116258503157707,0.00953214650451163,0.125080936820195
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COMMD9,COMM domain-containing protein 9,37368,-0.00584084746661158,0.00382401738513769,-0.0133359215414814,0.00165422660825828,0.126682175493259
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NMI,N-myc-interactor,37311,0.0107255854619525,0.00702638193633409,-0.00304612313326228,0.0244972940571673,0.126915510102223
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MSLNL,Mesothelin-like protein,37039,0.00540638310243696,0.00354192657391097,-0.00153579298242854,0.0123485591873025,0.126935231902251
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,37169,-0.00686013121698546,0.00450836818918761,-0.0156965328677932,0.00197627043382225,0.128122073940106
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",37382,-0.0153392850255553,0.010081153997483,-0.0350983468606221,0.00441977680951146,0.128137667081443
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C1R,Complement C1r subcomponent,37453,-0.00286046728931295,0.00188507040240909,-0.00655520527803476,0.000834270699408862,0.129180752638539
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,37056,-0.0132557682631305,0.0087596979445272,-0.0304247762344038,0.00391323970814285,0.130235613470089
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,36962,-0.0119805228626623,0.007940192310725,-0.0275432997916833,0.00358225406635869,0.131362401252327
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,39639,0.0250990118108567,0.0166536409235535,-0.00754212439930825,0.0577401480210216,0.131800282028102
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EPB41L5,Band 4.1-like protein 5,37039,-0.00944650139450014,0.00626935611132206,-0.0217344393726914,0.0028414365836911,0.131892621007642
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CBLN4,Cerebellin-4,40030,0.0045108305921623,0.00300696839070931,-0.00138282745362795,0.0104044886379526,0.133601366021274
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",37021,0.00634508286775004,0.00423124799025218,-0.00194816319314422,0.0146383289286443,0.133747952488631
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,36962,-0.0210445154237458,0.0140409618967179,-0.0485648007413129,0.00647576989382136,0.13395106362653
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,39788,-0.00378685783884762,0.00252745626228719,-0.00874067211293052,0.00116695643523528,0.134078211221419
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,37056,-0.00433414110600505,0.00289463076824772,-0.0100076174117706,0.00133933519976048,0.134338192900985
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",37039,-0.0123500311963494,0.00826492202480772,-0.0285492783649726,0.00384921597227369,0.135128809550008
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,36991,0.0104107565126445,0.00697445359212635,-0.00325917252792315,0.0240806855532122,0.135540147627274
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BSND,Barttin,36962,0.00488004103280782,0.00328826258976278,-0.00156495364312723,0.0113250357087429,0.137812053360232
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TLR2,Toll-like receptor 2,37169,-0.00327884935557137,0.00221808035969888,-0.00762628686058117,0.00106858814943843,0.139367909847514
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,39674,0.00848049836490472,0.00573788921934523,-0.00276576450501194,0.0197267612348214,0.139432447262248
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,37039,-0.0120814099340928,0.00819426651954955,-0.0281421723124099,0.00397935244422432,0.140404924231874
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,37147,0.0075231199941205,0.00512054518999159,-0.00251314857826302,0.017559388566504,0.141801431050984
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STAM,Signal transducing adapter molecule 1,37368,-0.00519290989910714,0.00354771163583632,-0.0121464247053463,0.00176060490713204,0.143289621610759
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,37388,0.00508757935873864,0.00347963349145942,-0.00173250228452182,0.0119076610019991,0.143736468339828
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,39585,-0.00805974397745713,0.00551276171552259,-0.0188647569398814,0.00274526898496716,0.143756900947803
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FRMD7,FERM domain-containing protein 7,37039,0.0047963970015539,0.00328160322655598,-0.00163554532249582,0.0112283393256036,0.143874218242455
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,37437,-0.00424575177514576,0.00290747243567145,-0.00994439774906181,0.00145289419877029,0.144233636277404
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FBN2,Fibrillin-2,37039,-0.00853612054420655,0.00586722647144155,-0.020035884428232,0.00296364333981888,0.145725825710951
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,37368,-0.00640847536814796,0.00441465779211763,-0.0150612046406985,0.00224425390440259,0.146626118138283
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",37411,0.0055858450222889,0.00385287815963083,-0.00196579617058753,0.0131374862151653,0.147141622037531
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DEFB118,Beta-defensin 118,36991,-0.00819098906761411,0.00567494451395692,-0.0193138803149697,0.00293190217974145,0.148942883862295
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,36991,-0.0147983009874517,0.0102722174461876,-0.0349318471819794,0.00533524520707606,0.149717586004225
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,40052,-0.00571359308011534,0.0039847375758661,-0.0135236787288129,0.00209649256858221,0.151628859779023
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,37021,-0.0139899586115135,0.00975854404422973,-0.0331167049382038,0.00513678771517679,0.151706984620485
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SEMA6C,Semaphorin-6C,37056,0.00365722041655373,0.00255113719981203,-0.00134300849507784,0.0086574493281853,0.151720195347618
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BRDT,Bromodomain testis-specific protein,37021,-0.00510923448804089,0.00356411765224093,-0.0120949050864331,0.00187643611035132,0.151732998755574
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,37039,-0.00993760735053809,0.00693298031613701,-0.0235262487701666,0.00365103406909045,0.151772497696153
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",37043,-0.0108858447999236,0.00760104866049906,-0.0257839001745017,0.00401221057465458,0.152124495296633
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",36962,-0.0128785801735878,0.00904036661569398,-0.030597698740348,0.00484053839317238,0.154307110995368
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,37382,-0.00354059979952487,0.00248785601123991,-0.0084167975815551,0.00133559798250536,0.15471487134882
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PGM2,Phosphoglucomutase-2,37039,-0.00836390390905965,0.00591062685079943,-0.0199487325366265,0.00322092471850723,0.157073923385537
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,37056,0.00310156913683217,0.0021955547907756,-0.001201718253088,0.00740485652675234,0.157779743096466
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,37368,-0.00657396815205371,0.00467713776140025,-0.0157411581643982,0.00259322186029078,0.159879700261332
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,39477,-0.00672097505664859,0.00478254469851325,-0.0160947626657346,0.00265281255243739,0.159947941066547
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,37169,0.00739426360710192,0.00527916169432709,-0.00295289331377918,0.017741420527983,0.161341747459413
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,39868,-0.00238692407323757,0.00170576046856408,-0.00573021459162317,0.000956366445148029,0.161733023657527
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MUC16,Mucin-16,39788,-0.0251566174102503,0.0180575586091845,-0.060549432284252,0.0102361974637514,0.163598404152586
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TSLP,Thymic stromal lymphopoietin,39585,-0.00808946765125021,0.00581057119612945,-0.0194781871956639,0.0032992518931635,0.163882028726497
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,39866,0.00466066377539337,0.00336220328252724,-0.00192925465836001,0.0112505822091468,0.16570718609204
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,36991,0.00756887533184414,0.00547798311065385,-0.0031679715650374,0.0183057222287257,0.167090365238127
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,37169,-0.00708427286654551,0.00515192999982677,-0.017182055666206,0.00301350993311497,0.16913238024222
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,37368,-0.0130261751064044,0.00950740429529055,-0.0316606875251738,0.00560833731236511,0.170675816503071
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,37368,-0.00556833783448529,0.00409573905968881,-0.0135959863914753,0.00245931072250477,0.173996934591921
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EXTL1,Exostosin-like 1,37021,-0.00631832698960848,0.00465228095742679,-0.015436797666165,0.00280014368694802,0.174450856455304
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,37169,-0.00898652318230376,0.00663982449712037,-0.0220005791966597,0.00402753283205217,0.175941980994731
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,39489,-0.00918278548952103,0.00679612336255884,-0.0225031872801363,0.00413761630109429,0.176657360563899
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCARB1,Scavenger receptor class B member 1,39489,-0.00746169089688055,0.00552888244601278,-0.0182983004910656,0.00337491869730451,0.177169029632099
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FCRL3,Fc receptor-like protein 3,39587,-0.00682801637025997,0.00505963950327354,-0.0167449097966761,0.00308887705615616,0.177193761051376
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,37021,0.00621120148873033,0.00460985724230842,-0.00282411870619418,0.0152465216836548,0.177883026507954
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NENF,Neudesin,37368,-0.0143867053003937,0.0106963399425455,-0.0353515315877828,0.00657812098699541,0.178643948399218
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,36962,0.00863117690486681,0.00642574952366804,-0.00396329216152255,0.0212256459712562,0.179224938235353
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GPR158,Probable G-protein coupled receptor 158,37411,0.00466345015043929,0.00348366334946131,-0.00216453001450488,0.0114914303153835,0.180702964920365
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",37411,-0.00845073198684107,0.00633106455273194,-0.0208596185101957,0.00395815453651354,0.18196284144274
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,37039,0.00413570948331249,0.00310008030085936,-0.00194044790637185,0.0102118668729968,0.182205516356584
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,39866,-0.00796034195942348,0.00597362679181773,-0.0196686504713862,0.00374796655253928,0.182688291835023
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINA6,Corticosteroid-binding globulin,37453,-0.00228293923602113,0.00171551534128789,-0.0056453493049454,0.00107947083290313,0.183290307534482
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FZD10,Frizzled-10,37039,-0.00775377096535833,0.00584661954756449,-0.0192131452785847,0.00370560334786807,0.184797341246234
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD109,CD109 antigen,39858,0.00433757385042358,0.00327164821942747,-0.00207485665965426,0.0107500043605014,0.184922590174477
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAMDC2,MAM domain-containing protein 2,37437,0.00424247324122564,0.00322068579825371,-0.00207007092335163,0.0105550174058029,0.187774480957375
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINI1,Neuroserpin,37088,0.00395530707932405,0.00300572471791494,-0.00193591336778924,0.00984652752643733,0.188222157030138
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,39749,-0.00630850886960226,0.00479858312886708,-0.0157137318021817,0.00309671406297721,0.188642920217615
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,39587,0.00384190496301724,0.00292440416654337,-0.00188992720340776,0.00957373712944224,0.188953081814544
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,WNT9A,Protein Wnt-9a,39587,-0.00357920736289918,0.00272928519376016,-0.0089286063426691,0.00177019161687074,0.189738987846255
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,37039,-0.00998437890145324,0.00762739243648447,-0.0249340680769628,0.00496531027405633,0.190551747145314
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,36991,0.0116925706358778,0.00895499353422665,-0.00585921669120643,0.029244357962962,0.191676121174296
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,37021,-0.00817258905584771,0.00627710446938125,-0.020475713815835,0.00413053570413954,0.192950116260409
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",37021,-0.0050350864156224,0.00386805791882963,-0.0126164799365285,0.00254630710528368,0.193038611412408
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLK7,Kallikrein-7,36818,0.00493581618779397,0.00381239486300327,-0.00253647774369245,0.0124081101192804,0.195455086600904
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",39489,-0.00545701413900393,0.00422645331341841,-0.013740862633304,0.00282683435529614,0.196668391400477
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STEAP4,Metalloreductase STEAP4,36991,0.00947717087431449,0.0073409727272672,-0.00491113567112922,0.0238654774197582,0.196727582146022
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,37056,-0.00469347097425375,0.00365269035554512,-0.0118527440711222,0.00246580212261469,0.198837428515317
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AFP,Alpha-fetoprotein,39699,0.00842156539586934,0.00655729206763947,-0.00443072705670402,0.0212738578484427,0.199053914002775
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARG2,"Arginase-2, mitochondrial",37368,0.00548762440637307,0.00427287824224499,-0.00288721694842712,0.0138624657611733,0.19906174359848
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,37368,0.00516832372729961,0.0040317978104141,-0.00273399998111202,0.0130706474357112,0.199903025775547
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,37411,-0.00298316394480998,0.00233232710512,-0.00755452507084518,0.00158819718122522,0.200901206019277
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,37382,0.00538855935496988,0.00421745712603504,-0.00287765661205879,0.0136547753219985,0.201384320429213
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RGS8,Regulator of G-protein signaling 8,39587,-0.00811953271651726,0.00638307802820556,-0.0206303656518002,0.00439130021876564,0.203377596562016
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",36991,0.006685562664338,0.0052665252368664,-0.00363682679992014,0.0170079521285961,0.204304992302864
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,JCHAIN,Immunoglobulin J chain,39587,-0.00745311472353186,0.00587503896915956,-0.0189681911030846,0.00406196165602088,0.204600094072602
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PMCH,Pro-MCH,37021,0.0102314913275014,0.00807578823215767,-0.00559705360752758,0.0260600362625305,0.205201280931669
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,37169,-0.00850649365837291,0.00671733385284586,-0.0216724680099508,0.00465948069320498,0.205410076756401
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,37388,-0.00344748921426289,0.00272752598325089,-0.00879344014143464,0.00189846171290886,0.206265442761362
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,39822,0.00579397868023238,0.00458958728066411,-0.00320161238986928,0.014789569750334,0.206816773980783
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,37368,-0.00349320510973553,0.00276999484165176,-0.00892239499937297,0.00193598477990192,0.207299201876619
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,39587,-0.00461462797247157,0.00366052662177974,-0.0117892601511599,0.00256000420621672,0.207455146479692
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,37437,0.00418395466427021,0.00332153226473758,-0.00232624857461544,0.0106941579031559,0.207818764454579
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CALCB,Calcitonin gene-related peptide 2,37388,0.00482823004932727,0.00383649751474688,-0.00269130507957662,0.0123477651782311,0.208232901051668
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,39477,0.0146504034348775,0.0116770613022472,-0.00823663671752702,0.0375374435872821,0.209631510122038
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,37338,-0.00548249110820238,0.00437354793720952,-0.014054645065133,0.00308966284872829,0.210024856104372
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HSP90B1,Endoplasmin,39405,-0.0081856015027826,0.00653643858900817,-0.0209970211372386,0.00462581813167341,0.210478324848625
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,37039,-0.012209266204587,0.0097942475950773,-0.0314059914909386,0.00698745908176446,0.212575453544144
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,S100A3,Protein S100-A3,37368,0.00548003089555757,0.00439698377267688,-0.00313805729888911,0.0140981190900042,0.212670046844866
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,37021,-0.010574341965166,0.00849022994302573,-0.0272151926534964,0.00606650872316446,0.21298054817249
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLC1A4,Neutral amino acid transporter A,37039,-0.00620377213562299,0.00501123547848163,-0.016025793673447,0.003618249402201,0.215748279541218
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,37453,0.0022444384821766,0.00181562994984853,-0.00131419621952651,0.00580307318387972,0.216414445835248
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,36962,-0.0100327601186696,0.00814106706966065,-0.0259892515752045,0.00592373133786528,0.217835158195202
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDSN,Corneodesmosin,39992,0.0050439244540816,0.00410364310745287,-0.00299921603652603,0.0130870649446892,0.219039754282002
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,39862,0.00293085456352611,0.0023935128401782,-0.00176043060322317,0.00762213973027538,0.220781993167208
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGFL4,Insulin growth factor-like family member 4,37056,-0.00916596015366387,0.00748815573257695,-0.0238427453895147,0.00551082508218696,0.220951032261698
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",36942,0.00299641932979763,0.0024670432777225,-0.00183898549453846,0.00783182415413373,0.224548567528992
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDC25A,M-phase inducer phosphatase 1,36962,0.00492403344571813,0.00406406086194486,-0.0030415258436938,0.0128895927351301,0.225685754636505
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,37021,0.00845347812977374,0.00698198968655671,-0.00523122165587742,0.0221381779154249,0.226011101786928
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EPN1,Epsin-1,37169,-0.0050632669051891,0.00420903938768585,-0.0133129841050534,0.00318645029467516,0.229016795376827
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,36991,0.00380023319727971,0.00316640795337906,-0.00240592639134325,0.0100063927859027,0.230094318173504
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,36991,0.0056477936393796,0.00470718683600491,-0.00357829255919003,0.0148738798379492,0.230229521734814
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPRING1,SREBP regulating gene protein,36962,-0.0069953857384107,0.00583960773480408,-0.0184410168986267,0.00445024542180528,0.230969643180584
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,37411,0.00429918588205636,0.00359161529372321,-0.00274038009364114,0.0113387518577539,0.231325066360078
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",39587,-0.0139712680825341,0.0117582927771078,-0.0370175219256654,0.00907498576059716,0.234770402348475
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACRV1,Acrosomal protein SP-10,37056,-0.00843416940650053,0.0071109383724967,-0.0223716086165941,0.005503269803593,0.235610529229293
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,39585,-0.0071178253600133,0.00600348379858725,-0.0188846536052443,0.00464900288521771,0.235791967575259
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,36962,0.00628352891263262,0.00530116843576058,-0.00410676122145812,0.0166738190467234,0.235916327599986
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,37437,-0.0045749979577842,0.00386471665492124,-0.0121498426014298,0.00299984668586144,0.23651846065246
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NECTIN1,Nectin-1,37056,-0.00369881245140881,0.0031271072577317,-0.00982794267656295,0.00243031777374533,0.236900858884184
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LBP,Lipopolysaccharide-binding protein,39931,0.00664957362475016,0.00562812781075001,-0.00438155688431985,0.0176807041338202,0.237425825385673
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,37437,-0.015432009020304,0.0130921297435199,-0.041092583317603,0.0102285652769949,0.238528707542229
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LY75,Lymphocyte antigen 75,39866,-0.00441963419420031,0.00375072026057984,-0.0117710459049368,0.00293177751653617,0.238677491231827
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,37368,-0.00559920912462944,0.00475903468206274,-0.0149269171014724,0.00372849885221353,0.239398677227022
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,37043,0.00454393863972993,0.00386456491855035,-0.00303060860062876,0.0121184858800886,0.239697776316538
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,39885,-0.00304419465766408,0.00258930413699867,-0.00811923076618148,0.00203084145085332,0.239739997554654
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DPT,Dermatopontin,40052,0.00305037095889794,0.00260036813803676,-0.00204635059165412,0.00814709250944999,0.240791606003601
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GBA,Lysosomal acid glucosylceramidase,37039,-0.00601998516669975,0.00514306376716566,-0.0161003901503444,0.00406041981694494,0.241818709098673
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,39805,-0.00382547888498667,0.00326933811582824,-0.01023338159201,0.00258242382203667,0.241974973510736
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,INSL3,Insulin-like 3,37388,0.00826288733653377,0.00706630529236623,-0.00558707103650404,0.0221128457095716,0.242288763157636
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HBZ,Hemoglobin subunit zeta,37437,0.0119547500791582,0.0102780669494928,-0.00819026114184773,0.0320997613001641,0.244796332905174
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MORN4,MORN repeat-containing protein 4,36962,-0.00903350340979943,0.00777784283913244,-0.024278075374499,0.00621106855490015,0.245483874710307
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RALB,Ras-related protein Ral-B,37056,-0.00330872363571069,0.00285062926133618,-0.00889595698792961,0.00227850971650823,0.245785168308219
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,39489,-0.00726237329199809,0.00626899571070946,-0.0195496048849886,0.00502485830099245,0.246694553643334
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",37043,0.0036695996529444,0.00317011026156041,-0.00254381645971401,0.0098830157656028,0.247063734593908
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MLLT1,Protein ENL,36962,0.00801818581591434,0.00696068303173117,-0.00562475292627874,0.0216611245581074,0.249372852681603
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,36991,0.00703276686850117,0.00611350762967223,-0.00494970808565641,0.0190152418226588,0.250014406236381
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ERC2,ERC protein 2,37039,-0.00841957432858484,0.00731996950458699,-0.0227667145575753,0.00592756590040566,0.250074197250572
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CHGB,Secretogranin-1,39952,0.00439972058430913,0.00382830277748099,-0.0031037528595536,0.0119031940281719,0.250465293185296
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,37169,0.00960025793469283,0.00836926652665032,-0.00680350445754179,0.0260040203269274,0.251367219784133
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LCP1,Plastin-2,37437,-0.00522031900600765,0.00456930413655871,-0.0141761551136627,0.00373551710164742,0.253276481847859
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",37021,-0.00447710301417229,0.00392666579888277,-0.0121733679799825,0.00321916195163794,0.254232363387747
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,37437,0.00276980503449225,0.00243502117993265,-0.00200283647817574,0.00754244654716023,0.255354812801905
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEP164,Centrosomal protein of 164 kDa,39587,-0.00665839284461306,0.00587613648410949,-0.0181756203534677,0.00485883466424153,0.25717934568519
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TFRC,Transferrin receptor protein 1,39918,0.00429690845899512,0.0037966828059795,-0.0031445898407247,0.0117384067587149,0.257755048459126
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,37056,0.00457599710581656,0.00405967343573254,-0.00338096282821921,0.0125329570398523,0.259685380525862
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OMP,Olfactory marker protein,36991,0.00531344193611006,0.00474892279058228,-0.0039944467334312,0.0146213306056513,0.263214750087859
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,39868,0.00304350680784082,0.00272305487899828,-0.00229368075499581,0.00838069437067745,0.263720016863196
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,37411,-0.00324731597287216,0.00290644849117417,-0.00894395501557353,0.0024493230698292,0.263894549883379
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,37169,-0.00474631901047197,0.00425006033726453,-0.0130764372715105,0.00358379925056651,0.264114940078951
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AMY2A,Pancreatic alpha-amylase,39246,-0.00507785824971454,0.00456711892852503,-0.0140294113496236,0.00387369485019451,0.266228772383716
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,37021,0.00775521260054643,0.00697888789629011,-0.00592340767618219,0.021433832877275,0.26648577623532
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPM1A,Protein phosphatase 1A,39477,-0.0032888874560592,0.00296334663515569,-0.00909704686096436,0.00251927194884595,0.267078257726179
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLK4,Kallikrein-4,40030,0.00647162614220849,0.00583489453901356,-0.00496476715425809,0.0179080194386751,0.267392849826151
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FBLN2,Fibulin-2,37437,0.0032639118886678,0.00294654826481952,-0.00251132271037847,0.00903914648771407,0.268008035283641
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,37039,-0.00317889701043783,0.00287528711421357,-0.00881445975429644,0.00245666573342077,0.268922947702064
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IFNL2,Interferon lambda-2,36991,-0.00669178578827326,0.00605281988009285,-0.0185553127532552,0.00517174117670873,0.268935102945721
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,39904,0.00688349776872609,0.00624174384739381,-0.00535032017216578,0.019117315709618,0.270123426124957
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,37169,0.00672759764576509,0.00610597810081913,-0.00524011943184041,0.0186953147233706,0.270566349259748
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,39477,0.00371183170553362,0.00338477347125095,-0.00292232429811824,0.0103459877091855,0.27282168259089
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",37056,-0.00533664394728259,0.0049071591176543,-0.014954675817885,0.00428138792331984,0.276826003625627
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,39908,0.00941130401483443,0.008699585877942,-0.00763988430593189,0.0264624923356007,0.279352961280144
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CXCL14,C-X-C motif chemokine 14,39587,-0.00645851132568956,0.00599582647122103,-0.0182103312092828,0.00529330855790365,0.281421821345059
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ENG,Endoglin,40052,0.0017702373653336,0.00164370288164216,-0.00145142028268503,0.00499189501335223,0.281504638295784
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,36991,0.0076858405383792,0.00716076289502862,-0.0063492547358769,0.0217209358126353,0.283144125041155
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,37021,0.00331063297007631,0.00308603135219183,-0.00273798848021967,0.00935925442037229,0.283389468880186
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,36962,-0.00309656666658177,0.00289095109763239,-0.00876283081794126,0.00256969748477772,0.284133476421649
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,36991,0.004478559877205,0.00418335812261594,-0.00372082204312223,0.0126779417975322,0.284384412971449
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NTF3,Neurotrophin-3,39866,0.00348989653303383,0.0032669952926441,-0.0029134142405486,0.00989320730661626,0.285433693026048
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VIT,Vitrin,37437,-0.00379724234704195,0.00358409318679261,-0.0108220649931555,0.00322758029907157,0.289404233924803
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,37169,0.00894423975565781,0.00845612297365148,-0.00762976127269908,0.0255182407840147,0.290200728272599
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PCDHB15,Protocadherin beta-15,37368,-0.00408015353046854,0.00387158114143807,-0.0116684525676872,0.00350814550675007,0.291960069829151
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UNG,Uracil-DNA glycosylase,37368,0.0035598172222158,0.00337907398442563,-0.00306316778725844,0.01018280223169,0.292135783490962
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,37437,-0.00261591214177591,0.00248434908743212,-0.00748523635314286,0.00225341206959105,0.292379553367361
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TEX101,Testis-expressed protein 101,37039,0.00498801187366461,0.0047471334393836,-0.00431636966752725,0.0142923934148565,0.293396426007443
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL5,Interleukin-5,39587,-0.0146724008754069,0.0140009807754924,-0.0421143231953721,0.0127695214445583,0.294675343725056
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLK1,Kallikrein-1,39720,0.0126770750299281,0.0121858471648182,-0.0112071854131156,0.0365613354729719,0.298211134343827
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IMPA1,Inositol monophosphatase 1,39749,-0.00617169215608855,0.00595192791088903,-0.017837470861431,0.00549408654925395,0.299787429103685
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EDNRB,Endothelin receptor type B,37056,-0.0046985923871219,0.00454548556250104,-0.0136077440896239,0.00421055931538014,0.301303199110631
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITGB6,Integrin beta-6,39587,0.00297380526500218,0.00287892866146623,-0.00266889491147162,0.00861650544147598,0.30164059648833
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,37039,-0.00514610603475968,0.00498437553051536,-0.0149154820745698,0.00462327000505042,0.301881477382323
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL33,Interleukin-33,39587,-0.00390238734575124,0.00379831374419169,-0.0113470822843669,0.00354230759286446,0.304247976678501
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CNPY2,Protein canopy homolog 2,39585,-0.00599131501913955,0.00583192889378798,-0.017421895650964,0.0054392656126849,0.304280942246713
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,36991,0.00490653037462453,0.00477656791783247,-0.00445554274432712,0.0142686034935762,0.304341295879357
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",37021,0.00850702254231204,0.00828526162059754,-0.00773209023405913,0.0247461353186832,0.304549669078623
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",37056,0.00351225491779006,0.00345160525833463,-0.00325289138854582,0.0102774012241259,0.308900323408892
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AMY2B,Alpha-amylase 2B,38832,-0.00472990918636296,0.00466662194214972,-0.0138764881929764,0.00441666982025048,0.310808328324086
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,37169,-0.00722007016395257,0.00713805959565155,-0.0212106669714296,0.00677052664352447,0.3118007376626
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SEPTIN3,Neuronal-specific septin-3,37411,-0.00753569438390135,0.00745264695228435,-0.0221428824103787,0.00707149364257597,0.311965880047703
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FAM171A2,Protein FAM171A2,37411,-0.015513530904304,0.0153434771037193,-0.0455867460275937,0.0145596842189858,0.311994695145378
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NLGN2,Neuroligin-2,36991,0.00463472862246155,0.00460452082842878,-0.00439013220125885,0.0136595894461819,0.314164589162842
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,37437,-0.00261258332307734,0.00260666697015533,-0.00772165058458179,0.00249648393842712,0.316231214490432
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,37021,-0.0057390496825909,0.00573626227124052,-0.0169821237342223,0.00550402436904052,0.317093798240774
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PALM,Paralemmin-1,37299,0.00277224124636789,0.00277303762850932,-0.00266291250551038,0.00820739499824616,0.317467509431574
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,37039,-0.00501750771210501,0.00503975306320468,-0.0148954237159862,0.00486040829177617,0.31946960710482
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CYTH3,Cytohesin-3,36962,-0.00701283025884924,0.00705269116640941,-0.0208361049450117,0.00681044442731321,0.320071775571662
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,37022,0.00376842796350248,0.0037949102435048,-0.00366959611376692,0.0112064520407719,0.320717667621267
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DCUN1D2,DCN1-like protein 2,36962,0.00776905212665727,0.00784196032325313,-0.00760119010691887,0.0231392943602334,0.321849014048255
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,37039,-0.00512033062356174,0.00518199279226363,-0.0152770364963985,0.00503637524927497,0.32312148094608
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RELB,Transcription factor RelB,37056,0.00472551183552904,0.00479355213734192,-0.00466985035366113,0.0141208740247192,0.324246458916239
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,37169,-0.0050142455475225,0.00508916316409958,-0.0149890053491577,0.00496051425411267,0.324504960469666
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ZNF174,Zinc finger protein 174,37056,0.00366381115743077,0.00372143664144011,-0.00363020465979185,0.0109578269746534,0.324880283034577
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL2,Interleukin-2,39587,0.00297588136324357,0.00302375267542022,-0.00295067388058007,0.0089024366070672,0.325047936484591
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STX5,Syntaxin-5,37056,-0.00389331670259436,0.00396858347320689,-0.0116717403100799,0.00388510690489114,0.326593788674693
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLNS1A,Methylosome subunit pICln,37039,-0.00320536827141242,0.00328795641966045,-0.0096497628539469,0.00323902631112206,0.329636878904694
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLSPN,Claspin,39453,-0.0032524364653655,0.00334210265785795,-0.00980295767476708,0.00329808474403608,0.330483554153836
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,40002,-0.00440060114060739,0.00454144031510386,-0.013301824158211,0.00450062187699618,0.332565697622903
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LRP2BP,LRP2-binding protein,37039,-0.00752925743187614,0.00778444332014436,-0.0227867663393591,0.00772825147560682,0.333452574742842
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TP53BP1,TP53-binding protein 1,37056,-0.0082730747112998,0.00857268566580175,-0.0250755386162712,0.00852938919367163,0.334537195958341
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RSPO1,R-spondin-1,39749,-0.00330358577114027,0.00342338881485406,-0.0100134278482542,0.00340625630597369,0.334557221284229
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLC13A1,Solute carrier family 13 member 1,37368,-0.00560883225468722,0.00582581940029233,-0.0170274382792602,0.00580977376988575,0.335688110073732
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TMEM25,Transmembrane protein 25,37411,0.00419672565834913,0.00437028157637664,-0.00436902623134908,0.0127624775480473,0.336927800844637
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,39585,-0.0031071812612339,0.00324147058345239,-0.00946046360480059,0.00324610108233279,0.337789402264621
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,39585,-0.00726301324499806,0.00758817551014897,-0.02213583724489,0.00760981075489392,0.338506859341391
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,37021,-0.00376353655031734,0.00394368985947848,-0.0114931686748952,0.00396609557426048,0.339939927500569
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,THPO,Thrombopoietin,39585,-0.00351747259353007,0.00369029790379804,-0.0107504564849742,0.00371551129791409,0.340519783515795
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,36991,0.00543592164030906,0.00573710391102615,-0.00580880202530219,0.0166806453059203,0.343400099933473
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SFRP1,Secreted frizzled-related protein 1,39689,0.0039007252041473,0.00412162176384323,-0.00417765345298544,0.01197910386128,0.343956285248212
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BGLAP,Osteocalcin,37437,-0.00794223581501891,0.00841929558153997,-0.0244440551548372,0.00855958352479942,0.345525172964278
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,40058,-0.00313601514525124,0.00333276898767876,-0.00966824236110162,0.00339621207059913,0.3467374160252
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MYOM2,Myomesin-2,37021,-0.00469381613723262,0.00502024495566862,-0.0145334962503431,0.00514586397587788,0.349817043089894
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,37039,0.0032679413551953,0.00349542574524744,-0.00358309310548968,0.0101189758158803,0.349846965874665
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SKIV2L,Helicase SKI2W,37021,0.00366311056618215,0.00392309158745862,-0.00402614894523675,0.011352370077601,0.350460018814876
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CHIT1,Chitotriosidase-1,39906,-0.0136346786828881,0.0146104728661395,-0.0422712055005215,0.0150018481347453,0.35072420589323
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,37015,0.00361622558137574,0.00389154865022789,-0.00401120977307092,0.0112436609358224,0.352776058925057
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SAG,S-arrestin,36991,0.00482257216835697,0.00519156570436472,-0.00535289661219788,0.0149980409489118,0.352945331014421
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TCP11,T-complex protein 11 homolog,37169,-0.0053852159915349,0.00581976166404981,-0.0167919488530725,0.00602151687000273,0.354809632373812
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ZPR1,Zinc finger protein ZPR1,36991,-0.00868086284602593,0.00938144684576954,-0.0270684986637342,0.00970677297168236,0.35481523873552
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MEP1B,Meprin A subunit beta,39868,-0.0103375412288832,0.0111791145156125,-0.0322486056794838,0.0115735232217174,0.355125956569257
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNPO1,Transportin-1,37169,0.00319919788774757,0.00346081597536954,-0.00358400142397672,0.00998239719947186,0.355291906791303
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,36991,0.005234238838197,0.00570476618607439,-0.0059471028865088,0.0164155805629028,0.358886906799992
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL24,Interleukin-24,39587,-0.00418521021231933,0.00458185347179152,-0.0131656430170307,0.00479522259239205,0.361029541622525
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,37039,-0.00921914676911429,0.0100964285574293,-0.0290081467416758,0.0105698532034472,0.361201557005011
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,36962,0.00328366023908149,0.0036223253978904,-0.00381609754078369,0.0103834180189467,0.364684683563879
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C7,Complement component C7,37149,-0.00283549545034203,0.00312889582206916,-0.00896813126159758,0.00329714036091352,0.364831202413009
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,40052,0.00275900512430924,0.00306634317841634,-0.00325102750538678,0.00876903775400526,0.368255779150127
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TPM3,Tropomyosin alpha-3 chain,37021,0.00386834256854688,0.00432470751292307,-0.00460808415678235,0.0123447692938761,0.371084179946524
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,36991,-0.00347395874398917,0.00388939672516762,-0.0110971763253177,0.00414925883733935,0.371773386692804
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,37169,-0.00683728303048473,0.00765569677094139,-0.0218424487015299,0.00816788264056039,0.371821152948054
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,36975,0.00300371904000104,0.00336373383496581,-0.00358919927653194,0.00959663735653402,0.371888725486065
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,39351,0.00733603280759591,0.00823973425332988,-0.00881384632893065,0.0234859119441225,0.373305787359064
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,39587,0.00309006636885496,0.00347850795711028,-0.00372780922708118,0.0099079419647911,0.374376327873686
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RAP1A,Ras-related protein Rap-1A,37056,0.00586578796207137,0.00662659226615093,-0.00712233287958445,0.0188539088037272,0.376070720695983
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRX,Cone-rod homeobox protein,39585,-0.00924668938135141,0.0104684067036626,-0.0297647665205301,0.0112713877578273,0.377090506840404
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BTNL10,Butyrophilin-like protein 10,36962,0.00339916436481271,0.00385006099155791,-0.0041469551786408,0.0109452839082662,0.377314148782517
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCGB1A1,Uteroglobin,39903,0.00468301858808513,0.00530796058805715,-0.00572058416450689,0.0150866213406771,0.37764768072487
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL9,Interleukin-9,37169,0.00491763254089919,0.00559676155143367,-0.0060520200999108,0.0158872851817092,0.37960325635319
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,37368,-0.00311516049154368,0.0035466007801443,-0.0100664980206265,0.00383617703753915,0.379768867000233
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,37021,0.00544758182191658,0.00620360812594337,-0.00671149010493243,0.0176066537487656,0.379888555731679
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BMP4,Bone morphogenetic protein 4,39720,0.00389368529375564,0.00445902013010535,-0.00484599416125085,0.0126333647487621,0.382558872664578
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BLMH,Bleomycin hydrolase,40052,-0.00269297998736665,0.00310449233719803,-0.00877778496827479,0.00339182499354149,0.38571044891193
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,36962,-0.00442890185231901,0.00515905068065782,-0.0145406411864083,0.00568283748177031,0.390647450952775
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NEB,Nebulin,37021,-0.00312674532478883,0.00365842593169653,-0.010297260150914,0.00404376950133638,0.392749657262802
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MDM1,Nuclear protein MDM1,37039,-0.00260414761495891,0.00305485402981746,-0.00859166151340113,0.00338336628348332,0.393973096299889
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGF6,Fibroblast growth factor 6,37056,0.00339177609607166,0.00399417865077066,-0.00443681405943883,0.0112203662515821,0.395796618873967
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,37039,-0.00304595152814401,0.00359486591734114,-0.0100918887261326,0.00399998566984463,0.396839959266208
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TCN2,Transcobalamin-2,40012,-0.00238745813342155,0.00283648593421533,-0.00794697056448359,0.0031720542976405,0.399970743609804
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,36991,0.00541986151304748,0.0064471042691506,-0.00721646285448769,0.0180561858805827,0.40055036680392
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PAPPA,Pappalysin-1,39587,0.00386974299205739,0.00460499012595603,-0.00515603765481643,0.0128955236389312,0.400732309011269
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NLGN1,Neuroligin-1,37039,-0.00547501766500213,0.00656796918798755,-0.0183482372734577,0.00739820194345346,0.404525090609571
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GNLY,Granulysin,39858,-0.00411904780782927,0.00494156149915307,-0.0138045083461693,0.00556641273051074,0.404546004068653
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,39477,0.00400197818050996,0.0048043016075131,-0.00541445297021571,0.0134184093312356,0.404858061939857
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SNAP25,Synaptosomal-associated protein 25,36991,0.00383021215945201,0.00461894030313554,-0.00522291083469366,0.0128833351535977,0.406983430836894
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,37021,0.00321022004784989,0.00387163466524819,-0.00437818389603657,0.0107986239917363,0.407026655964858
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,39990,-0.00500003916858061,0.00603054894917494,-0.0168199151089635,0.00681983677180226,0.407049675082162
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,39990,-0.00323138592710424,0.00389938905749959,-0.0108741884798034,0.00441141662559495,0.407291932149942
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GPR101,Probable G-protein coupled receptor 101,36991,0.00505222008822666,0.00612153454327722,-0.00694598761659669,0.01705042779305,0.409205378410784
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,39892,0.00280040975336761,0.00342470484784653,-0.00391201174841159,0.00951283125514681,0.413535893098926
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL24,C-C motif chemokine 24,39908,-0.00651987485380762,0.00800022219994061,-0.0222003103656912,0.00916056065807597,0.415106315389066
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLPS,Colipase,39836,0.00542399842096079,0.00671220044149544,-0.00773191444437027,0.0185799112862919,0.419056262967301
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,37368,0.00600646658233119,0.00747134116461737,-0.00863736210031885,0.0206502952649812,0.421449132213236
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,37169,-0.00306129251628678,0.00384436625198597,-0.0105962503701793,0.00447366533760572,0.425868311218652
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CHP1,Calcineurin B homologous protein 1,36991,-0.00561091538544874,0.00708990177514768,-0.0195071228647382,0.0082852920938407,0.428727609877667
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGF3,Fibroblast growth factor 3,37056,0.00236715110651204,0.00299985341964198,-0.00351256159598625,0.00824686380901033,0.430074211871776
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,37021,-0.00504523569656139,0.00639391643820513,-0.0175773119154435,0.00748684052232067,0.43008640087854
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ENSA,Alpha-endosulfine,37368,-0.00403704813490008,0.00511970029631151,-0.0140716607156706,0.00599756444587047,0.430399355617744
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,37169,-0.00310802641769147,0.00394184122243391,-0.0108340352136619,0.00461798237827899,0.430435457929075
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COPE,Coatomer subunit epsilon,39489,-0.00361363201621445,0.00459059419936654,-0.0126111966469729,0.00538393261454397,0.431187410511698
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MB,Myoglobin,40052,-0.00393554918890026,0.00503038441147491,-0.0137951026353911,0.00592400425759056,0.434017086663326
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KHDC3L,KH domain-containing protein 3,36962,0.00506684964576516,0.00648375121012289,-0.0076413027260757,0.017775002017606,0.434540907193018
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,40052,-0.00526110835685553,0.00676908905443976,-0.0185285229035575,0.00800630618984639,0.437037118042098
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,37056,0.00454974665199993,0.00586259051841862,-0.00694093076410056,0.0160404240681004,0.437724985700253
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,37169,-0.00496687345084845,0.00640266413398707,-0.0175160951534631,0.00758234825176621,0.43790977296904
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,40009,0.00529639272167761,0.00687780273998074,-0.00818410064868464,0.0187768860920399,0.441269361902801
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CPLX2,Complexin-2,36962,0.00224020035432637,0.00292549184701605,-0.00349376366582509,0.00797416437447783,0.443837852839814
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",36962,0.00404166256156115,0.00533725998160054,-0.00641936700237591,0.0145026921254982,0.448911199320431
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLXDC2,Plexin domain-containing protein 2,37388,0.00197611435543094,0.0026133109235393,-0.00314597505470609,0.00709820376556796,0.449558830608644
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RAB39B,Ras-related protein Rab-39B,37021,-0.00652317979693243,0.00864573304159131,-0.0234688165584514,0.0104224569645865,0.450564335082923
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SHD,SH2 domain-containing adapter protein D,37002,-0.00609765813249787,0.00810391974281395,-0.0219813408284132,0.00978602456341747,0.451804073597929
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,39720,0.002406578272147,0.00320421018927027,-0.00387367369882274,0.00868683024311673,0.452623151771229
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TOP1,DNA topoisomerase 1,37382,-0.00833154343617838,0.0111013538383384,-0.0300901969593216,0.0134271100869649,0.452967909263793
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEP290,Centrosomal protein of 290 kDa,37169,-0.00380439903652781,0.00507112402378314,-0.0137438021231428,0.00613500405008715,0.453142557736896
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NEO1,Neogenin,37411,-0.00157922645108893,0.00210993919104669,-0.00571470726554045,0.00255625436336258,0.45418962824955
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,39585,0.00230502336021199,0.00308757097251362,-0.0037466157459147,0.00835666246633868,0.455346938058283
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,40052,-0.00163593301008824,0.00219624204772071,-0.00594056742362084,0.00266870140344435,0.456356114502127
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NTF4,Neurotrophin-4,39477,-0.00287095420593102,0.00385890651399318,-0.0104344109733576,0.00469250256149561,0.456898994030218
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,37169,0.00423362449255204,0.00570476602868336,-0.00694771692366735,0.0154149659087714,0.458027354986228
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,37368,-0.00604422548668799,0.00815704140248246,-0.0220320266355536,0.00994357566217763,0.458716890314693
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCNE1,G1/S-specific cyclin-E1,37056,-0.00689626206077601,0.00932319895304492,-0.0251697320087441,0.011377207887192,0.459502250249654
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,37388,-0.00275869431839234,0.00375370857892416,-0.0101159631330837,0.00459857449629901,0.462397904722247
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ZNF75D,Zinc finger protein 75D,37169,-0.00424010545897869,0.00578535467998951,-0.0155794006317581,0.00709918971380074,0.463630326186281
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,37039,-0.00271447072604848,0.00374585994312888,-0.0100563562145811,0.00462741476248413,0.468674183117663
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LEG1,Protein LEG1 homolog,36703,0.00494049084656822,0.00682790148022793,-0.00844219605467851,0.018323177747815,0.469340589038544
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLXDC1,Plexin domain-containing protein 1,39477,-0.00241424690620134,0.00333897250003441,-0.00895863300626878,0.00413013919386609,0.46965947204513
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL31,Interleukin-31,37056,0.00404704040606347,0.00559935012896289,-0.0069276858467038,0.0150217666588307,0.469834217586601
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLSTN3,Calsyntenin-3,37388,-0.00212370636612869,0.00294849277195991,-0.00790275219917012,0.00365533946691275,0.471372160813719
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",37039,0.00540209363656839,0.00750640254850566,-0.0093104553585027,0.0201146426316395,0.471744169835762
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",37021,-0.0028625944277659,0.0039778461621261,-0.0106591729055331,0.00493398405000126,0.471762983165565
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,36991,-0.00304630981212833,0.00424193628261443,-0.0113605049260526,0.00526788530179594,0.472682918433553
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,36962,-0.00394006541151523,0.00549939865309026,-0.0147188867715721,0.00683875594854168,0.473723915798487
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BRD2,Bromodomain-containing protein 2,36991,0.00235342149793527,0.00330711252173587,-0.00412851904466704,0.00883536204053758,0.476710122389667
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TG,Thyroglobulin,37368,0.0075268993188034,0.0105865026245462,-0.0132226458253071,0.0282764444629139,0.477102602305437
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,37039,0.00251668029916238,0.00354753747312101,-0.00443649314815479,0.00946985374647955,0.478078832130678
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",37039,-0.00334046700901378,0.0047137188464674,-0.0125793559480899,0.00589842193006231,0.478542363777295
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DLGAP5,Disks large-associated protein 5,37411,0.00361258877287573,0.00512333353852862,-0.00642914496264036,0.0136543225083918,0.480744786493716
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,37124,-0.00267394513229416,0.00379479514050011,-0.0101117436076744,0.00476385334308606,0.481049839168794
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GH2,Growth hormone variant,39477,0.0112324548825816,0.0159476509062174,-0.0200249408936045,0.0424898506587676,0.481235997400313
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,37021,0.0038622210162701,0.00548496202125724,-0.00688830454539408,0.0146127465779343,0.481353525312005
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,37021,-0.00272413161597747,0.00386989803069753,-0.0103091317561446,0.00486086852418969,0.481489739605244
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,39489,-0.0033389890478253,0.00475382851012052,-0.0126564929276615,0.00597851483201093,0.48245333341728
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,37021,-0.0033355335909846,0.00477218451081727,-0.0126890152321865,0.00601794805021725,0.484593635646707
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GKN1,Gastrokine-1,39123,-0.00189662936187921,0.00272574647987412,-0.00723909246243248,0.00344583373867406,0.486552054437474
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",37043,-0.00476790885491057,0.00685520112815069,-0.0182041030660859,0.00866828535626479,0.486743627237624
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,37056,-0.00279612642022175,0.0040383027585278,-0.0107111998269362,0.00511894698649275,0.488697480355187
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RRP15,RRP15-like protein,36991,-0.00610554891606426,0.0088322441062562,-0.0234167473643264,0.0112056495321979,0.489402159357638
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,39489,-0.00265267973211507,0.00384224529783928,-0.0101834805158801,0.00487812105164991,0.489953979679782
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,37368,0.00384255013960305,0.00558395549954115,-0.00710200263949762,0.0147871029187037,0.491375650408764
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HMCN2,Hemicentin-2,37100,-0.00381000289427084,0.00554044110356713,-0.0146692674572624,0.00704926166872074,0.491671779959149
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RUVBL1,RuvB-like 1,39477,-0.00673022582507345,0.00985476002095357,-0.0260455554661425,0.0125851038159956,0.494653860483213
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,36991,-0.00480072580081413,0.00705185741743594,-0.0186223663389886,0.00902091473736031,0.496026093391201
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,37039,-0.00367592099990629,0.00540839937771343,-0.0142763837802246,0.00692454178041204,0.496726052869761
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TREML1,Trem-like transcript 1 protein,37445,-0.00350661780826369,0.00517204899229316,-0.0136438338331583,0.00663059821663091,0.49778709089415
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,39868,0.00184681451496646,0.0027328164604702,-0.00350950574755514,0.00720313477748806,0.499182706108497
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,37043,0.00385133098031095,0.00572526733102819,-0.00737019298850431,0.0150728549491262,0.501156221374313
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RBM19,Probable RNA-binding protein 19,37021,0.00311528883884194,0.00463282887494221,-0.00596505575604479,0.0121956334337287,0.501316887772571
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,37021,0.00337175448050697,0.00504271038424653,-0.00651195787261624,0.0132554668336302,0.503737306099159
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",39489,-0.00318313128812916,0.00480148501155583,-0.0125940419107786,0.00622777933452027,0.507374115013495
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,37039,0.00270488442531627,0.00408543968294363,-0.00530257735325323,0.0107123462038858,0.507932075094019
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,37043,0.00263521262708141,0.00398374782382982,-0.00517293310762504,0.0104433583617879,0.508309158863527
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,36962,0.0032259108330695,0.0048885703134618,-0.00635568698131563,0.0128075086474546,0.50933704948993
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,39489,-0.00345195344024744,0.00523716699968542,-0.0137168007596309,0.00681289387913599,0.509824510019045
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,37437,-0.0031742597053897,0.00483455063438421,-0.0126499789487828,0.00630145953800335,0.511463410733378
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,36962,-0.00381023845432959,0.00581257932729503,-0.0152028939358278,0.00758241702716867,0.5121471306558
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,37039,0.00237169038874901,0.00365943538944718,-0.00480080297456745,0.00954418375206548,0.516929742208851
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CORO6,Coronin-6,36991,-0.00238741355167224,0.00370278272732652,-0.00964486769723222,0.00487004059388775,0.519092702504451
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ZNF830,Zinc finger protein 830,37368,-0.00505579377304521,0.00785132361351083,-0.0204443880555264,0.010332800509436,0.519624247253355
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GSAP,Gamma-secretase-activating protein,39477,-0.00546918867502153,0.00853779287659321,-0.0222032627131442,0.0112648853631012,0.521801242314055
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CST6,Cystatin-M,39524,0.00291076703278869,0.00454959831896935,-0.00600644567239125,0.0118279797379686,0.52232141797644
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MYO6,Unconventional myosin-VI,37411,-0.00237195347257593,0.00372655333673308,-0.00967599801257276,0.0049320910674209,0.524460934338392
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",37021,0.00314217253308581,0.00495057928836379,-0.00656096287210722,0.0128453079382788,0.52562987458801
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",39826,-0.00335229553530692,0.00528340780988391,-0.0137077748426794,0.00700318377206553,0.525766957365083
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CXCL12,Stromal cell-derived factor 1,39587,-0.00243624307197973,0.00386866911332363,-0.010018834534094,0.00514634839013458,0.528875989399663
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OTOA,Otoancorin,36991,0.00324995115746094,0.00517568217508592,-0.00689438590570746,0.0133942882206293,0.530062609608423
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,37039,-0.00287848960469313,0.00460832682070207,-0.0119108101732692,0.00615383096388293,0.532226102856395
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,39794,0.00208198619479379,0.00333913131522697,-0.00446271118305106,0.00862668357263865,0.532957486590358
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,36962,-0.00259252745978636,0.00415992451123108,-0.0107459795017993,0.00556092458222655,0.533154077186832
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,37043,0.00161380569869919,0.00259450945816367,-0.0034714328393016,0.00669904423669998,0.533947349382336
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITGAX,Integrin alpha-X,37169,-0.00320431715158443,0.00516709077973433,-0.0133318150798637,0.00692318077669486,0.535176558642868
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EFNB2,Ephrin-B2,37039,-0.00364375650095991,0.00588071861951642,-0.0151699649952121,0.00788245199329227,0.535524796195393
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,37453,0.00112932322217809,0.00186749737882418,-0.00253097164031731,0.00478961808467348,0.545371518593759
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MN1,Transcriptional activator MN1,37039,0.00348976455417934,0.00577751860127789,-0.00783417190432531,0.014813701012684,0.545837546829908
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,40034,-0.00325716022642633,0.00540745162851278,-0.0138557654183114,0.00734144496545873,0.546951876666211
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VGF,Neurosecretory protein VGF,37411,-0.00171933177610624,0.00285613291248161,-0.00731735228457019,0.00387868873235772,0.547198247801144
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,39585,0.00193366215969476,0.00321539550470796,-0.00436851302953285,0.00823583734892237,0.547598151172696
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LMOD2,Leiomodin-2,36991,-0.003740602154993,0.00626552648543775,-0.016021034066451,0.00853982975646499,0.550508846391962
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACE,Angiotensin-converting enzyme,37445,-0.00148299619581057,0.0025011695614469,-0.0063852885362465,0.00341929614462536,0.553243829279703
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,36991,0.00173608778091379,0.00293310420186591,-0.00401279645474339,0.00748497201657097,0.553931533329325
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,37437,0.00196285766932309,0.00332547319254981,-0.00455506978807454,0.00848078512672072,0.555033459911271
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DSG3,Desmoglein-3,39964,-0.00190739503915928,0.00323311435205816,-0.00824429916919328,0.00442950909087472,0.555228461526282
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,37021,-0.00659675617038809,0.0112886565438654,-0.0287225229963643,0.0155290106555881,0.558981187156378
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,XG,Glycoprotein Xg,39985,0.00168678112448605,0.0029145208777902,-0.00402567979598274,0.00739924204495485,0.562765454937568
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINA1,Alpha-1-antitrypsin,37247,-0.000452508876318213,0.000788279137102663,-0.00199753598503943,0.00109251823240301,0.565945982600446
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",37139,-0.00358857712014158,0.00630045968689392,-0.0159374781064537,0.0087603238661705,0.568976399274378
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TMOD4,Tropomodulin-4,36962,0.00225878043672743,0.00397846064490525,-0.00553900242728686,0.0100565633007417,0.570212858160681
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,39829,-0.00485878888829609,0.00858373914332843,-0.0216829176092198,0.0119653398326276,0.571370648087406
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MMP15,Matrix metalloproteinase-15,37437,0.00272512229362719,0.00482645547798471,-0.00673473044322285,0.0121849750304772,0.572340317751846
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,37169,0.00368833386824641,0.00664400269716095,-0.00933391141818906,0.0167105791546819,0.578810065907162
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ECE1,Endothelin-converting enzyme 1,39489,-0.00186604862610474,0.00339308484239034,-0.0085164949171898,0.00478439766498031,0.582357157420413
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NRXN3,Neurexin-3,37039,-0.00187895228825851,0.00342519167554679,-0.00859232797233021,0.0048344233958132,0.583310894845539
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FOS,Proto-oncogene c-Fos,36931,-0.00187862289787986,0.00344607731088288,-0.00863293442721031,0.00487568863145059,0.585660885020297
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MYOM3,Myomesin-3,37124,0.00497973418559606,0.00913650874275011,-0.0129278229501942,0.0228872913213863,0.585737319434558
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BTLA,B- and T-lymphocyte attenuator,36962,-0.00459991319408998,0.00845964139571839,-0.021180810329698,0.0119809839415181,0.586624139902547
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PFDN2,Prefoldin subunit 2,39489,-0.00294285539307466,0.00541583871325999,-0.0135578992710642,0.00767218848491492,0.586876330188622
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,39477,-0.00304686298680131,0.00561052358161939,-0.0140434892067753,0.00794976323317269,0.587094763815146
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,37056,-0.00316207015299529,0.00585882693880215,-0.0146453709530475,0.00832123064705692,0.5894058354475
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,36962,-0.00169415910425104,0.00313946549396314,-0.0078475114724188,0.00445919326391673,0.589459341770356
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLK3,Prostate-specific antigen,37437,0.00410076034316624,0.00766141799574412,-0.0109156189284922,0.0191171396148247,0.592486993143079
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,39913,0.00509206581051111,0.00959421876363482,-0.0137126029662131,0.0238967345872353,0.595604127757378
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DUOX2,Dual oxidase 2,39585,-0.00365807882156228,0.0068986413115277,-0.0171794157921566,0.00986325814903201,0.595938632768493
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,37039,0.0035175214384842,0.00665066683053898,-0.0095177855493722,0.0165528284263406,0.596885424029402
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CR1,Complement receptor type 1,37420,-0.00183750941426346,0.00347749470283291,-0.00865339903181596,0.00497838020328904,0.597230142900971
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CA8,Carbonic anhydrase-related protein,37056,0.00133882415834604,0.00254212543748692,-0.00364374169912833,0.0063213900158204,0.598441745874488
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MTR,Methionine synthase,37021,0.00327973061932533,0.00627598636941739,-0.00902120266473275,0.0155806639033834,0.601272511623111
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITM2A,Integral membrane protein 2A,39866,0.00298348274322484,0.00573718915086229,-0.00826140799246525,0.0142283734789149,0.603053226472553
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,39949,0.00101847503696926,0.00196287008238501,-0.00282875032450535,0.00486570039844387,0.603858309470657
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HDAC8,Histone deacetylase 8,37056,-0.00319373396317898,0.00615842512081398,-0.0152642471999744,0.00887677927361643,0.604051270698527
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITGA2,Integrin alpha-2,37124,-0.0016946690673744,0.00328157650056628,-0.00812655900848431,0.00473722087373552,0.605570277252441
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FABP9,Fatty acid-binding protein 9,39866,0.00275711709062493,0.00536880439807325,-0.00776573952959864,0.0132799737108485,0.607577954572989
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,37411,0.00133743095779066,0.00261140591137269,-0.00378092462849982,0.00645578654408114,0.608554535250444
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,39477,-0.00626031635087928,0.0123176836401371,-0.0304029762855479,0.0178823435837894,0.611293540452597
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL25,Interleukin-25,36903,0.00169729173651683,0.0033468968934042,-0.0048626261745554,0.00825720964758905,0.612076390644756
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,37382,-0.0027272990719041,0.00540306831842419,-0.0133173129760155,0.00786271483220732,0.613729618760347
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NCLN,Nicalin,39587,-0.00256324586674207,0.00511515623231825,-0.0125889520820858,0.00746246034860169,0.616302108654317
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,37043,-0.00160501503007799,0.00320570355574451,-0.00788819399933723,0.00467816393918125,0.616608359216926
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,37021,0.00246562996450783,0.00495057249268718,-0.00723749212115903,0.0121687520501747,0.618457502420625
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PFDN4,Prefoldin subunit 4,36962,-0.00260760487096303,0.00530648845034624,-0.0130083222336417,0.0077931124917156,0.623152269193295
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TSPAN7,Tetraspanin-7,36991,0.0044966711988282,0.00920477150838298,-0.0135446809576024,0.0225380233552588,0.62519308880981
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",36991,-0.00218668787441354,0.00452877646172144,-0.0110630897393876,0.00668971399056047,0.629215287774848
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ROBO4,Roundabout homolog 4,37043,-0.000833967246966645,0.00174194830268214,-0.00424818592022364,0.00258025142629035,0.63212055193259
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AMIGO1,Amphoterin-induced protein 1,37039,-0.00233050195575082,0.00487598429117664,-0.011887431166457,0.0072264272549554,0.632690032323106
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,37056,0.00255688869491821,0.00537346816542709,-0.00797510890931888,0.0130888862991553,0.634199217082501
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,36991,-0.00254162135542145,0.0053434731336696,-0.0130148286974139,0.00793158598657097,0.634331878998176
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,36991,-0.00223889985745079,0.00474178648234741,-0.0115328013628517,0.00705500164795013,0.63681773262699
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,36430,-0.00237899114734344,0.00505058425302993,-0.0122781362832821,0.00752015398859522,0.637625443057436
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL17F,Interleukin-17F,39587,-0.00354166265923106,0.0075205424631755,-0.018281925887055,0.0111986005685929,0.637695964227395
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,37039,0.00187853880307227,0.00398914315844485,-0.00594018178747964,0.00969725939362417,0.637710760097351
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TRIM26,Tripartite motif-containing protein 26,36962,-0.00255580527745014,0.00544785070977231,-0.0132335926686039,0.00812198211370358,0.638977297329612
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],39788,0.00262057750721907,0.0055891120167089,-0.00833408204553037,0.0135752370599685,0.639167628013863
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PXDNL,Peroxidasin-like protein,37368,-0.00270587079785536,0.00579821099538359,-0.0140703643488072,0.00865862275309647,0.640741094963612
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,36962,-0.00262105624454973,0.00561696083552463,-0.013630299482178,0.00838818699307855,0.640770618806068
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HMMR,Hyaluronan mediated motility receptor,36942,0.0021523920024986,0.00463004794717489,-0.00692250197396418,0.0112272859789614,0.642028949418972
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NOS2,"Nitric oxide synthase, inducible",37021,0.00178373045894817,0.00385590042136963,-0.00577383436693631,0.00934129528483265,0.643660443960907
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KIF20B,Kinesin-like protein KIF20B,36991,0.00336684436960212,0.00733754656889468,-0.0110147469054315,0.0177484356446357,0.646348392067809
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",37021,0.00223903235819975,0.00488727074765297,-0.00734001830720007,0.0118180830235996,0.646862640452289
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MANSC1,MANSC domain-containing protein 1,39913,-0.00119758522415818,0.00261866121359322,-0.00633016120280088,0.00393499075448453,0.647442009508697
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SDC4,Syndecan-4,39868,-0.00199957085939307,0.00440296176794868,-0.0106293759245725,0.00663023420578634,0.64973261971723
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,37411,0.00146756613682411,0.00326979897760977,-0.00494123985929104,0.00787637213293926,0.653565386269317
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BRD1,Bromodomain-containing protein 1,37169,0.00134756412312906,0.00300754830225669,-0.00454723054929405,0.00724235879555218,0.654116701144435
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPM1B,Protein phosphatase 1B,37056,-0.00278213708423214,0.00621332632212451,-0.0149602566755962,0.0093959825071319,0.654327016615955
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,37021,0.00272411007868136,0.00608401993196409,-0.00920056898796826,0.014648789145331,0.654342169767975
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CAPS,Calcyphosin,37388,-0.003778987366825,0.00848124250205594,-0.0204022226708546,0.0128442479372046,0.655915002754851
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,39755,0.000988871171714735,0.00224445986695367,-0.00341027016751446,0.00538801251094393,0.659520803697829
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CASQ2,Calsequestrin-2,37021,-0.00207155888985086,0.00475189778992813,-0.01138527855811,0.00724216077840829,0.662884883002165
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KDM3A,Lysine-specific demethylase 3A,37056,0.00395373783693272,0.00907450958289946,-0.0138323009455502,0.0217397766194157,0.663063610467136
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,37056,-0.00193566498512057,0.00445274971899019,-0.0106630544343413,0.0067917244641002,0.663778391742604
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AHNAK2,Protein AHNAK2,37043,-0.00124559354647984,0.00286570477516876,-0.0068623749058106,0.00437118781285092,0.663819819370562
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RBM25,RNA-binding protein 25,36962,0.00191898107582322,0.00445420270700474,-0.00681125622990608,0.0106492183815525,0.666602838955666
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],39587,0.00226721693149833,0.00530778453659257,-0.00813604076022311,0.0126704746232198,0.669276367987145
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLC,Galectin-10,39841,0.00276118524284829,0.00646425330908613,-0.00990875124296052,0.0154311217286571,0.669278147595265
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,37169,0.00212059364775088,0.00497410940991784,-0.00762866079568809,0.0118698480911898,0.669876993166104
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PFDN6,Prefoldin subunit 6,37039,0.00273922929302539,0.0064428670177045,-0.00988879006167543,0.0153672486477262,0.670729251005854
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,36991,0.00243731850360538,0.00574307767443166,-0.00881911373828068,0.0136937507454914,0.671286616964912
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,37368,-0.00253066303762412,0.0059642462240754,-0.0142205856368119,0.00915925956156366,0.671349717149997
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITGB5,Integrin beta-5,39913,0.00154894033156358,0.00367780796417953,-0.0056595632782283,0.00875744394135546,0.673644935782993
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,37368,0.00181662383931955,0.00432594948540143,-0.00666223715206726,0.0102954848307064,0.674538563324256
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EPGN,Epigen,37368,0.00202340623699019,0.00486210764346107,-0.0075063247441935,0.0115531372181739,0.67730081515522
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ISM2,Isthmin-2,37437,0.00178003687741119,0.0043313160469097,-0.00670934257453183,0.0102694163293542,0.681101709221964
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LHB,Lutropin subunit beta,39477,-0.00350275869660904,0.00858628505257973,-0.0203318773996653,0.0133263600064472,0.683317368836228
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,37382,0.00671747324856438,0.0166075780553287,-0.02583337973988,0.0392683262370087,0.685864405470747
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NXPH1,Neurexophilin-1,39489,-0.00146810836788084,0.00364313652763353,-0.00860865596204256,0.00567243922628088,0.686969013116407
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,36991,0.00206562596639982,0.0051471435062914,-0.00802277530593134,0.012154027238731,0.688194741684267
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,36962,0.00355714028566848,0.00891280410244974,-0.013911955755133,0.02102623632647,0.6898227063169
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,37056,0.00168641862239277,0.00422657507241136,-0.00659766851953351,0.00997050576431904,0.689897016413207
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STX1B,Syntaxin-1B,37039,-0.00163266006951271,0.00414917189913091,-0.0097650369918093,0.00649971685278387,0.693963543311745
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,37021,-0.00187664757400622,0.00478513074548731,-0.0112555038351614,0.0075022086871489,0.694929255372832
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAPT,Microtubule-associated protein tau,39489,0.00196910520071518,0.00510880680543601,-0.00804415613793939,0.0119823665393698,0.699921524916554
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,39587,-0.00134456493703916,0.00352273524907073,-0.00824912602521779,0.00555999615113947,0.702702346064353
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,39749,0.00103330538284422,0.00273070325391605,-0.00431887299483124,0.00638548376051967,0.705136545745008
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,37411,0.00283625302595949,0.0075464991409451,-0.0119548852902929,0.0176273913422119,0.707044018493719
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,37039,-0.00281207920346639,0.00757303896398126,-0.0176552355728697,0.0120310771659369,0.710399431716816
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRC1,Protein regulator of cytokinesis 1,37368,0.00166787127646544,0.00449591493106464,-0.00714412198842126,0.0104798645413521,0.710662096647843
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EP300,Histone acetyltransferase p300,37056,0.00106512195004333,0.00288431907684318,-0.0045881434405693,0.00671838734065596,0.711924801118884
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPRR1B,Cornifin-B,37169,-0.00313932473491926,0.00856715257160708,-0.0199309437752691,0.0136522943054306,0.714044574273999
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,39866,0.00163087053194483,0.00446423279482124,-0.0071190257459048,0.0103807668097945,0.714877878260084
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HK2,Hexokinase-2,39585,-0.000965850188351927,0.00264547509920991,-0.00615098138280334,0.00421928100609949,0.715045274256905
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,37135,0.00180537468569129,0.0049519104446975,-0.00790036978591581,0.0115111191572984,0.715429671814473
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGF7,Fibroblast growth factor 7,36962,-0.00279845460266503,0.00776170434231216,-0.0180113951135969,0.0124144859082668,0.718444372294234
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,37039,0.00149574729188559,0.00417693288368974,-0.00669104116014629,0.00968253574391748,0.720276431098002
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CAPN3,Calpain-3,37368,-0.0013054812898035,0.00366775273617252,-0.00849427665270163,0.00588331407309463,0.721894859415082
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TBR1,T-box brain protein 1,37039,-0.00166212871219604,0.00470603658164956,-0.0108859604122292,0.00756170298783711,0.723951071494542
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGF16,Fibroblast growth factor 16,37056,-0.00166136622854788,0.00470751541492235,-0.0108880964417957,0.00756536398469993,0.72415566382798
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DCUN1D1,DCN1-like protein 1,36991,-0.00257817495679562,0.00732427771453021,-0.0169337592772748,0.0117774093636836,0.724840921187132
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRYBB2,Beta-crystallin B2,37388,-0.00193813074269842,0.00553503279499463,-0.0127867950208879,0.00891053353549105,0.726226291000469
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SUMF1,Formylglycine-generating enzyme,37056,-0.00232258543636697,0.00666317152128908,-0.0153824016180936,0.0107372307453596,0.727417292760999
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IKZF2,Zinc finger protein Helios,39477,-0.00316089299507701,0.00912465317440919,-0.021045213216919,0.014723427226765,0.729037475285598
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,37169,0.00114587312327578,0.00334907763753884,-0.00541831904630035,0.00771006529285191,0.732246512219812
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,39868,-0.00128764243637346,0.00379157093973174,-0.00871912147824767,0.00614383660550074,0.734157278177958
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TMEM132A,Transmembrane protein 132A,37043,-0.00205943295503462,0.00612364040316672,-0.0140617681452414,0.00994290223517215,0.736643515138862
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,37056,-0.00222759289639448,0.00666596614867868,-0.0152928865478047,0.0108377007550157,0.738253536061108
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,40052,-0.000505143520189434,0.00152025469576585,-0.0034848427238905,0.00247455568351164,0.739685474161925
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MYOM1,Myomesin-1,36991,0.00153135945298094,0.00463000216739414,-0.00754344479511157,0.0106061637010735,0.740840854162214
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,POMC,Pro-opiomelanocortin,37043,0.00226587423342176,0.00693355165215374,-0.0113238870047996,0.0158556354716431,0.743825487287619
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PSCA,Prostate stem cell antigen,37382,-0.00794001075815413,0.0247501483816026,-0.0564503015860953,0.0405702800697871,0.748361921023418
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,37043,-0.00113523928629179,0.00354091054923203,-0.00807542396278657,0.00580494539020299,0.74851361827886
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HMOX1,Heme oxygenase 1,39691,-0.00148001807605275,0.00462212536018745,-0.0105393837820202,0.00757934762991466,0.748818729288936
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,37021,0.00210663570689864,0.00658221743868761,-0.0107945104729291,0.0150077818867264,0.748935852075572
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDIA2,Protein disulfide-isomerase A2,36962,-0.00121800895472586,0.00387270874527645,-0.00880851809546771,0.00637250018601598,0.75313807813755
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",37056,-0.000910231676177347,0.00289750283230017,-0.00658933722748568,0.00476887387513099,0.753417019611532
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PCARE,Photoreceptor cilium actin regulator,36991,0.00261302966657366,0.00833086507707995,-0.013715465884503,0.0189415252176504,0.753786953513856
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,40009,-0.00141276103794499,0.00450750329926627,-0.0102474675045069,0.00742194542861689,0.753962377522961
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLK15,Kallikrein-15,37351,-0.00152030775251585,0.00490847137746489,-0.011140911652347,0.00810029614731534,0.756769999875923
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGF12,Fibroblast growth factor 12,37056,-0.00140043740658683,0.00456699605860337,-0.0103517496814494,0.00755087486827577,0.759119952524359
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,36991,0.00172642483075335,0.00563618062165654,-0.00932048918769347,0.0127733388492002,0.759372625429561
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EPHA10,Ephrin type-A receptor 10,39489,0.00190370497841291,0.00622401776306259,-0.0102953698371898,0.0141027797940156,0.759712024974096
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BRK1,Protein BRICK1,39489,-0.00129982083943131,0.00431970766600545,-0.00976644786480198,0.00716680618593936,0.763491080685336
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HIP1,Huntingtin-interacting protein 1,37021,-0.000974037393139077,0.00326866643128905,-0.00738062359846562,0.00543254881218746,0.765713752497
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",36962,-0.00146644008991686,0.00495005841587671,-0.0111685545850352,0.0082356744052015,0.767046132625561
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDH6,Cadherin-6,39868,-0.00107964175561649,0.00369129691663542,-0.00831458371222191,0.00615530020098893,0.769921113536704
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRR4,Proline-rich protein 4,37031,0.00198254458754411,0.00681217817318553,-0.0113693246318995,0.0153344138069877,0.771033365098815
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",37021,0.00109965136340081,0.00380047140860164,-0.0063492725974584,0.00854857532426002,0.772321138875976
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,37169,0.00184643139247565,0.00641263627959318,-0.010722335715527,0.0144151985004783,0.773399908053621
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,39801,-0.00501432099078501,0.0181300984779444,-0.0405493140075561,0.0305206720259861,0.78211051468643
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FH,"Fumarate hydratase, mitochondrial",36991,0.00223203770955862,0.00808026170918615,-0.0136052752404462,0.0180693506595635,0.782373195932419
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",36962,-0.00152301287063907,0.00553667479531018,-0.012374895469447,0.00932886972816888,0.783261283340969
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACTN2,Alpha-actinin-2,37021,-0.00157018965502323,0.00575594160734095,-0.0128518352054115,0.00971145589536502,0.785015408502537
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GJA8,Gap junction alpha-8 protein,36962,-0.00154689922088474,0.00582585725236108,-0.0129655794355125,0.00987178099374296,0.790610755000692
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",39064,0.000741273798052293,0.00281781178280123,-0.00478163729623812,0.00626418489234271,0.792502364842012
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TPBGL,Trophoblast glycoprotein-like,37039,0.00103606935324398,0.00395773356908418,-0.00672108844216102,0.00879322714864897,0.793492450326411
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL21R,Interleukin-21 receptor,37056,0.00137552443988777,0.00529808214007349,-0.00900871655465627,0.0117597654344318,0.795155664097234
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,37169,0.00181604171198772,0.00707126366737558,-0.0120436350760684,0.0156757185000439,0.797321724239222
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CPA4,Carboxypeptidase A4,36868,0.00108501207020226,0.00425108016868047,-0.00724710506041145,0.00941712920081598,0.798547883656313
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BCAM,Basal cell adhesion molecule,39858,0.000578765411856543,0.00228332626905674,-0.00389655407549467,0.00505408489920775,0.799904676427707
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,39477,-0.000793680647081828,0.00313620844827533,-0.00694064920570148,0.00535328791153782,0.800217359534754
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL1A,Interleukin-1 alpha,39587,0.00129762055435871,0.00518147976137085,-0.00885807977792816,0.0114533208866456,0.802254733897692
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RPA2,Replication protein A 32 kDa subunit,37056,0.000771784569813178,0.00311273801387426,-0.00532918193738037,0.00687275107700672,0.804181629245205
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",36991,0.00133939495990907,0.00548399556509637,-0.00940923634767982,0.012088026267498,0.807051041319254
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,36991,-0.00276040873598245,0.0113811929367097,-0.0250675468919335,0.0195467294199686,0.808364587690973
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",37411,0.00085303267425432,0.00352048987400643,-0.00604712747879828,0.00775319282730692,0.808547424026512
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,36991,0.00178867404625197,0.00749832075411425,-0.012908034631812,0.0164853827243159,0.811463471822534
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,37039,-0.00081690060095067,0.00343562129882523,-0.00755071834664812,0.00591691714474678,0.812060266294422
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GAGE2A,G antigen 2A,36962,-0.00140347083662403,0.00594900887080671,-0.0130635282234052,0.0102565865501571,0.813500958208903
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,40009,0.00058778341291674,0.00259867578852598,-0.00450562113259417,0.00568118795842766,0.821059821644067
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APOH,Beta-2-glycoprotein 1,39858,0.000770669140258941,0.00344324065913828,-0.00597808255165208,0.00751942083216996,0.822899543401989
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINF2,Alpha-2-antiplasmin,37224,0.000289533131867001,0.00131551233789523,-0.00228887105040764,0.00286793731414164,0.82580322779544
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,36991,0.00105435738524157,0.00479994580403938,-0.00835353639067562,0.0104622511611588,0.826139164269027
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FABP6,Gastrotropin,39564,0.00113900389968768,0.00523515904784955,-0.00912190783409744,0.0113999156334728,0.827768424684511
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,37348,-0.000864458769618212,0.00399530985334459,-0.00869526608217361,0.00696634854293719,0.828703874128011
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HDAC9,Histone deacetylase 9,36991,0.00129817360740737,0.00627464977778334,-0.011000139957048,0.0135964871718627,0.836097566035342
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TEF,Thyrotroph embryonic factor,37021,0.000842002926072097,0.00413318361991228,-0.00725903696895596,0.00894304282110016,0.838577209132936
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,39788,-0.000403838479618764,0.00199016951054303,-0.00430457072028311,0.00349689376104558,0.839202791862533
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,37056,-0.00179389061581584,0.00886662060360259,-0.0191724669988769,0.0155846857672452,0.839670042826201
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL20,Interleukin-20,39587,-0.000937707718866271,0.00473819591520406,-0.0102245717126662,0.00834915627493369,0.843122766261352
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FAM171B,Protein FAM171B,37368,-0.00052949262589058,0.00270028757252929,-0.00582205626804798,0.00476307101626682,0.844544633456505
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DNM1,Dynamin-1,37382,-0.00214722305287948,0.0111847534061517,-0.0240693397289368,0.0197748936231778,0.847762568727724
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MANSC4,MANSC domain-containing protein 4,37021,-0.00115782085695411,0.00607099178012249,-0.0130569647459942,0.010741323032086,0.848752904100216
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SHC1,SHC-transforming protein 1,36962,-0.00212009749901441,0.0112724985858915,-0.0242141947273617,0.0199739997293328,0.850819218470683
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SEPTIN7,Septin-7,37169,0.00093429293232384,0.00501538670728822,-0.00889586501396106,0.0107644508786087,0.852223855780087
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MTPN,Myotrophin,39585,0.000571088328546476,0.00313970395575497,-0.00558273142473327,0.00672490808182622,0.855669503255156
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAGEA3,Melanoma-associated antigen 3,37169,0.00148828922474223,0.0081871109605694,-0.0145584482579738,0.0175350267074583,0.855754679550855
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAG,Myelin-associated glycoprotein,37039,-0.00080411973616868,0.00450470739498958,-0.00963334623034826,0.0080251067580109,0.85832792835909
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CA11,Carbonic anhydrase-related protein 11,39477,-0.000540511945441153,0.0030440138777999,-0.00650677914592895,0.00542575525504665,0.859066498209723
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,36991,-0.00130758153291352,0.00742083194974873,-0.015852412154421,0.013237249088594,0.860136262277736
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ESR1,Estrogen receptor,37056,0.00101782936169459,0.0057935667294737,-0.0103375614280739,0.012373220151463,0.860545934332391
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SOX9,Transcription factor SOX-9,37039,0.000463062139934061,0.00263800385562426,-0.0047074254170895,0.00563354969695762,0.860661928803937
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRG2,Bone marrow proteoglycan,37437,-0.000858807525278907,0.0049366511651384,-0.0105346438089502,0.00881702875839237,0.861895083928801
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,37382,0.00138668429212642,0.00820331091550507,-0.0146918051022635,0.0174651736865164,0.865768031671693
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VWF,von Willebrand factor,40052,-0.00117790308646933,0.00708960981716269,-0.0150735383281082,0.0127177321551695,0.868044930950633
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,37039,0.000881710580892104,0.00531036888884936,-0.00952661244125265,0.0112900336030369,0.868131437285906
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MELTF,Melanotransferrin,37437,0.000469440942141697,0.00283090540815706,-0.00507913365784613,0.00601801554212953,0.868295457755185
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,H2AP,Huntingtin-interacting protein M,36962,0.000809783543375976,0.00488580590032817,-0.00876639602126724,0.0103859631080192,0.868362500565864
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,37382,0.002332436512959,0.0142118538605977,-0.0255227970538125,0.0301876700797305,0.869639847423975
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NRN1,Neuritin,37411,-0.000560635819155064,0.00343809668323865,-0.00729930531830281,0.00617803367999268,0.870469096809028
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,37124,-0.000590159621514292,0.00366072657146729,-0.00776518370159018,0.0065848644585616,0.87192747201609
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EXOSC10,Exosome component 10,37021,-0.000939854460097576,0.00594061223341211,-0.0125834544375853,0.0107037455173902,0.874295051453206
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,37169,-0.000950224918021333,0.00617971564525776,-0.0130624675827265,0.0111620177466839,0.877797242682427
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPON1,Spondin-1,39885,-0.000472406009681606,0.00309044741944381,-0.00652968295179147,0.00558487093242826,0.878510549636857
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,S100A13,Protein S100-A13,37056,-0.000495676038232677,0.00338868361457435,-0.0071374959227984,0.00614614384633304,0.883707387024477
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TGFBR1,TGF-beta receptor type-1,37056,-0.000307377619447944,0.00212227687725944,-0.00446704029887645,0.00385228505998056,0.884844234515133
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MSMB,Beta-microseminoprotein,39780,0.000902098589019104,0.00650447747254176,-0.0118466772571628,0.013650874435201,0.889697772777873
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,40052,-0.000299775529824601,0.00220159075273763,-0.00461489340519036,0.00401534234554116,0.891693999315516
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,37021,-0.000606111296652334,0.00451319728462692,-0.00945197797452109,0.00823975538121642,0.893169351286289
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TET2,Methylcytosine dioxygenase TET2,37161,-0.00129579192949362,0.00966352535430153,-0.0202363016239246,0.0176447177649374,0.893332632698101
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGLON5,IgLON family member 5,36962,0.00120561586406906,0.00899412377399501,-0.0164228667329612,0.0188340984610993,0.893369177595285
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HRAS,GTPase Hras,37161,0.00127916947623962,0.00955100751963088,-0.0174408052622369,0.0199991442147161,0.893459702065591
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TPT1,Translationally-controlled tumor protein,39587,0.000843948852699746,0.00633148093801041,-0.0115657537858007,0.0132536514912002,0.89396252396083
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",36962,-0.000622918007660109,0.00475810801920539,-0.00994880972530267,0.00870297370998246,0.895842846661142
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HLA_DRA,,39799,-0.00044939099906085,0.00344438302112673,-0.00720038172046924,0.00630159972234754,0.896195695364202
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HEBP1,Heme-binding protein 1,39585,-0.00065115867537023,0.0051987595315535,-0.0108407273572151,0.00953841000647463,0.900325097139566
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,37021,-0.00061067005644116,0.0049272949943412,-0.0102681682453499,0.0090468281324676,0.901367709030217
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",37056,0.000719996227463895,0.00583740095968473,-0.0107213096535182,0.012161302108446,0.901838227321652
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SHH,Sonic hedgehog protein,37056,0.000519408881518564,0.00425349633657244,-0.00781744393816343,0.00885626170120055,0.90281107245471
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDC123,Cell division cycle protein 123 homolog,36962,-0.000757696739595488,0.00620522344217655,-0.0129199346862615,0.0114045412070706,0.902816722537162
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDH4,Cadherin-4,36991,0.000550970901493493,0.00457231169289509,-0.00841076001658089,0.00951270181956787,0.904087651273264
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GFRA2,GDNF family receptor alpha-2,39788,0.000241247702331253,0.00202055530215211,-0.00371904068988689,0.00420153609454939,0.90496255508345
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPESP1,Sperm equatorial segment protein 1,37437,0.000338517837437675,0.00284283508057203,-0.00523343892048351,0.00591047459535886,0.905215678131465
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,39444,-0.000323634619167886,0.00274292775828497,-0.00569977302540643,0.00505250378707065,0.906078091960916
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLSTN1,Calsyntenin-1,39489,0.000565674346161061,0.00488566004855847,-0.00901021934901354,0.0101415680413357,0.907826340949212
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,40030,0.000655661640306644,0.00568543945159012,-0.01048779968481,0.0117991229654233,0.908190581510764
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,39866,-0.0010249951150362,0.00898919008153531,-0.0186438076748454,0.016593817444773,0.909219166195868
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,37149,-0.000585620027098868,0.00530460387200354,-0.0109826436162258,0.00981140356202807,0.912095052161499
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HRG,Histidine-rich glycoprotein,37380,-0.00031055770187156,0.00308613766468297,-0.00635938752465019,0.00573827212090706,0.919845758369509
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,39477,-0.000532678093051019,0.00530624801641034,-0.0109329242052153,0.00986756801911324,0.920038412638112
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,36962,0.000245810792556145,0.00255941666637427,-0.00477064587353742,0.00526226745864971,0.923488902533816
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL13,Interleukin-13,39587,-0.000453885847680445,0.00473034627801773,-0.00972536455259519,0.0088175928572343,0.923559974398465
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,37039,0.00071700086714291,0.00760782077387091,-0.0141943278496441,0.0156283295839299,0.924915783961621
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,37169,0.000702810717891303,0.00749800764666384,-0.0139932842695698,0.0153989057053524,0.925322669899918
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TSC1,Hamartin,37056,0.00067153137162314,0.00744804095498112,-0.0139266289001399,0.0152696916433861,0.92815973160414
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTTG1,Securin,37169,0.000367247229444011,0.00407869795950041,-0.00762700077117678,0.00836149523006481,0.928256536926357
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DENND2B,DENN domain-containing protein 2B,37021,0.000451709684219283,0.00502472713161264,-0.00939675549374149,0.0103001748621801,0.928370150143253
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",37056,-0.000236692549814107,0.00270748295647177,-0.00554335914449877,0.00506997404487056,0.930337710300016
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,36962,-0.000538603319821964,0.00619010017425859,-0.0126711996613688,0.0115939930217249,0.930664545890696
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEP152,Centrosomal protein of 152 kDa,36962,0.000351545763584674,0.00407064464528362,-0.00762691774117122,0.00833000926834057,0.931180607822808
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ICOSLG,ICOS ligand,39788,-0.000155503949609135,0.00183002237073278,-0.00374234779624538,0.00343133989702711,0.932283290202888
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MUC2,Mucin-2,37437,-0.000738595259164731,0.00878169205507477,-0.0179507116871113,0.0164735211687818,0.932973188987472
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TAP1,Antigen peptide transporter 1,37169,-0.000474129743830636,0.00574929877667387,-0.0117427553461114,0.0107944958584502,0.934276278176379
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ALMS1,Alstrom syndrome protein 1,37169,-0.000358792967284926,0.00437739538731762,-0.00893848792642746,0.0082209019918576,0.934675822909472
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDCL2,Phosducin-like protein 2,36962,-0.000416353396891401,0.00517990787777012,-0.0105689728373208,0.00973626604353804,0.935937427389752
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLC44A4,Choline transporter-like protein 4,37039,0.000521904380285508,0.00661960890328284,-0.0124525290701489,0.0134963378307199,0.93715935262909
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DEFB116,Beta-defensin 116,36991,-0.000571129133397168,0.00756053329442896,-0.0153897743904779,0.0142475161236836,0.939785545244265
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CPB2,Carboxypeptidase B2,37424,0.000165349944256838,0.0022010890043626,-0.00414878450429386,0.00447948439280753,0.940118847045394
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CASP4,Caspase-4,37169,0.00119797614889908,0.0161118006914784,-0.0303811532063985,0.0327771055041967,0.940729861135272
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PYDC1,Pyrin domain-containing protein 1,37043,0.000291895885742275,0.00403288789808523,-0.00761256439450478,0.00819635616598933,0.942301494665244
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,37169,0.000286323941964747,0.00405607951986914,-0.00766359191697877,0.00823623980090827,0.943724092259472
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,36962,-0.00043191422724408,0.00621242571826692,-0.0126082686350472,0.0117444401805591,0.9445733931264
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DCC,Netrin receptor DCC,37039,0.000150182928016556,0.00220786114454641,-0.00417722491529442,0.00447759077132753,0.945769226390788
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UBQLN3,Ubiquilin-3,37021,0.000304795166477787,0.0045792907463128,-0.00867061469629531,0.00928020502925088,0.946933423172452
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLK12,Kallikrein-12,39477,0.000798709287972409,0.0133653070508835,-0.0253972925317593,0.0269947111077041,0.952347635719193
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,37043,-0.00136793696063067,0.0252162464700304,-0.0507917800418902,0.0480559061206289,0.956738210243275
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KCNIP4,Kv channel-interacting protein 4,39489,0.000272737787541096,0.00509065737759329,-0.00970495067254175,0.0102504262476239,0.957273549107091
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BRD3,Bromodomain-containing protein 3,37021,0.000228552019585423,0.00452079063316031,-0.00863219762140878,0.00908930166057963,0.959680280975965
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ENPEP,Glutamyl aminopeptidase,37021,0.000192910486101785,0.00408208394149172,-0.00780797403922199,0.00819379501142556,0.962308443176419
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TLR4,Toll-like receptor 4,37056,-0.000105436816422979,0.0026870879372,-0.00537212917333498,0.00516125554048902,0.96870097576264
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLK6,Kallikrein-6,39889,-0.000108051220553388,0.00286531091956438,-0.00572406062289958,0.00550795818179281,0.969919276213553
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FOLR3,Folate receptor gamma,39858,-0.000654094270191491,0.0183339421038007,-0.0365886207936409,0.035280432253258,0.971540606810019
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TCN1,Transcobalamin-1,37235,-0.000112342471773885,0.00333419853551948,-0.00664737160139206,0.00642268665784429,0.973121669619722
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PVALB,Parvalbumin alpha,39971,0.000307304249285707,0.011071248439106,-0.0213923426913621,0.0220069511899335,0.977856333913178
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OSTN,Osteocrin,37039,-0.00010847444901735,0.00408298000987006,-0.00811111526836267,0.00789416637032797,0.978805121508138
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,37039,-0.000122735937937214,0.00471810303129547,-0.00937021787927634,0.00912474600340191,0.97924669999051
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,39866,-9.55123425986153e-05,0.00397621182114759,-0.0078888875120479,0.00769786282685066,0.980836205858751
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,40058,7.70812315262776e-05,0.00356157975896593,-0.00690361509604695,0.00705777755909951,0.982733455817307
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,37039,0.000126891471303654,0.00629228216040271,-0.0122059815630857,0.012459764505693,0.983911089737178
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,39881,-8.97666717478005e-05,0.00478187098927567,-0.00946223381072811,0.0092827004672325,0.985022992603223
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PGR,Progesterone receptor,37056,-0.000138663152059582,0.0102368209619633,-0.0202028322375076,0.0199255059333884,0.989192767054746
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NINJ1,Ninjurin-1,39477,6.99383007383254e-05,0.00547641021799273,-0.0106638257265274,0.0108037023280041,0.989810792477258
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,39489,-6.00226801338371e-05,0.00823205959050893,-0.0161948594775313,0.0160748141172637,0.994182503317315
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TXK,Tyrosine-protein kinase TXK,37169,6.55146019888391e-06,0.00725172907515743,-0.0142068375271097,0.0142199404475075,0.999279177422683
